code,name
A0021,"Ambulance service, outside state per mile, transport (medicaid only)"
A0080,"Non-emergency transportation, per mile - vehicle provided by volunteer (individual or organization), with no vested interest"
A0090,"Non-emergency transportation, per mile - vehicle provided by individual (family member, self, neighbor) with vested interest"
A0100,Non-emergency transportation; taxi
A0110,"Non-emergency transportation and bus, intra or inter state carrier"
A0120,"Non-emergency transportation: mini-bus, mountain area transports, or other transportation systems"
A0130,Non-emergency transportation: wheelchair van
A0140,Non-emergency transportation and air travel (private or commercial) intra or inter state
A0160,Non-emergency transportation: per mile - case worker or social worker
A0170,"Transportation ancillary: parking fees, tolls, other"
A0180,Non-emergency transportation: ancillary: lodging-recipient
A0190,Non-emergency transportation: ancillary: meals-recipient
A0200,Non-emergency transportation: ancillary: lodging escort
A0210,Non-emergency transportation: ancillary: meals-escort
A0225,"Ambulance service, neonatal transport, base rate, emergency transport, one way"
A0380,Bls mileage (per mile)
A0382,Bls routine disposable supplies
A0384,Bls specialized service disposable supplies; defibrillation (used by als ambulances and bls ambulances in jurisdictions where defibrillation is permitted in bls ambulances)
A0390,Als mileage (per mile)
A0392,Als specialized service disposable supplies; defibrillation (to be used only in jurisdictions where defibrillation cannot be performed in bls ambulances)
A0394,Als specialized service disposable supplies; iv drug therapy
A0396,Als specialized service disposable supplies; esophageal intubation
A0398,Als routine disposable supplies
A0420,"Ambulance waiting time (als or bls), one half (1/2) hour increments"
A0422,"Ambulance (als or bls) oxygen and oxygen supplies, life sustaining situation"
A0424,"Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review)"
A0425,"Ground mileage, per statute mile"
A0426,"Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)"
A0427,"Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)"
A0428,"Ambulance service, basic life support, non-emergency transport, (bls)"
A0429,"Ambulance service, basic life support, emergency transport (bls-emergency)"
A0430,"Ambulance service, conventional air services, transport, one way (fixed wing)"
A0431,"Ambulance service, conventional air services, transport, one way (rotary wing)"
A0432,"Paramedic intercept (pi), rural area, transport furnished by a volunteer ambulance company which is prohibited by state law from billing third party payers"
A0433,"Advanced life support, level 2 (als 2)"
A0434,Specialty care transport (sct)
A0435,"Fixed wing air mileage, per statute mile"
A0436,"Rotary wing air mileage, per statute mile"
A0888,"Noncovered ambulance mileage, per mile (e.g., for miles traveled beyond closest appropriate facility)"
A0998,"Ambulance response and treatment, no transport"
A0999,Unlisted ambulance service
A2001,"Innovamatrix ac, per square centimeter"
A2002,"Mirragen advanced wound matrix, per square centimeter"
A2004,"Xcellistem, 1 mg"
A2005,"Microlyte matrix, per square centimeter"
A2006,"Novosorb synpath dermal matrix, per square centimeter"
A2007,"Restrata, per square centimeter"
A2008,"Theragenesis, per square centimeter"
A2009,"Symphony, per square centimeter"
A2010,"Apis, per square centimeter"
A2011,"Supra sdrm, per square centimeter"
A2012,"Suprathel, per square centimeter"
A2013,"Innovamatrix fs, per square centimeter"
A2014,"Omeza collagen matrix, per 100 mg"
A2015,"Phoenix wound matrix, per square centimeter"
A2016,"Permeaderm b, per square centimeter"
A2017,"Permeaderm glove, each"
A2018,"Permeaderm c, per square centimeter"
A2019,"Kerecis omega3 marigen shield, per square centimeter"
A2020,Ac5 advanced wound system (ac5)
A2021,"Neomatrix, per square centimeter"
A2022,"Innovaburn or innovamatrix xl, per square centimeter"
A2023,"Innovamatrix pd, 1 mg"
A2024,"Resolve matrix or xenopatch, per square centimeter"
A2025,"Miro3d, per cubic centimeter"
A2026,"Restrata minimatrix, 5 mg"
A2027,"Matriderm, per square centimeter"
A2028,"Micromatrix flex, per mg"
A2029,"Mirotract wound matrix sheet, per cubic centimeter"
A2030,"Miro3d fibers, per milligram"
A2031,"Mirodry wound matrix, per square centimeter"
A2032,"Myriad matrix, per square centimeter"
A2033,"Myriad morcells, 4 milligrams"
A2034,"Foundation drs solo, per square centimeter"
A2035,"Corplex p or theracor p or allacor p, per milligram"
A2036,"Cohealyx collagen dermal matrix, per square centimeter"
A2037,"G4derm plus, per milliliter"
A2038,"Marigen pacto, per square centimeter"
A2039,"Innovamatrix fd, per square centimeter"
A4100,"Skin substitute, fda cleared as a device, not otherwise specified"
A4206,"Syringe with needle, sterile, 1 cc or less, each"
A4207,"Syringe with needle, sterile 2 cc, each"
A4208,"Syringe with needle, sterile 3 cc, each"
A4209,"Syringe with needle, sterile 5 cc or greater, each"
A4210,"Needle-free injection device, each"
A4211,Supplies for self-administered injections
A4212,Non-coring needle or stylet with or without catheter
A4213,"Syringe, sterile, 20 cc or greater, each"
A4215,"Needle, sterile, any size, each"
A4216,"Sterile water, saline and/or dextrose, diluent/flush, 10 ml"
A4217,"Sterile water/saline, 500 ml"
A4218,"Sterile saline or water, metered dose dispenser, 10 ml"
A4220,Refill kit for implantable infusion pump
A4221,"Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs  separately)"
A4222,"Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)"
A4223,"Infusion supplies not used with external infusion pump, per cassette or bag (list drugs separately)"
A4224,"Supplies for maintenance of insulin infusion catheter, per week"
A4225,"Supplies for external insulin infusion pump, syringe type cartridge, sterile, each"
A4226,"Supplies for maintenance of insulin infusion pump with dosage rate adjustment using therapeutic continuous glucose sensing, per week"
A4230,"Infusion set for external insulin pump, non needle cannula type"
A4231,"Infusion set for external insulin pump, needle type"
A4232,"Syringe with needle for external insulin pump, sterile, 3 cc"
A4233,"Replacement battery, alkaline (other than j cell), for use with medically necessary home blood glucose monitor owned by patient, each"
A4234,"Replacement battery, alkaline, j cell, for use with medically necessary home blood glucose monitor owned by patient, each"
A4235,"Replacement battery, lithium, for use with medically necessary home blood glucose monitor owned by patient, each"
A4236,"Replacement battery, silver oxide, for use with medically necessary home blood glucose monitor owned by patient, each"
A4238,"Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service"
A4239,"Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service"
A4244,"Alcohol or peroxide, per pint"
A4245,"Alcohol wipes, per box"
A4246,"Betadine or phisohex solution, per pint"
A4247,"Betadine or iodine swabs/wipes, per box"
A4248,"Chlorhexidine containing antiseptic, 1 ml"
A4250,Urine test or reagent strips or tablets (100 tablets or strips)
A4252,"Blood ketone test or reagent strip, each"
A4253,"Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips"
A4255,"Platforms for home blood glucose monitor, 50 per box"
A4256,"Normal, low and high calibrator solution / chips"
A4257,"Replacement lens shield cartridge for use with laser skin piercing device, each"
A4258,"Spring-powered device for lancet, each"
A4259,"Lancets, per box of 100"
A4261,Cervical cap for contraceptive use
A4262,"Temporary, absorbable lacrimal duct implant, each"
A4263,"Permanent, long term, non-dissolvable lacrimal duct implant, each"
A4264,Permanent implantable contraceptive intratubal occlusion device(s) and delivery system
A4265,"Paraffin, per pound"
A4266,Diaphragm for contraceptive use
A4267,"Contraceptive supply, condom, male, each"
A4268,"Contraceptive supply, condom, female, each"
A4269,"Contraceptive supply, spermicide (e.g., foam, gel), each"
A4270,"Disposable endoscope sheath, each"
A4271,"Integrated lancing and blood sample testing cartridges for home blood glucose monitor, per 50 tests"
A4280,"Adhesive skin support attachment for use with external breast prosthesis, each"
A4281,"Tubing for breast pump, replacement"
A4282,"Adapter for breast pump, replacement"
A4283,"Cap for breast pump bottle, replacement"
A4284,"Breast shield and splash protector for use with breast pump, replacement"
A4285,"Polycarbonate bottle for use with breast pump, replacement"
A4286,"Locking ring for breast pump, replacement"
A4287,"Disposable collection and storage bag for breast milk, any size, any type, each"
A4288,"Valve for breast pump, replacement"
A4290,"Sacral nerve stimulation test lead, each"
A4300,"Implantable access catheter, (e.g., venous, arterial, epidural subarachnoid, or peritoneal, etc.) external access"
A4301,"Implantable access total catheter, port/reservoir (e.g., venous, arterial, epidural, subarachnoid, peritoneal, etc.)"
A4305,"Disposable drug delivery system, flow rate of 50 ml or greater per hour"
A4306,"Disposable drug delivery system, flow rate of less than 50 ml per hour"
A4310,Insertion tray without drainage bag and without catheter (accessories only)
A4311,"Insertion tray without drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)"
A4312,"Insertion tray without drainage bag with indwelling catheter, foley type, two-way, all silicone"
A4313,"Insertion tray without drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation"
A4314,"Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.)"
A4315,"Insertion tray with drainage bag with indwelling catheter, foley type, two-way, all silicone"
A4316,"Insertion tray with drainage bag with indwelling catheter, foley type, three-way, for continuous irrigation"
A4320,"Irrigation tray with bulb or piston syringe, any purpose"
A4321,Therapeutic agent for urinary catheter irrigation
A4322,"Irrigation syringe, bulb or piston, each"
A4326,"Male external catheter with integral collection chamber, any type, each"
A4327,"Female external urinary collection device; meatal cup, each"
A4328,"Female external urinary collection device; pouch, each"
A4330,"Perianal fecal collection pouch with adhesive, each"
A4331,"Extension drainage tubing, any type, any length, with connector/adaptor, for use with urinary leg bag or urostomy pouch, each"
A4332,"Lubricant, individual sterile packet, each"
A4333,"Urinary catheter anchoring device, adhesive skin attachment, each"
A4334,"Urinary catheter anchoring device, leg strap, each"
A4335,Incontinence supply; miscellaneous
A4336,"Incontinence supply, urethral insert, any type, each"
A4337,"Incontinence supply, rectal insert, any type, each"
A4338,"Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each"
A4340,"Indwelling catheter; specialty type, (e.g., coude, mushroom, wing, etc.), each"
A4341,"Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each"
A4342,"Accessories for patient inserted indwelling intraurethral drainage device with valve, replacement only, each"
A4344,"Indwelling catheter, foley type, two-way, all silicone or polyurethane, each"
A4346,"Indwelling catheter; foley type, three way for continuous irrigation, each"
A4349,"Male external catheter, with or without adhesive, disposable, each"
A4351,"Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each"
A4352,"Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each"
A4353,"Intermittent urinary catheter, with insertion supplies"
A4354,Insertion tray with drainage bag but without catheter
A4355,"Irrigation tubing set for continuous bladder irrigation through a three-way indwelling foley catheter, each"
A4356,"External urethral clamp or compression device (not to be used for catheter clamp), each"
A4357,"Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each"
A4358,"Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each"
A4360,"Disposable external urethral clamp or compression device, with pad and/or pouch, each"
A4361,"Ostomy faceplate, each"
A4362,"Skin barrier; solid, 4 x 4 or equivalent; each"
A4363,"Ostomy clamp, any type, replacement only, each"
A4364,"Adhesive, liquid or equal, any type, per oz"
A4366,"Ostomy vent, any type, each"
A4367,"Ostomy belt, each"
A4368,"Ostomy filter, any type, each"
A4369,"Ostomy skin barrier, liquid (spray, brush, etc.), per oz"
A4371,"Ostomy skin barrier, powder, per oz"
A4372,"Ostomy skin barrier, solid 4 x 4 or equivalent, standard wear, with built-in convexity, each"
A4373,"Ostomy skin barrier, with flange (solid, flexible or accordion), with built-in convexity, any size, each"
A4375,"Ostomy pouch, drainable, with faceplate attached, plastic, each"
A4376,"Ostomy pouch, drainable, with faceplate attached, rubber, each"
A4377,"Ostomy pouch, drainable, for use on faceplate, plastic, each"
A4378,"Ostomy pouch, drainable, for use on faceplate, rubber, each"
A4379,"Ostomy pouch, urinary, with faceplate attached, plastic, each"
A4380,"Ostomy pouch, urinary, with faceplate attached, rubber, each"
A4381,"Ostomy pouch, urinary, for use on faceplate, plastic, each"
A4382,"Ostomy pouch, urinary, for use on faceplate, heavy plastic, each"
A4383,"Ostomy pouch, urinary, for use on faceplate, rubber, each"
A4384,"Ostomy faceplate equivalent, silicone ring, each"
A4385,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each"
A4387,"Ostomy pouch, closed, with barrier attached, with built-in convexity (1 piece), each"
A4388,"Ostomy pouch, drainable, with extended wear barrier attached, (1 piece), each"
A4389,"Ostomy pouch, drainable, with barrier attached, with built-in convexity (1 piece), each"
A4390,"Ostomy pouch, drainable, with extended wear barrier attached, with built-in convexity (1 piece), each"
A4391,"Ostomy pouch, urinary, with extended wear barrier attached (1 piece), each"
A4392,"Ostomy pouch, urinary, with standard wear barrier attached, with built-in convexity (1 piece), each"
A4393,"Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity (1 piece), each"
A4394,"Ostomy deodorant, with or without lubricant, for use in ostomy pouch, per fluid ounce"
A4395,"Ostomy deodorant for use in ostomy pouch, solid, per tablet"
A4396,Ostomy belt with peristomal hernia support
A4397,"Irrigation supply; sleeve, eachTerminated December 31, 2021."
A4398,"Ostomy irrigation supply; bag, each"
A4399,"Ostomy irrigation supply; cone/catheter, with or without brush"
A4400,Ostomy irrigation set
A4402,"Lubricant, per ounce"
A4404,"Ostomy ring, each"
A4405,"Ostomy skin barrier, non-pectin based, paste, per ounce"
A4406,"Ostomy skin barrier, pectin-based, paste, per ounce"
A4407,"Ostomy skin barrier, with flange (solid, flexible, or accordion), extended wear, with built-in convexity, 4 x 4 inches or smaller, each"
A4408,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, with built-in convexity, larger than 4 x 4 inches, each"
A4409,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, 4 x 4 inches or smaller, each"
A4410,"Ostomy skin barrier, with flange (solid, flexible or accordion), extended wear, without built-in convexity, larger than 4 x 4 inches, each"
A4411,"Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, with built-in convexity, each"
A4412,"Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), without filter, each"
A4413,"Ostomy pouch, drainable, high output, for use on a barrier with flange (2 piece system), with filter, each"
A4414,"Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, 4 x 4 inches or smaller, each"
A4415,"Ostomy skin barrier, with flange (solid, flexible or accordion), without built-in convexity, larger than 4 x 4 inches, each"
A4416,"Ostomy pouch, closed, with barrier attached, with filter (1 piece), each"
A4417,"Ostomy pouch, closed, with barrier attached, with built-in convexity, with filter (1 piece), each"
A4418,"Ostomy pouch, closed; without barrier attached, with filter (1 piece), each"
A4419,"Ostomy pouch, closed; for use on barrier with non-locking flange, with filter (2 piece), each"
A4420,"Ostomy pouch, closed; for use on barrier with locking flange (2 piece), each"
A4421,Ostomy supply; miscellaneous
A4422,"Ostomy absorbent material (sheet/pad/crystal packet) for use in ostomy pouch to thicken liquid stomal output, each"
A4423,"Ostomy pouch, closed; for use on barrier with locking flange, with filter (2 piece), each"
A4424,"Ostomy pouch, drainable, with barrier attached, with filter (1 piece), each"
A4425,"Ostomy pouch, drainable; for use on barrier with non-locking flange, with filter (2 piece system), each"
A4426,"Ostomy pouch, drainable; for use on barrier with locking flange (2 piece system), each"
A4427,"Ostomy pouch, drainable; for use on barrier with locking flange, with filter (2 piece system), each"
A4428,"Ostomy pouch, urinary, with extended wear barrier attached, with faucet-type tap with valve (1 piece), each"
A4429,"Ostomy pouch, urinary, with barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each"
A4430,"Ostomy pouch, urinary, with extended wear barrier attached, with built-in convexity, with faucet-type tap with valve (1 piece), each"
A4431,"Ostomy pouch, urinary; with barrier attached, with faucet-type tap with valve (1 piece), each"
A4432,"Ostomy pouch, urinary; for use on barrier with non-locking flange, with faucet-type tap with valve (2 piece), each"
A4433,"Ostomy pouch, urinary; for use on barrier with locking flange (2 piece), each"
A4434,"Ostomy pouch, urinary; for use on barrier with locking flange, with faucet-type tap with valve (2 piece), each"
A4435,"Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each"
A4436,"Irrigation supply; sleeve, reusable, per month"
A4437,"Irrigation supply; sleeve, disposable, per month"
A4438,"Adhesive clip applied to the skin to secure external electrical nerve stimulator controller, each"
A4450,"Tape, non-waterproof, per 18 square inches"
A4452,"Tape, waterproof, per 18 square inches"
A4453,"Rectal catheter with or without balloon, for use with any type transanal irrigation system, each"
A4455,"Adhesive remover or solvent (for tape, cement or other adhesive), per ounce"
A4456,"Adhesive remover, wipes, any type, each"
A4457,"Enema tube, with or without adapter, any type, replacement only, each"
A4458,"Enema bag with tubing, reusable"
A4459,"Manual transanal irrigation system, includes water reservoir, pump, tubing, and accessories, without catheter, any type"
A4461,"Surgical dressing holder, non-reusable, each"
A4463,"Surgical dressing holder, reusable, each"
A4465,Non-elastic binder for extremity
A4466,"Garment, belt, sleeve or other covering, elastic or similar stretchable material, any type, eachTerminated December 31, 2016."
A4467,"Belt, strap, sleeve, garment, or covering, any type"
A4468,"Exsufflation belt, includes all supplies and accessories"
A4470,Gravlee jet washer
A4480,Vabra aspirator
A4481,"Tracheostoma filter, any type, any size, each"
A4483,"Moisture exchanger, disposable, for use with invasive mechanical ventilation"
A4490,"Surgical stockings above knee length, each"
A4495,"Surgical stockings thigh length, each"
A4500,"Surgical stockings below knee length, each"
A4510,"Surgical stockings full length, each"
A4520,"Incontinence garment, any type, (e.g., brief, diaper), each"
A4540,"Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper arm"
A4541,Monthly supplies for use of device coded at e0733
A4542,Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wrist
A4543,"Supplies for transcutaneous electrical nerve stimulator, for nerves in the auricular region, per month"
A4544,Electrode for external lower extremity nerve stimulator for restless legs syndrome
A4545,"Supplies and accessories for external tibial nerve stimulator (e.g., socks, gel pads, electrodes, etc.), needed for one month"
A4550,Surgical trays
A4553,"Non-disposable underpads, all sizes"
A4554,"Disposable underpads, all sizes"
A4555,"Electrode/transducer for use with electrical stimulation device used for cancer treatment, replacement only"
A4556,"Electrodes, (e.g., apnea monitor), per pair"
A4557,"Lead wires, (e.g., apnea monitor), per pair"
A4558,"Conductive gel or paste, for use with electrical device (e.g., tens, nmes), per oz"
A4559,"Coupling gel or paste, for use with ultrasound device, per oz"
A4560,"Neuromuscular electrical stimulator (nmes), disposable, replacement only"
A4561,"Pessary, reusable, rubber, any type"
A4562,"Pessary, reusable, non rubber, any type"
A4563,"Rectal control system for vaginal insertion, for long term use, includes pump and all supplies and accessories, any type each"
A4564,"Pessary, disposable, any type"
A4565,Slings
A4566,"Shoulder sling or vest design, abduction restrainer, with or without swathe control, prefabricated, includes fitting and adjustment"
A4570,Splint
A4575,"Topical hyperbaric oxygen chamber, disposable"
A4580,"Cast supplies (e.g., plaster)"
A4590,"Special casting material (e.g., fiberglass)"
A4593,"Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, controller"
A4594,"Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each"
A4595,"Electrical stimulator supplies, 2 lead, per month, (e.g., tens, nmes)"
A4596,"Cranial electrotherapy stimulation (ces) system supplies and accessories, per month"
A4600,"Sleeve for intermittent limb compression device, replacement only, each"
A4601,"Lithium ion battery, rechargeable, for non-prosthetic use, replacement"
A4602,"Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each"
A4604,Tubing with integrated heating element for use with positive airway pressure device
A4605,"Tracheal suction catheter, closed system, each"
A4606,"Oxygen probe for use with oximeter device, replacement"
A4608,"Transtracheal oxygen catheter, each"
A4611,"Battery, heavy duty; replacement for patient owned ventilator"
A4612,Battery cables; replacement for patient-owned ventilator
A4613,Battery charger; replacement for patient-owned ventilator
A4614,"Peak expiratory flow rate meter, hand held"
A4615,"Cannula, nasal"
A4616,"Tubing (oxygen), per foot"
A4617,Mouth piece
A4618,Breathing circuits
A4619,Face tent
A4620,Variable concentration mask
A4623,"Tracheostomy, inner cannula"
A4624,"Tracheal suction catheter, any type other than closed system, each"
A4625,Tracheostomy care kit for new tracheostomy
A4626,"Tracheostomy cleaning brush, each"
A4627,"Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler"
A4628,"Oral and/or oropharyngeal suction catheter, each"
A4629,Tracheostomy care kit for established tracheostomy
A4630,"Replacement batteries, medically necessary, transcutaneous electrical stimulator, owned by patient"
A4633,"Replacement bulb/lamp for ultraviolet light therapy system, each"
A4634,"Replacement bulb for therapeutic light box, tabletop model"
A4635,"Underarm pad, crutch, replacement, each"
A4636,"Replacement, handgrip, cane, crutch, or walker, each"
A4637,"Replacement, tip, cane, crutch, walker, each."
A4638,"Replacement battery for patient-owned ear pulse generator, each"
A4639,"Replacement pad for infrared heating pad system, each"
A4640,Replacement pad for use with medically necessary alternating pressure pad owned by patient
A4641,"Radiopharmaceutical, diagnostic, not otherwise classified"
A4642,"Indium in-111 satumomab pendetide, diagnostic, per study dose, up to 6 millicuries"
A4648,"Tissue marker, implantable, any type, each"
A4649,Surgical supply; miscellaneous
A4650,"Implantable radiation dosimeter, each"
A4651,"Calibrated microcapillary tube, each"
A4652,Microcapillary tube sealant
A4653,"Peritoneal dialysis catheter anchoring device, belt, each"
A4657,"Syringe, with or without needle, each"
A4660,Sphygmomanometer/blood pressure apparatus with cuff and stethoscope
A4663,Blood pressure cuff only
A4670,Automatic blood pressure monitor
A4671,"Disposable cycler set used with cycler dialysis machine, each"
A4672,"Drainage extension line, sterile, for dialysis, each"
A4673,"Extension line with easy lock connectors, used with dialysis"
A4674,"Chemicals/antiseptics solution used to clean/sterilize dialysis equipment, per 8 oz"
A4680,"Activated carbon filter for hemodialysis, each"
A4690,"Dialyzer (artificial kidneys), all types, all sizes, for hemodialysis, each"
A4706,"Bicarbonate concentrate, solution, for hemodialysis, per gallon"
A4707,"Bicarbonate concentrate, powder, for hemodialysis, per packet"
A4708,"Acetate concentrate solution, for hemodialysis, per gallon"
A4709,"Acid concentrate, solution, for hemodialysis, per gallon"
A4714,"Treated water (deionized, distilled, or reverse osmosis) for peritoneal dialysis, per gallon"
A4719,"""y set"" tubing for peritoneal dialysis"
A4720,"Dialysate solution, any concentration of dextrose, fluid volume greater than 249 cc, but less than or equal to 999 cc, for peritoneal dialysis"
A4721,"Dialysate solution, any concentration of dextrose, fluid volume greater than 999 cc but less than or equal to 1999 cc, for peritoneal dialysis"
A4722,"Dialysate solution, any concentration of dextrose, fluid volume greater than 1999 cc but less than or equal to 2999 cc, for peritoneal dialysis"
A4723,"Dialysate solution, any concentration of dextrose, fluid volume greater than 2999 cc but less than or equal to 3999 cc, for peritoneal dialysis"
A4724,"Dialysate solution, any concentration of dextrose, fluid volume greater than 3999 cc but less than or equal to 4999 cc, for peritoneal dialysis"
A4725,"Dialysate solution, any concentration of dextrose, fluid volume greater than 4999 cc but less than or equal to 5999 cc, for peritoneal dialysis"
A4726,"Dialysate solution, any concentration of dextrose, fluid volume greater than 5999 cc, for peritoneal dialysis"
A4728,"Dialysate solution, non-dextrose containing, 500 ml"
A4730,"Fistula cannulation set for hemodialysis, each"
A4736,"Topical anesthetic, for dialysis, per gram"
A4737,"Injectable anesthetic, for dialysis, per 10 ml"
A4740,"Shunt accessory, for hemodialysis, any type, each"
A4750,"Blood tubing, arterial or venous, for hemodialysis, each"
A4755,"Blood tubing, arterial and venous combined, for hemodialysis, each"
A4760,"Dialysate solution test kit, for peritoneal dialysis, any type, each"
A4765,"Dialysate concentrate, powder, additive for peritoneal dialysis, per packet"
A4766,"Dialysate concentrate, solution, additive for peritoneal dialysis, per 10 ml"
A4770,"Blood collection tube, vacuum, for dialysis, per 50"
A4771,"Serum clotting time tube, for dialysis, per 50"
A4772,"Blood glucose test strips, for dialysis, per 50"
A4773,"Occult blood test strips, for dialysis, per 50"
A4774,"Ammonia test strips, for dialysis, per 50"
A4802,"Protamine sulfate, for hemodialysis, per 50 mg"
A4860,"Disposable catheter tips for peritoneal dialysis, per 10"
A4870,Plumbing and/or electrical work for home hemodialysis equipment
A4890,"Contracts, repair and maintenance, for hemodialysis equipment"
A4911,"Drain bag/bottle, for dialysis, each"
A4913,"Miscellaneous dialysis supplies, not otherwise specified"
A4918,"Venous pressure clamp, for hemodialysis, each"
A4927,"Gloves, non-sterile, per 100"
A4928,"Surgical mask, per 20"
A4929,"Tourniquet for dialysis, each"
A4930,"Gloves, sterile, per pair"
A4931,"Oral thermometer, reusable, any type, each"
A4932,"Rectal thermometer, reusable, any type, each"
A5051,"Ostomy pouch, closed; with barrier attached (1 piece), each"
A5052,"Ostomy pouch, closed; without barrier attached (1 piece), each"
A5053,"Ostomy pouch, closed; for use on faceplate, each"
A5054,"Ostomy pouch, closed; for use on barrier with flange (2 piece), each"
A5055,Stoma cap
A5056,"Ostomy pouch, drainable, with extended wear barrier attached, with filter, (1 piece), each"
A5057,"Ostomy pouch, drainable, with extended wear barrier attached, with built in convexity, with filter, (1 piece), each"
A5061,"Ostomy pouch, drainable; with barrier attached, (1 piece), each"
A5062,"Ostomy pouch, drainable; without barrier attached (1 piece), each"
A5063,"Ostomy pouch, drainable; for use on barrier with flange (2 piece system), each"
A5071,"Ostomy pouch, urinary; with barrier attached (1 piece), each"
A5072,"Ostomy pouch, urinary; without barrier attached (1 piece), each"
A5073,"Ostomy pouch, urinary; for use on barrier with flange (2 piece), each"
A5081,"Stoma plug or seal, any type"
A5082,Continent device; catheter for continent stoma
A5083,"Continent device, stoma absorptive cover for continent stoma"
A5093,Ostomy accessory; convex insert
A5102,"Bedside drainage bottle with or without tubing, rigid or expandable, each"
A5105,"Urinary suspensory with leg bag, with or without tube, each"
A5112,"Urinary drainage bag, leg or abdomen, latex, with or without tube, with straps, each"
A5113,"Leg strap; latex, replacement only, per set"
A5114,"Leg strap; foam or fabric, replacement only, per set"
A5120,"Skin barrier, wipes or swabs, each"
A5121,"Skin barrier; solid, 6 x 6 or equivalent, each"
A5122,"Skin barrier; solid, 8 x 8 or equivalent, each"
A5126,Adhesive or non-adhesive; disk or foam pad
A5131,"Appliance cleaner, incontinence and ostomy appliances, per 16 oz."
A5200,"Percutaneous catheter/tube anchoring device, adhesive skin attachment"
A5500,"For diabetics only, fitting (including follow-up), custom preparation and supply of off-the-shelf depth-inlay shoe manufactured to accommodate multi-density insert(s), per shoe"
A5501,"For diabetics only, fitting (including follow-up), custom preparation and supply of shoe molded from cast(s) of patient's foot (custom molded shoe), per shoe"
A5503,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with roller or rigid rocker bottom, per shoe"
A5504,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with wedge(s), per shoe"
A5505,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with metatarsal bar, per shoe"
A5506,"For diabetics only, modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe with off-set heel(s), per shoe"
A5507,"For diabetics only, not otherwise specified modification (including fitting) of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe"
A5508,"For diabetics only, deluxe feature of off-the-shelf depth-inlay shoe or custom-molded shoe, per shoe"
A5510,"For diabetics only, direct formed, compression molded to patient's foot without external heat source, multiple-density insert(s) prefabricated, per shoe"
A5512,"For diabetics only, multiple density insert, direct formed, molded to foot after external heat source of 230 degrees fahrenheit or higher, total contact with patient's foot, including arch, base layer minimum of 1/4 inch material of shore a 35 durometer or 3/16 inch material of shore a 40 durometer (or higher), prefabricated, each"
A5513,"For diabetics only, multiple density insert, custom molded from model of patient's foot, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each"
A5514,"For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, each"
A6000,Non-contact wound warming wound cover for use with the non-contact wound warming device and warming card
A6010,"Collagen based wound filler, dry form, sterile, per gram of collagen"
A6011,"Collagen based wound filler, gel/paste, per gram of collagen"
A6021,"Collagen dressing, sterile, size 16 sq. in. or less, each"
A6022,"Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each"
A6023,"Collagen dressing, sterile, size more than 48 sq. in., each"
A6024,"Collagen dressing wound filler, sterile, per 6 inches"
A6025,"Gel sheet for dermal or epidermal application, (e.g., silicone, hydrogel, other), each"
A6154,"Wound pouch, each"
A6196,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing"
A6197,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing"
A6198,"Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 48 sq. in., each dressing"
A6199,"Alginate or other fiber gelling dressing, wound filler, sterile, per 6 inches"
A6203,"Composite dressing, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing"
A6204,"Composite dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing"
A6205,"Composite dressing, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing"
A6206,"Contact layer, sterile, 16 sq. in. or less, each dressing"
A6207,"Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing"
A6208,"Contact layer, sterile, more than 48 sq. in., each dressing"
A6209,"Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6210,"Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing"
A6211,"Foam dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing"
A6212,"Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing"
A6213,"Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing"
A6214,"Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing"
A6215,"Foam dressing, wound filler, sterile, per gram"
A6216,"Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6217,"Gauze, non-impregnated, non-sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing"
A6218,"Gauze, non-impregnated, non-sterile, pad size more than 48 sq. in., without adhesive border, each dressing"
A6219,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing"
A6220,"Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing"
A6221,"Gauze, non-impregnated, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing"
A6222,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6223,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing"
A6224,"Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 48 sq. in., without adhesive border, each dressing"
A6228,"Gauze, impregnated, water or normal saline, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6229,"Gauze, impregnated, water or normal saline, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing"
A6230,"Gauze, impregnated, water or normal saline, sterile, pad size more than 48 sq. in., without adhesive border, each dressing"
A6231,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size 16 sq. in. or less, each dressing"
A6232,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size greater than 16 sq. in., but less than or equal to 48 sq. in., each dressing"
A6233,"Gauze, impregnated, hydrogel, for direct wound contact, sterile, pad size more than 48 sq. in., each dressing"
A6234,"Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6235,"Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing"
A6236,"Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing"
A6237,"Hydrocolloid dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing"
A6238,"Hydrocolloid dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing"
A6239,"Hydrocolloid dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing"
A6240,"Hydrocolloid dressing, wound filler, paste, sterile, per ounce"
A6241,"Hydrocolloid dressing, wound filler, dry form, sterile, per gram"
A6242,"Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6243,"Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing"
A6244,"Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing"
A6245,"Hydrogel dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing"
A6246,"Hydrogel dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing"
A6247,"Hydrogel dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing"
A6248,"Hydrogel dressing, wound filler, gel, per fluid ounce"
A6250,"Skin sealants, protectants, moisturizers, ointments, any type, any size"
A6251,"Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6252,"Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing"
A6253,"Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., without adhesive border, each dressing"
A6254,"Specialty absorptive dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing"
A6255,"Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing"
A6256,"Specialty absorptive dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing"
A6257,"Transparent film, sterile, 16 sq. in. or less, each dressing"
A6258,"Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing"
A6259,"Transparent film, sterile, more than 48 sq. in., each dressing"
A6260,"Wound cleansers, any type, any size"
A6261,"Wound filler, gel/paste, per fluid ounce, not otherwise specified"
A6262,"Wound filler, dry form, per gram, not otherwise specified"
A6266,"Gauze, impregnated, other than water, normal saline, or zinc paste, sterile, any width, per linear yard"
A6402,"Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6403,"Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing"
A6404,"Gauze, non-impregnated, sterile, pad size more than 48 sq. in., without adhesive border, each dressing"
A6407,"Packing strips, non-impregnated, sterile, up to 2 inches in width, per linear yard"
A6410,"Eye pad, sterile, each"
A6411,"Eye pad, non-sterile, each"
A6412,"Eye patch, occlusive, each"
A6413,"Adhesive bandage, first-aid type, any size, each"
A6441,"Padding bandage, non-elastic, non-woven/non-knitted, width greater than or equal to three inches and less than five inches, per yard"
A6442,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width less than three inches, per yard"
A6443,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to three inches and less than five inches, per yard"
A6444,"Conforming bandage, non-elastic, knitted/woven, non-sterile, width greater than or equal to 5 inches, per yard"
A6445,"Conforming bandage, non-elastic, knitted/woven, sterile, width less than three inches, per yard"
A6446,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard"
A6447,"Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to five inches, per yard"
A6448,"Light compression bandage, elastic, knitted/woven, width less than three inches, per yard"
A6449,"Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard"
A6450,"Light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard"
A6451,"Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard"
A6452,"High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard"
A6453,"Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard"
A6454,"Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard"
A6455,"Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to five inches, per yard"
A6456,"Zinc paste impregnated bandage, non-elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard"
A6457,"Tubular dressing with or without elastic, any width, per linear yard"
A6460,"Synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing"
A6461,"Synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing"
A6501,"Compression burn garment, bodysuit (head to foot), custom fabricated"
A6502,"Compression burn garment, chin strap, custom fabricated"
A6503,"Compression burn garment, facial hood, custom fabricated"
A6504,"Compression burn garment, glove to wrist, custom fabricated"
A6505,"Compression burn garment, glove to elbow, custom fabricated"
A6506,"Compression burn garment, glove to axilla, custom fabricated"
A6507,"Compression burn garment, foot to knee length, custom fabricated"
A6508,"Compression burn garment, foot to thigh length, custom fabricated"
A6509,"Compression burn garment, upper trunk to waist including arm openings (vest), custom fabricated"
A6510,"Compression burn garment, trunk, including arms down to leg openings (leotard), custom fabricated"
A6511,"Compression burn garment, lower trunk including leg openings (panty), custom fabricated"
A6512,"Compression burn garment, not otherwise classified"
A6513,"Compression burn mask, face and/or neck, plastic or equal, custom fabricated"
A6515,"Gradient compression wrap with adjustable straps, full leg, each, custom"
A6516,"Gradient compression wrap with adjustable straps, foot, each, custom"
A6517,"Gradient compression wrap with adjustable straps, below knee, each, custom"
A6518,"Gradient compression wrap with adjustable straps, arm, each, custom"
A6519,"Gradient compression garment, not otherwise specified, for nighttime use, each"
A6520,"Gradient compression garment, glove, padded, for nighttime use, each"
A6521,"Gradient compression garment, glove, padded, for nighttime use, custom, each"
A6522,"Gradient compression garment, arm, padded, for nighttime use, each"
A6523,"Gradient compression garment, arm, padded, for nighttime use, custom, each"
A6524,"Gradient compression garment, lower leg and foot, padded, for nighttime use, each"
A6525,"Gradient compression garment, lower leg and foot, padded, for nighttime use, custom, each"
A6526,"Gradient compression garment, full leg and foot, padded, for nighttime use, each"
A6527,"Gradient compression garment, full leg and foot, padded, for nighttime use, custom, each"
A6528,"Gradient compression garment, bra, for nighttime use, each"
A6529,"Gradient compression garment, bra, for nighttime use, custom, each"
A6530,"Gradient compression stocking, below knee, 18-30 mmhg, each"
A6531,"Gradient compression stocking, below knee, 30-40 mmhg, used as a surgical dressing, each"
A6532,"Gradient compression stocking, below knee, 40-50 mmhg, used as a surgical dressing, each"
A6533,"Gradient compression stocking, thigh length, 18-30 mmhg, each"
A6534,"Gradient compression stocking, thigh length, 30-40 mmhg, each"
A6535,"Gradient compression stocking, thigh length, 40 mmhg or greater, each"
A6536,"Gradient compression stocking, full length/chap style, 18-30 mmhg, each"
A6537,"Gradient compression stocking, full length/chap style, 30-40 mmhg, each"
A6538,"Gradient compression stocking, full length/chap style, 40 mmhg or greater, each"
A6539,"Gradient compression stocking, waist length, 18-30 mmhg, each"
A6540,"Gradient compression stocking, waist length, 30-40 mmhg, each"
A6541,"Gradient compression stocking, waist length, 40 mmhg or greater, each"
A6544,"Gradient compression stocking, garter belt"
A6545,"Gradient compression wrap, non-elastic, below knee, 30-50 mmhg, used as a surgical dressing, each"
A6549,"Gradient compression garment, not otherwise specified, for daytime use, each"
A6550,"Wound care set, for negative pressure wound therapy electrical pump, includes all supplies and accessories"
A6552,"Gradient compression stocking, below knee, 30-40 mmhg, each"
A6553,"Gradient compression stocking, below knee, 30-40 mmhg, custom, each"
A6554,"Gradient compression stocking, below knee, 40 mmhg or greater, each"
A6555,"Gradient compression stocking, below knee, 40 mmhg or greater, custom, each"
A6556,"Gradient compression stocking, thigh length, 18-30 mmhg, custom, each"
A6557,"Gradient compression stocking, thigh length, 30-40 mmhg, custom, each"
A6558,"Gradient compression stocking, thigh length, 40 mmhg or greater, custom, each"
A6559,"Gradient compression stocking, full length/chap style, 18-30 mmhg, custom, each"
A6560,"Gradient compression stocking, full length/chap style, 30-40 mmhg, custom, each"
A6561,"Gradient compression stocking, full length/chap style, 40 mmhg or greater, custom, each"
A6562,"Gradient compression stocking, waist length, 18-30 mmhg, custom, each"
A6563,"Gradient compression stocking, waist length, 30-40 mmhg, custom, each"
A6564,"Gradient compression stocking, waist length, 40 mmhg or greater, custom, each"
A6565,"Gradient compression gauntlet, custom, each"
A6566,"Gradient compression garment, neck/head, each"
A6567,"Gradient compression garment, neck/head, custom, each"
A6568,"Gradient compression garment, torso and shoulder, each"
A6569,"Gradient compression garment, torso/shoulder, custom, each"
A6570,"Gradient compression garment, genital region, each"
A6571,"Gradient compression garment, genital region, custom, each"
A6572,"Gradient compression garment, toe caps, each"
A6573,"Gradient compression garment, toe caps, custom, each"
A6574,"Gradient compression arm sleeve and glove combination, custom, each"
A6575,"Gradient  compression arm sleeve and glove combination, each"
A6576,"Gradient  compression arm sleeve, custom, medium weight, each"
A6577,"Gradient  compression arm sleeve, custom, heavy weight, each"
A6578,"Gradient  compression arm sleeve, each"
A6579,"Gradient compression glove, custom, medium weight, each"
A6580,"Gradient  compression glove, custom, heavy weight, each"
A6581,"Gradient compression glove, each"
A6582,"Gradient compression gauntlet, each"
A6583,"Gradient compression wrap with adjustable straps, below knee, each"
A6584,"Gradient compression wrap with adjustable straps, not otherwise specified"
A6585,"Gradient compression wrap with adjustable straps, above knee, each"
A6586,"Gradient compression wrap with adjustable straps, full leg, each"
A6587,"Gradient compression wrap with adjustable straps, foot, each"
A6588,"Gradient compression wrap with adjustable straps, arm, each"
A6589,"Gradient pressure wrap with adjustable straps, bra, each"
A6590,"External urinary catheters; disposable, with wicking material, for use with suction pump, per month"
A6591,"External urinary catheter; non-disposable, for use with suction pump, per month"
A6593,"Accessory for gradient compression garment or wrap with adjustable straps, not-otherwise specified"
A6594,"Gradient compression bandaging supply, bandage liner, lower extremity, any size or length, each"
A6595,"Gradient compression bandaging supply, bandage liner, upper extremity, any size or length, each"
A6596,"Gradient compression bandaging supply, conforming gauze, per linear yard, any width, each"
A6597,"Gradient compression bandage roll, elastic long stretch, linear yard, any width, each"
A6598,"Gradient compression bandage roll, elastic medium stretch, per linear yard, any width, each"
A6599,"Gradient compression bandage roll, inelastic short stretch, per linear yard, any width, each"
A6600,"Gradient compression bandaging supply, high density foam sheet, per 250 square centimeters, each"
A6601,"Gradient compression bandaging supply, high density foam pad, any size or shape, each"
A6602,"Gradient compression bandaging supply, high density foam roll for bandage, per linear yard, any width, each"
A6603,"Gradient compression bandaging supply, low density channel foam sheet, per 250 square centimeters, each"
A6604,"Gradient compression bandaging supply, low density flat foam sheet, per 250 square centimeters, each"
A6605,"Gradient compression bandaging supply, padded foam, per linear yard, any width, each"
A6606,"Gradient compression bandaging supply, padded textile, per linear yard, any width, each"
A6607,"Gradient compression bandaging supply, tubular protective absorption layer, per linear yard, any width, each"
A6608,"Gradient compression bandaging supply, tubular protective absorption padded layer, per linear yard, any width, each"
A6609,"Gradient compression bandaging supply, not otherwise specified"
A6610,"Gradient compression stocking, below knee, 18-30 mmhg, custom, each"
A6611,"Gradient compression wrap with adjustable straps, above knee, each, custom"
A7000,"Canister, disposable, used with suction pump, each"
A7001,"Canister, non-disposable, used with suction pump, each"
A7002,"Tubing, used with suction pump, each"
A7003,"Administration set, with small volume nonfiltered pneumatic nebulizer, disposable"
A7004,"Small volume nonfiltered pneumatic nebulizer, disposable"
A7005,"Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable"
A7006,"Administration set, with small volume filtered pneumatic nebulizer"
A7007,"Large volume nebulizer, disposable, unfilled, used with aerosol compressor"
A7008,"Large volume nebulizer, disposable, prefilled, used with aerosol compressor"
A7009,"Reservoir bottle, non-disposable, used with large volume ultrasonic nebulizer"
A7010,"Corrugated tubing, disposable, used with large volume nebulizer, 100 feet"
A7011,"Corrugated tubing, non-disposable, used with large volume nebulizer, 10 feetTerminated December 31, 2015."
A7012,"Water collection device, used with large volume nebulizer"
A7013,"Filter, disposable, used with aerosol compressor or ultrasonic generator"
A7014,"Filter, nondisposable, used with aerosol compressor or ultrasonic generator"
A7015,"Aerosol mask, used with dme nebulizer"
A7016,"Dome and mouthpiece, used with small volume ultrasonic nebulizer"
A7017,"Nebulizer, durable, glass or autoclavable plastic, bottle type, not used with oxygen"
A7018,"Water, distilled, used with large volume nebulizer, 1000 ml"
A7020,"Interface for cough stimulating device, includes all components, replacement only"
A7021,"Supplies and accessories for lung expansion airway clearance, continuous high frequency oscillation, and nebulization device (e.g., handset, nebulizer kit, biofilter)"
A7023,"Mechanical allergen particle barrier/inhalation filter, cream, nasal, topical"
A7025,"High frequency chest wall oscillation system vest, replacement for use with patient owned equipment, each"
A7026,"High frequency chest wall oscillation system hose, replacement for use with patient owned equipment, each"
A7027,"Combination oral/nasal mask, used with continuous positive airway pressure device, each"
A7028,"Oral cushion for combination oral/nasal mask, replacement only, each"
A7029,"Nasal pillows for combination oral/nasal mask, replacement only, pair"
A7030,"Full face mask used with positive airway pressure device, each"
A7031,"Face mask interface, replacement for full face mask, each"
A7032,"Cushion for use on nasal mask interface, replacement only, each"
A7033,"Pillow for use on nasal cannula type interface, replacement only, pair"
A7034,"Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap"
A7035,Headgear used with positive airway pressure device
A7036,Chinstrap used with positive airway pressure device
A7037,Tubing used with positive airway pressure device
A7038,"Filter, disposable, used with positive airway pressure device"
A7039,"Filter, non disposable, used with positive airway pressure device"
A7040,One way chest drain valve
A7041,Water seal drainage container and tubing for use with implanted chest tube
A7042,"Implanted pleural catheter, eachTerminated December 31, 2014."
A7043,"Vacuum drainage bottle and tubing for use with implanted catheterTerminated December 31, 2014."
A7044,"Oral interface used with positive airway pressure device, each"
A7045,"Exhalation port with or without swivel used with accessories for positive airway devices, replacement only"
A7046,"Water chamber for humidifier, used with positive airway pressure device, replacement, each"
A7047,"Oral interface used with respiratory suction pump, each"
A7048,"Vacuum drainage collection unit and tubing kit, including all supplies needed for collection unit change, for use with implanted catheter, each"
A7049,Expiratory positive airway pressure intranasal resistance valve
A7501,"Tracheostoma valve, including diaphragm, each"
A7502,"Replacement diaphragm/faceplate for tracheostoma valve, each"
A7503,"Filter holder or filter cap, reusable, for use in a tracheostoma heat and moisture exchange system, each"
A7504,"Filter for use in a tracheostoma heat and moisture exchange system, each"
A7505,"Housing, reusable without adhesive, for use in a heat and moisture exchange system and/or with a tracheostoma valve, each"
A7506,"Adhesive disc for use in a heat and moisture exchange system and/or with tracheostoma valve, any type each"
A7507,"Filter holder and integrated filter without adhesive, for use in a tracheostoma heat and moisture exchange system, each"
A7508,"Housing and integrated adhesive, for use in a tracheostoma heat and moisture exchange system and/or with a tracheostoma valve, each"
A7509,"Filter holder and integrated filter housing, and adhesive, for use as a tracheostoma heat and moisture exchange system, each"
A7520,"Tracheostomy/laryngectomy tube, non-cuffed, polyvinylchloride (pvc), silicone or equal, each"
A7521,"Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each"
A7522,"Tracheostomy/laryngectomy tube, stainless steel or equal (sterilizable and reusable), each"
A7523,"Tracheostomy shower protector, each"
A7524,"Tracheostoma stent/stud/button, each"
A7525,"Tracheostomy mask, each"
A7526,"Tracheostomy tube collar/holder, each"
A7527,"Tracheostomy/laryngectomy tube plug/stop, each"
A8000,"Helmet, protective, soft, prefabricated, includes all components and accessories"
A8001,"Helmet, protective, hard, prefabricated, includes all components and accessories"
A8002,"Helmet, protective, soft, custom fabricated, includes all components and accessories"
A8003,"Helmet, protective, hard, custom fabricated, includes all components and accessories"
A8004,"Soft interface for helmet, replacement only"
A9150,Non-prescription drugs
A9152,"Single vitamin/mineral/trace element, oral, per dose, not otherwise specified"
A9153,"Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified"
A9154,"Artificial saliva, 1 ml"
A9155,"Artificial saliva, 30 mlTerminated March 31, 2025."
A9156,"Oral mucoadhesive, any type (liquid, gel, paste, etc.), per 1 ml"
A9180,"Pediculosis (lice infestation) treatment, topical, for administration by patient/caretaker"
A9268,"Programmer for transient, orally ingested capsule"
A9269,"Programable, transient, orally ingested capsule, for use with external programmer, per month"
A9270,Non-covered item or service
A9272,"Wound suction, disposable, includes dressing, all accessories and components, any type, each"
A9273,"Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type"
A9274,"External ambulatory insulin delivery system, disposable, each, includes all supplies and accessories"
A9275,"Home glucose disposable monitor, includes test strips"
A9276,"Sensor; invasive (e.g., subcutaneous), disposable, for use with non-durable medical equipment interstitial continuous glucose monitoring system, one unit = 1 day supply"
A9277,"Transmitter; external, for use with non-durable medical equipment interstitial continuous glucose monitoring system"
A9278,"Receiver (monitor); external, for use with non-durable medical equipment interstitial continuous glucose monitoring system"
A9279,"Monitoring feature/device, stand-alone or integrated, any type, includes all accessories, components and electronics, not otherwise classified"
A9280,"Alert or alarm device, not otherwise classified"
A9281,"Reaching/grabbing device, any type, any length, each"
A9282,"Wig, any type, each"
A9283,"Foot pressure off loading/supportive device, any type, each"
A9284,"Spirometer, non-electronic, includes all accessories"
A9285,Inversion/eversion correction device
A9286,"Hygienic item or device, disposable or non-disposable, any type, each"
A9291,"Prescription digital cognitive and/or behavioral therapy, fda cleared, per course of treatment"
A9292,"Prescription digital visual therapy, software-only, fda cleared, per course of treatment"
A9293,"Fertility cycle (contraception & conception) tracking software application, fda cleared, per month, includes accessories (e.g., thermometer)"
A9300,Exercise equipment
A9500,"Technetium tc-99m sestamibi, diagnostic, per study dose"
A9501,"Technetium tc-99m teboroxime, diagnostic, per study dose"
A9502,"Technetium tc-99m tetrofosmin, diagnostic, per study dose"
A9503,"Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries"
A9504,"Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries"
A9505,"Thallium tl-201 thallous chloride, diagnostic, per millicurie"
A9506,"Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible"
A9507,"Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries"
A9508,"Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie"
A9509,"Iodine i-123 sodium iodide, diagnostic, per millicurie"
A9510,"Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries"
A9512,"Technetium tc-99m pertechnetate, diagnostic, per millicurie"
A9513,"Lutetium lu 177, dotatate, therapeutic, 1 millicurie"
A9515,"Choline c-11, diagnostic, per study dose up to 20 millicuries"
A9516,"Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries"
A9517,"Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie"
A9520,"Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries"
A9521,"Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries"
A9524,"Iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries"
A9526,"Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries"
A9527,"Iodine i-125, sodium iodide solution, therapeutic, per millicurie"
A9528,"Iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie"
A9529,"Iodine i-131 sodium iodide solution, diagnostic, per millicurie"
A9530,"Iodine i-131 sodium iodide solution, therapeutic, per millicurie"
A9531,"Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries)"
A9532,"Iodine i-125 serum albumin, diagnostic, per 5 microcuries"
A9536,"Technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries"
A9537,"Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries"
A9538,"Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries"
A9539,"Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries"
A9540,"Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries"
A9541,"Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries"
A9542,"Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries"
A9543,"Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries"
A9544,"Iodine i-131 tositumomab, diagnostic, per study doseTerminated December 31, 2016."
A9545,"Iodine i-131 tositumomab, therapeutic, per treatment doseTerminated December 31, 2016."
A9546,"Cobalt co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie"
A9547,"Indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie"
A9548,"Indium in-111 pentetate, diagnostic, per 0.5 millicurie"
A9550,"Technetium tc-99m sodium gluceptate, diagnostic, per study dose, up to 25 millicurie"
A9551,"Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries"
A9552,"Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries"
A9553,"Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries"
A9554,"Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries"
A9555,"Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries"
A9556,"Gallium ga-67 citrate, diagnostic, per millicurie"
A9557,"Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries"
A9558,"Xenon xe-133 gas, diagnostic, per 10 millicuries"
A9559,"Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie"
A9560,"Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries"
A9561,"Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries"
A9562,"Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries"
A9563,"Sodium phosphate p-32, therapeutic, per millicurie"
A9564,"Chromic phosphate p-32 suspension, therapeutic, per millicurie"
A9566,"Technetium tc-99m fanolesomab, diagnostic, per study dose, up to 25 millicuries"
A9567,"Technetium tc-99m pentetate, diagnostic, aerosol, per study dose, up to 75 millicuries"
A9568,"Technetium tc-99m arcitumomab, diagnostic, per study dose, up to 45 millicuries"
A9569,"Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose"
A9570,"Indium in-111 labeled autologous white blood cells, diagnostic, per study dose"
A9571,"Indium in-111 labeled autologous platelets, diagnostic, per study dose"
A9572,"Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries"
A9573,"Injection, gadopiclenol, 1 ml"
A9575,"Injection, gadoterate meglumine, 0.1 ml"
A9576,"Injection, gadoteridol, (prohance multipack), per ml"
A9577,"Injection, gadobenate dimeglumine (multihance), per ml"
A9578,"Injection, gadobenate dimeglumine (multihance multipack), per ml"
A9579,"Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml"
A9580,"Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries"
A9581,"Injection, gadoxetate disodium, 1 ml"
A9582,"Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries"
A9583,"Injection, gadofosveset trisodium, 1 ml"
A9584,"Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries"
A9585,"Injection, gadobutrol, 0.1 ml"
A9586,"Florbetapir f18, diagnostic, per study dose, up to 10 millicuries"
A9587,"Gallium ga-68, dotatate, diagnostic, 0.1 millicurie"
A9588,"Fluciclovine f-18, diagnostic, 1 millicurie"
A9589,"Instillation, hexaminolevulinate hydrochloride, 100 mg"
A9590,"Iodine i-131, iobenguane, 1 millicurie"
A9591,"Fluoroestradiol f 18, diagnostic, 1 millicurie"
A9592,"Copper cu-64, dotatate, diagnostic, 1 millicurie"
A9593,"Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie"
A9594,"Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie"
A9595,"Piflufolastat f-18, diagnostic, 1 millicurie"
A9596,"Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie"
A9597,"Positron emission tomography radiopharmaceutical, diagnostic, for tumor identification, not otherwise classified"
A9598,"Positron emission tomography radiopharmaceutical, diagnostic, for non-tumor identification, not otherwise classified"
A9599,"Radiopharmaceutical, diagnostic, for beta-amyloid positron emission tomography (pet) imaging, per study dose, not otherwise specifiedTerminated December 31, 2017."
A9600,"Strontium sr-89 chloride, therapeutic, per millicurie"
A9601,"Flortaucipir f 18 injection, diagnostic, 1 millicurie"
A9602,"Fluorodopa f-18, diagnostic, per millicurie"
A9603,"Injection, pafolacianine, 0.1 mg"
A9604,"Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries"
A9606,"Radium ra-223 dichloride, therapeutic, per microcurie"
A9607,"Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie"
A9608,"Flotufolastat f 18, diagnostic, 1 millicurie"
A9609,Fludeoxyglucose f18 up to 15 millicuries
A9610,"Xenon xe-129 hyperpolarized gas, diagnostic, per study dose"
A9611,"Flurpiridaz f 18, diagnostic, 1 millicurie"
A9612,"Injection, fluorescein, 1 mg"
A9615,"Injection, pegulicianine, 1 mg"
A9616,"Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurie"
A9697,"Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose"
A9698,"Non-radioactive contrast imaging material, not otherwise classified, per study"
A9699,"Radiopharmaceutical, therapeutic, not otherwise classified"
A9700,"Supply of injectable contrast material for use in echocardiography, per study"
A9800,"Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie"
A9900,"Miscellaneous dme supply, accessory, and/or service component of another hcpcs code"
A9901,"Dme delivery, set up, and/or dispensing service component of another hcpcs code"
A9999,"Miscellaneous dme supply or accessory, not otherwise specified"
B4034,"Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape"
B4035,"Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape"
B4036,"Enteral feeding supply kit; gravity fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape"
B4081,Nasogastric tubing with stylet
B4082,Nasogastric tubing without stylet
B4083,Stomach tube - levine type
B4087,"Gastrostomy/jejunostomy tube, standard, any material, any type, each"
B4088,"Gastrostomy/jejunostomy tube, low-profile, any material, any type, each"
B4100,"Food thickener, administered orally, per ounce"
B4102,"Enteral formula, for adults, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit"
B4103,"Enteral formula, for pediatrics, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit"
B4104,"Additive for enteral formula (e.g., fiber)"
B4105,"In-line cartridge containing digestive enzyme(s) for enteral feeding, each"
B4148,"Enteral feeding supply kit; elastomeric control fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape"
B4149,"Enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4150,"Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4152,"Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4153,"Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4154,"Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4155,"Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit"
B4157,"Enteral formula, nutritionally complete, for special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4158,"Enteral formula, for pediatrics, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit"
B4159,"Enteral formula, for pediatrics, nutritionally complete soy based with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber and/or iron, administered through an enteral feeding tube, 100 calories = 1 unit"
B4160,"Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4161,"Enteral formula, for pediatrics, hydrolyzed/amino acids and peptide chain proteins, includes fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4162,"Enteral formula, for pediatrics, special metabolic needs for inherited disease of metabolism, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit"
B4164,"Parenteral nutrition solution: carbohydrates (dextrose), 50% or less (500 ml = 1 unit) - home mix"
B4168,"Parenteral nutrition solution; amino acid, 3.5%, (500 ml = 1 unit) - home mix"
B4172,"Parenteral nutrition solution; amino acid, 5.5% through 7%, (500 ml = 1 unit) - home mix"
B4176,"Parenteral nutrition solution; amino acid, 7% through 8.5%, (500 ml = 1 unit) - home mix"
B4178,"Parenteral nutrition solution: amino acid, greater than 8.5% (500 ml = 1 unit) - home mix"
B4180,"Parenteral nutrition solution; carbohydrates (dextrose), greater than 50% (500 ml = 1 unit) - home mix"
B4185,"Parenteral nutrition solution, not otherwise specified, 10 grams lipids"
B4187,"Omegaven, 10 grams lipids"
B4189,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 10 to 51 grams of protein - premix"
B4193,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, 52 to 73 grams of protein - premix"
B4197,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix"
B4199,"Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, over 100 grams of protein - premix"
B4216,"Parenteral nutrition; additives (vitamins, trace elements, heparin, electrolytes), home mix, per day"
B4220,"Parenteral nutrition supply kit; premix, per day"
B4222,"Parenteral nutrition supply kit; home mix, per day"
B4224,"Parenteral nutrition administration kit, per day"
B5000,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, renal-aminosyn-rf, nephramine, renamine-premix"
B5100,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, hepatic, hepatamine-premix"
B5200,"Parenteral nutrition solution compounded amino acid and carbohydrates with electrolytes, trace elements, and vitamins, including preparation, any strength, stress-branch chain amino acids-freamine-hbc-premix"
B9000,"Enteral nutrition infusion pump - without alarmTerminated December 31, 2016."
B9002,"Enteral nutrition infusion pump, any type"
B9004,"Parenteral nutrition infusion pump, portable"
B9006,"Parenteral nutrition infusion pump, stationary"
B9998,Noc for enteral supplies
B9999,Noc for parenteral supplies
C1052,"Hemostatic agent, gastrointestinal, topical"
C1062,"Intravertebral body fracture augmentation with implant (e.g., metal, polymer)"
C1300,"Hyperbaric oxygen under pressure, full body chamber, per 30 minute intervalTerminated December 31, 2014."
C1600,"Catheter, transluminal intravascular lesion preparation device, bladed, sheathed (insertable)"
C1601,"Endoscope, single-use (i.e. disposable), pulmonary, imaging/illumination device (insertable)"
C1602,"Orthopedic/device/drug matrix/absorbable bone void filler, antimicrobial-eluting (implantable)"
C1603,"Retrieval device, insertable, laser (used to retrieve intravascular inferior vena cava filter)"
C1604,"Graft, transmural transvenous arterial bypass (implantable), with all delivery system components"
C1605,"Pacemaker, leadless, dual chamber (right atrial and right ventricular implantable components), rate-responsive, including all necessary components for implantation"
C1606,"Adapter, single-use (i.e. disposable), for attaching ultrasound system to upper gastrointestinal endoscope"
C1713,Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)
C1714,"Catheter, transluminal atherectomy, directional"
C1715,Brachytherapy needle
C1716,"Brachytherapy source, non-stranded, gold-198, per source"
C1717,"Brachytherapy source, non-stranded, high dose rate iridium-192, per source"
C1719,"Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source"
C1721,"Cardioverter-defibrillator, dual chamber (implantable)"
C1722,"Cardioverter-defibrillator, single chamber (implantable)"
C1724,"Catheter, transluminal atherectomy, rotational"
C1725,"Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)"
C1726,"Catheter, balloon dilatation, non-vascular"
C1727,"Catheter, balloon tissue dissector, non-vascular (insertable)"
C1728,"Catheter, brachytherapy seed administration"
C1729,"Catheter, drainage"
C1730,"Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)"
C1731,"Catheter, electrophysiology, diagnostic, other than 3d mapping (20 or more electrodes)"
C1732,"Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping"
C1733,"Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip"
C1734,Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)
C1735,"Catheter(s), intravascular for renal denervation, radiofrequency, including all single use system components"
C1736,"Catheter(s), intravascular for renal denervation, ultrasound, including all single use system components"
C1737,"Joint fusion and fixation device(s), sacroiliac and pelvis, including all system components (implantable)"
C1738,"Powered, single-use (i.e. disposable) endoscopic ultrasound-guided biopsy device"
C1739,"Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system"
C1740,"Leadless electrode, transmitter, battery (all implantable), for sequential left ventricular pacing"
C1741,"Anchor/screw for bone fixation, absorbable (implantable)"
C1742,"Pressure monitoring system, compartmental intramuscular (implantable), continuous, including all components (e.g., introducer, sensor), excludes mobile (wireless) software application"
C1747,"Endoscope, single-use (i.e. disposable), urinary tract, imaging/illumination device (insertable)"
C1748,"Endoscope, single-use (i.e. disposable), upper gi, imaging/illumination device (insertable)"
C1749,"Endoscope, retrograde imaging/illumination colonoscope device (implantable)"
C1750,"Catheter, hemodialysis/peritoneal, long-term"
C1751,"Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)"
C1752,"Catheter, hemodialysis/peritoneal, short-term"
C1753,"Catheter, intravascular ultrasound"
C1754,"Catheter, intradiscal"
C1755,"Catheter, intraspinal"
C1756,"Catheter, pacing, transesophageal"
C1757,"Catheter, thrombectomy/embolectomy"
C1758,"Catheter, ureteral"
C1759,"Catheter, intracardiac echocardiography"
C1760,"Closure device, vascular (implantable/insertable)"
C1761,"Catheter, transluminal intravascular lithotripsy, coronary"
C1762,"Connective tissue, human (includes fascia lata)"
C1763,"Connective tissue, non-human (includes synthetic)"
C1764,"Event recorder, cardiac (implantable)"
C1765,Adhesion barrier
C1766,"Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away"
C1767,"Generator, neurostimulator (implantable), non-rechargeable"
C1768,"Graft, vascular"
C1769,Guide wire
C1770,"Imaging coil, magnetic resonance (insertable)"
C1771,"Repair device, urinary, incontinence, with sling graft"
C1772,"Infusion pump, programmable (implantable)"
C1773,"Retrieval device, insertable (used to retrieve fractured medical devices)"
C1776,Joint device (implantable)
C1777,"Lead, cardioverter-defibrillator, endocardial single coil (implantable)"
C1778,"Lead, neurostimulator (implantable)"
C1779,"Lead, pacemaker, transvenous vdd single pass"
C1780,"Lens, intraocular (new technology)"
C1781,Mesh (implantable)
C1782,Morcellator
C1783,"Ocular implant, aqueous drainage assist device"
C1784,"Ocular device, intraoperative, detached retina"
C1785,"Pacemaker, dual chamber, rate-responsive (implantable)"
C1786,"Pacemaker, single chamber, rate-responsive (implantable)"
C1787,"Patient programmer, neurostimulator"
C1788,"Port, indwelling (implantable)"
C1789,"Prosthesis, breast (implantable)"
C1813,"Prosthesis, penile, inflatable"
C1814,"Retinal tamponade device, silicone oil"
C1815,"Prosthesis, urinary sphincter (implantable)"
C1816,"Receiver and/or transmitter, neurostimulator (implantable)"
C1817,"Septal defect implant system, intracardiac"
C1818,Integrated keratoprosthesis
C1819,Surgical tissue localization and excision device (implantable)
C1820,"Generator, neurostimulator (implantable), with rechargeable battery and charging system"
C1821,Interspinous process distraction device (implantable)
C1822,"Generator, neurostimulator (implantable), high frequency, with rechargeable battery and charging system"
C1823,"Generator, neurostimulator (implantable), non-rechargeable, with transvenous sensing and stimulation leads"
C1824,"Generator, cardiac contractility modulation (implantable)"
C1825,"Generator, neurostimulator (implantable), non-rechargeable with carotid sinus baroreceptor stimulation lead(s)"
C1826,"Generator, neurostimulator (implantable), includes closed feedback loop leads and all implantable components, with rechargeable battery and charging system"
C1827,"Generator, neurostimulator (implantable), non-rechargeable, with implantable stimulation lead and external paired stimulation controller"
C1830,Powered bone marrow biopsy needle
C1831,"Interbody cage, anterior, lateral or posterior, personalized (implantable)"
C1832,"Autograft suspension, including cell processing and application, and all system components"
C1833,"Monitor, cardiac, including intracardiac lead and all system components (implantable)"
C1834,"Pressure sensor system, includes all components (e.g., introducer, sensor), intramuscular (implantable), excludes mobile (wireless) software applicationTerminated March 31, 2023."
C1839,Iris prosthesis
C1840,"Lens, intraocular (telescopic)"
C1841,"Retinal prosthesis, includes all internal and external componentsTerminated December 31, 2022."
C1842,"Retinal prosthesis, includes all internal and external components; add-on to c1841Terminated December 31, 2022."
C1849,"Skin substitute, synthetic, resorbable, per square centimeterTerminated December 31, 2022."
C1874,"Stent, coated/covered, with delivery system"
C1875,"Stent, coated/covered, without delivery system"
C1876,"Stent, non-coated/non-covered, with delivery system"
C1877,"Stent, non-coated/non-covered, without delivery system"
C1878,"Material for vocal cord medialization, synthetic (implantable)"
C1880,Vena cava filter
C1881,Dialysis access system (implantable)
C1882,"Cardioverter-defibrillator, other than single or dual chamber (implantable)"
C1883,"Adapter/extension, pacing lead or neurostimulator lead (implantable)"
C1884,Embolization protective system
C1885,"Catheter, transluminal angioplasty, laser"
C1886,"Catheter, extravascular tissue ablation, any modality (insertable)"
C1887,"Catheter, guiding (may include infusion/perfusion capability)"
C1888,"Catheter, ablation, non-cardiac, endovascular (implantable)"
C1889,"Implantable/insertable device, not otherwise classified"
C1890,No implantable/insertable device used with device-intensive procedures
C1891,"Infusion pump, non-programmable, permanent (implantable)"
C1892,"Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away"
C1893,"Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away"
C1894,"Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser"
C1895,"Lead, cardioverter-defibrillator, endocardial dual coil (implantable)"
C1896,"Lead, cardioverter-defibrillator, other than endocardial single or dual coil (implantable)"
C1897,"Lead, neurostimulator test kit (implantable)"
C1898,"Lead, pacemaker, other than transvenous vdd single pass"
C1899,"Lead, pacemaker/cardioverter-defibrillator combination (implantable)"
C1900,"Lead, left ventricular coronary venous system"
C1982,"Catheter, pressure-generating, (e.g., one-way valve, intermittently occlusive)"
C2596,"Probe, image-guided, robotic, waterjet ablation"
C2613,Lung biopsy plug with delivery system
C2614,"Probe, percutaneous lumbar discectomy"
C2615,"Sealant, pulmonary, liquid"
C2616,"Brachytherapy source, non-stranded, yttrium-90, per source"
C2617,"Stent, non-coronary, temporary, without delivery system"
C2618,"Probe/needle, cryoablation"
C2619,"Pacemaker, dual chamber, non rate-responsive (implantable)"
C2620,"Pacemaker, single chamber, non rate-responsive (implantable)"
C2621,"Pacemaker, other than single or dual chamber (implantable)"
C2622,"Prosthesis, penile, non-inflatable"
C2623,"Catheter, transluminal angioplasty, drug-coated, non-laser"
C2624,"Implantable wireless pulmonary artery pressure sensor with delivery catheter, including all system components"
C2625,"Stent, non-coronary, temporary, with delivery system"
C2626,"Infusion pump, non-programmable, temporary (implantable)"
C2627,"Catheter, suprapubic/cystoscopic"
C2628,"Catheter, occlusion"
C2629,"Introducer/sheath, other than guiding, other than intracardiac electrophysiological, laser"
C2630,"Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, cool-tip"
C2631,"Repair device, urinary, incontinence, without sling graft"
C2634,"Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source"
C2635,"Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source"
C2636,"Brachytherapy linear source, non-stranded, palladium-103, per 1 mm"
C2637,"Brachytherapy source, non-stranded, ytterbium-169, per source"
C2638,"Brachytherapy source, stranded, iodine-125, per source"
C2639,"Brachytherapy source, non-stranded, iodine-125, per source"
C2640,"Brachytherapy source, stranded, palladium-103, per source"
C2641,"Brachytherapy source, non-stranded, palladium-103, per source"
C2642,"Brachytherapy source, stranded, cesium-131, per source"
C2643,"Brachytherapy source, non-stranded, cesium-131, per source"
C2644,"Brachytherapy source, cesium-131 chloride solution, per millicurie"
C2645,"Brachytherapy planar source, palladium-103, per square millimeter"
C2698,"Brachytherapy source, stranded, not otherwise specified, per source"
C2699,"Brachytherapy source, non-stranded, not otherwise specified, per source"
C5271,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area"
C5272,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)"
C5273,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children"
C5274,"Application of low cost skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)"
C5275,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface area"
C5276,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; each additional 25 sq cm wound surface area, or part thereof (list separately in addition to code for primary procedure)"
C5277,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and children"
C5278,"Application of low cost skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; each additional 100 sq cm wound surface area, or part thereof, or each additional 1% of body area of infants and children, or part thereof (list separately in addition to code for primary procedure)"
C7500,"Debridement, bone including epidermis, dermis, subcutaneous tissue, muscle and/or fascia, if performed, first 20 sq cm or less with manual preparation and insertion of deep (e.g., subfacial) drug-delivery device(s)"
C7501,"Percutaneous breast biopsies using stereotactic guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral and bilateral (for single lesion biopsy, use appropriate code)"
C7502,"Percutaneous breast biopsies using magnetic resonance guidance, with placement of breast localization device(s) (e.g., clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, all lesions unilateral or bilateral (for single lesion biopsy, use appropriate code)"
C7503,"Open biopsy or excision of deep cervical node(s) with intraoperative identification (e.g., mapping) of sentinel lymph node(s) including injection of non-radioactive dye when performed"
C7504,"Percutaneous vertebroplasties (bone biopsies included when performed), first cervicothoracic and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance"
C7505,"Percutaneous vertebroplasties (bone biopsies included when performed), first lumbosacral and any additional cervicothoracic or lumbosacral vertebral bodies, unilateral or bilateral injection, inclusive of all imaging guidance"
C7506,"Arthrodesis, interphalangeal joints, with or without internal fixation"
C7507,"Percutaneous vertebral augmentations, first thoracic and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance"
C7508,"Percutaneous vertebral augmentations, first lumbar and any additional thoracic or lumbar vertebral bodies, including cavity creations (fracture reductions and bone biopsies included when performed) using mechanical device (e.g., kyphoplasty), unilateral or bilateral cannulations, inclusive of all imaging guidance"
C7509,"Bronchoscopy, rigid or flexible, diagnostic with cell washing(s) when performed, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed"
C7510,"Bronchoscopy, rigid or flexible, with bronchial alveolar lavage(s), with computer-assisted image-guided navigation, including fluoroscopic guidance when performed"
C7511,"Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with computer-assisted image-guided navigation, including fluoroscopic guidance when performed"
C7512,"Bronchoscopy, rigid or flexible, with single or multiple bronchial or endobronchial biopsy(ies), single or multiple sites, with transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance when performed"
C7513,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty of central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report"
C7514,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with all angioplasty in the central dialysis segment, and transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all required imaging, radiological supervision and interpretation, image documentation and report"
C7515,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with dialysis circuit permanent endovascular embolization or occlusion of main circuit or any accessory veins, including all required imaging, radiological supervision and interpretation, image documentation and report"
C7516,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report"
C7517,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation"
C7518,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging, supervision, interpretation and report"
C7519,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress"
C7520,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) includes intraprocedural injection(s) for bypass graft angiography with iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation"
C7521,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography with right heart catheterization with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report"
C7522,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right heart catheterization, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress"
C7523,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report"
C7524,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress"
C7525,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report"
C7526,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress"
C7527,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with endoluminal imaging of initial coronary vessel or graft using intravascular ultrasound (ivus) or optical coherence tomography (oct) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report"
C7528,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress"
C7529,"Catheter placement in coronary artery(ies) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation, with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (initial coronary vessel or graft) during coronary angiography including pharmacologically induced stress"
C7530,"Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of contrast, all necessary imaging from the arterial anastomosis and adjacent artery through entire venous outflow including the inferior or superior vena cava, fluoroscopic guidance, with transluminal balloon angioplasty, peripheral dialysis segment, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty and all angioplasty in the central dialysis segment, with transcatheter placement of intravascular stent(s), central dialysis segment, performed through dialysis circuit, including all imaging, radiological supervision and interpretation, documentation and report"
C7531,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal angioplasty with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation"
C7532,"Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the angioplasty within the same artery, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation"
C7533,"Percutaneous transluminal coronary angioplasty, single major coronary artery or branch with transcatheter placement of radiation delivery device for subsequent coronary intravascular brachytherapy"
C7534,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with atherectomy, includes angioplasty within the same vessel, when performed with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation"
C7535,"Revascularization, endovascular, open or percutaneous, femoral, popliteal artery(ies), unilateral, with transluminal stent placement(s), includes angioplasty within the same vessel, when performed, with intravascular ultrasound (initial noncoronary vessel) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation"
C7537,"Insertion of new or replacement of permanent pacemaker with atrial transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)"
C7538,"Insertion of new or replacement of permanent pacemaker with ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (e.g., for upgrade to dual chamber system)"
C7539,"Insertion of new or replacement of permanent pacemaker with atrial and ventricular transvenous electrode(s), with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)"
C7540,"Removal of permanent pacemaker pulse generator with replacement of pacemaker pulse generator, dual lead system, with insertion of pacing electrode, cardiac venous system, for left ventricular pacing, at time of insertion of implantable defibrillator or pacemaker pulse generator (eg, for upgrade to dual chamber system)"
C7541,"Diagnostic endoscopic retrograde cholangiopancreatography (ercp), including collection of specimen(s) by brushing or washing, when performed, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)"
C7542,"Endoscopic retrograde cholangiopancreatography (ercp) with biopsy, single or multiple, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)"
C7543,"Endoscopic retrograde cholangiopancreatography (ercp) with sphincterotomy/papillotomy, with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)"
C7544,"Endoscopic retrograde cholangiopancreatography (ercp) with removal of calculi/debris from biliary/pancreatic duct(s), with endoscopic cannulation of papilla with direct visualization of pancreatic/common bile ducts(s)"
C7545,"Percutaneous exchange of biliary drainage catheter (eg, external, internal-external, or conversion of internal-external to external only), with removal of calculi/debris from biliary duct(s) and/or gallbladder, including destruction of calculi by any method (eg, mechanical, electrohydraulic, lithotripsy) when performed, including diagnostic cholangiography(ies) when performed, imaging guidance (eg, fluoroscopy), and all associated radiological supervision and interpretation"
C7546,"Removal and replacement of externally accessible nephroureteral catheter (eg, external/internal stent) requiring fluoroscopic guidance, with ureteral stricture balloon dilation, including imaging guidance and all associated radiological supervision and interpretation"
C7547,"Convert nephrostomy catheter to nephroureteral catheter, percutaneous via pre-existing nephrostomy tract, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation"
C7548,"Exchange nephrostomy catheter, percutaneous, with ureteral stricture balloon dilation, including diagnostic nephrostogram and/or ureterogram when performed, imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation"
C7549,"Change of ureterostomy tube or externally accessible ureteral stent via ileal conduit with ureteral stricture balloon dilation, including imaging guidance (eg, ultrasound and/or fluoroscopy) and all associated radiological supervision and interpretation"
C7550,"Cystourethroscopy, with biopsy(ies) with adjunctive blue light cystoscopy with fluorescent imaging agent"
C7551,"Excision of major peripheral nerve neuroma, except sciatic, with implantation of nerve end into bone or muscle"
C7552,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) including intraprocedural injection(s) for bypass graft angiography and right heart catheterization with intravascular doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress, initial vessel"
C7553,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed"
C7554,Cystourethroscopy with adjunctive blue light cystoscopy with fluorescent imaging agent
C7555,"Thyroidectomy, total or complete with parathyroid autotransplantation"
C7556,"Bronchoscopy, rigid or flexible, with bronchial alveolar lavage and transendoscopic endobronchial ultrasound (ebus) during bronchoscopic diagnostic or therapeutic intervention(s) for peripheral lesion(s), including fluoroscopic guidance, when performed"
C7557,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed and intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention"
C7558,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performedTerminated December 31, 2024."
C7560,Endoscopic retrograde cholangiopancreatography (ercp) with removal of foreign body(s) or stent(s) from biliary/pancreatic duct(s) and endoscopic cannulation of papilla with direct visualization of pancreatic/common bile duct(s)
C7562,"Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed with intraprocedural coronary fractional flow reserve (ffr) with 3d functional mapping of color-coded ffr values for the coronary tree, derived from coronary angiogram data, for real-time review and interpretation of possible atherosclerotic stenosis(es) intervention"
C7563,"Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), open or percutaneous, including all imaging and radiological supervision and interpretation necessary to perform the  angioplasty within the same artery, initial artery and all additional arteries"
C7564,"Percutaneous transluminal mechanical thrombectomy, vein(s), including intraprocedural pharmacological thrombolytic injections and fluoroscopic guidance with intravascular ultrasound (noncoronary vessel(s)) during diagnostic evaluation and/or therapeutic intervention, including radiological supervision and interpretation"
C7565,"Repair of anterior abdominal hernia(s) (ie, epigastric, incisional, ventral, umbilical, spigelian), any approach (i.e., open, laparoscopic, robotic), recurrent, including implantation of mesh or other prosthesis when performed, total length of defect(s) less than 3 cm, reducible with removal of total or near total non-infected mesh or other prosthesis at the time of initial or recurrent anterior abdominal hernia repair or parastomal hernia repair"
C7900,"Service for diagnosis, evaluation, or treatment of a mental health  or substance use disorder, 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service"
C7901,"Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service"
C7902,"Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)"
C7903,"Group psychotherapy service for diagnosis, evaluation, or treatment of a mental health or substance use disorder provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service"
C8000,"Support device, extravascular, for arteriovenous fistula (implantable)"
C8001,"3d anatomical segmentation imaging for preoperative planning, data preparation and transmission, obtained from previous diagnostic computed tomographic or magnetic resonance examination of the same anatomy"
C8002,"Preparation of skin cell suspension autograft, automated, including all enzymatic processing and device components (do not report with manual suspension preparation)"
C8003,"Implantation of medial knee extraarticular implantable shock absorber spanning the knee joint from distal femur to proximal tibia, open, includes measurements, positioning and adjustments, with imaging guidance (e.g., fluoroscopy)"
C8004,"Simulation angiogram with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the angiogram, for subsequent therapeutic radioembolization of tumors"
C8005,"Bronchoscopy, rigid or flexible, non-thermal transbronchial ablation of lesion(s) by pulsed electric field (pef) energy, including fluoroscopic and/or ultrasound guidance, when performed, with computed tomography acquisition(s) and 3d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) of lung(s) and all mediastinal and/or hilar lymph node stations or structures, and therapeutic intervention(s)"
C8006,"Insertion of pleural-peritoneal shunt with intercostal pump chamber, including imaging, injection(s) of contrast with radiological supervision and interpretation, when performed"
C8900,"Magnetic resonance angiography with contrast, abdomen"
C8901,"Magnetic resonance angiography without contrast, abdomen"
C8902,"Magnetic resonance angiography without contrast followed by with contrast, abdomen"
C8903,"Magnetic resonance imaging with contrast, breast; unilateral"
C8904,"Magnetic resonance imaging without contrast, breast; unilateralTerminated December 31, 2018."
C8905,"Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral"
C8906,"Magnetic resonance imaging with contrast, breast; bilateral"
C8907,"Magnetic resonance imaging without contrast, breast; bilateralTerminated December 31, 2018."
C8908,"Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral"
C8909,"Magnetic resonance angiography with contrast, chest (excluding myocardium)"
C8910,"Magnetic resonance angiography without contrast, chest (excluding myocardium)"
C8911,"Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium)"
C8912,"Magnetic resonance angiography with contrast, lower extremity"
C8913,"Magnetic resonance angiography without contrast, lower extremity"
C8914,"Magnetic resonance angiography without contrast followed by with contrast, lower extremity"
C8918,"Magnetic resonance angiography with contrast, pelvis"
C8919,"Magnetic resonance angiography without contrast, pelvis"
C8920,"Magnetic resonance angiography without contrast followed by with contrast, pelvis"
C8921,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete"
C8922,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study"
C8923,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography"
C8924,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study"
C8925,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report"
C8926,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; including probe placement, image acquisition, interpretation and report"
C8927,"Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, for monitoring purposes, including probe placement, real time 2-dimensional image acquisition and interpretation leading to ongoing (continuous) assessment of (dynamically changing) cardiac pumping function and to therapeutic measures on an immediate time basis"
C8928,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report"
C8929,"Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography"
C8930,"Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision"
C8931,"Magnetic resonance angiography with contrast, spinal canal and contents"
C8932,"Magnetic resonance angiography without contrast, spinal canal and contents"
C8933,"Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents"
C8934,"Magnetic resonance angiography with contrast, upper extremity"
C8935,"Magnetic resonance angiography without contrast, upper extremity"
C8936,"Magnetic resonance angiography without contrast followed by with contrast, upper extremity"
C8937,"Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure)"
C8957,"Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump"
C9014,"Injection, cerliponase alfa, 1 mgTerminated December 31, 2018."
C9015,"Injection, c-1 esterase inhibitor (human), haegarda, 10 unitsTerminated December 31, 2018."
C9016,"Injection, triptorelin extended release, 3.75 mgTerminated December 31, 2018."
C9021,"Injection, obinutuzumab, 10 mgTerminated December 31, 2014."
C9022,"Injection, elosulfase alfa, 1mgTerminated December 31, 2014."
C9023,"Injection, testosterone undecanoate, 1 mgTerminated December 31, 2014."
C9024,"Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabineTerminated December 31, 2018."
C9025,"Injection, ramucirumab, 5 mgTerminated December 31, 2015."
C9026,"Injection, vedolizumab, 1 mgTerminated December 31, 2015."
C9027,"Injection, pembrolizumab, 1 mgTerminated December 31, 2015."
C9028,"Injection, inotuzumab ozogamicin, 0.1 mgTerminated December 31, 2018."
C9029,"Injection, guselkumab, 1 mgTerminated December 31, 2018."
C9030,"Injection, copanlisib, 1 mgTerminated December 31, 2018."
C9031,"Lutetium lu 177, dotatate, therapeutic, 1 mciTerminated December 31, 2018."
C9032,"Injection, voretigene neparvovec-rzyl, 1 billion vector genomeTerminated December 31, 2018."
C9033,"Injection, fosnetupitant 235 mg and palonosetron 0.25 mgTerminated December 31, 2018."
C9034,"Injection, dexamethasone 9%, intraocular, 1 mcgTerminated December 31, 2018."
C9035,"Injection, aripiprazole lauroxil (aristada initio), 1 mgTerminated September 30, 2019."
C9036,"Injection, patisiran, 0.1 mgTerminated September 30, 2019."
C9037,"Injection, risperidone (perseris), 0.5 mgTerminated September 30, 2019."
C9038,"Injection, mogamulizumab-kpkc, 1 mgTerminated September 30, 2019."
C9039,"Injection, plazomicin, 5 mgTerminated September 30, 2019."
C9040,"Injection, fremanezumab-vfrm, 1mgTerminated September 30, 2019."
C9041,"Injection, coagulation factor xa (recombinant), inactivated (andexxa), 10 mgTerminated June 30, 2020."
C9042,"Injection, bendamustine hcl (belrapzo), 1 mgTerminated June 30, 2019."
C9043,"Injection, levoleucovorin, 1 mgTerminated December 31, 2019."
C9044,"Injection, cemiplimab-rwlc, 1 mgTerminated September 30, 2019."
C9045,"Injection, moxetumomab pasudotox-tdfk, 0.01 mgTerminated September 30, 2019."
C9046,"Cocaine hydrochloride nasal solution (goprelto), 1 mg"
C9047,"Injection, caplacizumab-yhdp, 1 mg"
C9048,"Dexamethasone, lacrimal ophthalmic insert, 0.1 mgTerminated September 30, 2019."
C9049,"Injection, tagraxofusp-erzs, 10 mcgTerminated September 30, 2019."
C9050,"Injection, emapalumab-lzsg, 1 mgTerminated September 30, 2019."
C9051,"Injection, omadacycline, 1 mgTerminated September 30, 2019."
C9052,"Injection, ravulizumab-cwvz, 10 mgTerminated September 30, 2019."
C9053,"Injection,  crizanlizumab-tmca, 1 mgTerminated June 30, 2020."
C9054,"Injection, lefamulin (xenleta), 1 mgTerminated June 30, 2020."
C9055,"Injection, brexanolone, 1mgTerminated September 30, 2020."
C9056,"Injection, givosiran, 0.5 mgTerminated June 30, 2020."
C9057,"Injection, cetirizine hydrochloride, 1 mgTerminated June 30, 2020."
C9058,"Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo) 0.5 mgTerminated June 30, 2020."
C9059,"Injection, meloxicam, 1 mgTerminated September 30, 2020."
C9060,"Fluoroestradiol f18, diagnostic, 1 mciTerminated December 31, 2020."
C9061,"Injection, teprotumumab-trbw, 10 mgTerminated September 30, 2020."
C9062,"Injection, daratumumab 10 mg and hyaluronidase-fihjTerminated December 31, 2020."
C9063,"Injection, eptinezumab-jjmr, 1 mgTerminated September 30, 2020."
C9064,"Mitomycin pyelocalyceal instillation, 1 mgTerminated December 31, 2020."
C9065,"Injection, romidepsin, non-lyophilized (e.g. liquid), 1mgTerminated September 30, 2021."
C9066,"Injection, sacituzumab govitecan-hziy, 2.5 mgTerminated December 31, 2020."
C9067,"Gallium ga-68, dotatoc, diagnostic, 0.01 mci"
C9068,"Copper cu-64, dotatate, diagnostic, 1 millicurieTerminated March 31, 2021."
C9069,"Injection, belantamab mafodontin-blmf, 0.5 mgTerminated March 31, 2021."
C9070,"Injection, tafasitamab-cxix, 2 mgTerminated March 31, 2021."
C9071,"Injection, viltolarsen, 10 mgTerminated March 31, 2021."
C9072,"Injection, immune globulin (asceniv), 500 mgTerminated March 31, 2021."
C9073,"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseTerminated March 31, 2021."
C9074,"Injection, lumasiran, 0.5 mgTerminated June 30, 2021."
C9075,"Injection, casimersen, 10 mgTerminated September 30, 2021."
C9076,"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseTerminated September 30, 2021."
C9077,"Injection, cabotegravir and rilpivirine, 2mg/3mgTerminated September 30, 2021."
C9078,"Injection, trilaciclib, 1 mgTerminated September 30, 2021."
C9079,"Injection, evinacumab-dgnb, 5 mgTerminated September 30, 2021."
C9080,"Injection, melphalan flufenamide hydrochloride, 1 mgTerminated September 30, 2021."
C9081,"Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseTerminated December 31, 2021."
C9082,"Injection, dostarlimab-gxly, 100 mgTerminated December 31, 2021."
C9083,"Injection, amivantamab-vmjw, 10 mgTerminated December 31, 2021."
C9084,"Injection, loncastuximab tesirine-lpyl, 0.1 mgTerminated March 31, 2022."
C9085,"Injection, avalglucosidase alfa-ngpt, 4 mgTerminated March 31, 2022."
C9086,"Injection, anifrolumab-fnia, 1 mgTerminated March 31, 2022."
C9087,"Injection, cyclophosphamide, (auromedics), 10 mgTerminated March 31, 2022."
C9088,"Instillation, bupivacaine and meloxicam, 1 mg/0.03 mgTerminated September 30, 2025."
C9089,"Bupivacaine, collagen-matrix implant, 1 mg"
C9090,"Injection, plasminogen, human-tvmh, 1 mgTerminated June 30, 2022."
C9091,"Injection, sirolimus protein-bound particles, 1 mgTerminated June 30, 2022."
C9092,"Injection, triamcinolone acetonide, suprachoroidal (xipere), 1 mgTerminated June 30, 2022."
C9093,"Injection, ranibizumab, via sustained release intravitreal implant (susvimo), 0.1 mgTerminated June 30, 2022."
C9094,"Inj, sutimlimab-jome, 10 mgTerminated September 30, 2022."
C9095,"Inj, tebentafusp-tebn, 1 mcgTerminated September 30, 2022."
C9096,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgramTerminated September 30, 2022."
C9097,"Inj, faricimab-svoa, 0.1 mgTerminated September 30, 2022."
C9098,"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic doseTerminated September 30, 2022."
C9101,"Injection, oliceridine, 0.1 mg"
C9113,"Injection, pantoprazole sodium, per vialTerminated June 30, 2024."
C9121,"Injection, argatroban, per 5 mgTerminated December 31, 2016."
C9122,"Mometasone furoate sinus implant, 10 micrograms (sinuva)Terminated March 31, 2021."
C9132,"Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activityTerminated June 30, 2021."
C9133,"Factor ix (antihemophilic factor, recombinant), rixubis, per i.u.Terminated December 31, 2014."
C9134,"Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.Terminated December 31, 2014."
C9135,"Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.Terminated December 31, 2014."
C9136,"Injection, factor viii, fc fusion protein, (recombinant), per i.u.Terminated March 31, 2015."
C9137,"Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.Terminated December 31, 2016."
C9138,"Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.Terminated December 31, 2016."
C9139,"Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.Terminated December 31, 2016."
C9140,"Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.Terminated December 31, 2017."
C9141,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.Terminated June 30, 2019."
C9142,"Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mgTerminated December 31, 2022."
C9143,"Cocaine hydrochloride nasal solution (numbrino), 1 mg"
C9144,"Injection, bupivacaine (posimir), 1 mg"
C9145,"Injection, aprepitant, (aponvie), 1 mg"
C9146,"Injection, mirvetuximab soravtansine-gynx, 1 mgTerminated June 30, 2023."
C9147,"Injection, tremelimumab-actl, 1 mgTerminated June 30, 2023."
C9148,"Injection, teclistamab-cqyv, 0.5 mgTerminated June 30, 2023."
C9149,"Injection, teplizumab-mzwv, 5 mcgTerminated June 30, 2023."
C9150,"Xenon xe-129 hyperpolarized gas, diagnostic, per study doseTerminated September 30, 2024."
C9151,"Injection, pegcetacoplan, 1 mgTerminated September 30, 2023."
C9152,"Injection, aripiprazole, (abilify asimtufii), 1 mgTerminated December 31, 2023."
C9153,"Injection, amisulpride, 1 mgTerminated December 31, 2023."
C9154,"Injection, buprenorphine extended-release (brixadi), 1 mgTerminated December 31, 2023."
C9155,"Injection, epcoritamab-bysp, 0.16 mgTerminated December 31, 2023."
C9156,"Flotufolastat f 18, diagnostic, 1 millicurieTerminated December 31, 2023."
C9157,"Injection, tofersen, 1 mgTerminated December 31, 2023."
C9158,"Injection, risperidone, (uzedy), 1 mgTerminated December 31, 2023."
C9159,"Injection, prothrombin complex concentrate (human), balfaxar, per i.u. of factor ix activityTerminated March 31, 2024."
C9160,"Injection, daxibotulinumtoxina-lanm, 1 unitTerminated March 31, 2024."
C9161,"Injection, aflibercept hd, 1 mgTerminated March 31, 2024."
C9162,"Injection, avacincaptad pegol, 0.1 mgTerminated March 31, 2024."
C9163,"Injection, talquetamab-tgvs, 0.25 mgTerminated March 31, 2024."
C9164,"Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)Terminated March 31, 2024."
C9165,"Injection, elranatamab-bcmm, 1 mgTerminated March 31, 2024."
C9166,"Injection, secukinumab, intravenous, 1 mgTerminated June 30, 2024."
C9167,"Injection, adamts13, recombinant-krhn, 10 iuTerminated June 30, 2024."
C9168,"Injection, mirikizumab-mrkz, 1 mgTerminated June 30, 2024."
C9169,"Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgramTerminated December 31, 2024."
C9170,"Injection, tarlatamab-dlle, 1 mgTerminated December 31, 2024."
C9171,"Injection, pegulicianine, 1 mgTerminated December 31, 2024."
C9172,"Injection, fidanacogene elaparvovec-dzkt, per therapeutic doseTerminated December 31, 2024."
C9173,"Injection, filgrastim-txid (nypozi), biosimilar, 1 microgramTerminated June 30, 2025."
C9174,"Injection, datopotamab deruxtecan-dlnk, 1 mgTerminated September 30, 2025."
C9175,"Injection, treosulfan, 50 mgTerminated September 30, 2025."
C9248,"Injection, clevidipine butyrate, 1 mgTerminated September 30, 2025."
C9250,"Human plasma fibrin sealant, vapor-heated, solvent-detergent (artiss), 2 ml"
C9254,"Injection, lacosamide, 1 mg"
C9257,"Injection, bevacizumab, 0.25 mg"
C9275,"Injection, hexaminolevulinate hydrochloride, 100 mg, per study doseTerminated December 31, 2018."
C9285,"Lidocaine 70 mg/tetracaine 70 mg, per patch"
C9290,"Injection, bupivacaine liposome, 1 mgTerminated December 31, 2024."
C9293,"Injection, glucarpidase, 10 units"
C9300,"Injection, indigotindisulfonate sodium, 1 mgTerminated June 30, 2025."
C9301,"Obecabtagene autoleucel, up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic doseTerminated June 30, 2025."
C9302,"Injection, zanidatamab-hrii, 2 mgTerminated June 30, 2025."
C9303,"Injection, zolbetuximab-clzb, 1 mgTerminated June 30, 2025."
C9304,"Injection, marstacimab-hncq, 0.5 mgTerminated June 30, 2025."
C9305,"Injection, nipocalimab-aahu, 3 mg"
C9306,"Injection, telisotuzumab vedotin-tllv, 1 mg"
C9349,"Puraply, and puraply antimicrobial, any type, per square centimeterTerminated December 31, 2016."
C9352,"Microporous collagen implantable tube (neuragen nerve guide), per centimeter length"
C9353,"Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter length"
C9354,"Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeter"
C9355,"Collagen nerve cuff (neuromatrix), per 0.5 centimeter length"
C9356,"Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter"
C9358,"Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimeters"
C9359,"Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 cc"
C9360,"Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimeters"
C9361,"Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter length"
C9362,"Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 cc"
C9363,"Skin substitute, integra meshed bilayer wound matrix, per square centimeter"
C9364,"Porcine implant, permacol, per square centimeter"
C9399,Unclassified drugs or biologicals
C9407,"Iodine i-131 iobenguane, diagnostic, 1 millicurieTerminated December 31, 2019."
C9408,"Iodine i-131 iobenguane, therapeutic, 1 millicurieTerminated December 31, 2019."
C9441,"Injection, ferric carboxymaltose, 1 mgTerminated June 30, 2014."
C9442,"Injection, belinostat, 10 mgTerminated December 31, 2015."
C9443,"Injection, dalbavancin, 10 mgTerminated December 31, 2015."
C9444,"Injection, oritavancin, 10 mgTerminated December 31, 2015."
C9445,"Injection, c-1 esterase inhibitor (recombinant), ruconest, 10 unitsTerminated December 31, 2015."
C9446,"Injection, tedizolid phosphate, 1 mgTerminated December 31, 2015."
C9447,"Injection, phenylephrine and ketorolac, 4 ml vialTerminated September 30, 2019."
C9448,"Netupitant 300 mg and palonosetron 0.5 mg, oralTerminated June 30, 2015."
C9449,"Injection, blinatumomab, 1 mcgTerminated December 31, 2015."
C9450,"Injection, fluocinolone acetonide intravitreal implant, 0.01 mgTerminated December 31, 2015."
C9451,"Injection, peramivir, 1 mgTerminated December 31, 2015."
C9452,"Injection, ceftolozane 50 mg and tazobactam 25 mgTerminated December 31, 2015."
C9453,"Injection, nivolumab, 1 mgTerminated December 31, 2015."
C9454,"Injection, pasireotide long acting, 1 mgTerminated December 31, 2015."
C9455,"Injection, siltuximab, 10 mgTerminated December 31, 2015."
C9456,"Injection, isavuconazonium sulfate, 1 mgTerminated December 31, 2015."
C9457,"Injection, sulfur hexafluoride lipid microsphere, per mlTerminated December 31, 2015."
C9458,"Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuriesTerminated June 30, 2016."
C9459,"Flutemetamol f18, diagnostic, per study dose, up to 5 millicuriesTerminated June 30, 2016."
C9460,"Injection, cangrelor, 1 mg"
C9461,"Choline c 11, diagnostic, per study doseTerminated December 31, 2016."
C9462,"Injection, delafloxacin, 1 mg"
C9463,"Injection, aprepitant, 1 mgTerminated December 31, 2018."
C9464,"Injection, rolapitant, 0.5 mgTerminated December 31, 2018."
C9465,"Hyaluronan or derivative, durolane, for intra-articular injection, per doseTerminated December 31, 2018."
C9466,"Injection, benralizumab, 1 mgTerminated December 31, 2018."
C9467,"Injection, rituximab and hyaluronidase, 10 mgTerminated December 31, 2018."
C9468,"Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.Terminated December 31, 2018."
C9469,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mgTerminated June 30, 2018."
C9470,"Injection, aripiprazole lauroxil, 1 mgTerminated December 31, 2016."
C9471,"Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mgTerminated December 31, 2016."
C9472,"Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)Terminated December 31, 2016."
C9473,"Injection, mepolizumab, 1 mgTerminated December 31, 2016."
C9474,"Injection, irinotecan liposome, 1 mgTerminated December 31, 2016."
C9475,"Injection, necitumumab, 1 mgTerminated December 31, 2016."
C9476,"Injection, daratumumab, 10 mgTerminated December 31, 2016."
C9477,"Injection, elotuzumab, 1 mgTerminated December 31, 2016."
C9478,"Injection, sebelipase alfa, 1 mgTerminated December 31, 2016."
C9479,"Instillation, ciprofloxacin otic suspension, 6 mgTerminated December 31, 2016."
C9480,"Injection, trabectedin, 0.1 mgTerminated December 31, 2016."
C9481,"Injection, reslizumab, 1 mgTerminated December 31, 2016."
C9482,"Injection, sotalol hydrochloride, 1 mg"
C9483,"Injection, atezolizumab, 10 mgTerminated December 31, 2017."
C9484,"Injection, eteplirsen, 10 mgTerminated December 31, 2017."
C9485,"Injection, olaratumab, 10 mgTerminated December 31, 2017."
C9486,"Injection, granisetron extended release, 0.1 mgTerminated December 31, 2017."
C9487,"Ustekinumab, for intravenous injection, 1 mgTerminated June 30, 2017."
C9488,"Injection, conivaptan hydrochloride, 1 mg"
C9489,"Injection, nusinersen, 0.1 mgTerminated December 31, 2017."
C9490,"Injection, bezlotoxumab, 10 mgTerminated December 31, 2017."
C9491,"Injection, avelumab, 10 mgTerminated December 31, 2017."
C9492,"Injection, durvalumab, 10 mgTerminated December 31, 2018."
C9493,"Injection, edaravone, 1 mgTerminated December 31, 2018."
C9494,"Injection, ocrelizumab, 1 mgTerminated December 31, 2017."
C9497,"Loxapine, inhalation powder, 10 mgTerminated December 31, 2018."
C9507,"Plasma, high titer covid-19 convalescent, each unit"
C9600,"Percutaneous transcatheter placement of drug eluting intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch"
C9601,"Percutaneous transcatheter placement of drug-eluting intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)"
C9602,"Percutaneous transluminal coronary atherectomy, with drug eluting intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch"
C9603,"Percutaneous transluminal coronary atherectomy, with drug-eluting intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure)"
C9604,"Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel"
C9605,"Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure)"
C9606,"Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel"
C9607,"Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; single vessel"
C9608,"Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of drug-eluting intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure)"
C9610,"Catheter, transluminal drug delivery with or without angioplasty, coronary, non-laser (insertable)"
C9724,"Endoscopic full-thickness plication of the stomach using endoscopic plication system (eps); includes endoscopyTerminated December 31, 2015."
C9725,Placement of endorectal intracavitary applicator for high intensity brachytherapy
C9726,"Placement and removal (if performed) of applicator into breast for intraoperative radiation therapy, add-on to primary breast procedure"
C9727,Insertion of implants into the soft palate; minimum of three implants
C9728,"Placement of interstitial device(s) for radiation therapy/surgery guidance (e.g., fiducial markers, dosimeter), for other than the following sites (any approach): abdomen, pelvis, prostate, retroperitoneum, thorax, single or multiple"
C9733,Non-ophthalmic fluorescent vascular angiography
C9734,"Focused ultrasound ablation/therapeutic intervention, other than uterine leiomyomata, with magnetic resonance (mr) guidance"
C9735,"Anoscopy; with directed submucosal injection(s), any substanceTerminated December 31, 2014."
C9737,"Laparoscopy, surgical, esophageal sphincter augmentation with device (e.g., magnetic band)Terminated June 30, 2015."
C9738,Adjunctive blue light cystoscopy with fluorescent imaging agent  (list separately in addition to code for primary procedure)
C9739,"Cystourethroscopy, with insertion of transprostatic implant; 1 to 3 implants"
C9740,"Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants"
C9741,"Right heart catheterization with implantation of wireless pressure sensor in the pulmonary artery, including any type of measurement, angiography, imaging supervision, interpretation, and reportTerminated December 31, 2018."
C9742,"Laryngoscopy, flexible fiberoptic, with injection into vocal cord(s), therapeutic, including diagnostic laryngoscopy, if performedTerminated December 31, 2016."
C9743,"Injection/implantation of bulking or spacer material (any type) with or without image guidance (not to be used if a more specific code applies)Terminated June 30, 2016."
C9744,"Ultrasound, abdominal, with contrastTerminated December 31, 2018."
C9745,"Nasal endoscopy, surgical; balloon dilation of eustachian tubeTerminated December 31, 2020."
C9746,"Transperineal implantation of permanent adjustable balloon continence device, with cystourethroscopy, when performed and/or fluoroscopy, when performedTerminated June 30, 2019."
C9747,"Ablation of prostate, transrectal, high intensity focused ultrasound (hifu), including imaging guidanceTerminated December 31, 2020."
C9748,"Transurethral destruction of prostate tissue; by radiofrequency water vapor (steam) thermal therapyTerminated December 31, 2018."
C9749,"Repair of nasal vestibular lateral wall stenosis with implant(s)Terminated December 31, 2020."
C9750,"Insertion or removal and replacement of intracardiac ischemia monitoring system including imaging supervision and interpretation and peri-operative interrogation and programming; complete system (includes device and electrode)Terminated December 31, 2018."
C9751,"Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by microwave energy, including  fluoroscopic guidance, when performed, with computed tomography acquisition(s) and 3-d rendering, computer-assisted, image-guided navigation, and endobronchial ultrasound (ebus) guided transtracheal and/or transbronchial sampling (e.g., aspiration[s]/biopsy[ies]) and all mediastinal and/or hilar lymph node stations or structures and therapeutic intervention(s)"
C9752,"Destruction of intraosseous basivertebral nerve, first two vertebral bodies, including imaging guidance (e.g., fluoroscopy), lumbar/sacrumTerminated December 31, 2021."
C9753,"Destruction of intraosseous basivertebral nerve, each additional vertebral body, including imaging guidance (e.g., fluoroscopy), lumbar/sacrum (list separately in addition to code for primary procedure)Terminated December 31, 2021."
C9754,"Creation of arteriovenous fistula,  percutaneous; direct, any site, including  all imaging and radiologic supervision and interpretation, when performed and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization, when performed)Terminated June 30, 2020."
C9755,"Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, when performed) and fistulogram(s), angiography, venography, and/or ultrasound, with radiologic supervision and interpretation, when performedTerminated June 30, 2020."
C9756,Intraoperative near-infrared fluorescence lymphatic mapping of lymph node(s) (sentinel or tumor draining) with administration of indocyanine green (icg) (list separately in addition to code for primary procedure)
C9757,"Laminotomy (hemilaminectomy), with decompression of nerve root(s), including partial facetectomy, foraminotomy and excision of herniated intervertebral disc, and repair of annular defect with implantation of bone anchored annular closure device, including annular defect  measurement, alignment and sizing assessment, and image guidance; 1 interspace, lumbar"
C9758,"Blinded procedure for nyha class iii/iv heart failure; transcatheter implantation of interatrial shunt or placebo control, including right heart catheterization, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study"
C9759,"Transcatheter intraoperative blood vessel microinfusion(s) (e.g., intraluminal, vascular wall and/or perivascular) therapy, any vessel, including radiological supervision and interpretation, when performed"
C9760,"Non-randomized, non-blinded procedure for nyha class ii, iii, iv heart failure; transcatheter implantation of interatrial shunt, including right and left heart catheterization, transeptal puncture, trans-esophageal echocardiography (tee)/intracardiac echocardiography (ice), and all imaging with or without guidance (e.g., ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study"
C9761,"Cystourethroscopy, with ureteroscopy and/or pyeloscopy, with lithotripsy, and ureteral catheterization for steerable vacuum aspiration of the kidney, collecting system, ureter, bladder, and urethra if applicable (must use a steerable ureteral catheter)"
C9762,"Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging"
C9763,"Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging"
C9764,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, includes angioplasty within the same vessel(s), when performed"
C9765,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty within the same vessel(s), when performed"
C9766,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel(s), when performed"
C9767,"Revascularization, endovascular, open or percutaneous, lower extremity artery(ies), except tibial/peroneal; with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel(s), when performed"
C9768,Endoscopic ultrasound-guided direct measurement of hepatic portosystemic pressure gradient by any method (list separately in addition to code for primary procedure)
C9769,"Cystourethroscopy, with insertion of temporary prostatic implant/stent with fixation/anchor and incisional strutsTerminated December 31, 2024."
C9770,"Vitrectomy, mechanical, pars plana approach, with subretinal injection of pharmacologic/biologic agentTerminated December 31, 2023."
C9771,"Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateralTerminated December 31, 2023."
C9772,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies), with intravascular lithotripsy, includes angioplasty within the same vessel (s), when performed"
C9773,"Revascularization, endovascular, open or percutaneous,  tibial/peroneal artery(ies); with intravascular lithotripsy, and transluminal stent placement(s), includes angioplasty  within the same vessel(s), when performed"
C9774,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and atherectomy, includes angioplasty within the same vessel (s), when performed"
C9775,"Revascularization, endovascular, open or percutaneous, tibial/peroneal artery(ies); with intravascular lithotripsy and transluminal stent placement(s), and atherectomy, includes angioplasty within the same vessel (s), when performed"
C9776,"Intraoperative near-infrared fluorescence imaging of major extra-hepatic bile duct(s) (e.g., cystic duct, common bile duct and common hepatic duct) with intravenous administration of indocyanine green (icg) (list separately in addition to code for primary procedure)"
C9777,"Esophageal mucosal integrity testing by electrical impedance, transoral, includes esophagoscopy or esophagogastroduodenoscopy"
C9778,"Colpopexy, vaginal; minimally invasive extra-peritoneal approach (sacrospinous)"
C9779,"Endoscopic submucosal dissection (esd), including endoscopy or colonoscopy, mucosal closure, when performed"
C9780,"Insertion of central venous catheter through central venous occlusion via inferior and superior approaches (e.g., inside-out technique), including imaging guidance"
C9781,"Arthroscopy, shoulder, surgical; with implantation of subacromial spacer (e.g., balloon), includes debridement (e.g., limited or extensive), subacromial decompression, acromioplasty, and biceps tenodesis when performed"
C9782,"Blinded procedure for new york heart association (nyha) class ii or iii heart failure, or canadian cardiovascular society (ccs) class iii or iv chronic refractory angina; transcatheter intramyocardial transplantation of autologous bone marrow cells (e.g., mononuclear) or placebo control, autologous bone marrow harvesting and preparation for transplantation, left heart catheterization including ventriculography, all laboratory services, and all imaging with or without guidance (e.g., transthoracic echocardiography, ultrasound, fluoroscopy), performed in an approved investigational device exemption (ide) study"
C9783,"Blinded procedure for transcatheter implantation of coronary sinus reduction device or placebo control, including vascular access and closure, right heart catheterization, venous and coronary sinus angiography, imaging guidance and supervision and interpretation when performed in an approved investigational device exemption (ide) study"
C9784,"Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components"
C9785,"Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components"
C9786,"Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and reportTerminated December 31, 2024."
C9787,"Gastric electrophysiology mapping with simultaneous patient symptom profilingTerminated June 30, 2024."
C9788,"Opto-acoustic imaging, breast (including axilla when performed), unilateral, with image documentation, analysis and report, obtained with ultrasound examinationTerminated December 31, 2023."
C9789,"Instillation of anti-neoplastic pharmacologic/biologic agent into renal pelvis, any method, including all imaging guidance, including volumetric measurement if performed"
C9790,"Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidanceTerminated June 30, 2024."
C9791,"Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent"
C9792,"Blinded or nonblinded procedure for symptomatic new york heart association (nyha) class ii, iii, iva heart failure; transcatheter implantation of left atrial to coronary sinus shunt using jugular vein access, including all imaging necessary to intra procedurally map the coronary sinus for optimal shunt placement (e.g., tee or ice ultrasound, fluoroscopy), performed under general anesthesia in an approved investigational device exemption (ide) study)"
C9793,"3d predictive model generation for pre-planning of a cardiac procedure, using data from cardiac computed tomographic angiography and/or magnetic resonance imaging with report"
C9794,"Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)Terminated December 31, 2024."
C9795,"Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractionsTerminated December 31, 2024."
C9796,"Repair of enterocutaneous fistula small intestine or colon (excluding anorectal fistula) with plug (e.g., porcine small intestine submucosa [sis])"
C9797,"Vascular embolization or occlusion procedure with use of a pressure-generating catheter (e.g., one-way valve, intermittently occluding), inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction"
C9800,"Dermal injection procedure(s) for facial lipodystrophy syndrome (lds) and provision of radiesse or sculptra dermal filler, including all items and suppliesTerminated December 31, 2016."
C9803,"Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen sourceTerminated December 31, 2023."
C9804,"Elastomeric infusion pump (e.g., on-q* pump with bolus), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)"
C9806,"Rotary peristaltic infusion pump (e.g., ambit pump), including catheter and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)"
C9807,"Nerve stimulator, percutaneous, peripheral (e.g., sprint peripheral nerve stimulation system), including electrode and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)"
C9808,"Nerve cryoablation probe (e.g., cryoice, cryosphere, cryosphere max, cryoice cryosphere, cryoice cryo2), including probe and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)"
C9809,"Cryoablation needle (e.g., iovera system), including needle/tip and all disposable system components, non-opioid medical device (must be a qualifying medicare non-opioid medical device for post-surgical pain relief in accordance with section 4135 of the caa, 2023)"
C9898,Radiolabeled product provided during a hospital inpatient stay
C9899,"Implanted prosthetic device, payable only for inpatients who do not have inpatient coverage"
C9901,"Endoscopic defect closure within the entire gastrointestinal tract, including upper endoscopy (including diagnostic, if performed) or colonoscopy (including diagnostic, if performed), with all system and tissue anchoring components"
E0100,"Cane, includes canes of all materials, adjustable or fixed, with tip"
E0105,"Cane, quad or three prong, includes canes of all materials, adjustable or fixed, with tips"
E0110,"Crutches, forearm, includes crutches of various materials, adjustable or fixed, pair, complete with tips and handgrips"
E0111,"Crutch forearm, includes crutches of various materials, adjustable or fixed, each, with tip and handgrips"
E0112,"Crutches underarm, wood, adjustable or fixed, pair, with pads, tips and handgrips"
E0113,"Crutch underarm, wood, adjustable or fixed, each, with pad, tip and handgrip"
E0114,"Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips"
E0116,"Crutch, underarm, other than wood, adjustable or fixed, with pad, tip, handgrip, with or without shock absorber, each"
E0117,"Crutch, underarm, articulating, spring assisted, each"
E0118,"Crutch substitute, lower leg platform, with or without wheels, each"
E0130,"Walker, rigid (pickup), adjustable or fixed height"
E0135,"Walker, folding (pickup), adjustable or fixed height"
E0140,"Walker, with trunk support, adjustable or fixed height, any type"
E0141,"Walker, rigid, wheeled, adjustable or fixed height"
E0143,"Walker, folding, wheeled, adjustable or fixed height"
E0144,"Walker, enclosed, four sided framed, rigid or folding, wheeled with posterior seat"
E0147,"Walker, heavy duty, multiple braking system, variable wheel resistance"
E0148,"Walker, heavy duty, without wheels, rigid or folding, any type, each"
E0149,"Walker, heavy duty, wheeled, rigid or folding, any type"
E0150,"Combination wheeled walker with seat and transport chair, folding, adjustable or fixed height"
E0152,"Walker, battery powered, wheeled, folding, adjustable or fixed height"
E0153,"Platform attachment, forearm crutch, each"
E0154,"Platform attachment, walker, each"
E0155,"Wheel attachment, rigid pick-up walker, per pair"
E0156,"Seat attachment, walker"
E0157,"Crutch attachment, walker, each"
E0158,"Leg extensions for walker, per set of four (4)"
E0159,"Brake attachment for wheeled walker, replacement, each"
E0160,"Sitz type bath or equipment, portable, used with or without commode"
E0161,"Sitz type bath or equipment, portable, used with or without commode, with faucet attachment/s"
E0162,Sitz bath chair
E0163,"Commode chair, mobile or stationary, with fixed arms"
E0165,"Commode chair, mobile or stationary, with detachable arms"
E0167,"Pail or pan for use with commode chair, replacement only"
E0168,"Commode chair, extra wide and/or heavy duty, stationary or mobile, with or without arms, any type, each"
E0170,"Commode chair with integrated seat lift mechanism, electric, any type"
E0171,"Commode chair with integrated seat lift mechanism, non-electric, any type"
E0172,"Seat lift mechanism placed over or on top of toilet, any type"
E0175,"Foot rest, for use with commode chair, each"
E0181,"Powered pressure reducing mattress overlay/pad, alternating, with pump, includes heavy duty"
E0182,"Pump for alternating pressure pad, for replacement only"
E0183,"Powered pressure reducing underlay/pad, alternating, with pump, includes heavy duty"
E0184,Dry pressure mattress
E0185,"Gel or gel-like pressure pad for mattress, standard mattress length and width"
E0186,Air pressure mattress
E0187,Water pressure mattress
E0188,Synthetic sheepskin pad
E0189,"Lambswool sheepskin pad, any size"
E0190,"Positioning cushion/pillow/wedge, any shape or size, includes all components and accessories"
E0191,"Heel or elbow protector, each"
E0193,Powered air flotation bed (low air loss therapy)
E0194,Air fluidized bed
E0196,Gel pressure mattress
E0197,"Air pressure pad for mattress, standard mattress length and width"
E0198,"Water pressure pad for mattress, standard mattress length and width"
E0199,"Dry pressure pad for mattress, standard mattress length and width"
E0200,"Heat lamp, without stand (table model), includes bulb, or infrared element"
E0201,"Penile contracture device, manual, greater than 3 lbs traction force"
E0202,Phototherapy (bilirubin) light with photometer
E0203,"Therapeutic lightbox, minimum 10,000 lux, table top model"
E0205,"Heat lamp, with stand, includes bulb, or infrared element"
E0210,"Electric heat pad, standard"
E0215,"Electric heat pad, moist"
E0217,Water circulating heat pad with pump
E0218,"Fluid circulating cold pad with pump, any type"
E0221,Infrared heating pad system
E0225,"Hydrocollator unit, includes pads"
E0231,"Non-contact wound warming device (temperature control unit, ac adapter and power cord) for use with warming card and wound cover"
E0232,Warming card for use with the non contact wound warming device and non contact wound warming wound cover
E0235,"Paraffin bath unit, portable (see medical supply code a4265 for paraffin)"
E0236,Pump for water circulating pad
E0239,"Hydrocollator unit, portable"
E0240,"Bath/shower chair, with or without wheels, any size"
E0241,"Bath tub wall rail, each"
E0242,"Bath tub rail, floor base"
E0243,"Toilet rail, each"
E0244,Raised toilet seat
E0245,Tub stool or bench
E0246,Transfer tub rail attachment
E0247,Transfer bench for tub or toilet with or without commode opening
E0248,"Transfer bench, heavy duty, for tub or toilet with or without commode opening"
E0249,"Pad for water circulating heat unit, for replacement only"
E0250,"Hospital bed, fixed height, with any type side rails, with mattress"
E0251,"Hospital bed, fixed height, with any type side rails, without mattress"
E0255,"Hospital bed, variable height, hi-lo, with any type side rails, with mattress"
E0256,"Hospital bed, variable height, hi-lo, with any type side rails, without mattress"
E0260,"Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress"
E0261,"Hospital bed, semi-electric (head and foot adjustment), with any type side rails, without mattress"
E0265,"Hospital bed, total electric (head, foot and height adjustments), with any type side rails, with mattress"
E0266,"Hospital bed, total electric (head, foot and height adjustments), with any type side rails, without mattress"
E0270,"Hospital bed, institutional type includes: oscillating, circulating and stryker frame, with mattress"
E0271,"Mattress, innerspring"
E0272,"Mattress, foam rubber"
E0273,Bed board
E0274,Over-bed table
E0275,"Bed pan, standard, metal or plastic"
E0276,"Bed pan, fracture, metal or plastic"
E0277,Powered pressure-reducing air mattress
E0280,"Bed cradle, any type"
E0290,"Hospital bed, fixed height, without side rails, with mattress"
E0291,"Hospital bed, fixed height, without side rails, without mattress"
E0292,"Hospital bed, variable height, hi-lo, without side rails, with mattress"
E0293,"Hospital bed, variable height, hi-lo, without side rails, without mattress"
E0294,"Hospital bed, semi-electric (head and foot adjustment), without side rails, with mattress"
E0295,"Hospital bed, semi-electric (head and foot adjustment), without side rails, without mattress"
E0296,"Hospital bed, total electric (head, foot and height adjustments), without side rails, with mattress"
E0297,"Hospital bed, total electric (head, foot and height adjustments), without side rails, without mattress"
E0300,"Pediatric crib, hospital grade, fully enclosed, with or without top enclosure"
E0301,"Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, without mattress"
E0302,"Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, without mattress"
E0303,"Hospital bed, heavy duty, extra wide, with weight capacity greater than 350 pounds, but less than or equal to 600 pounds, with any type side rails, with mattress"
E0304,"Hospital bed, extra heavy duty, extra wide, with weight capacity greater than 600 pounds, with any type side rails, with mattress"
E0305,"Bed side rails, half length"
E0310,"Bed side rails, full length"
E0315,"Bed accessory: board, table, or support device, any type"
E0316,"Safety enclosure frame/canopy for use with hospital bed, any type"
E0325,"Urinal; male, jug-type, any material"
E0326,"Urinal; female, jug-type, any material"
E0328,"Hospital bed, pediatric, manual, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress"
E0329,"Hospital bed, pediatric, electric or semi-electric, 360 degree side enclosures, top of headboard, footboard and side rails up to 24 inches above the spring, includes mattress"
E0350,Control unit for electronic bowel irrigation/evacuation system
E0352,"Disposable pack (water reservoir bag, speculum, valving mechanism and collection bag/box) for use with the electronic bowel irrigation/evacuation system"
E0370,Air pressure elevator for heel
E0371,"Nonpowered advanced pressure reducing overlay for mattress, standard mattress length and width"
E0372,"Powered air overlay for mattress, standard mattress length and width"
E0373,Nonpowered advanced pressure reducing mattress
E0424,"Stationary compressed gaseous oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing"
E0425,"Stationary compressed gas system, purchase; includes regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing"
E0430,"Portable gaseous oxygen system, purchase; includes regulator, flowmeter, humidifier, cannula or mask, and tubing"
E0431,"Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing"
E0433,"Portable liquid oxygen system, rental; home liquefier used to fill portable liquid oxygen containers, includes portable containers, regulator, flowmeter, humidifier, cannula or mask and tubing, with or without supply reservoir and contents gauge"
E0434,"Portable liquid oxygen system, rental; includes portable container, supply reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or mask, and tubing"
E0435,"Portable liquid oxygen system, purchase; includes portable container, supply reservoir, flowmeter, humidifier, contents gauge, cannula or mask, tubing and refill adaptor"
E0439,"Stationary liquid oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, & tubing"
E0440,"Stationary liquid oxygen system, purchase; includes use of reservoir, contents indicator, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing"
E0441,"Stationary oxygen contents, gaseous, 1 month's supply = 1 unit"
E0442,"Stationary oxygen contents, liquid, 1 month's supply = 1 unit"
E0443,"Portable oxygen contents, gaseous, 1 month's supply = 1 unit"
E0444,"Portable oxygen contents, liquid, 1 month's supply = 1 unit"
E0445,Oximeter device for measuring blood oxygen levels non-invasively
E0446,"Topical oxygen delivery system, not otherwise specified, includes all supplies and accessories"
E0447,"Portable oxygen contents, liquid, 1 month's supply = 1 unit, prescribed amount at rest or nighttime exceeds 4 liters per minute (lpm)"
E0450,"Volume control ventilator, without pressure support mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)Terminated December 31, 2015."
E0455,"Oxygen tent, excluding croup or pediatric tents"
E0457,Chest shell (cuirass)
E0459,Chest wrap
E0460,"Negative pressure ventilator; portable or stationaryTerminated December 31, 2015."
E0461,"Volume control ventilator, without pressure support mode, may include pressure control mode, used with non-invasive interface (e.g., mask)Terminated December 31, 2015."
E0462,Rocking bed with or without side rails
E0463,"Pressure support ventilator with volume control mode, may include pressure control mode, used with invasive interface (e.g., tracheostomy tube)Terminated December 31, 2015."
E0464,"Pressure support ventilator with volume control mode, may include pressure control mode, used with non-invasive interface (e.g., mask)Terminated December 31, 2015."
E0465,"Home ventilator, any type, used with invasive interface, (e.g., tracheostomy tube)"
E0466,"Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)"
E0467,"Home ventilator, multi-function respiratory device, also performs any or all of the additional functions of oxygen concentration, drug nebulization, aspiration, and cough stimulation, includes all accessories, components and supplies for all functions"
E0468,"Home ventilator, dual-function respiratory device, also performs additional function of cough stimulation, includes all accessories, components and supplies for all functions"
E0469,"Lung expansion airway clearance, continuous high frequency oscillation, and nebulization device"
E0470,"Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)"
E0471,"Respiratory assist device, bi-level pressure capability, with back-up rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)"
E0472,"Respiratory assist device, bi-level pressure capability, with backup rate feature, used with invasive interface, e.g., tracheostomy tube (intermittent assist device with continuous positive airway pressure device)"
E0480,"Percussor, electric or pneumatic, home model"
E0481,Intrapulmonary percussive ventilation system and related accessories
E0482,"Cough stimulating device, alternating positive and negative airway pressure"
E0483,"High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each"
E0484,"Oscillatory positive expiratory pressure device, non-electric, any type, each"
E0485,"Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, prefabricated, includes fitting and adjustment"
E0486,"Oral device/appliance used to reduce upper airway collapsibility, adjustable or non-adjustable, custom fabricated, includes fitting and adjustment"
E0487,"Spirometer, electronic, includes all accessories"
E0490,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by hardware remote"
E0491,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by hardware remote, 90-day supply"
E0492,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone application"
E0493,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supply"
E0500,"Ippb machine, all types, with built-in nebulization; manual or automatic valves; internal or external power source"
E0530,"Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any type"
E0550,"Humidifier, durable for extensive supplemental humidification during ippb treatments or oxygen delivery"
E0555,"Humidifier, durable, glass or autoclavable plastic bottle type, for use with regulator or flowmeter"
E0560,"Humidifier, durable for supplemental humidification during ippb treatment or oxygen delivery"
E0561,"Humidifier, non-heated, used with positive airway pressure device"
E0562,"Humidifier, heated, used with positive airway pressure device"
E0565,"Compressor, air power source for equipment which is not self-contained or cylinder driven"
E0570,"Nebulizer, with compressor"
E0572,"Aerosol compressor, adjustable pressure, light duty for intermittent use"
E0574,Ultrasonic/electronic aerosol generator with small volume nebulizer
E0575,"Nebulizer, ultrasonic, large volume"
E0580,"Nebulizer, durable, glass or autoclavable plastic, bottle type, for use with regulator or flowmeter"
E0585,"Nebulizer, with compressor and heater"
E0600,"Respiratory suction pump, home model, portable or stationary, electric"
E0601,Continuous positive airway pressure (cpap) device
E0602,"Breast pump, manual, any type"
E0603,"Breast pump, electric (ac and/or dc), any type"
E0604,"Breast pump, hospital grade, electric (ac and / or dc), any type"
E0605,"Vaporizer, room type"
E0606,Postural drainage board
E0607,Home blood glucose monitor
E0610,"Pacemaker monitor, self-contained, (checks battery depletion, includes audible and visible check systems)"
E0615,"Pacemaker monitor, self contained, checks battery depletion and other pacemaker components, includes digital/visible check systems"
E0616,"Implantable cardiac event recorder with memory, activator and programmer"
E0617,External defibrillator with integrated electrocardiogram analysis
E0618,"Apnea monitor, without recording feature"
E0619,"Apnea monitor, with recording feature"
E0620,"Skin piercing device for collection of capillary blood, laser, each"
E0621,"Sling or seat, patient lift, canvas or nylon"
E0625,"Patient lift, bathroom or toilet, not otherwise classified"
E0627,"Seat lift mechanism, electric, any type"
E0628,"Separate seat lift mechanism for use with patient owned furniture-electricTerminated December 31, 2016."
E0629,"Seat lift mechanism, non-electric, any type"
E0630,"Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)"
E0635,"Patient lift, electric with seat or sling"
E0636,"Multipositional patient support system, with integrated lift, patient accessible controls"
E0637,"Combination sit to stand frame/table system, any size including pediatric, with seat lift feature, with or without wheels"
E0638,"Standing frame/table system, one position (e.g., upright, supine or prone stander), any size including pediatric, with or without wheels"
E0639,"Patient lift, moveable from room to room with disassembly and reassembly, includes all components/accessories"
E0640,"Patient lift, fixed system, includes all components/accessories"
E0641,"Standing frame/table system, multi-position (e.g., three-way stander), any size including pediatric, with or without wheels"
E0642,"Standing frame/table system, mobile (dynamic stander), any size including pediatric"
E0650,"Pneumatic compressor, non-segmental home model"
E0651,"Pneumatic compressor, segmental home model without calibrated gradient pressure"
E0652,"Pneumatic compressor, segmental home model with calibrated gradient pressure"
E0655,"Non-segmental pneumatic appliance for use with pneumatic compressor, half arm"
E0656,"Segmental pneumatic appliance for use with pneumatic compressor, trunk"
E0657,"Segmental pneumatic appliance for use with pneumatic compressor, chest"
E0658,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest"
E0659,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest"
E0660,"Non-segmental pneumatic appliance for use with pneumatic compressor, full leg"
E0665,"Non-segmental pneumatic appliance for use with pneumatic compressor, full arm"
E0666,"Non-segmental pneumatic appliance for use with pneumatic compressor, half leg"
E0667,"Segmental pneumatic appliance for use with pneumatic compressor, full leg"
E0668,"Segmental pneumatic appliance for use with pneumatic compressor, full arm"
E0669,"Segmental pneumatic appliance for use with pneumatic compressor, half leg"
E0670,"Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full legs and trunk"
E0671,"Segmental gradient pressure pneumatic appliance, full leg"
E0672,"Segmental gradient pressure pneumatic appliance, full arm"
E0673,"Segmental gradient pressure pneumatic appliance, half leg"
E0675,"Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system)"
E0676,"Intermittent limb compression device (includes all accessories), not otherwise specified"
E0677,"Non-pneumatic sequential compression garment, trunk"
E0678,"Non-pneumatic sequential compression garment, full leg"
E0679,"Non-pneumatic sequential compression garment, half leg"
E0680,Non-pneumatic compression controller with sequential calibrated gradient pressure
E0681,Non-pneumatic compression controller without calibrated gradient pressure
E0682,"Non-pneumatic sequential compression garment, full arm"
E0683,"Non-pneumatic, non-sequential, peristaltic wave compression pump"
E0691,"Ultraviolet light therapy system, includes bulbs/lamps, timer and eye protection; treatment area 2 square feet or less"
E0692,"Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 4 foot panel"
E0693,"Ultraviolet light therapy system panel, includes bulbs/lamps, timer and eye protection, 6 foot panel"
E0694,"Ultraviolet multidirectional light therapy system in 6 foot cabinet, includes bulbs/lamps, timer and eye protection"
E0700,"Safety equipment, device or accessory, any type"
E0705,"Transfer device, any type, each"
E0710,"Restraints, any type (body, chest, wrist or ankle)"
E0711,"Upper extremity medical tubing/lines enclosure or covering device, restricts elbow range of motion"
E0715,Intravaginal device intended to strengthen pelvic floor muscles during kegel exercises
E0716,Supplies and accessories for intravaginal device intended to strengthen pelvic floor muscles during kegel exercises
E0720,"Transcutaneous electrical nerve stimulation (tens) device, two lead, localized stimulation"
E0721,Transcutaneous electrical nerve stimulator for nerves in the auricular region
E0730,"Transcutaneous electrical nerve stimulation (tens) device, four or more leads, for multiple nerve stimulation"
E0731,Form fitting conductive garment for delivery of tens or nmes (with conductive fibers separated from the patient's skin by layers of fabric)
E0732,"Cranial electrotherapy stimulation (ces) system, any type"
E0733,Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerve
E0734,External upper limb tremor stimulator of the peripheral nerves of the wrist
E0735,Non-invasive vagus nerve stimulator
E0736,Transcutaneous tibial nerve stimulator
E0737,"Transcutaneous tibial nerve stimulator, controlled by phone application"
E0738,"Upper extremity rehabilitation system providing active assistance to facilitate muscle re-education, include microprocessor, all components and accessories"
E0739,"Rehabilitation system with interactive interface providing active assistance in rehabilitation therapy, includes all components and accessories, motors, microprocessors, sensors"
E0740,"Non-implanted pelvic floor electrical stimulator, complete system"
E0743,"External lower extremity nerve stimulator for restless legs syndrome, each"
E0744,Neuromuscular stimulator for scoliosis
E0745,"Neuromuscular stimulator, electronic shock unit"
E0746,"Electromyography (emg), biofeedback device"
E0747,"Osteogenesis stimulator, electrical, non-invasive, other than spinal applications"
E0748,"Osteogenesis stimulator, electrical, non-invasive, spinal applications"
E0749,"Osteogenesis stimulator, electrical, surgically implanted"
E0755,Electronic salivary reflex stimulator (intra-oral/non-invasive)
E0760,"Osteogenesis stimulator, low intensity ultrasound, non-invasive"
E0761,"Non-thermal pulsed high frequency radiowaves, high peak power electromagnetic energy treatment device"
E0762,"Transcutaneous electrical joint stimulation device system, includes all accessories"
E0764,"Functional neuromuscular stimulation, transcutaneous stimulation of sequential muscle groups of ambulation with computer control, used for walking by spinal cord injured, entire system, after completion of training program"
E0765,"Fda approved nerve stimulator, for treatment of nausea and vomiting"
E0766,"Electrical stimulation device used for cancer treatment, includes all accessories, any type"
E0767,"Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories"
E0769,"Electrical stimulation or electromagnetic wound treatment device, not otherwise classified"
E0770,"Functional electrical stimulator, transcutaneous stimulation of nerve and/or muscle groups, any type, complete system, not otherwise specified"
E0776,Iv pole
E0779,"Ambulatory infusion pump, mechanical, reusable, for infusion 8 hours or greater"
E0780,"Ambulatory infusion pump, mechanical, reusable, for infusion less than 8 hours"
E0781,"Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient"
E0782,"Infusion pump, implantable, non-programmable (includes all components, e.g., pump, catheter, connectors, etc.)"
E0783,"Infusion pump system, implantable, programmable (includes all components, e.g., pump, catheter, connectors, etc.)"
E0784,"External ambulatory infusion pump, insulin"
E0785,"Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement"
E0786,"Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter)"
E0787,"External ambulatory infusion pump, insulin, dosage rate adjustment using therapeutic continuous glucose sensing"
E0791,"Parenteral infusion pump, stationary, single or multi-channel"
E0830,"Ambulatory traction device, all types, each"
E0840,"Traction frame, attached to headboard, cervical traction"
E0849,"Traction equipment, cervical, free-standing stand/frame, pneumatic, applying traction force to other than mandible"
E0850,"Traction stand, free standing, cervical traction"
E0855,Cervical traction equipment not requiring additional stand or frame
E0856,"Cervical traction device, with inflatable air bladder(s)"
E0860,"Traction equipment, overdoor, cervical"
E0870,"Traction frame, attached to footboard, extremity traction, (e.g., buck's)"
E0880,"Traction stand, free standing, extremity traction"
E0890,"Traction frame, attached to footboard, pelvic traction"
E0900,"Traction stand, free standing, pelvic traction, (e.g., buck's)"
E0910,"Trapeze bars, a/k/a patient helper, attached to bed, with grab bar"
E0911,"Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, attached to bed, with grab bar"
E0912,"Trapeze bar, heavy duty, for patient weight capacity greater than 250 pounds, free standing, complete with grab bar"
E0920,"Fracture frame, attached to bed, includes weights"
E0930,"Fracture frame, free standing, includes weights"
E0935,Continuous passive motion exercise device for use on knee only
E0936,Continuous passive motion exercise device for use other than knee
E0940,"Trapeze bar, free standing, complete with grab bar"
E0941,"Gravity assisted traction device, any type"
E0942,Cervical head harness/halter
E0944,Pelvic belt/harness/boot
E0945,Extremity belt/harness
E0946,"Fracture, frame, dual with cross bars, attached to bed, (e.g., balken, 4 poster)"
E0947,"Fracture frame, attachments for complex pelvic traction"
E0948,"Fracture frame, attachments for complex cervical traction"
E0950,"Wheelchair accessory, tray, each"
E0951,"Heel loop/holder, any type, with or without ankle strap, each"
E0952,"Toe loop/holder, any type, each"
E0953,"Wheelchair accessory, lateral thigh or knee support, any type including fixed mounting hardware, each"
E0954,"Wheelchair accessory, foot box, any type, includes attachment and mounting hardware, each foot"
E0955,"Wheelchair accessory, headrest, cushioned, any type, including fixed mounting hardware, each"
E0956,"Wheelchair accessory, lateral trunk or hip support, any type, including fixed mounting hardware, each"
E0957,"Wheelchair accessory, medial thigh support, any type, including fixed mounting hardware, each"
E0958,"Manual wheelchair accessory, one-arm drive attachment, each"
E0959,"Manual wheelchair accessory, adapter for amputee, each"
E0960,"Wheelchair accessory, shoulder harness/straps or chest strap, including any type mounting hardware"
E0961,"Manual wheelchair accessory, wheel lock brake extension (handle), each"
E0966,"Manual wheelchair accessory, headrest extension, each"
E0967,"Manual wheelchair accessory, hand rim with projections, any type, replacement only, each"
E0968,"Commode seat, wheelchair"
E0969,"Narrowing device, wheelchair"
E0970,"No. 2 footplates, except for elevating leg rest"
E0971,"Manual wheelchair accessory, anti-tipping device, each"
E0973,"Wheelchair accessory, adjustable height, detachable armrest, complete assembly, each"
E0974,"Manual wheelchair accessory, anti-rollback device, each"
E0978,"Wheelchair accessory, positioning belt/safety belt/pelvic strap, each"
E0980,"Safety vest, wheelchair"
E0981,"Wheelchair accessory, seat upholstery, replacement only, each"
E0982,"Wheelchair accessory, back upholstery, replacement only, each"
E0983,"Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, joystick control"
E0984,"Manual wheelchair accessory, power add-on to convert manual wheelchair to motorized wheelchair, tiller control"
E0985,"Wheelchair accessory, seat lift mechanism"
E0986,"Manual wheelchair accessory, power assist system"
E0988,"Manual wheelchair accessory, lever-activated, wheel drive, pair"
E0990,"Wheelchair accessory, elevating leg rest, complete assembly, each"
E0992,"Manual wheelchair accessory, solid seat insert"
E0994,"Arm rest, each"
E0995,"Wheelchair accessory, calf rest/pad, replacement only, each"
E1002,"Wheelchair accessory, power seating system, tilt only"
E1003,"Wheelchair accessory, power seating system, recline only, without shear reduction"
E1004,"Wheelchair accessory, power seating system, recline only, with mechanical shear reduction"
E1005,"Wheelchair accessory, power seating system, recline only, with power shear reduction"
E1006,"Wheelchair accessory, power seating system, combination tilt and recline, without shear reduction"
E1007,"Wheelchair accessory, power seating system, combination tilt and recline, with mechanical shear reduction"
E1008,"Wheelchair accessory, power seating system, combination tilt and recline, with power shear reduction"
E1009,"Wheelchair accessory, addition to power seating system, mechanically linked leg elevation system, including pushrod and leg rest, each"
E1010,"Wheelchair accessory, addition to power seating system, power leg elevation system, including leg rest, pair"
E1011,"Modification to pediatric size wheelchair, width adjustment package (not to be dispensed with initial chair)"
E1012,"Wheelchair accessory, addition to power seating system, center mount power elevating leg rest/platform, complete system, any type, each"
E1014,"Reclining back, addition to pediatric size wheelchair"
E1015,"Shock absorber for manual wheelchair, each"
E1016,"Shock absorber for power wheelchair, each"
E1017,"Heavy duty shock absorber for heavy duty or extra heavy duty manual wheelchair, each"
E1018,"Heavy duty shock absorber for heavy duty or extra heavy duty power wheelchair, each"
E1020,"Residual limb support system for wheelchair, any type"
E1022,"Wheelchair transportation securement system, any type includes all components and accessories"
E1023,"Wheelchair transit securement system, includes all components and accessories"
E1028,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware, other"
E1029,"Wheelchair accessory, ventilator tray, fixed"
E1030,"Wheelchair accessory, ventilator tray, gimbaled"
E1031,"Rollabout chair, any and all types with casters 5"" or greater"
E1032,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware used with joystick or other drive control interface"
E1033,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for headrest, cushioned, any type"
E1034,"Wheelchair accessory, manual swingaway, retractable or removable mounting hardware for lateral trunk or hip support, any type"
E1035,"Multi-positional patient transfer system, with integrated seat, operated by care giver, patient weight capacity up to and including 300 lbs"
E1036,"Multi-positional patient transfer system, extra-wide, with integrated seat, operated by caregiver, patient weight capacity greater than 300 lbs"
E1037,"Transport chair, pediatric size"
E1038,"Transport chair, adult size, patient weight capacity up to and including 300 pounds"
E1039,"Transport chair, adult size, heavy duty, patient weight capacity greater than 300 pounds"
E1050,"Fully-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests"
E1060,"Fully-reclining wheelchair, detachable arms, desk or full length, swing away detachable elevating legrests"
E1070,"Fully-reclining wheelchair, detachable arms (desk or full length) swing away detachable footrest"
E1083,"Hemi-wheelchair, fixed full length arms, swing away detachable elevating leg rest"
E1084,"Hemi-wheelchair, detachable arms desk or full length arms, swing away detachable elevating leg rests"
E1085,"Hemi-wheelchair, fixed full length arms, swing away detachable foot rests"
E1086,"Hemi-wheelchair detachable arms desk or full length, swing away detachable footrests"
E1087,"High strength lightweight wheelchair, fixed full length arms, swing away detachable elevating leg rests"
E1088,"High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable elevating leg rests"
E1089,"High strength lightweight wheelchair, fixed length arms, swing away detachable footrest"
E1090,"High strength lightweight wheelchair, detachable arms desk or full length, swing away detachable foot rests"
E1092,"Wide heavy duty wheel chair, detachable arms (desk or full length), swing away detachable elevating leg rests"
E1093,"Wide heavy duty wheelchair, detachable arms desk or full length arms, swing away detachable footrests"
E1100,"Semi-reclining wheelchair, fixed full length arms, swing away detachable elevating leg rests"
E1110,"Semi-reclining wheelchair, detachable arms (desk or full length) elevating leg rest"
E1130,"Standard wheelchair, fixed full length arms, fixed or swing away detachable footrests"
E1140,"Wheelchair, detachable arms, desk or full length, swing away detachable footrests"
E1150,"Wheelchair, detachable arms, desk or full length swing away detachable elevating legrests"
E1160,"Wheelchair, fixed full length arms, swing away detachable elevating legrests"
E1161,"Manual adult size wheelchair, includes tilt in space"
E1170,"Amputee wheelchair, fixed full length arms, swing away detachable elevating legrests"
E1171,"Amputee wheelchair, fixed full length arms, without footrests or legrest"
E1172,"Amputee wheelchair, detachable arms (desk or full length) without footrests or legrest"
E1180,"Amputee wheelchair, detachable arms (desk or full length) swing away detachable footrests"
E1190,"Amputee wheelchair, detachable arms (desk or full length) swing away detachable elevating legrests"
E1195,"Heavy duty wheelchair, fixed full length arms, swing away detachable elevating legrests"
E1200,"Amputee wheelchair, fixed full length arms, swing away detachable footrest"
E1220,"Wheelchair; specially sized or constructed, (indicate brand name, model number, if any) and justification"
E1221,"Wheelchair with fixed arm, footrests"
E1222,"Wheelchair with fixed arm, elevating legrests"
E1223,"Wheelchair with detachable arms, footrests"
E1224,"Wheelchair with detachable arms, elevating legrests"
E1225,"Wheelchair accessory, manual semi-reclining back, (recline greater than 15 degrees, but less than 80 degrees), each"
E1226,"Wheelchair accessory, manual fully reclining back, (recline greater than 80 degrees), each"
E1227,Special height arms for wheelchair
E1228,Special back height for wheelchair
E1229,"Wheelchair, pediatric size, not otherwise specified"
E1230,Power operated vehicle (three or four wheel nonhighway) specify brand name and model number
E1231,"Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, with seating system"
E1232,"Wheelchair, pediatric size, tilt-in-space, folding, adjustable, with seating system"
E1233,"Wheelchair, pediatric size, tilt-in-space, rigid, adjustable, without seating system"
E1234,"Wheelchair, pediatric size, tilt-in-space, folding, adjustable, without seating system"
E1235,"Wheelchair, pediatric size, rigid, adjustable, with seating system"
E1236,"Wheelchair, pediatric size, folding, adjustable, with seating system"
E1237,"Wheelchair, pediatric size, rigid, adjustable, without seating system"
E1238,"Wheelchair, pediatric size, folding, adjustable, without seating system"
E1239,"Power wheelchair, pediatric size, not otherwise specified"
E1240,"Lightweight wheelchair, detachable arms, (desk or full length) swing away detachable, elevating legrest"
E1250,"Lightweight wheelchair, fixed full length arms, swing away detachable footrest"
E1260,"Lightweight wheelchair, detachable arms (desk or full length) swing away detachable footrest"
E1270,"Lightweight wheelchair, fixed full length arms, swing away detachable elevating legrests"
E1280,"Heavy duty wheelchair, detachable arms (desk or full length) elevating legrests"
E1285,"Heavy duty wheelchair, fixed full length arms, swing away detachable footrest"
E1290,"Heavy duty wheelchair, detachable arms (desk or full length) swing away detachable footrest"
E1295,"Heavy duty wheelchair, fixed full length arms, elevating legrest"
E1296,Special wheelchair seat height from floor
E1297,"Special wheelchair seat depth, by upholstery"
E1298,"Special wheelchair seat depth and/or width, by construction"
E1300,"Whirlpool, portable (overtub type)"
E1301,"Whirlpool tub, walk-in, portable"
E1310,"Whirlpool, non-portable (built-in type)"
E1352,"Oxygen accessory, flow regulator capable of positive inspiratory pressure"
E1353,Regulator
E1354,"Oxygen accessory, wheeled cart for portable cylinder or portable concentrator, any type, replacement only, each"
E1355,Stand/rack
E1356,"Oxygen accessory, battery pack/cartridge for portable concentrator, any type, replacement only, each"
E1357,"Oxygen accessory, battery charger for portable concentrator, any type, replacement only, each"
E1358,"Oxygen accessory, dc power adapter for portable concentrator, any type, replacement only, each"
E1372,Immersion external heater for nebulizer
E1390,"Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate"
E1391,"Oxygen concentrator, dual delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate, each"
E1392,"Portable oxygen concentrator, rental"
E1399,"Durable medical equipment, miscellaneous"
E1405,Oxygen and water vapor enriching system with heated delivery
E1406,Oxygen and water vapor enriching system without heated delivery
E1500,"Centrifuge, for dialysis"
E1510,"Kidney, dialysate delivery syst kidney machine, pump recirculating, air removal syst, flowrate meter, power off, heater and temperature control with alarm, i.v. poles, pressure gauge, concentrate container"
E1520,Heparin infusion pump for hemodialysis
E1530,"Air bubble detector for hemodialysis, each, replacement"
E1540,"Pressure alarm for hemodialysis, each, replacement"
E1550,"Bath conductivity meter for hemodialysis, each"
E1560,"Blood leak detector for hemodialysis, each, replacement"
E1570,"Adjustable chair, for esrd patients"
E1575,"Transducer protectors/fluid barriers, for hemodialysis, any size, per 10"
E1580,Unipuncture control system for hemodialysis
E1590,Hemodialysis machine
E1592,Automatic intermittent peritoneal dialysis system
E1594,Cycler dialysis machine for peritoneal dialysis
E1600,Delivery and/or installation charges for hemodialysis equipment
E1610,"Reverse osmosis water purification system, for hemodialysis"
E1615,"Deionizer water purification system, for hemodialysis"
E1620,"Blood pump for hemodialysis, replacement"
E1625,"Water softening system, for hemodialysis"
E1629,Tablo hemodialysis system for the billable dialysis service
E1630,Reciprocating peritoneal dialysis system
E1632,"Wearable artificial kidney, each"
E1634,"Peritoneal dialysis clamps, each"
E1635,Compact (portable) travel hemodialyzer system
E1636,"Sorbent cartridges, for hemodialysis, per 10"
E1637,"Hemostats, each"
E1639,"Scale, each"
E1699,"Dialysis equipment, not otherwise specified"
E1700,Jaw motion rehabilitation system
E1701,"Replacement cushions for jaw motion rehabilitation system, pkg. of 6"
E1702,"Replacement measuring scales for jaw motion rehabilitation system, pkg. of 200"
E1800,"Dynamic adjustable elbow extension and flexion device, includes soft interface material"
E1801,"Static progressive stretch/patient actualized serial stretch elbow device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories"
E1802,"Dynamic adjustable forearm pronation/supination device, includes soft interface material"
E1803,"Dynamic adjustable elbow extension only device, includes soft interface material"
E1804,"Dynamic adjustable elbow flexion only device, includes soft interface material"
E1805,"Dynamic adjustable wrist extension and flexion device, includes soft interface material"
E1806,"Static progressive stretch wrist device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories"
E1807,"Dynamic adjustable wrist extension only device, includes soft interface material"
E1808,"Dynamic adjustable wrist flexion only device, includes soft interface material"
E1810,"Dynamic adjustable knee extension and flexion device, includes soft interface material"
E1811,"Static progressive stretch/patient actualized serial stretch knee device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories"
E1812,"Dynamic knee, extension/flexion device with active resistance control"
E1813,"Dynamic adjustable knee extension only device, includes soft interface material"
E1814,"Dynamic adjustable knee flexion only device, includes soft interface material"
E1815,"Dynamic adjustable ankle extension and flexion device, includes soft interface material"
E1816,"Static progressive stretch/patient actualized serial stretch ankle device, flexion and/or extension, with or without range of motion adjustment, includes all components and accessories"
E1818,"Static progressive stretch/patient actualized serial stretch forearm pronation / supination device, with or without range of motion adjustment, includes all components and accessories"
E1820,"Replacement soft interface material, dynamic adjustable extension/flexion device"
E1821,Replacement soft interface material/cuffs for bi-directional static progressive stretch device
E1822,"Dynamic adjustable ankle extension only device, includes soft interface material"
E1823,"Dynamic adjustable ankle flexion only device, includes soft interface material"
E1825,"Dynamic adjustable finger extension and flexion device, includes soft interface material"
E1826,"Dynamic adjustable finger extension only device, includes soft interface material"
E1827,"Dynamic adjustable finger flexion only device, includes soft interface material"
E1828,"Dynamic adjustable toe extension only device, includes soft interface material"
E1829,"Dynamic adjustable toe flexion only device, includes soft interface material"
E1830,"Dynamic adjustable toe extension and flexion device, includes soft interface material"
E1831,"Static progressive stretch toe device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories"
E1832,"Static progressive stretch finger device, extension and/or flexion, with or without range of motion adjustment, includes all components and accessories"
E1840,"Dynamic adjustable shoulder flexion / abduction / rotation device, includes soft interface material"
E1841,"Static progressive stretch/patient actualized serial stretch shoulder device, with or without range of motion adjustment, includes all components and accessories"
E1902,"Communication board, non-electronic augmentative or alternative communication device"
E1905,"Virtual reality cognitive behavioral therapy device (cbt), including pre-programmed therapy software"
E2000,"Gastric suction pump, home model, portable or stationary, electric"
E2001,"Suction pump, home model, portable or stationary, electric, any type, for use with external urine and/or fecal management system"
E2100,Blood glucose monitor with integrated voice synthesizer
E2101,Blood glucose monitor with integrated lancing/blood sample
E2102,"Adjunctive, non-implanted continuous glucose monitor or receiver"
E2103,"Non-adjunctive, non-implanted continuous glucose monitor or receiver"
E2104,Home blood glucose monitor for use with integrated lancing/blood sample testing cartridge
E2120,Pulse generator system for tympanic treatment of inner ear endolymphatic fluid
E2201,"Manual wheelchair accessory, nonstandard seat frame, width greater than or equal to 20 inches and less than 24 inches"
E2202,"Manual wheelchair accessory, nonstandard seat frame width, 24-27 inches"
E2203,"Manual wheelchair accessory, nonstandard seat frame depth, 20 to less than 22 inches"
E2204,"Manual wheelchair accessory, nonstandard seat frame depth, 22 to 25 inches"
E2205,"Manual wheelchair accessory, handrim without projections (includes ergonomic or contoured), any type, replacement only, each"
E2206,"Manual wheelchair accessory, wheel lock assembly, complete, replacement only, each"
E2207,"Wheelchair accessory, crutch and cane holder, each"
E2208,"Wheelchair accessory, cylinder tank carrier, each"
E2209,"Accessory, arm trough, with or without hand support, each"
E2210,"Wheelchair accessory, bearings, any type, replacement only, each"
E2211,"Manual wheelchair accessory, pneumatic propulsion tire, any size, each"
E2212,"Manual wheelchair accessory, tube for pneumatic propulsion tire, any size, each"
E2213,"Manual wheelchair accessory, insert for pneumatic propulsion tire (removable), any type, any size, each"
E2214,"Manual wheelchair accessory, pneumatic caster tire, any size, each"
E2215,"Manual wheelchair accessory, tube for pneumatic caster tire, any size, each"
E2216,"Manual wheelchair accessory, foam filled propulsion tire, any size, each"
E2217,"Manual wheelchair accessory, foam filled caster tire, any size, each"
E2218,"Manual wheelchair accessory, foam propulsion tire, any size, each"
E2219,"Manual wheelchair accessory, foam caster tire, any size, each"
E2220,"Manual wheelchair accessory, solid (rubber/plastic) propulsion tire, any size, replacement only, each"
E2221,"Manual wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each"
E2222,"Manual wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each"
E2224,"Manual wheelchair accessory, propulsion wheel excludes tire, any size, replacement only, each"
E2225,"Manual wheelchair accessory, caster wheel excludes tire, any size, replacement only, each"
E2226,"Manual wheelchair accessory, caster fork, any size, replacement only, each"
E2227,"Manual wheelchair accessory, gear reduction drive wheel, each"
E2228,"Manual wheelchair accessory, wheel braking system and lock, complete, each"
E2230,"Manual wheelchair accessory, manual standing system"
E2231,"Manual wheelchair accessory, solid seat support base (replaces sling seat), includes any type mounting hardware"
E2291,"Back, planar, for pediatric size wheelchair including fixed attaching hardware"
E2292,"Seat, planar, for pediatric size wheelchair including fixed attaching hardware"
E2293,"Back, contoured, for pediatric size wheelchair including fixed attaching hardware"
E2294,"Seat, contoured, for pediatric size wheelchair including fixed attaching hardware"
E2295,"Manual wheelchair accessory, for pediatric size wheelchair, dynamic seating frame, allows coordinated movement of multiple positioning features"
E2298,"Complex rehabilitative power wheelchair accessory, power seat elevation system, any type"
E2300,"Wheelchair accessory, power seat elevation system, any typeTerminated March 31, 2024."
E2301,"Wheelchair accessory, power standing system, any type"
E2310,"Power wheelchair accessory, electronic connection between wheelchair controller and one power seating system motor, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware"
E2311,"Power wheelchair accessory, electronic connection between wheelchair controller and two or more power seating system motors, including all related electronics, indicator feature, mechanical function selection switch, and fixed mounting hardware"
E2312,"Power wheelchair accessory, hand or chin control interface, mini-proportional remote joystick, proportional, including fixed mounting hardware"
E2313,"Power wheelchair accessory, harness for upgrade to expandable controller, including all fasteners, connectors and mounting hardware, each"
E2321,"Power wheelchair accessory, hand control interface, remote joystick, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware"
E2322,"Power wheelchair accessory, hand control interface, multiple mechanical switches, nonproportional, including all related electronics, mechanical stop switch, and fixed mounting hardware"
E2323,"Power wheelchair accessory, specialty joystick handle for hand control interface, prefabricated"
E2324,"Power wheelchair accessory, chin cup for chin control interface"
E2325,"Power wheelchair accessory, sip and puff interface, nonproportional, including all related electronics, mechanical stop switch, and manual swingaway mounting hardware"
E2326,"Power wheelchair accessory, breath tube kit for sip and puff interface"
E2327,"Power wheelchair accessory, head control interface, mechanical, proportional, including all related electronics, mechanical direction change switch, and fixed mounting hardware"
E2328,"Power wheelchair accessory, head control or extremity control interface, electronic, proportional, including all related electronics and fixed mounting hardware"
E2329,"Power wheelchair accessory, head control interface, contact switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware"
E2330,"Power wheelchair accessory, head control interface, proximity switch mechanism, nonproportional, including all related electronics, mechanical stop switch, mechanical direction change switch, head array, and fixed mounting hardware"
E2331,"Power wheelchair accessory, attendant control, proportional, including all related electronics and fixed mounting hardware"
E2340,"Power wheelchair accessory, nonstandard seat frame width, 20-23 inches"
E2341,"Power wheelchair accessory, nonstandard seat frame width, 24-27 inches"
E2342,"Power wheelchair accessory, nonstandard seat frame depth, 20 or 21 inches"
E2343,"Power wheelchair accessory, nonstandard seat frame depth, 22-25 inches"
E2351,"Power wheelchair accessory, electronic interface to operate speech generating device using power wheelchair control interface"
E2358,"Power wheelchair accessory, group 34 non-sealed lead acid battery, each"
E2359,"Power wheelchair accessory, group 34 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)"
E2360,"Power wheelchair accessory, 22nf non-sealed lead acid battery, each"
E2361,"Power wheelchair accessory, 22nf sealed lead acid battery, each, (e.g., gel cell, absorbed glassmat)"
E2362,"Power wheelchair accessory, group 24 non-sealed lead acid battery, each"
E2363,"Power wheelchair accessory, group 24 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)"
E2364,"Power wheelchair accessory, u-1 non-sealed lead acid battery, each"
E2365,"Power wheelchair accessory, u-1 sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)"
E2366,"Power wheelchair accessory, battery charger, single mode, for use with only one battery type, sealed or non-sealed, each"
E2367,"Power wheelchair accessory, battery charger, dual mode, for use with either battery type, sealed or non-sealed, each"
E2368,"Power wheelchair component, drive wheel motor, replacement only"
E2369,"Power wheelchair component, drive wheel gear box, replacement only"
E2370,"Power wheelchair component, integrated drive wheel motor and gear box combination, replacement only"
E2371,"Power wheelchair accessory, group 27 sealed lead acid battery, (e.g., gel cell, absorbed glassmat), each"
E2372,"Power wheelchair accessory, group 27 non-sealed lead acid battery, each"
E2373,"Power wheelchair accessory, hand or chin control interface, compact remote joystick, proportional, including fixed mounting hardware"
E2374,"Power wheelchair accessory, hand or chin control interface, standard remote joystick (not including controller), proportional, including all related electronics and fixed mounting hardware, replacement only"
E2375,"Power wheelchair accessory, non-expandable controller, including all related electronics and mounting hardware, replacement only"
E2376,"Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, replacement only"
E2377,"Power wheelchair accessory, expandable controller, including all related electronics and mounting hardware, upgrade provided at initial issue"
E2378,"Power wheelchair component, actuator, replacement only"
E2381,"Power wheelchair accessory, pneumatic drive wheel tire, any size, replacement only, each"
E2382,"Power wheelchair accessory, tube for pneumatic drive wheel tire, any size, replacement only, each"
E2383,"Power wheelchair accessory, insert for pneumatic drive wheel tire (removable), any type, any size, replacement only, each"
E2384,"Power wheelchair accessory, pneumatic caster tire, any size, replacement only, each"
E2385,"Power wheelchair accessory, tube for pneumatic caster tire, any size, replacement only, each"
E2386,"Power wheelchair accessory, foam filled drive wheel tire, any size, replacement only, each"
E2387,"Power wheelchair accessory, foam filled caster tire, any size, replacement only, each"
E2388,"Power wheelchair accessory, foam drive wheel tire, any size, replacement only, each"
E2389,"Power wheelchair accessory, foam caster tire, any size, replacement only, each"
E2390,"Power wheelchair accessory, solid (rubber/plastic) drive wheel tire, any size, replacement only, each"
E2391,"Power wheelchair accessory, solid (rubber/plastic) caster tire (removable), any size, replacement only, each"
E2392,"Power wheelchair accessory, solid (rubber/plastic) caster tire with integrated wheel, any size, replacement only, each"
E2394,"Power wheelchair accessory, drive wheel excludes tire, any size, replacement only, each"
E2395,"Power wheelchair accessory, caster wheel excludes tire, any size, replacement only, each"
E2396,"Power wheelchair accessory, caster fork, any size, replacement only, each"
E2397,"Power wheelchair accessory, lithium-based battery, each"
E2398,"Wheelchair accessory, dynamic positioning hardware for back"
E2402,"Negative pressure wound therapy electrical pump, stationary or portable"
E2500,"Speech generating device, digitized speech, using pre-recorded messages, less than or equal to 8 minutes recording time"
E2502,"Speech generating device, digitized speech, using pre-recorded messages, greater than 8 minutes but less than or equal to 20 minutes recording time"
E2504,"Speech generating device, digitized speech, using pre-recorded messages, greater than 20 minutes but less than or equal to 40 minutes recording time"
E2506,"Speech generating device, digitized speech, using pre-recorded messages, greater than 40 minutes recording time"
E2508,"Speech generating device, synthesized speech, requiring message formulation by spelling and access by physical contact with the device"
E2510,"Speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access"
E2511,"Speech generating software program, for personal computer or personal digital assistant"
E2512,"Accessory for speech generating device, mounting system"
E2513,"Accessory for speech generating device, electromyographic sensor"
E2599,"Accessory for speech generating device, not otherwise classified"
E2601,"General use wheelchair seat cushion, width less than 22 inches, any depth"
E2602,"General use wheelchair seat cushion, width 22 inches or greater, any depth"
E2603,"Skin protection wheelchair seat cushion, width less than 22 inches, any depth"
E2604,"Skin protection wheelchair seat cushion, width 22 inches or greater, any depth"
E2605,"Positioning wheelchair seat cushion, width less than 22 inches, any depth"
E2606,"Positioning wheelchair seat cushion, width 22 inches or greater, any depth"
E2607,"Skin protection and positioning wheelchair seat cushion, width less than 22 inches, any depth"
E2608,"Skin protection and positioning wheelchair seat cushion, width 22 inches or greater, any depth"
E2609,"Custom fabricated wheelchair seat cushion, any size"
E2610,"Wheelchair seat cushion, powered"
E2611,"General use wheelchair back cushion, width less than 22 inches, any height, including any type mounting hardware"
E2612,"General use wheelchair back cushion, width 22 inches or greater, any height, including any type mounting hardware"
E2613,"Positioning wheelchair back cushion, posterior, width less than 22 inches, any height, including any type mounting hardware"
E2614,"Positioning wheelchair back cushion, posterior, width 22 inches or greater, any height, including any type mounting hardware"
E2615,"Positioning wheelchair back cushion, posterior-lateral, width less than 22 inches, any height, including any type mounting hardware"
E2616,"Positioning wheelchair back cushion, posterior-lateral, width 22 inches or greater, any height, including any type mounting hardware"
E2617,"Custom fabricated wheelchair back cushion, any size, including any type mounting hardware"
E2619,"Replacement cover for wheelchair seat cushion or back cushion, each"
E2620,"Positioning wheelchair back cushion, planar back with lateral supports, width less than 22 inches, any height, including any type mounting hardware"
E2621,"Positioning wheelchair back cushion, planar back with lateral supports, width 22 inches or greater, any height, including any type mounting hardware"
E2622,"Skin protection wheelchair seat cushion, adjustable, width less than 22 inches, any depth"
E2623,"Skin protection wheelchair seat cushion, adjustable, width 22 inches or greater, any depth"
E2624,"Skin protection and positioning wheelchair seat cushion, adjustable, width less than 22 inches, any depth"
E2625,"Skin protection and positioning wheelchair seat cushion, adjustable, width 22 inches or greater, any depth"
E2626,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable"
E2627,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, adjustable rancho type"
E2628,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, reclining"
E2629,"Wheelchair accessory, shoulder elbow, mobile arm support attached to wheelchair, balanced, friction arm support (friction dampening to proximal and distal joints)"
E2630,"Wheelchair accessory, shoulder elbow, mobile arm support, monosuspension arm and hand support, overhead elbow forearm hand sling support, yoke type suspension support"
E2631,"Wheelchair accessory, addition to mobile arm support, elevating proximal arm"
E2632,"Wheelchair accessory, addition to mobile arm support, offset or lateral rocker arm with elastic balance control"
E2633,"Wheelchair accessory, addition to mobile arm support, supinator"
E3000,"Speech volume modulation system, any type, including all components and accessories"
E3200,"Gait modulation system, rhythmic auditory stimulation, including restricted therapy software, all components and accessories, prescription only"
E8000,"Gait trainer, pediatric size, posterior support, includes all accessories and components"
E8001,"Gait trainer, pediatric size, upright support, includes all accessories and components"
E8002,"Gait trainer, pediatric size, anterior support, includes all accessories and components"
G0008,Administration of influenza virus vaccine
G0009,Administration of pneumococcal vaccine
G0010,Administration of hepatitis b vaccine
G0011,"Individual counseling for pre-exposure prophylaxis (prep) by physician or qualified health care professional (qhp) to prevent human immunodeficiency virus (hiv), includes hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence, 15-30 minutes"
G0012,"Injection of pre-exposure prophylaxis (prep) drug for hiv prevention, under skin or into muscle"
G0013,"Individual counseling for pre-exposure prophylaxis (prep) by clinical staff to prevent human immunodeficiency virus (hiv), includes: hiv risk assessment (initial or continued assessment of risk), hiv risk reduction and medication adherence"
G0017,"Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); first 60 minutes"
G0018,"Psychotherapy for crisis furnished in an applicable site of service (any place of service at which the non-facility rate for psychotherapy for crisis services applies, other than the office setting); each additional 30 minutes (list separately in addition to code for primary service)"
G0019,"Community health integration services performed by certified or trained auxiliary personnel, including a community health worker, under the direction of a physician or other practitioner; 60 minutes per calendar month, in the following activities to address social determinants of health (sdoh) need(s) that are significantly limiting the ability to diagnose or treat problem(s) addressed in an initiating visit: person-centered assessment, performed to better understand the individualized context of the intersection between the sdoh need(s) and the problem(s) addressed in the initiating visit. ++ conducting a person-centered assessment to understand patient's life story, strengths, needs, goals, preferences and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal-setting and establishing an action plan. ++ providing tailored support to the patient as needed to accomplish the practitioner's treatment plan. practitioner, home-, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; and from home- and community-based service providers, social service providers, and caregiver (if applicable). ++ communication with practitioners, home- and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) to address the sdoh need(s). health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, and preferences, in the context of the sdoh need(s), and educating the patient on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services addressing the sdoh need(s), in ways that are more likely to promote personalized and effective diagnosis or treatment. health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care and helping secure appointments with them. facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals. facilitating and providing social and emotional support to help the patient cope with the problem(s) addressed in the initiating visit, the sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals. leveraging lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals"
G0022,"Community health integration services, each additional 30 minutes per calendar month (list separately in addition to g0019)"
G0023,"Principal illness navigation services by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a patient navigator; 60 minutes per calendar month, in the following activities:  person-centered assessment, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered assessment to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors and including unmet sdoh needs (that are not separately billed). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the practitioner's treatment plan.  identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services.  practitioner, home, and community-based care coordination. ++ coordinating receipt of needed services from healthcare practitioners, providers, and facilities; home- and community-based service providers; and caregiver (if applicable). ++ communication with practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ coordination of care transitions between and among health care practitioners and settings, including transitions involving referral to other clinicians; follow-up after an emergency department visit; or follow-up after discharges from hospitals, skilled nursing facilities or other health care facilities. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s).  health education- helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making.  building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition.  health care access / health system navigation. ++ helping the patient access healthcare, including identifying appropriate practitioners or providers for clinical care,  and helping secure appointments with them. ++ providing the patient with information/resources to consider participation in clinical trials or clinical research as applicable.  facilitating behavioral change as necessary for meeting diagnosis and treatment goals, including promoting patient motivation to participate in care and reach person-centered diagnosis or treatment goals.  facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet diagnosis and treatment goals.  leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals"
G0024,"Principal illness navigation services, additional 30 minutes per calendar month (list separately in addition to g0023)"
G0027,Semen analysis; presence and/or motility of sperm excluding huhner
G0028,"Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)Terminated December 31, 2022."
G0029,Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period
G0030,"Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user"
G0031,Palliative care services given to patient any time during the measurement period
G0032,"Two or more antipsychotic prescriptions ordered for patients who had a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder on or between january 1 of the year prior to the measurement period and the index prescription start date (ipsd) for antipsychotics"
G0033,"Two or more benzodiazepine prescriptions ordered for patients who had a diagnosis of seizure disorders, rapid eye movement sleep behavior disorder, benzodiazepine withdrawal, ethanol withdrawal, or severe generalized anxiety disorder on or between january 1 of the year prior to the measurement period and the ipsd for benzodiazepines"
G0034,Patients receiving palliative care during the measurement period
G0035,Patient has any emergency department encounter during the performance period with place of service indicator 23
G0036,Patient or care partner decline assessment
G0037,"On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available"
G0038,Clinician determines patient does not require referral
G0039,"Patient not referred, reason not otherwise specified"
G0040,Patient already receiving physical/occupational/speech/recreational therapy during the measurement period
G0041,Patient and/or care partner decline referral
G0042,"Referral to physical, occupational, speech, or recreational therapy"
G0043,Patients with mechanical prosthetic heart valve
G0044,Patients with moderate or severe mitral stenosis
G0045,Clinical follow-up and mrs score assessed at 90 days following endovascular stroke intervention
G0046,Clinical follow-up and mrs score not assessed at 90 days following endovascular stroke intervention
G0047,Pediatric patient with minor blunt head trauma and pecarn prediction criteria are not assessed
G0048,Patients who receive palliative care services any time during the intake period through the end of the measurement year
G0049,With maintenance hemodialysis (in-center and home hd) for the complete reporting month
G0050,Patients with a catheter that have limited life expectancy
G0051,Patients under hospice care in the current reporting month
G0052,Patients on peritoneal dialysis for any portion of the reporting month
G0053,Advancing rheumatology patient care mips value pathways
G0054,Coordinating stroke care to promote prevention and cultivate positive outcomes mips value pathways
G0055,Advancing care for heart disease mips value pathways
G0056,"Optimizing chronic disease management mips value pathwaysTerminated December 31, 2023."
G0057,Proposed adopting best practices and promoting patient safety within emergency medicine mips value pathways
G0058,Improving care for lower extremity joint repair mips value pathways
G0059,Patient safety and support of positive experiences with anesthesia mips value pathways
G0060,Allergy/immunology mips specialty set
G0061,Anesthesiology mips specialty set
G0062,Audiology mips specialty set
G0063,Cardiology mips specialty set
G0064,Certified nurse midwife mips specialty set
G0065,Chiropractic medicine mips specialty set
G0066,Clinical social work mips specialty set
G0067,Dentistry mips specialty set
G0068,"Professional services for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes"
G0069,"Professional services for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes"
G0070,"Professional services for the administration of intravenous chemotherapy or other intravenous highly complex drug or biological infusion for each infusion drug administration calendar day in the individual's home, each 15 minutes"
G0071,"Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only"
G0076,"Brief (20 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0077,"Limited (30 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0078,"Moderate (45 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0079,"Comprehensive (60 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0080,"Extensive (75 minutes) care management home visit for a new patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0081,"Brief (20 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0082,"Limited (30 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0083,"Moderate (45 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0084,"Comprehensive (60 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0085,"Extensive (75 minutes) care management home visit for an existing patient. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0086,"Limited (30 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0087,"Comprehensive (60 minutes) care management home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility)"
G0088,"Professional services, initial visit, for the administration of anti-infective, pain management, chelation, pulmonary hypertension, inotropic, or other intravenous infusion drug or biological (excluding chemotherapy or other highly complex drug or biological) for each infusion drug administration calendar day in the individual's home, each 15 minutes"
G0089,"Professional services, initial visit, for the administration of subcutaneous immunotherapy or other subcutaneous infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes"
G0090,"Professional services, initial visit, for the administration of intravenous chemotherapy or other highly complex infusion drug or biological for each infusion drug administration calendar day in the individual's home, each 15 minutes"
G0101,Cervical or vaginal cancer screening; pelvic and clinical breast examination
G0102,Prostate cancer screening; digital rectal examination
G0103,Prostate cancer screening; prostate specific antigen test (psa)
G0104,Colorectal cancer screening; flexible sigmoidoscopy
G0105,Colorectal cancer screening; colonoscopy on individual at high risk
G0106,"Colorectal cancer screening; alternative to g0104, screening sigmoidoscopy, barium enemaTerminated December 31, 2024."
G0108,"Diabetes outpatient self-management training services, individual, per 30 minutes"
G0109,"Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes"
G0117,Glaucoma screening for high risk patients furnished by an optometrist or ophthalmologist
G0118,Glaucoma screening for high risk patient furnished under the direct supervision of an optometrist or ophthalmologist
G0120,"Colorectal cancer screening; alternative to g0105, screening colonoscopy, barium enema.Terminated December 31, 2024."
G0121,Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk
G0122,"Colorectal cancer screening; barium enemaTerminated December 31, 2024."
G0123,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision"
G0124,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician"
G0127,"Trimming of dystrophic nails, any number"
G0128,"Direct (face-to-face with patient) skilled nursing services of a registered nurse provided in a comprehensive outpatient rehabilitation facility, each 10 minutes beyond the first 5 minutes"
G0129,"Occupational therapy services requiring the skills of a qualified occupational therapist, furnished as a component of a partial hospitalization or intensive outpatient treatment program, per session (45 minutes or more)"
G0130,"Single energy x-ray absorptiometry (sexa) bone density study, one or more sites; appendicular skeleton (peripheral) (e.g., radius, wrist, heel)"
G0136,"Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes"
G0137,"Intensive outpatient services; weekly bundle, minimum of 9 services over a 7 contiguous day period, which can include individual and group therapy with physicians or psychologists (or other mental health professionals to the extent authorized under state law); occupational therapy requiring the skills of a qualified occupational therapist; services of social workers, trained psychiatric nurses, and other staff trained to work with psychiatric patients; individualized activity therapies that are not primarily recreational or diversionary; family counseling (the primary purpose of which is treatment of the individual's condition); patient training and education (to the extent that training and educational activities are closely and clearly related to individual's care and treatment); diagnostic services; and such other items and services (excluding meals and transportation) that are reasonable and necessary for the diagnosis or active treatment of the individual's condition, reasonably expected to improve or maintain the individual's condition and functional level and to prevent relapse or hospitalization, and furnished pursuant to such guidelines relating to frequency and duration of services in accordance with a physician certification and plan of treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
G0138,"Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga"
G0140,"Principal illness navigation - peer support by certified or trained auxiliary personnel under the direction of a physician or other practitioner, including a certified peer specialist; 60 minutes per calendar month, in the following activities:  person-centered interview, performed to better understand the individual context of the serious, high-risk condition. ++ conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes, including understanding cultural and linguistic factors, and including unmet sdoh needs (that are not billed separately). ++ facilitating patient-driven goal setting and establishing an action plan. ++ providing tailored support as needed to accomplish the person-centered goals in the practitioner's treatment plan. identifying or referring patient (and caregiver or family, if applicable) to appropriate supportive services. practitioner, home, and community-based care communication. ++ assist the patient in communicating with their practitioners, home-, and community-based service providers, hospitals, and skilled nursing facilities (or other health care facilities) regarding the patient's psychosocial strengths and needs, goals, preferences, and desired outcomes, including cultural and linguistic factors. ++ facilitating access to community-based social services (e.g., housing, utilities, transportation, food assistance) as needed to address sdoh need(s). health education. helping the patient contextualize health education provided by the patient's treatment team with the patient's individual needs, goals, preferences, and sdoh need(s), and educating the patient (and caregiver if applicable) on how to best participate in medical decision-making. building patient self-advocacy skills, so that the patient can interact with members of the health care team and related community-based services (as needed), in ways that are more likely to promote personalized and effective treatment of their condition. developing and proposing strategies to help meet person-centered treatment goals and supporting the patient in using chosen strategies to reach person-centered treatment goals. facilitating and providing social and emotional support to help the patient cope with the condition, sdoh need(s), and adjust daily routines to better meet person-centered diagnosis and treatment goals. leverage knowledge of the serious, high-risk condition and/or lived experience when applicable to provide support, mentorship, or inspiration to meet treatment goals"
G0141,"Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician"
G0143,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision"
G0144,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision"
G0145,"Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision"
G0146,"Principal illness navigation - peer support, additional 30 minutes per calendar month (list separately in addition to g0140)"
G0147,"Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision"
G0148,"Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening"
G0151,"Services performed by a qualified physical therapist in the home health or hospice setting, each 15 minutes"
G0152,"Services performed by a qualified occupational therapist in the home health or hospice setting, each 15 minutes"
G0153,"Services performed by a qualified speech-language pathologist in the home health or hospice setting, each 15 minutes"
G0154,"Direct skilled nursing services of a licensed nurse (lpn or rn) in the home health or hospice setting, each 15 minutesTerminated February 29, 2016."
G0155,"Services of clinical social worker in home health or hospice settings, each 15 minutes"
G0156,"Services of home health/hospice aide in home health or hospice settings, each 15 minutes"
G0157,"Services performed by a qualified physical therapist assistant in the home health or hospice setting, each 15 minutes"
G0158,"Services performed by a qualified occupational therapist assistant in the home health or hospice setting, each 15 minutes"
G0159,"Services performed by a qualified physical therapist, in the home health setting, in the establishment or delivery of a safe and effective physical therapy maintenance program, each 15 minutes"
G0160,"Services performed by a qualified occupational therapist, in the home health setting, in the establishment or delivery of a safe and effective occupational therapy maintenance program, each 15 minutes"
G0161,"Services performed by a qualified speech-language pathologist, in the home health setting, in the establishment or delivery of a safe and effective speech-language pathology maintenance program, each 15 minutes"
G0162,Skilled services by a registered nurse (rn) for management and evaluation of the plan of care; each 15 minutes (the patient's underlying condition or complication requires an rn to ensure that essential non-skilled care achieves its purpose in the home health or hospice setting)
G0163,"Skilled services of a licensed nurse (lpn or rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)Terminated December 31, 2016."
G0164,"Skilled services of a licensed nurse (lpn or rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutesTerminated December 31, 2016."
G0166,"External counterpulsation, per treatment session"
G0168,Wound closure utilizing tissue adhesive(s) only
G0173,"Linear accelerator based stereotactic radiosurgery, complete course of therapy in one sessionTerminated December 31, 2014."
G0175,Scheduled interdisciplinary team conference (minimum of three exclusive of patient care nursing staff) with patient present
G0176,"Activity therapy, such as music, dance, art or play therapies not for recreation, related to the care and treatment of patient's disabling mental health problems, per session (45 minutes or more)"
G0177,Training and educational services related to the care and treatment of patient's disabling mental health problems per session (45 minutes or more)
G0179,"Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care"
G0180,"Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care"
G0181,Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans
G0182,"Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patient status, review of laboratory and other studies, communication (including telephone calls) with other health care professionals involved in the patient's care, integration of new information into the medical treatment plan and/or adjustment of medical therapy, within a calendar month, 30 minutes or more"
G0183,"Quantitative software measurements of cardiac volume, cardiac chambers volumes and left ventricular wall mass derived from ct scan(s) data of the chest/heart (with or without contrast)"
G0186,"Destruction of localized lesion of choroid (for example, choroidal neovascularization); photocoagulation, feeder vessel technique (one or more sessions)"
G0202,"Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performedTerminated December 31, 2017."
G0204,"Diagnostic mammography, including computer-aided detection (cad) when performed; bilateralTerminated December 31, 2017."
G0206,"Diagnostic mammography, including computer-aided detection (cad) when performed; unilateralTerminated December 31, 2017."
G0219,Pet imaging whole body; melanoma for non-covered indications
G0235,"Pet imaging, any site, not otherwise specified"
G0237,"Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)"
G0238,"Therapeutic procedures to improve respiratory function, other than described by g0237, one on one, face to face, per 15 minutes (includes monitoring)"
G0239,"Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring)"
G0245,"Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that consists of at least the following elements: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of a protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear and (4) patient education"
G0246,"Follow-up physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include at least the following: (1) a patient history, (2) a physical examination that includes: (a) visual inspection of the forefoot, hindfoot and toe web spaces, (b) evaluation of protective sensation, (c) evaluation of foot structure and biomechanics, (d) evaluation of vascular status and skin integrity, and (e) evaluation and recommendation of footwear, and (3) patient education"
G0247,"Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following if present: (1) local care of superficial wounds, (2) debridement of corns and calluses, and (3) trimming and debridement of nails"
G0248,"Demonstration, prior to initiation of home inr monitoring, for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria, under the direction of a physician; includes: face-to-face demonstration of use and care of the inr monitor, obtaining at least one blood sample, provision of instructions for reporting home inr test results, and documentation of patient's ability to perform testing and report results"
G0249,"Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the home and reporting of test results to physician; testing not occurring more frequently than once a week; testing materials, billing units of service include 4 tests"
G0250,"Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequently than once a week; billing units of service include 4 tests"
G0251,"Linear accelerator based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, maximum five sessions per course of treatmentTerminated December 31, 2014."
G0252,"Pet imaging, full and partial-ring pet scanners only, for initial diagnosis of breast cancer and/or surgical planning for breast cancer (e.g., initial staging of axillary lymph nodes)"
G0255,"Current perception threshold/sensory nerve conduction test, (snct) per limb, any nerve"
G0257,Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility
G0259,Injection procedure for sacroiliac joint; arthrography
G0260,"Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography"
G0268,Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing
G0269,"Placement of occlusive device into either a venous or arterial access site, post surgical or interventional procedure (e.g., angioseal plug, vascular plug)"
G0270,"Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes"
G0271,"Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes"
G0276,"Blinded procedure for lumbar stenosis, percutaneous image-guided lumbar decompression (pild) or placebo-control, performed in an approved coverage with evidence development (ced) clinical trial"
G0277,"Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval"
G0278,"Iliac and/or femoral artery angiography, non-selective, bilateral or ipsilateral to catheter insertion, performed at the same time as cardiac catheterization and/or coronary angiography, includes positioning or placement of the catheter in the distal aorta or ipsilateral femoral or iliac artery, injection of dye, production of permanent images, and radiologic supervision and interpretation (list separately in addition to primary procedure)"
G0279,"Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)"
G0281,"Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care"
G0282,"Electrical stimulation, (unattended), to one or more areas, for wound care other than described in g0281"
G0283,"Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care"
G0288,"Reconstruction, computed tomographic angiography of aorta for surgical planning for vascular surgery"
G0289,"Arthroscopy, knee, surgical, for removal of loose body, foreign body, debridement/shaving of articular cartilage (chondroplasty) at the time of other surgical knee arthroscopy in a different compartment of the same knee"
G0293,"Noncovered surgical procedure(s) using conscious sedation, regional, general or spinal anesthesia in a medicare qualifying clinical trial, per day"
G0294,"Noncovered procedure(s) using either no anesthesia or local anesthesia only, in a medicare qualifying clinical trial, per day"
G0295,"Electromagnetic therapy, to one or more areas, for wound care other than described in g0329 or for other uses"
G0296,Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making)
G0297,"Low dose ct scan (ldct) for lung cancer screeningTerminated December 31, 2020."
G0299,"Direct skilled nursing services of a registered nurse (rn) in the home health or hospice setting, each 15 minutes"
G0300,"Direct skilled nursing services of a licensed practical nurse (lpn) in the home health or hospice setting, each 15 minutes"
G0302,"Pre-operative pulmonary surgery services for preparation for lvrs, complete course of services, to include a minimum of 16 days of services"
G0303,"Pre-operative pulmonary surgery services for preparation for lvrs, 10 to 15 days of services"
G0304,"Pre-operative pulmonary surgery services for preparation for lvrs, 1 to 9 days of services"
G0305,"Post-discharge pulmonary surgery services after lvrs, minimum of 6 days of services"
G0306,"Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count"
G0307,"Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count)"
G0308,"Creation of subcutaneous pocket with insertion of 180 day implantable interstitial glucose sensor, including system activation and patient trainingTerminated December 31, 2022."
G0309,"Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 180 day implantable sensor, including system activationTerminated December 31, 2022."
G0310,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service, 5 to 15 mins time (this code is used for medicaid billing purposes)"
G0311,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service,  16-30 mins time (this code is used for medicaid billing purposes)"
G0312,"Immunization counseling by a physician or other qualified health care professional when the vaccine(s) is not administered on the same date of service for ages under 21, 5 to 15 mins time (this code is used for medicaid billing purposes)"
G0313,"Immunization counseling by a physician or other qualified health care professional when  the vaccine(s) is not administered on the same date of service for ages under 21, 16-30 mins time (this code is used for medicaid billing purposes)"
G0314,"Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 16-30 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)"
G0315,"Immunization counseling by a physician or other qualified health care professional for covid-19, ages under 21, 5-15 mins time (this code is used for the medicaid early and periodic screening, diagnostic, and treatment benefit (epsdt)"
G0316,"Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99223, 99233, and 99236 for hospital inpatient or observation care evaluation and management services). (do not report g0316 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418, 99415, 99416). (do not report g0316 for any time unit less than 15 minutes)"
G0317,"Prolonged nursing facility evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99306, 99310 for nursing facility evaluation and management services). (do not report g0317 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99418). (do not report g0317 for any time unit less than 15 minutes)"
G0318,"Prolonged home or residence evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99345, 99350 for home or residence evaluation and management services). (do not report g0318 on the same date of service as other prolonged services for evaluation and management 99358, 99359, 99417). (do not report g0318 for any time unit less than 15 minutes)"
G0320,Home health services furnished using synchronous telemedicine rendered via a real-time two-way audio and video telecommunications system
G0321,Home health services furnished using synchronous telemedicine rendered via telephone or other real-time interactive audio-only telecommunications system
G0322,"The collection of physiologic data digitally stored and/or transmitted by the patient to the home health agency (i.e., remote patient monitoring)"
G0323,"Care management services for behavioral health conditions, at least 20 minutes of clinical psychologist, clinical social worker, mental health counselor, or marriage and family therapist time, per calendar month. (these services include the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, coordination with and/or referral to physicians and practitioners who are authorized by medicare to prescribe medications and furnish e/m services, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care team)"
G0327,Colorectal cancer screening; blood-based biomarker
G0328,"Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous"
G0329,"Electromagnetic therapy, to one or more areas for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care"
G0330,"Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room"
G0333,Pharmacy dispensing fee for inhalation drug(s); initial 30-day supply as a beneficiary
G0337,"Hospice evaluation and counseling services, pre-election"
G0339,"Image-guided robotic linear accelerator-based stereotactic radiosurgery, complete course of therapy in one session or first session of fractionated treatment"
G0340,"Image-guided robotic linear accelerator-based stereotactic radiosurgery, delivery including collimator changes and custom plugging, fractionated treatment, all lesions, per session, second through fifth sessions, maximum five sessions per course of treatment"
G0341,"Percutaneous islet cell transplant, includes portal vein catheterization and infusion"
G0342,"Laparoscopy for islet cell transplant, includes portal vein catheterization and infusion"
G0343,"Laparotomy for islet cell transplant, includes portal vein catheterization and infusion"
G0364,"Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of serviceTerminated December 31, 2017."
G0365,"Vessel mapping of vessels for hemodialysis access (services for preoperative vessel mapping prior to creation of hemodialysis access using an autogenous hemodialysis conduit, including arterial inflow and venous outflow)Terminated December 31, 2019."
G0372,Physician service required to establish and document the need for a power mobility device
G0378,"Hospital observation service, per hour"
G0379,Direct admission of patient for hospital observation care
G0380,"Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"
G0381,"Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"
G0382,"Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"
G0383,"Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"
G0384,"Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment)"
G0389,"Ultrasound b-scan and/or real time with image documentation; for abdominal aortic aneurysm (aaa) screeningTerminated December 31, 2016."
G0390,Trauma response team associated with hospital critical care service
G0396,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes"
G0397,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and intervention, greater than 30 minutes"
G0398,"Home sleep study test (hst) with type ii portable monitor, unattended; minimum of 7 channels: eeg, eog, emg, ecg/heart rate, airflow, respiratory effort and oxygen saturation"
G0399,"Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation"
G0400,"Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels"
G0402,"Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment"
G0403,"Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report"
G0404,"Electrocardiogram, routine ecg with 12 leads; tracing only, without interpretation and report, performed as a screening for the initial preventive physical examination"
G0405,"Electrocardiogram, routine ecg with 12 leads; interpretation and report only, performed as a screening for the initial preventive physical examination"
G0406,"Follow-up inpatient consultation, limited, physicians typically spend 15 minutes communicating with the patient via telehealth"
G0407,"Follow-up inpatient consultation, intermediate, physicians typically spend 25 minutes communicating with the patient via telehealth"
G0408,"Follow-up inpatient consultation, complex, physicians typically spend 35 minutes communicating with the patient via telehealth"
G0409,"Social work and psychological services, directly relating to and/or furthering the patient's rehabilitation goals, each 15 minutes, face-to-face; individual (services provided by a corf-qualified social worker or psychologist in a corf)"
G0410,"Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes"
G0411,"Interactive group psychotherapy, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes"
G0412,"Open treatment of iliac spine(s), tuberosity avulsion, or iliac wing fracture(s), unilateral or bilateral for pelvic bone fracture patterns which do not disrupt the pelvic ring includes internal fixation, when performed"
G0413,"Percutaneous skeletal fixation of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, (includes ilium, sacroiliac joint and/or sacrum)"
G0414,"Open treatment of anterior pelvic bone fracture and/or dislocation for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation when performed (includes pubic symphysis and/or superior/inferior rami)"
G0415,"Open treatment of posterior pelvic bone fracture and/or dislocation, for fracture patterns which disrupt the pelvic ring, unilateral or bilateral, includes internal fixation, when performed (includes ilium, sacroiliac joint and/or sacrum)"
G0416,"Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method"
G0417,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, 21-40 specimensTerminated December 31, 2014."
G0418,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, 41-60 specimensTerminated December 31, 2014."
G0419,"Surgical pathology, gross and microscopic examination, for prostate needle  biopsy, any method, >60 specimensTerminated December 31, 2014."
G0420,"Face-to-face educational services related to the care of chronic kidney disease; individual, per session, per one hour"
G0421,"Face-to-face educational services related to the care of chronic kidney disease; group, per session, per one hour"
G0422,"Intensive cardiac rehabilitation; with or without continuous ecg monitoring with exercise, per session"
G0423,"Intensive cardiac rehabilitation; with or without continuous ecg monitoring; without exercise, per session"
G0424,"Pulmonary rehabilitation, including exercise (includes monitoring), one hour, per session, up to two sessions per dayTerminated December 31, 2021."
G0425,"Telehealth consultation, emergency department or initial inpatient, typically 30 minutes communicating with the patient via telehealth"
G0426,"Telehealth consultation, emergency department or initial inpatient, typically 50 minutes communicating with the patient via telehealth"
G0427,"Telehealth consultation, emergency department or initial inpatient, typically 70 minutes or more communicating with the patient via telehealth"
G0428,"Collagen meniscus implant procedure for filling meniscal defects (e.g., cmi, collagen scaffold, menaflex)"
G0429,"Dermal filler injection(s) for the treatment of facial lipodystrophy syndrome (lds) (e.g., as a result of highly active antiretroviral therapy)"
G0431,"Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounterTerminated December 31, 2015."
G0432,"Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening"
G0433,"Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening"
G0434,"Drug screen, other than chromatographic; any number of drug classes, by clia waived test or moderate complexity test, per patient encounterTerminated December 31, 2015."
G0435,"Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening"
G0436,"Smoking and tobacco cessation counseling visit for the asymptomatic patient; intermediate, greater than 3 minutes, up to 10 minutesTerminated September 30, 2016."
G0437,"Smoking and tobacco cessation counseling visit for the asymptomatic patient; intensive, greater than 10 minutesTerminated September 30, 2016."
G0438,"Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit"
G0439,"Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit"
G0442,"Annual alcohol misuse screening, 5 to 15 minutes"
G0443,"Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes"
G0444,"Annual depression screening, 5 to 15 minutes"
G0445,"High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes"
G0446,"Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes"
G0447,"Face-to-face behavioral counseling for obesity, 15 minutes"
G0448,"Insertion or replacement of a permanent pacing cardioverter-defibrillator system with transvenous lead(s), single or dual chamber with insertion of pacing electrode, cardiac venous system, for left ventricular pacing"
G0451,"Development testing, with interpretation and report, per standardized instrument form"
G0452,Molecular pathology procedure; physician interpretation and report
G0453,"Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)"
G0454,"Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist"
G0455,"Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen"
G0456,"Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimetersTerminated December 31, 2014."
G0457,"Negative pressure wound therapy, (e.g. vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimetersTerminated December 31, 2014."
G0458,"Low dose rate (ldr) prostate brachytherapy services, composite rate"
G0459,"Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy"
G0460,"Autologous platelet rich plasma or other blood-derived product for non-diabetic chronic wounds/ulcers, including as applicable phlebotomy, centrifugation or mixing, and all other preparatory procedures, administration and dressings, per treatment"
G0461,"Immunohistochemistry or immunocytochemistry, per specimen; first single or multiplex antibody stainTerminated December 31, 2014."
G0462,"Immunohistochemistry or immunocytochemistry, per specimen; each additional single or multiplex antibody stain (list separately in addition to code for primary procedure)Terminated December 31, 2014."
G0463,Hospital outpatient clinic visit for assessment and management of a patient
G0464,"Colorectal cancer screening; stool-based dna and fecal occult hemoglobin (e.g., kras, ndrg4 and bmp3)Terminated December 31, 2015."
G0465,"Autologous platelet rich plasma (prp) or other blood-derived product for diabetic chronic wounds/ulcers, using an fda-cleared device for this indication, (includes as applicable administration, dressings, phlebotomy, centrifugation or mixing, and all other preparatory procedures, per treatment)"
G0466,"Federally qualified health center (fqhc) visit, new patient; a medically-necessary, face-to-face encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit"
G0467,"Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit"
G0468,"Federally qualified health center (fqhc) visit, ippe or awv; a fqhc visit that includes an initial preventive physical examination (ippe) or annual wellness visit (awv) and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving an ippe or awv"
G0469,"Federally qualified health center (fqhc) visit, mental health, new patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between a new patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit"
G0470,"Federally qualified health center (fqhc) visit, mental health, established patient; a medically-necessary, face-to-face mental health encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a mental health visit"
G0471,Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha)
G0472,"Hepatitis c antibody screening, for individual at high risk and other covered indication(s)"
G0473,"Face-to-face behavioral counseling for obesity, group (2-10), 30 minutes"
G0475,"Hiv antigen/antibody, combination assay, screening"
G0476,"Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test"
G0477,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical observation only (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of serviceTerminated December 31, 2016."
G0478,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) read by instrument-assisted direct optical observation (e.g., dipsticks, cups, cards, cartridges), includes sample validation when performed, per date of serviceTerminated December 31, 2016."
G0479,"Drug test(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, tof, maldi, ldtd, desi, dart, ghpc, gc mass spectrometry), includes sample validation when performed, per date of serviceTerminated December 31, 2016."
G0480,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed"
G0481,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed"
G0482,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed"
G0483,"Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed"
G0490,Face-to-face home health nursing visit by a rural health clinic (rhc) or federally qualified health center (fqhc) in an area with a shortage of home health agencies;  (services limited to rn or lpn only)
G0491,Dialysis procedure at a medicare certified esrd facility for acute kidney injury without esrd
G0492,Dialysis procedure with single evaluation by a physician or other qualified health care professional  for acute kidney injury without esrd
G0493,"Skilled services of a registered nurse (rn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)"
G0494,"Skilled services of a licensed practical nurse (lpn) for the observation and assessment of the patient's condition, each 15 minutes (the change in the patient's condition requires skilled nursing personnel to identify and evaluate the patient's need for possible modification of treatment in the home health or hospice setting)"
G0495,"Skilled services of a registered nurse (rn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes"
G0496,"Skilled services of a licensed practical nurse (lpn), in the training and/or education of a patient or family member, in the home health or hospice setting, each 15 minutes"
G0498,"Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion"
G0499,"Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result"
G0500,"Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)"
G0501,"Resource-intensive services for patients for whom the use of specialized mobility-assistive technology (such as adjustable height chairs or tables, patient lift, and adjustable padded leg supports) is medically necessary and used during the provision of an office/outpatient, evaluation and management  visit (list separately in addition to primary service)"
G0502,"Initial psychiatric collaborative care management, first 70 minutes in the first calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements: outreach to and engagement in treatment of a patient directed by the treating physician or other qualified health care professional; initial assessment of the patient, including administration of validated rating scales, with the development of an individualized treatment plan;  review by the psychiatric consultant with modifications of the plan if recommended;  entering patient in a registry and tracking patient follow-up and progress using the registry, with appropriate documentation, and participation in weekly caseload consultation with the psychiatric consultant; and provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategiesTerminated December 31, 2017."
G0503,"Subsequent psychiatric collaborative care management, first 60 minutes in a subsequent month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional, with the following required elements:  tracking patient follow-up and progress using the registry, with appropriate documentation;  participation in weekly caseload consultation with the psychiatric consultant;  ongoing collaboration with and coordination of the patient's mental health care with the treating physician or other qualified health care professional and any other treating mental health providers;  additional review of progress and recommendations for changes in treatment, as indicated, including medications, based on recommendations provided by the psychiatric consultant;  provision of brief interventions using evidence-based techniques such as behavioral activation, motivational interviewing, and other focused treatment strategies;  monitoring of patient outcomes using validated rating scales; and relapse prevention planning with patients as they achieve remission of symptoms and/or other treatment goals and are prepared for discharge from active treatmentTerminated December 31, 2017."
G0504,"Initial or subsequent psychiatric collaborative care management, each additional 30 minutes in a calendar month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional (list separately in addition to code for primary procedure);  (use g0504 in conjunction with g0502, g0503)Terminated December 31, 2017."
G0505,"Cognition and functional assessment using standardized instruments with development of recorded care plan for the patient with cognitive impairment, history obtained from patient and/or caregiver, in office or other outpatient setting or home or domiciliary or rest homeTerminated December 31, 2017."
G0506,Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service)
G0507,"Care management services for behavioral health conditions, at least 20 minutes of clinical staff time, directed by a physician or other qualified health care professional, per calendar month, with the following required elements: initial assessment or follow-up monitoring, including the use of applicable validated rating scales; behavioral health care planning in relation to behavioral/psychiatric health problems, including revision for patients who are not progressing or whose status changes; facilitating and coordinating treatment such as psychotherapy, pharmacotherapy, counseling and/or psychiatric consultation; and continuity of care with a designated member of the care teamTerminated December 31, 2017."
G0508,"Telehealth consultation, critical care, initial , physicians typically spend 60 minutes communicating with the patient and providers via telehealth"
G0509,"Telehealth consultation, critical care, subsequent, physicians typically spend 50 minutes communicating with the patient and providers via telehealth"
G0511,"Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month"
G0512,"Rural health clinic or federally qualified health center (rhc/fqhc) only, psychiatric collaborative care model (psychiatric cocm), 60 minutes or more of clinical staff time for psychiatric cocm services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm) and including services furnished by a behavioral health care manager and consultation with a psychiatric consultant, per calendar month"
G0513,"Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preventive service)"
G0514,"Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; each additional 30 minutes (list separately in addition to code g0513 for additional 30 minutes of preventive service)"
G0515,"Development of cognitive skills to improve attention, memory, problem solving (includes compensatory training), direct (one-on-one) patient contact, each 15 minutesTerminated December 31, 2019."
G0516,"Insertion of non-biodegradable drug delivery implants, 4 or more (services for subdermal rod implant)"
G0517,"Removal of non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)"
G0518,"Removal with reinsertion, non-biodegradable drug delivery implants, 4 or more (services for subdermal implants)"
G0519,"Management of new patient-caregiver dyad with dementia, low complexity, for use in cmmi model"
G0520,"Management of new patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model"
G0521,"Management of new patient-caregiver dyad with dementia, high complexity, for use in cmmi model"
G0522,"Management of a new patient with dementia, low complexity, for use in cmmi model"
G0523,"Management of a new patient with dementia, moderate to high complexity, for use in cmmi model"
G0524,"Management of established patient-caregiver dyad with dementia, low complexity, for use in cmmi model"
G0525,"Management of established patient-caregiver dyad with dementia, moderate complexity, for use in cmmi model"
G0526,"Management of established patient-caregiver dyad with dementia, high complexity, for use in cmmi model"
G0527,"Management of established patient with dementia, low complexity, for use in cmmi model"
G0528,"Management of established patient with dementia, moderate to high complexity, for use in cmmi model"
G0529,"In-home respite care, 4-hour unit, for use in cmmi model"
G0530,"Adult day center, 8-hour unit, for use in cmmi model"
G0531,"Facility-based respite, 24-hour unit, for use in cmmi model"
G0532,"Take-home supply of nasal nalmefene hydrochloride; one carton of two, 2.7 mg per 0.1 ml nasal sprays (provision of the services by a medicare-enrolled opioid treatment program);( list separately in addition to each primary code)"
G0533,"Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
G0534,"Coordinated care and/or referral services, such as to adequate and accessible community resources to address unmet health-related social needs, including harm reduction interventions and recovery support services a patient needs and wishes to pursue, which significantly limit the ability to diagnose or treat an opioid use disorder; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)"
G0535,"Patient navigational services, provided directly or by referral; including helping the patient to navigate health systems and identify care providers and supportive services, to build patient self-advocacy and communication skills with care providers, and to promote patient-driven action plans and goals; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)"
G0536,"Peer recovery support services, provided directly or by referral; including leveraging knowledge of the condition or lived experience to provide support, mentorship, or inspiration to meet oud treatment and recovery goals; conducting a person-centered interview to understand the patient's life story, strengths, needs, goals, preferences, and desired outcomes; developing and proposing strategies to help meet person-centered treatment goals; assisting the patient in locating or navigating recovery support services; each additional 30 minutes of services (provision of the services by a medicare-enrolled opioid treatment program); (list separately in addition to each primary code)"
G0537,"Administration of a standardized, evidence-based atherosclerotic cardiovascular disease (ascvd) risk assessment, 5-15 minutes, not more often than every 12 months"
G0538,Atherosclerotic cardiovascular disease (ascvd) risk management services; clinical staff time; per calendar month
G0539,"Caregiver training in behavior management/modification for caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; initial 30 minutes"
G0540,"Caregiver training in behavior management/modification for parent(s)/guardian(s)/caregiver(s) of patients with a mental or physical health diagnosis, administered by physician or other qualified health care professional (without the patient present), face-to-face; each additional 15 minutes"
G0541,"Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; initial 30 minutes"
G0542,"Caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face; each additional 15 minutes (list separately in addition to code for primary service) (use g0542 in conjunction with g0541)"
G0543,"Group caregiver training in direct care strategies and techniques to support care for patients with an ongoing condition or illness and to reduce complications (including, but not limited to, techniques to prevent decubitus ulcer formation, wound care, and infection control) (without the patient present), face-to-face with multiple sets of caregivers"
G0544,"Post discharge telephonic follow-up contacts performed in conjunction with a discharge from the emergency department for behavioral health or other crisis encounter, 4 calls per calendar month"
G0545,"Visit complexity inherent to hospital inpatient or observation care associated with a confirmed or suspected infectious disease by an infectious diseases specialist, including disease transmission risk assessment and mitigation, public health investigation, analysis, and testing, and complex antimicrobial therapy counseling and treatment (add-on code, list separately in addition to hospital inpatient or observation evaluation and management visit, initial, same day discharge, subsequent or discharge)"
G0546,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty   whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 5-10 minutes of medical consultative discussion and review"
G0547,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 11-20 minutes of medical consultative discussion and review"
G0548,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 21-30 minutes of medical consultative discussion and review"
G0549,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a verbal and written report to the patient's treating/requesting practitioner; 31 or more minutes of medical consultative discussion and review"
G0550,"Interprofessional telephone/internet/electronic health record assessment and management service provided by a practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, including a written report to the patient's treating/requesting practitioner, 5 minutes or more of medical consultative time"
G0551,"Interprofessional telephone/internet/electronic health record referral service(s) provided by a treating/requesting practitioner in a specialty whose covered services are limited by statute to services for the diagnosis and treatment of mental illness, 30 minutes"
G0552,"Supply of digital mental health treatment device and initial education and onboarding, per course of treatment that augments a behavioral therapy plan"
G0553,"First 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing information related to the use of the dmht device, including patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month"
G0554,"Each additional 20 minutes of monthly treatment management services directly related to the patient's therapeutic use of the digital mental health treatment (dmht) device that augments a behavioral therapy plan, physician/other qualified health care professional time reviewing data generated from the dmht device from patient observations and patient specific inputs in a calendar month and requiring at least one interactive communication with the patient/caregiver during the calendar month"
G0555,"Provision of replacement patient electronics system (e.g., system pillow, handheld reader) for home pulmonary artery pressure monitoring"
G0556,"Advanced primary care management services for a patient with one chronic condition [expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline], or fewer, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate: consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan with typical care plan elements when clinically relevant; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology"
G0557,"Advanced primary care management services for a patient with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate: consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology"
G0558,"Advanced primary care management services for a patient that is a qualified medicare beneficiary with multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, which place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, provided by clinical staff and directed by a physician or other qualified health care professional who is responsible for all primary care and serves as the continuing focal point for all needed health care services, per calendar month, with the following elements, as appropriate:   consent; ++  inform the patient of the availability of the service; that only one practitioner can furnish and be paid for the service during a calendar month; of the right to stop the services at any time (effective at the end of the calendar month); and that cost sharing may apply. ++  document in patient's medical record that consent was obtained. initiation during a qualifying visit for new patients or patients not seen within 3 years; provide 24/7 access for urgent needs to care team/practitioner, including providing patients/caregivers with a way to contact health care professionals in the practice to discuss urgent needs regardless of the time of day or day of week; continuity of care with a designated member of the care team with whom the patient is able to schedule successive routine appointments; deliver care in alternative ways to traditional office visits to best meet the patient's needs, such as home visits and/or expanded hours; overall comprehensive care management; ++  systematic needs assessment (medical and psychosocial). ++  system-based approaches to ensure receipt of preventive services. ++  medication reconciliation, management and oversight of self-management. development, implementation, revision, and maintenance of an electronic patient-centered comprehensive care plan; ++  care plan is available timely within and outside the billing practice as appropriate to individuals involved in the beneficiary's care, can be routinely accessed and updated by care team/practitioner, and copy of care plan to patient/caregiver; coordination of care transitions between and among health care providers and settings, including referrals to other clinicians and follow-up after an emergency department visit and discharges from hospitals, skilled nursing facilities or other health care facilities as applicable; ++  ensure timely exchange of electronic health information with other practitioners and providers to support continuity of care. ++  ensure timely follow-up communication (direct contact, telephone, electronic) with the patient and/or caregiver after an emergency department visit and discharges from hospitals, skilled nursing facilities, or other health care facilities, within 7 calendar days of discharge, as clinically indicated. ongoing communication and coordinating receipt of needed services from practitioners, home- and community-based service providers, community-based social service providers, hospitals, and skilled nursing facilities (or other health care facilities), and document communication regarding the patient's psychosocial strengths and needs, functional deficits, goals, preferences, and desired outcomes, including cultural and linguistic factors, in the patient's medical record; enhanced opportunities for the beneficiary and any caregiver to communicate with the care team/practitioner regarding the beneficiary's care through the use of asynchronous non-face-to-face consultation methods other than telephone, such as secure messaging, email, internet, or patient portal, and other communication-technology based services, including remote evaluation of pre-recorded patient information and interprofessional telephone/internet/ehr referral service(s), to maintain ongoing communication with patients, as appropriate; ++  ensure access to patient-initiated digital communications that require a clinical decision, such as virtual check-ins and digital online assessment and management and e/m visits (or e-visits). analyze patient population data to identify gaps in care and offer additional interventions, as appropriate; risk stratify the practice population based on defined diagnoses, claims, or other electronic data to identify and target services to patients; be assessed through performance measurement of primary care quality, total cost of care, and meaningful use of certified ehr technology"
G0559,"Post-operative follow-up visit complexity inherent to evaluation and management services addressing surgical procedure(s), provided by a physician or qualified health care professional who is not the practitioner who performed the procedure (or in the same group practice) and is of the same or of a different specialty than the practitioner who performed the procedure, within the 90-day global period of the procedure(s), once per 90-day global period, when there has not been a formal transfer of care and requires the following required elements, when possible and applicable:    reading available surgical note to understand the relative success of the procedure, the anatomy that was affected, and potential complications that could have arisen due to the unique circumstances of the patient's operation.    research the procedure to determine expected post-operative course and potential complications (in the case of doing a post-op for a procedure outside the specialty).    evaluate and physically examine the patient to determine whether the post-operative course is progressing appropriately.    communicate with the practitioner who performed the procedure if any questions or concerns arise. (list separately in addition to office/outpatient evaluation and management visit, new or established)"
G0560,"Safety planning interventions, each 20 minutes personally performed by the billing practitioner, including assisting the patient in the identification of the following personalized elements of a safety plan: recognizing warning signs of an impending suicidal or substance use-related crisis; employing internal coping strategies; utilizing social contacts and social settings as a means of distraction from suicidal thoughts or risky substance use; utilizing family members, significant others, caregivers, and/or friends to help resolve the crisis; contacting mental health or substance use disorder professionals or agencies; and making the environment safe"
G0561,"Tympanostomy with local or topical anesthesia and insertion of a ventilating tube when performed with tympanostomy tube delivery device, unilateral (list separately in addition to 69433) (do not use in conjunction with 0583t)"
G0562,"Therapeutic radiology simulation-aided field setting; complex, including acquisition of pet and ct imaging data required for radiopharmaceutical-directed radiation therapy treatment planning (i.e., modeling)"
G0563,"Stereotactic body radiation therapy, treatment delivery, per fraction to 1 or more lesions, including image guidance and real-time positron emissions-based delivery adjustments to 1 or more lesions, entire course not to exceed 5 fractions"
G0564,"Creation of subcutaneous pocket with insertion of 365 day implantable interstitial glucose sensor, including system activation and patient trainingTerminated March 31, 2025."
G0565,"Removal of implantable interstitial glucose sensor with creation of subcutaneous pocket at different anatomic site and insertion of new 365 day implantable sensor, including system activationTerminated March 31, 2025."
G0566,"3d radiodensity-value bone imaging, algorithm derived, from previous magnetic resonance examination of the same anatomy"
G0567,"Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique"
G0659,"Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes"
G0908,"Most recent hemoglobin (hgb) level > 12.0 g/dlTerminated December 31, 2014."
G0909,"Hemoglobin level measurement not documented, reason not givenTerminated December 31, 2014."
G0910,"Most recent hemoglobin level <= 12.0 g/dlTerminated December 31, 2014."
G0913,Improvement in visual function achieved within 90 days following cataract surgery
G0914,Patient care survey was not completed by patient
G0915,Improvement in visual function not achieved within 90 days following cataract surgery
G0916,Satisfaction with care achieved within 90 days following cataract surgery
G0917,Patient care survey was not completed by patient
G0918,Satisfaction with care not achieved within 90 days following cataract surgery
G0919,"Influenza immunization ordered or recommended (to be given at alternate location or alternate provider); vaccine not available at time of visitTerminated December 31, 2014."
G0920,"Type, anatomic location, and activity all documentedTerminated December 31, 2014."
G0921,"Documentation of patient reason(s) for not being able to assess (e.g., patient refuses endoscopic and/or radiologic assessment)Terminated December 31, 2014."
G0922,"No documentation of disease type, anatomic location, and activity, reason not givenTerminated December 31, 2014."
G1000,"Clinical decision support mechanism applied pathways, as defined by the medicare appropriate use criteria programTerminated March 31, 2020."
G1001,"Clinical decision support mechanism evicore, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1002,"Clinical decision support mechanism medcurrent, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1003,"Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1004,"Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1005,"Clinical decision support mechanism national imaging associates, as defined by the medicare appropriate use criteria programTerminated December 31, 2020."
G1006,"Clinical decision support mechanism test appropriate, as defined by the medicare appropriate use criteria programTerminated December 31, 2020."
G1007,"Clinical decision support mechanism aim specialty health, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1008,"Clinical decision support mechanism cranberry peak, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1009,"Clinical decision support mechanism sage health management solutions, as defined by the medicare appropriate use criteria programTerminated March 31, 2022."
G1010,"Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1011,"Clinical decision support mechanism, qualified tool not otherwise specified, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1012,"Clinical decision support mechanism agilemd, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1013,"Clinical decision support mechanism evidencecare imagingcare, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1014,"Clinical decision support mechanism inveniqa semantic answers in medicine, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1015,"Clinical decision support mechanism reliant medical group, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1016,"Clinical decision support mechanism speed of care, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1017,"Clinical decision support mechanism healthhelp, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1018,"Clinical decision support mechanism infinx, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1019,"Clinical decision support mechanism logicnets, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1020,"Clinical decision support mechanism curbside clinical augmented workflow, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1021,"Clinical decision support mechanism ehealthline clinical decision support mechanism, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1022,"Clinical decision support mechanism intermountain clinical decision support mechanism, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1023,"Clinical decision support mechanism persivia clinical decision support, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1024,"Clinical decision support mechanism radrite, as defined by the medicare appropriate use criteria programTerminated December 31, 2024."
G1025,Patient-months where there are more than one medicare capitated payment (mcp) provider listed for the month
G1026,The number of adult patient-months in the denominator who were on maintenance hemodialysis using a catheter continuously for three months or longer under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month
G1027,The number of adult patient-months in the denominator who were on maintenance hemodialysis under the care of the same practitioner or group partner as of the last hemodialysis session of the reporting month using a catheter continuously for less than three months
G1028,Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
G2000,"Blinded administration of convulsive therapy procedure, either electroconvulsive therapy (ect, current covered gold standard) or magnetic seizure therapy (mst, non-covered experimental therapy), performed in an approved ide-based clinical trial, per treatment session"
G2001,"Brief (20 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2002,"Limited (30 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2003,"Moderate (45 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2004,"Comprehensive (60 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2005,"Extensive (75 minutes) in-home visit for a new patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2006,"Brief (20 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2007,"Limited (30 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2008,"Moderate (45 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2009,"Comprehensive (60 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2010,"Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment"
G2011,"Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention, 5-14 minutes"
G2012,"Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussionTerminated December 31, 2024."
G2013,"Extensive (75 minutes) in-home visit for an existing patient post-discharge. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2014,"Limited (30 minutes) care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility and no more than 9 times.)"
G2015,"Comprehensive (60 mins) home care plan oversight. for use only in a medicare-approved cmmi model. (services must be furnished within a beneficiary's home, domiciliary, rest home, assisted living and/or nursing facility within 90 days following discharge from an inpatient facility.)"
G2020,Services for high intensity clinical services associated with the initial engagement and outreach of beneficiaries assigned to the sip component of the pcf model (do not bill with chronic care management codes)
G2021,Health care practitioners rendering treatment in place (tip)
G2022,"A model participant (ambulance supplier/provider), the beneficiary refuses services covered under the model (transport to an alternate destination/treatment in place)"
G2023,"Specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen sourceTerminated May 11, 2023."
G2024,"Specimen collection for severe acute respiratory syndrome coronavirus  2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a  snf or by a laboratory on behalf of a hha, any specimen sourceTerminated May 11, 2023."
G2025,Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only
G2058,"Chronic care management services, each additional 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month (list separately in addition to code for primary procedure). (do not report g2058 for care management services of less than 20 minutes additional to the first 20 minutes of chronic care management services during a calendar month). (use g2058 in conjunction with 99490). (do not report 99490, g2058 in the same calendar month as 99487, 99489, 99491)).Terminated December 31, 2020."
G2061,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 5-10 minutesTerminated December 31, 2020."
G2062,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 11-20 minutesTerminated December 31, 2020."
G2063,"Qualified nonphysician healthcare professional online assessment and management service, for an established patient, for up to seven days, cumulative time during the 7 days; 21 or more minutesTerminated December 31, 2020."
G2064,"Comprehensive care management services for a single high-risk disease, e.g., principal care management, at least 30 minutes of physician  or other qualified health care professional  time per calendar month with the following elements: one complex chronic condition lasting  at least 3 months,  which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been the cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbiditiesTerminated December 31, 2021."
G2065,"Comprehensive care management for a single high-risk disease services, e.g. principal care management, at least 30 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month with the following elements: one complex chronic condition lasting at least 3 months, which is the focus of the care plan, the condition is of sufficient severity to place patient at risk of hospitalization or have been cause of a recent hospitalization, the condition requires development or revision of disease-specific care plan, the condition requires frequent adjustments in the medication regimen, and/or the management of the condition is unusually complex due to comorbiditiesTerminated December 31, 2021."
G2066,"Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of resultsTerminated December 31, 2023."
G2067,"Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
G2068,"Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
G2069,"Medication assisted treatment, buprenorphine (injectable) administered on a monthly basis; bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
G2070,"Medication assisted treatment, buprenorphine (implant insertion); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)Terminated December 31, 2024."
G2071,"Medication assisted treatment, buprenorphine (implant removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)Terminated December 31, 2024."
G2072,"Medication assisted treatment, buprenorphine (implant insertion and removal); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)Terminated December 31, 2024."
G2073,"Medication assisted treatment, naltrexone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
G2074,"Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)"
G2075,"Medication assisted treatment, medication not otherwise specified; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program)"
G2076,"Intake activities, including initial medical examination that is conducted by an appropriately licensed practitioner and preparation of a care plan, which may be informed by administration of a standardized, evidence-based social determinants of health risk assessment to identify unmet health-related social needs, and that includes the patient's goals and mutually agreed-upon actions for the patient to meet those goals, including harm reduction interventions; the patient's needs and goals in the areas of education, vocational training, and employment; and the medical and psychiatric, psychosocial, economic, legal, housing, and other recovery support services that a patient needs and wishes to pursue, conducted by an appropriately licensed/credentialed personnel (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code"
G2077,"Periodic assessment; assessing periodically by an otp practitioner and includes a  review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical and psychiatric treatment needs and goals; assessment may be informed by administration of a standardized, evidence-based social determinants of health risk assessment to identify unmet health-related social needs, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code"
G2078,Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
G2079,Take-home supply of buprenorphine (oral); up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
G2080,"Each additional 30 minutes of counseling in a week of medication assisted treatment, (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure"
G2081,"Patients age 66 and older in institutional special needs plans (snp) or residing in long-term care with a pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period"
G2082,"Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation"
G2083,"Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of  greater than 56 mg esketamine nasal self-administration, includes 2 hours post-administration observation"
G2086,"Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month"
G2087,"Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month"
G2088,"Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; each additional 30 minutes beyond the first 120 minutes (list separately in addition to code for primary procedure)"
G2089,"Most recent hemoglobin a1c (hba1c) level 7.0 to 9.0%Terminated December 31, 2020."
G2090,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
G2091,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
G2092,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy prescribed or currently being taken
G2093,"Documentation of medical reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., hypotensive patients who are at immediate risk of cardiogenic shock, hospitalized patients who have experienced marked azotemia, allergy, intolerance, other medical reasons)"
G2094,"Documentation of patient reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., patient declined, other patient reasons)"
G2095,"Documentation of system reason(s) for not prescribing ace inhibitor or arb or arni therapy (e.g., other system reasons)Terminated December 31, 2022."
G2096,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) or angiotensin receptor-neprilysin inhibitor (arni) therapy was not prescribed, reason not given"
G2097,"Episodes where the patient had a competing diagnosis on or within three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, chronic sinusitis, infection of the adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti)"
G2098,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
G2099,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
G2100,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
G2101,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
G2102,"Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewedTerminated December 31, 2020."
G2103,"Seven standard field stereoscopic photos with interpretation by an ophthalmologist or optometrist documented and reviewedTerminated December 31, 2020."
G2104,"Eye imaging validated to match diagnosis from seven standard field stereoscopic photos results documented and reviewedTerminated December 31, 2020."
G2105,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period"
G2106,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
G2107,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
G2108,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement periodTerminated December 31, 2023."
G2109,"Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement periodTerminated December 31, 2023."
G2110,"Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement periodTerminated December 31, 2023."
G2112,"Patient receiving <=5 mg daily prednisone (or equivalent), or ra activity is worsening, or glucocorticoid use is for less than 6 months"
G2113,"Patient receiving >5 mg daily prednisone (or equivalent) for longer than 6 months, and improvement or no change in disease activity"
G2114,"Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement periodTerminated December 31, 2020."
G2115,Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
G2116,Patients 66 - 80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
G2117,"Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement periodTerminated December 31, 2020."
G2118,Patients 81 years of age and older with at least one claim/encounter for frailty during the measurement period
G2119,"Within the past 2 years, calcium and/or vitamin d optimization has been ordered or performedTerminated December 31, 2020."
G2120,"Within the past 2 years, calcium and/or vitamin d optimization has not been ordered or performedTerminated December 31, 2020."
G2121,"Depression, anxiety, apathy, and psychosis assessed"
G2122,"Depression, anxiety, apathy, and psychosis not assessed"
G2123,"Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement periodTerminated December 31, 2020."
G2124,"Patients 66-80 years of age and had at least one claim/encounter for frailty during the measurement period and a dispensed dementia medicationTerminated December 31, 2020."
G2125,Patients 81 years of age and older with at least one claim/encounter for frailty during the six months prior to the measurement period through  december 31 of the measurement period
G2126,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
G2127,Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
G2128,"Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g. history of gastrointestinal bleed, intra-cranial bleed, blood disorders, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)"
G2129,"Procedure-related bp's not taken during an outpatient visit. examples include same day surgery, ambulatory service center, g.i. lab, dialysis, infusion center, chemotherapy"
G2130,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 days during the measurement periodTerminated December 31, 2020."
G2131,"Patients 81 years and older with a diagnosis of frailtyTerminated December 31, 2020."
G2132,"Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement periodTerminated December 31, 2020."
G2133,"Patients 66-80 years of age with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement periodTerminated December 31, 2020."
G2134,"Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement periodTerminated December 31, 2020."
G2135,"Patients 66 years of age or older with at least one claim/encounter for frailty during the measurement period and either one acute inpatient encounter with a diagnosis of advanced illness or two outpatient, observation, ed or nonacute inpatient encounters on different dates of service with an advanced illness diagnosis during the measurement period or the year prior to the measurement periodTerminated December 31, 2020."
G2136,Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater
G2137,Back pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points
G2138,Back pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater
G2139,Back pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and back pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points
G2140,Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of 5.0 points or greater
G2141,Leg pain measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated improvement of less than 5.0 points
G2142,Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 30 points or greater
G2143,Functional status measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of less than 30 points
G2144,Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6-20 weeks) postoperatively was less than or equal to 22 or functional status measured by the odi version 2.1a within three months preoperatively and at three months (6-20 weeks) postoperatively demonstrated an improvement of 30 points or greater
G2145,Functional status measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively was greater than 22 and functional status measured by the odi version 2.1a within three months preoperatively and at three months (6 - 20 weeks) postoperatively demonstrated an improvement of less than 30 points
G2146,Leg pain as measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was less than or equal to 3.0 or leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated an improvement of 5.0 points or greater
G2147,Leg pain measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively was greater than 3.0 and leg pain measured by the visual analog scale (vas) or numeric pain scale within three months preoperatively and at one year (9 to 15 months) postoperatively demonstrated improvement of less than 5.0 points
G2148,Multimodal pain management was used
G2149,"Documentation of medical reason(s) for not using multimodal pain management (e.g., allergy to multiple classes of analgesics, intubated patient, hepatic failure, patient reports no pain during pacu stay, other medical reason(s))"
G2150,Multimodal pain management was not used
G2151,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care"
G2152,Residual score for the neck impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
G2153,"In hospice or using hospice services during the measurement periodTerminated December 31, 2020."
G2154,"Patient received at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement periodTerminated December 31, 2020."
G2155,"Patient had history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)Terminated December 31, 2020."
G2156,"Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the start of the measurement period and the end of the measurement period; or have history of at least one of the following contraindications any time during or before the measurement period: anaphylaxis due to tdap vaccine, anaphylaxis due to td vaccine or its components; encephalopathy due to tdap or td vaccination (post tetanus vaccination encephalitis, post diphtheria vaccination encephalitis or post pertussis vaccination encephalitis.)Terminated December 31, 2020."
G2157,"Patients received both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during the measurement periodTerminated December 31, 2020."
G2158,"Patient had prior pneumococcal vaccine adverse reaction any time during or before the measurement periodTerminated December 31, 2020."
G2159,"Patient did not receive both the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine at least 12 months apart, with the first occurrence after the age of 60 before or during measurement period; or have prior pneumococcal vaccine adverse reaction any time during or before the measurement periodTerminated December 31, 2020."
G2160,"Patient received at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement periodTerminated December 31, 2020."
G2161,"Patient had prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement periodTerminated December 31, 2020."
G2162,"Patient did not receive at least one dose of the herpes zoster live vaccine or two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period; or have prior adverse reaction caused by zoster vaccine or its components any time during or before the measurement periodTerminated December 31, 2020."
G2163,"Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement periodTerminated December 31, 2020."
G2164,"Patient had a prior influenza virus vaccine adverse reaction any time before or during the measurement periodTerminated December 31, 2020."
G2165,"Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period; or did not have a prior influenza virus vaccine adverse reaction any time before or during the measurement periodTerminated December 31, 2020."
G2166,"Patient refused to participate at admission and/or discharge; patient unable to complete the neck fs prom at admission or discharge due to cognitive deficit, visual deficit, motor deficit, language barrier, or low reading level, and a suitable proxy/recorder is not available; patient self-discharged early; medical reasonTerminated December 31, 2020."
G2167,Residual score for the neck impairment successfully calculated and the score was less than zero (< 0)
G2168,"Services performed by a physical therapist assistant in the home health setting in the delivery of a safe and effective physical therapy maintenance program, each 15 minutes"
G2169,"Services performed by an occupational therapist assistant in the home health setting in the delivery of a safe and effective occupational therapy maintenance program, each 15 minutes"
G2170,"Percutaneous arteriovenous fistula creation (avf), direct, any site, by tissue approximation using thermal resistance energy, and secondary procedures to redirect blood flow (e.g., transluminal balloon angioplasty, coil embolization) when performed, and includes all imaging and radiologic guidance, supervision and interpretation, when performedTerminated December 31, 2022."
G2171,"Percutaneous arteriovenous fistula creation (avf), direct, any site, using magnetic-guided arterial and venous catheters and radiofrequency energy, including flow-directing procedures (e.g., vascular coil embolization with radiologic supervision and interpretation, wen performed) and fistulogram(s), angiography, enography, and/or ultrasound, with radiologic supervision and interpretation, when performedTerminated December 31, 2022."
G2172,All inclusive payment for services related to highly coordinated and integrated opioid use disorder (oud) treatment services furnished for the demonstration project
G2173,"Uri episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)"
G2174,Uri episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date
G2175,"Episodes where the patient had a comorbid condition during the 12 months prior to or on the episode date (e.g., tuberculosis, neutropenia, cystic fibrosis, chronic bronchitis, pulmonary edema, respiratory failure, rheumatoid lung disease)"
G2176,"Outpatient, ed, or observation visits that result in an inpatient admission"
G2177,Acute bronchitis/bronchiolitis episodes when the patient had a new or refill prescription of antibiotics (table 1) in the 30 days prior to the episode date
G2178,"Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measure, for example patient bilateral amputee; patient has condition that would not allow them to accurately respond to a neurological exam (dementia, alzheimer's, etc.); patient has previously documented diabetic peripheral neuropathy with loss of protective sensation"
G2179,Clinician documented that patient had medical reason for not performing lower extremity neurological exam
G2180,Clinician documented that patient was not an eligible candidate for evaluation of footwear as patient is bilateral lower extremity amputee
G2181,Bmi not documented due to medical reason or patient refusal of height or weight measurement
G2182,Patient receiving first-time biologic and/or immune response modifier therapy
G2183,Documentation patient unable to communicate and informant not available
G2184,Patient does not have a caregiver
G2185,Documentation caregiver is trained and certified in dementia care
G2186,Patient /caregiver dyad has been referred to appropriate resources and connection to those resources is confirmed
G2187,Patients with clinical indications for imaging of the head: head trauma
G2188,Patients with clinical indications for imaging of the head: new or change in headache above 50 years of age
G2189,Patients with clinical indications for imaging of the head: abnormal neurologic exam
G2190,Patients with clinical indications for imaging of the head: headache radiating to the neck
G2191,Patients with clinical indications for imaging of the head: positional headaches
G2192,Patients with clinical indications for imaging of the head: temporal headaches in patients over 55 years of age
G2193,Patients with clinical indications for imaging of the head: new onset headache in pre-school children or younger (<6 years of age)
G2194,Patients with clinical indications for imaging of the head: new onset headache in pediatric patients with disabilities for which headache is a concern as inferred from behavior
G2195,Patients with clinical indications for imaging of the head: occipital headache in children
G2196,Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method
G2197,Patient screened for unhealthy alcohol use using a systematic screening method and not identified as an unhealthy alcohol user
G2198,"Documentation of medical reason(s) for not screening for unhealthy alcohol use using a systematic screening method (e.g., limited life expectancy, other medical reasons)Terminated December 31, 2022."
G2199,Patient not screened for unhealthy alcohol use using a systematic screening method
G2200,Patient identified as an unhealthy alcohol user received brief counseling
G2201,"Documentation of medical reason(s) for not providing brief counseling (e.g., limited life expectancy, other medical reasons)Terminated December 31, 2022."
G2202,Patient did not receive brief counseling if identified as an unhealthy alcohol user
G2203,"Documentation of medical reason(s) for not providing brief counseling if identified as an unhealthy alcohol user (e.g., limited life expectancy, other medical reasons)Terminated December 31, 2022."
G2204,Patients between 45 and 85 years of age who received a screening colonoscopy during the performance period
G2205,Patients with pregnancy during adjuvant treatment course
G2206,Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy
G2207,"Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course)"
G2208,Patient did not receive adjuvant treatment course including both chemotherapy and her2-targeted therapy
G2209,Patient refused to participate
G2210,"Residual score for the neck impairment not measured because the patient did not complete the neck fs prom at initial evaluation and/or near discharge, reason not given"
G2211,"Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition.  (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)"
G2212,"Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes)"
G2213,"Initiation of medication for the treatment of opioid use disorder in the emergency department setting, including assessment, referral to ongoing care, and arranging access to supportive services (list separately in addition to code for primary procedure)"
G2214,"Initial or subsequent psychiatric collaborative care management, first 30 minutes in a month of behavioral health care manager activities, in consultation with a psychiatric consultant, and directed by the treating physician or other qualified health care professional"
G2215,Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
G2216,Take-home supply of injectable naloxone (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure
G2250,"Remote assessment of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment"
G2251,"Brief communication technology-based service, e.g. virtual check-in, by a qualified health care professional who cannot report evaluation and management services, provided to an established patient, not originating from a related service provided within the previous 7 days nor leading to a service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of clinical discussion"
G2252,"Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion"
G3001,"Administration and supply of tositumomab, 450 mgTerminated December 31, 2016."
G3002,"Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.)"
G3003,"Each additional 15 minutes of chronic pain management and treatment by a physician or other qualified health care professional, per calendar month. (list separately in addition to code for g3002. when using g3003, 15 minutes must be met or exceeded.)"
G4000,Dermatology mips specialty set
G4001,Diagnostic radiology mips specialty set
G4002,Electrophysiology cardiac specialist mips specialty set
G4003,Emergency medicine mips specialty set
G4004,Endocrinology mips specialty set
G4005,Family medicine mips specialty set
G4006,Gastro-enterology mips specialty set
G4007,General surgery mips specialty set
G4008,Geriatrics mips specialty set
G4009,Hospitalists mips specialty set
G4010,Infectious disease mips specialty set
G4011,Internal medicine mips specialty set
G4012,Interventional radiology mips specialty set
G4013,Mental/behavioral and psychiatry mips specialty set
G4014,Nephrology mips specialty set
G4015,Neurology mips specialty set
G4016,Neurosurgical mips specialty set
G4017,Nutrition/dietician mips specialty set
G4018,Obstetrics/gynecology mips specialty set
G4019,Oncology/hematology mips specialty set
G4020,Ophthalmology/optometry mips specialty set
G4021,Orthopedic surgery mips specialty set
G4022,Otolaryngology mips specialty set
G4023,Pathology mips specialty set
G4024,Pediatrics mips specialty set
G4025,Physical medicine mips specialty set
G4026,Physical therapy/occupational therapy mips specialty set
G4027,Plastic surgery mips specialty set
G4028,Podiatry mips specialty set
G4029,Preventive medicine mips specialty set
G4030,Pulmonology mips specialty set
G4031,Radiation oncology mips specialty set
G4032,Rheumatology mips specialty set
G4033,Skilled nursing facility mips specialty set
G4034,Speech language pathology mips specialty set
G4035,Thoracic surgery mips specialty set
G4036,Urgent care mips specialty set
G4037,Urology mips specialty set
G4038,Vascular surgery mips specialty set
G6001,Ultrasonic guidance for placement of radiation therapy fields
G6002,Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy
G6003,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: up to 5 mev"
G6004,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 6-10 mev"
G6005,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 11-19 mev"
G6006,"Radiation treatment delivery, single treatment area, single port or parallel opposed ports, simple blocks or no blocks: 20 mev or greater"
G6007,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: up to 5 mev"
G6008,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 6-10 mev"
G6009,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 11-19 mev"
G6010,"Radiation treatment delivery, 2 separate treatment areas, 3 or more ports on a single treatment area, use of multiple blocks: 20 mev or greater"
G6011,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; up to 5 mev"
G6012,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev"
G6013,"Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev"
G6014,"Radiation treatment delivery, 3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater"
G6015,"Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session"
G6016,"Compensator-based beam modulation treatment delivery of inverse planned treatment using 3 or more high resolution (milled or cast) compensator, convergent beam modulated fields, per treatment session"
G6017,"Intra-fraction localization and tracking of target or patient motion during delivery of radiation therapy (eg,3d positional tracking, gating, 3d surface tracking), each fraction of treatment"
G6018,"Ileoscopy, through stoma; with transendoscopic stent placement (includes predilation)Terminated December 31, 2015."
G6019,"Colonoscopy through stoma; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare techniqueTerminated December 31, 2015."
G6020,"Colonoscopy through stoma; with transendoscopic stent placement (includes predilation)Terminated December 31, 2015."
G6021,"Unlisted procedure, intestineTerminated December 31, 2015."
G6022,"Sigmoidoscopy, flexible; with ablation of tumor(s), polyp(s), or other lesions(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare techniqueTerminated December 31, 2015."
G6023,"Sigmoidoscopy, flexible; with transendoscopic stent placement (includes predilation)Terminated December 31, 2015."
G6024,"Colonoscopy, flexible; proximal to splenic flexure; with ablation of tumor(s), polyp(s), or other lesion(s) not amenable to removal by hot biopsy forceps, bipolar cautery or snare techniqueTerminated December 31, 2015."
G6025,"Colonoscopy, flexible, proximal to splenic flexure; with transendoscopic stent placement (includes predilation)Terminated December 31, 2015."
G6027,"Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); diagnostic, including collection of specimen(s) by brushing or washing when performedTerminated December 31, 2015."
G6028,"Anoscopy, high resolution (hra) (with magnification and chemical agent enhancement); with biopsy(ies)Terminated December 31, 2015."
G6030,"AmitriptylineTerminated December 31, 2015."
G6031,"BenzodiazepinesTerminated December 31, 2015."
G6032,"DesipramineTerminated December 31, 2015."
G6034,"DoxepinTerminated December 31, 2015."
G6035,"GoldTerminated December 31, 2015."
G6036,"Assay of imipramineTerminated December 31, 2015."
G6037,"NortriptylineTerminated December 31, 2015."
G6038,"SalicylateTerminated December 31, 2015."
G6039,"AcetaminophenTerminated December 31, 2015."
G6040,"Alcohol (ethanol); any specimen except breathTerminated December 31, 2015."
G6041,"Alkaloids, urine, quantitativeTerminated December 31, 2015."
G6042,"Amphetamine or methamphetamineTerminated December 31, 2015."
G6043,"Barbiturates, not elsewhere specifiedTerminated December 31, 2015."
G6044,"Cocaine or metaboliteTerminated December 31, 2015."
G6045,"DihydrocodeinoneTerminated December 31, 2015."
G6046,"DihydromorphinoneTerminated December 31, 2015."
G6047,"DihydrotestosteroneTerminated December 31, 2015."
G6048,"DimethadioneTerminated December 31, 2015."
G6049,"EpiandrosteroneTerminated December 31, 2015."
G6050,"EthchlorvynolTerminated December 31, 2015."
G6051,"FlurazepamTerminated December 31, 2015."
G6052,"MeprobamateTerminated December 31, 2015."
G6053,"MethadoneTerminated December 31, 2015."
G6054,"MethsuximideTerminated December 31, 2015."
G6055,"NicotineTerminated December 31, 2015."
G6056,"Opiate(s), drug and metabolites, each procedureTerminated December 31, 2015."
G6057,"PhenothiazineTerminated December 31, 2015."
G6058,"Drug confirmation, each procedureTerminated December 31, 2015."
G8126,"Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week)  acute treatment phaseTerminated December 31, 2014."
G8127,"Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phaseTerminated December 31, 2014."
G8128,"Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measureTerminated December 31, 2014."
G8395,Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function
G8396,Left ventricular ejection fraction (lvef) not performed or documented
G8397,"Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy"
G8398,"Dilated macular or fundus exam not performedTerminated December 31, 2020."
G8399,Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed
G8400,"Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given"
G8401,"Clinician documented that patient was not an eligible candidate for screeningTerminated December 31, 2016."
G8404,Lower extremity neurological exam performed and documented
G8405,Lower extremity neurological exam not performed
G8406,"Clinician documented that patient was not an eligible candidate for lower extremity neurological exam measureTerminated December 31, 2014."
G8410,Footwear evaluation performed and documented
G8415,Footwear evaluation was not performed
G8416,Clinician documented that patient was not an eligible candidate for footwear evaluation measure
G8417,Bmi is documented above normal parameters and a follow-up plan is documented
G8418,Bmi is documented below normal parameters and a follow-up plan is documented
G8419,"Bmi documented outside normal parameters, no follow-up plan documented, no reason given"
G8420,Bmi is documented within normal parameters and no follow-up plan is required
G8421,Bmi not documented and no reason is given
G8422,"Bmi not documented, documentation the patient is not eligible for bmi calculationTerminated December 31, 2021."
G8427,"Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications"
G8428,"Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given"
G8430,"Documentation of a medical reason(s) for not documenting, updating, or reviewing the patient's current medications list (e.g., patient is in an urgent or emergent medical situation)"
G8431,Screening for depression is documented as being positive and a follow-up plan is documented
G8432,"Depression screening not documented, reason not given"
G8433,"Screening for depression not completed, documented patient or medical reason"
G8442,"Pain assessment not documented as being performed, documentation the patient is not eligible for a pain assessment using a standardized tool at the time of the encounterTerminated December 31, 2020."
G8450,Beta-blocker therapy prescribed
G8451,"Beta-blocker therapy for lvef <=40% not prescribed for reasons documented by the clinician (e.g., low blood pressure, fluid overload, asthma, patients recently treated with an intravenous positive inotropic agent, allergy, intolerance, other medical reasons, patient declined, other patient reasons)"
G8452,Beta-blocker therapy not prescribed
G8458,"Clinician documented that patient is not an eligible candidate for genotype testing; patient not receiving antiviral treatment for hepatitis c during the measurement period (e.g. genotype test done prior to the reporting period, patient declines, patient not a candidate for antiviral treatment)Terminated December 31, 2016."
G8460,"Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis cTerminated December 31, 2016."
G8461,"Patient receiving antiviral treatment for hepatitis c during the measurement periodTerminated December 31, 2016."
G8464,"Clinician documented that prostate cancer patient is not an eligible candidate for adjuvant hormonal therapy; low or intermediate risk of recurrence or risk of recurrence not determinedTerminated December 31, 2014."
G8465,High or very high risk of recurrence of prostate cancer
G8473,Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed
G8474,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for reasons documented by the clinician (e.g., allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (e.g., patient declined, other patient reasons)"
G8475,"Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given"
G8476,Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg
G8477,Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg
G8478,"Blood pressure measurement not performed or documented, reason not given"
G8482,"Influenza immunization administered or previously receivedTerminated December 31, 2024."
G8483,"Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)Terminated December 31, 2024."
G8484,"Influenza immunization was not administered, reason not givenTerminated December 31, 2024."
G8485,"I intend to report the diabetes mellitus (dm) measures groupTerminated December 31, 2016."
G8486,"I intend to report the preventive care measures groupTerminated December 31, 2016."
G8487,"I intend to report the chronic kidney disease (ckd) measures groupTerminated December 31, 2016."
G8489,"I intend to report the coronary artery disease (cad) measures groupTerminated December 31, 2016."
G8490,"I intend to report the rheumatoid arthritis (ra) measures groupTerminated December 31, 2016."
G8491,"I intend to report the hiv/aids measures groupTerminated December 31, 2016."
G8492,"I intend to report the perioperative care measures groupTerminated December 31, 2014."
G8493,"I intend to report the back pain measures groupTerminated December 31, 2014."
G8494,"All quality actions for the applicable measures in the diabetes mellitus (dm) measures group have been performed for this patientTerminated December 31, 2016."
G8495,"All quality actions for the applicable measures in the chronic kidney disease (ckd) measures group have been performed for this patientTerminated December 31, 2016."
G8496,"All quality actions for the applicable measures in the preventive care measures group have been performed for this patientTerminated December 31, 2016."
G8497,"All quality actions for the applicable measures in the coronary artery bypass graft (cabg) measures group have been performed for this patientTerminated December 31, 2016."
G8498,"All quality actions for the applicable measures in the coronary artery disease (cad) measures group have been performed for this patientTerminated December 31, 2016."
G8499,"All quality actions for the applicable measures in the rheumatoid arthritis (ra) measures group have been performed for this patientTerminated December 31, 2016."
G8500,"All quality actions for the applicable measures in the hiv/aids measures group have been performed for this patientTerminated December 31, 2016."
G8501,"All quality actions for the applicable measures in the perioperative care measures group have been performed for this patientTerminated December 31, 2014."
G8502,"All quality actions for the applicable measures in the back pain measures group have been performed for this patientTerminated December 31, 2014."
G8506,"Patient receiving angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapyTerminated December 31, 2023."
G8509,"Pain assessment documented as positive using a standardized tool, follow-up plan not documented, reason not givenTerminated December 31, 2020."
G8510,"Screening for depression is documented as negative, a follow-up plan is not required"
G8511,"Screening for depression documented as positive, follow-up plan not documented, reason not given"
G8530,"Autogenous av fistula receivedTerminated December 31, 2015."
G8531,"Clinician documented that patient was not an eligible candidate for autogenous av fistulaTerminated December 31, 2015."
G8532,"Clinician documented that patient received vascular access other than autogenous av fistula, reason not givenTerminated December 31, 2015."
G8535,"Elder maltreatment screen not documented; documentation that patient is not eligible for the elder maltreatment screen at the time of the encounter related to one of the following reasons: (1) patient refuses to participate in the screening and has reasonable decisional capacity for self-protection, or (2) patient is in an urgent or emergent situation where time is of the essence and to delay treatment to perform the screening would jeopardize the patient's health status"
G8536,"No documentation of an elder maltreatment screen, reason not given"
G8539,Functional outcome assessment documented as positive using a standardized tool and a care plan based on identified deficiencies is documented within two days of the functional outcome assessment
G8540,"Functional outcome assessment not documented as being performed, documentation the patient is not eligible for a functional outcome assessment using a standardized tool at the time of the encounter"
G8541,"Functional outcome assessment using a standardized tool not documented, reason not given"
G8542,"Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required"
G8543,"Documentation of a positive functional outcome assessment using a standardized tool; care plan not documented within two days of assessment, reason not given"
G8544,"I intend to report the coronary artery bypass graft (cabg) measures groupTerminated December 31, 2016."
G8545,"I intend to report the hepatitis c measures groupTerminated December 31, 2016."
G8547,"I intend to report the ischemic vascular disease (ivd) measures groupTerminated December 31, 2014."
G8548,"I intend to report the heart failure (hf) measures groupTerminated December 31, 2016."
G8549,"All quality actions for the applicable measures in the hepatitis c measures group have been performed for this patientTerminated December 31, 2016."
G8551,"All quality actions for the applicable measures in the heart failure (hf) measures group have been performed for this patientTerminated December 31, 2016."
G8552,"All quality actions for the applicable measures in the ischemic vascular disease (ivd) measures group have been performed for this patientTerminated December 31, 2014."
G8559,Patient referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation
G8560,Patient has a history of active drainage from the ear within the previous 90 days
G8561,Patient is not eligible for the referral for otologic evaluation for patients with a history of active drainage measure
G8562,Patient does not have a history of active drainage from the ear within the previous 90 days
G8563,"Patient not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given"
G8564,"Patient was referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not specified)"
G8565,Verification and documentation of sudden or rapidly progressive hearing loss
G8566,"Patient is not eligible for the ""referral for otologic evaluation for sudden or rapidly progressive hearing loss"" measure"
G8567,Patient does not have verification and documentation of sudden or rapidly progressive hearing loss
G8568,"Patient was not referred to a physician (preferably a physician with training in disorders of the ear) for an otologic evaluation, reason not given"
G8569,Prolonged postoperative intubation (> 24 hrs) required
G8570,Prolonged postoperative intubation (> 24 hrs) not required
G8571,"Development of deep sternal wound infection/mediastinitis within 30 days postoperativelyTerminated December 31, 2020."
G8572,"No deep sternal wound infection/mediastinitisTerminated December 31, 2020."
G8573,"Stroke following isolated cabg surgeryTerminated December 31, 2020."
G8574,"No stroke following isolated cabg surgeryTerminated December 31, 2020."
G8575,Developed postoperative renal failure or required dialysis
G8576,No postoperative renal failure/dialysis not required
G8577,"Re-exploration required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native, vessel, graft, or both), valve dysfunction, aortic reintervention, or other cardiac reason"
G8578,"Re-exploration not required due to mediastinal bleeding with or without tamponade, unplanned coronary artery intervention (native, vessel, graft, or both), valve dysfunction, aortic reintervention, or other cardiac reason"
G8579,"Antiplatelet medication at dischargeTerminated December 31, 2014."
G8580,"Antiplatelet medication contraindicatedTerminated December 31, 2014."
G8581,"No antiplatelet medication at dischargeTerminated December 31, 2014."
G8582,"Beta-blocker at dischargeTerminated December 31, 2014."
G8583,"Beta-blocker contraindicatedTerminated December 31, 2014."
G8584,"No beta-blocker at dischargeTerminated December 31, 2014."
G8585,"Anti-lipid treatment at dischargeTerminated December 31, 2014."
G8586,"Anti-lipid treatment contraindicatedTerminated December 31, 2014."
G8587,"No anti-lipid treatment at dischargeTerminated December 31, 2014."
G8593,"Lipid profile results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)Terminated December 31, 2014."
G8594,"Lipid profile not performed, reason not givenTerminated December 31, 2014."
G8595,"Most recent ldl-c < 100 mg/dlTerminated December 31, 2014."
G8597,"Most recent ldl-c >= 100 mg/dlTerminated December 31, 2014."
G8598,Aspirin or another antiplatelet therapy used
G8599,"Aspirin or another antiplatelet therapy not used, reason not given"
G8600,Iv thrombolytic therapy initiated within 4.5 hours (<= 270 minutes) of time last known well
G8601,"Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well for reasons documented by clinician (e.g. patient enrolled in clinical trial for stroke, patient admitted for elective carotid intervention)"
G8602,"Iv thrombolytic therapy not initiated within 4.5 hours (<= 270 minutes) of time last known well, reason not given"
G8627,"Surgical procedure performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)Terminated December 31, 2020."
G8628,"Surgical procedure not performed within 30 days following cataract surgery for major complications (e.g., retained nuclear fragments, endophthalmitis, dislocated or wrong power iol, retinal detachment, or wound dehiscence)Terminated December 31, 2020."
G8629,"Documentation of order for prophylactic parenteral antibiotic to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)Terminated December 31, 2014."
G8630,"Documentation that administration of prophylactic parenteral antibiotics was initiated within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required), as orderedTerminated December 31, 2014."
G8631,"Clinician documented that patient was not an eligible candidate for ordering prophylactic parenteral antibiotics to be given within one hour (if fluoroquinolone or vancomycin, two hours) prior to surgical incision (or start of procedure when no incision is required)Terminated December 31, 2014."
G8632,"Prophylactic parenteral antibiotics were not ordered to be given or given within one hour (if fluoroquinolone or vancomycin, two hours) prior to the surgical incision (or start of procedure when no incision is required), reason not givenTerminated December 31, 2014."
G8633,Pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribed
G8634,"Clinician documented patient not an eligible candidate to receive pharmacologic therapy for osteoporosisTerminated December 31, 2016."
G8635,"Pharmacologic therapy for osteoporosis was not prescribed, reason not given"
G8645,"I intend to report the asthma measures groupTerminated December 31, 2016."
G8646,"All quality actions for the applicable measures in the asthma measures group have been performed for this patientTerminated December 31, 2016."
G8647,Residual score for the knee impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
G8648,Residual score for the knee impairment successfully calculated and the score was less than zero (< 0)
G8649,"Risk-adjusted functional status change residual score for the knee impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriateTerminated December 31, 2019."
G8650,"Residual score for the knee impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given"
G8651,Residual score for the hip impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
G8652,Residual score for the hip impairment successfully calculated and the score was less than zero (< 0)
G8653,"Risk-adjusted functional status change residual scores for the hip impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriateTerminated December 31, 2019."
G8654,"Residual score for the hip impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given"
G8655,"Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was equal to zero (0) or greater than zero ( > 0)"
G8656,"Residual score for the lower leg, foot or ankle impairment successfully calculated and the score was less than zero (< 0)"
G8657,"Risk-adjusted functional status change residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriateTerminated December 31, 2019."
G8658,"Residual score for the lower leg, foot or ankle impairment not measured because the patient did not complete the lepf prom at initial evaluation and/or near discharge, reason not given"
G8659,Residual score for the low back impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
G8660,Residual score for the low back impairment successfully calculated and the score was less than zero (< 0)
G8661,"Risk-adjusted functional status change residual score for the low back impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriate"
G8662,"Residual score for the low back impairment not measured because the patient did not complete the low back fs prom at initial evaluation and/or near discharge, reason not given"
G8663,Residual score for the shoulder impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)
G8664,Residual score for the shoulder impairment successfully calculated and the score was less than zero (< 0)
G8665,"Risk-adjusted functional status change residual score for the shoulder impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriateTerminated December 31, 2019."
G8666,"Residual score for the shoulder impairment not measured because the patient did not complete the shoulder fs prom at initial evaluation and/or near discharge, reason not given"
G8667,"Residual score for the elbow, wrist or hand impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)"
G8668,"Residual score for the elbow, wrist or hand impairment successfully calculated and the score was less than zero (< 0)"
G8669,"Risk-adjusted functional status change residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriateTerminated December 31, 2019."
G8670,"Residual score for the elbow, wrist or hand impairment not measured because the patient did not complete the elbow/wrist/hand fs prom at initial evaluation and/or near discharge, reason not given"
G8671,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was equal to zero (0) or greater than zero (> 0)Terminated December 31, 2020."
G8672,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment successfully calculated and the score was less than zero (< 0)Terminated December 31, 2020."
G8673,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the fs status survey near discharge, patient not appropriateTerminated December 31, 2019."
G8674,"Risk-adjusted functional status change residual score for the neck, cranium, mandible, thoracic spine, ribs or other general orthopedic impairment not measured because the patient did not complete the general orthopedic fs prom at initial evaluation and/or near discharge, reason not givenTerminated December 31, 2020."
G8682,"Lvf testing documented as being performed prior to discharge or in the previous 12 monthsTerminated December 31, 2014."
G8683,"Lvf testing not performed prior to discharge or in the previous 12 months for a medical or patient documented reasonTerminated December 31, 2014."
G8685,"Lvf testing not documented as being performed prior to discharge or in the previous 12 months, reason not givenTerminated December 31, 2014."
G8694,Current or prior left ventricular ejection fraction (lvef) < = 40% or documentation of moderate or severe lvsd
G8696,"Antithrombotic therapy prescribed at dischargeTerminated December 31, 2017."
G8697,"Antithrombotic therapy not prescribed for documented reasons (e.g., patient had stroke during hospital stay, patient expired during inpatient stay, other medical reason(s)); (e.g., patient left against medical advice, other patient reason(s))Terminated December 31, 2017."
G8698,"Antithrombotic therapy was not prescribed at discharge, reason not givenTerminated December 31, 2017."
G8699,"Rehabilitation services (occupational, physical or speech) ordered at or prior to dischargeTerminated December 31, 2014."
G8700,"Rehabilitation services (occupational, physical or speech) not indicated at or prior to dischargeTerminated December 31, 2014."
G8701,"Rehabilitation services were not ordered, reason not otherwise specifiedTerminated December 31, 2014."
G8702,"Documentation that prophylactic antibiotics were given within 4 hours prior to surgical incision or intraoperativelyTerminated December 31, 2014."
G8703,"Documentation that prophylactic antibiotics were neither given within 4 hours prior to surgical incision nor intraoperativelyTerminated December 31, 2014."
G8704,"12-lead electrocardiogram (ecg) performedTerminated December 31, 2014."
G8705,"Documentation of medical reason(s) for not performing a 12-lead electrocardiogram (ecg)Terminated December 31, 2014."
G8706,"Documentation of patient reason(s) for not performing a 12-lead electrocardiogram (ecg)Terminated December 31, 2014."
G8707,"12-lead electrocardiogram (ecg) not performed, reason not givenTerminated December 31, 2014."
G8708,Patient not prescribed antibiotic
G8709,"Uri episodes when the patient had competing diagnoses on or three days after the episode date (e.g., intestinal infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis, mastoiditis, or bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia/gonococcal infections, venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis or uti, and acne)"
G8710,Patient prescribed antibiotic
G8711,Prescribed antibiotic on or within 3 days after the episode date
G8712,Antibiotic not prescribed or dispensed
G8713,"Spkt/v greater than or equal to 1.2 (single-pool clearance of urea [kt] / volume [v])Terminated December 31, 2015."
G8714,"Hemodialysis treatment performed exactly three times per week for > 90 daysTerminated December 31, 2015."
G8717,"Spkt/v less than 1.2 (single-pool clearance of urea [kt] / volume [v]), reason not givenTerminated December 31, 2015."
G8718,"Total kt/v greater than or equal to 1.7 per week (total clearance of urea [kt] / volume [v])Terminated December 31, 2015."
G8720,"Total kt/v less than 1.7 per week (total clearance of urea [kt] / volume [v])Terminated December 31, 2015."
G8721,"Pt category (primary tumor), pn category (regional lymph nodes), and histologic grade were documented in pathology report"
G8722,"Documentation of medical reason(s) for not including the pt category, the pn category or the histologic grade in the pathology report (e.g., re-excision without residual tumor; non-carcinomasanal canal)"
G8723,Specimen site is other than anatomic location of primary tumor
G8724,"Pt category, pn category and histologic grade were not documented in the pathology report, reason not given"
G8725,"Fasting lipid profile performed (triglycerides, ldl-c, hdl-c and total cholesterol)Terminated December 31, 2016."
G8726,"Clinician has documented reason for not performing fasting lipid profile (e.g., patient declined, other patient reasons)Terminated December 31, 2016."
G8728,"Fasting lipid profile not performed, reason not givenTerminated December 31, 2016."
G8730,"Pain assessment documented as positive using a standardized tool and a follow-up plan is documentedTerminated December 31, 2020."
G8731,"Pain assessment using a standardized tool is documented as negative, no follow-up plan requiredTerminated December 31, 2020."
G8732,"No documentation of pain assessment, reason not givenTerminated December 31, 2020."
G8733,Elder maltreatment screen documented as positive and a follow-up plan is documented
G8734,"Elder maltreatment screen documented as negative, follow-up is not required"
G8735,"Elder maltreatment screen documented as positive, follow-up plan not documented, reason not given"
G8736,"Most current ldl-c <100mg/dlTerminated December 31, 2014."
G8737,"Most current ldl-c >=100mg/dlTerminated December 31, 2014."
G8738,"Left ventricular ejection fraction (lvef) < 40% or documentation of severely or moderately depressed left ventricular systolic functionTerminated December 31, 2014."
G8739,"Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic functionTerminated December 31, 2014."
G8740,"Left ventricular ejection fraction (lvef) not performed or assessed, reason not givenTerminated December 31, 2014."
G8749,"Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)"
G8751,"Smoking status and exposure to second hand smoke in the home not assessed, reason not givenTerminated December 31, 2014."
G8752,Most recent systolic blood pressure < 140 mmhg
G8753,Most recent systolic blood pressure >= 140 mmhg
G8754,Most recent diastolic blood pressure < 90 mmhg
G8755,Most recent diastolic blood pressure >= 90 mmhg
G8756,"No documentation of blood pressure measurement, reason not given"
G8757,"All quality actions for the applicable measures in the chronic obstructive pulmonary disease (copd) measures group have been performed for this patientTerminated December 31, 2016."
G8758,"All quality actions for the applicable measures in the inflammatory bowel disease (ibd) measures group have been performed for this patientTerminated December 31, 2016."
G8759,"All quality actions for the applicable measures in the sleep apnea measures group have been performed for this patientTerminated December 31, 2016."
G8761,"All quality actions for the applicable measures in the dementia measures group have been performed for this patientTerminated December 31, 2016."
G8762,"All quality actions for the applicable measures in the parkinson's disease measures group have been performed for this patientTerminated December 31, 2016."
G8763,"All quality actions for the applicable measures in the hypertension (htn) measures group have been performed for this patientTerminated December 31, 2014."
G8764,"All quality actions for the applicable measures in the cardiovascular prevention measures group have bee performed for this patientTerminated December 31, 2014."
G8765,"All quality actions for the applicable measures in the cataract measures group have been performed for this patientTerminated December 31, 2016."
G8767,"Lipid panel results documented and reviewed (must include total cholesterol, hdl-c, triglycerides and calculated ldl-c)Terminated December 31, 2014."
G8768,"Documentation of medical reason(s) for not performing lipid profile (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)Terminated December 31, 2014."
G8769,"Lipid profile not performed, reason not givenTerminated December 31, 2014."
G8770,"Urine protein test result documented and reviewedTerminated December 31, 2014."
G8771,"Documentation of diagnosis of chronic kidney diseaseTerminated December 31, 2014."
G8772,"Documentation of medical reason(s) for not performing urine protein test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not cllinically appropriate)Terminated December 31, 2014."
G8773,"Urine protein test was not performed, reason not givenTerminated December 31, 2014."
G8774,"Serum creatinine test result documented and reviewedTerminated December 31, 2014."
G8775,"Documentation of medical reason(s) for not performing serum creatinine test (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)Terminated December 31, 2014."
G8776,"Serum creatinine test not performed, reason not givenTerminated December 31, 2014."
G8777,"Diabetes screening test performedTerminated December 31, 2014."
G8778,"Documentation of medical reason(s) for not performing diabetes screening test (e.g., patients with a diagnosis of diabetes, or with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)Terminated December 31, 2014."
G8779,"Diabetes screening test not performed, reason not givenTerminated December 31, 2014."
G8780,"Counseling for diet and physical activity performedTerminated December 31, 2014."
G8781,"Documentation of medical reason(s) for patient not receiving counseling for diet and physical activity (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)Terminated December 31, 2014."
G8782,"Counseling for diet and physical activity not performed, reason not givenTerminated December 31, 2014."
G8783,"Normal blood pressure reading documented, follow-up not required"
G8784,"Patient not eligible (e.g., documentation the patient is not eligible due to active diagnosis of hypertension, patient refuses, urgent or emergent situation)Terminated December 31, 2016."
G8785,"Blood pressure reading not documented, reason not given"
G8797,Specimen site other than anatomic location of esophagus
G8798,Specimen site other than anatomic location of prostate
G8806,Performance of trans-abdominal or trans-vaginal ultrasound and pregnancy location documented
G8807,"Trans-abdominal or trans-vaginal ultrasound not performed for reasons documented by clinician (e.g., patient has a documented intrauterine pregnancy [iup])"
G8808,"Trans-abdominal or trans-vaginal ultrasound not performed, reason not given"
G8809,"Rh-immunoglobulin (rhogam) orderedTerminated December 31, 2020."
G8810,"Rh-immunoglobulin (rhogam) not ordered for reasons documented by clinician (e.g., patient had prior documented receipt of rhogam within 12 weeks, patient refusal)Terminated December 31, 2020."
G8811,"Documentation rh-immunoglobulin (rhogam) was not ordered, reason not givenTerminated December 31, 2020."
G8815,"Documented reason in the medical records for why the statin therapy was not prescribed (i.e., lower extremity bypass was for a patient with non-artherosclerotic disease)"
G8816,Statin medication prescribed at discharge
G8817,"Statin therapy not prescribed at discharge, reason not given"
G8818,"Patient discharge to home no later than post-operative day #7Terminated December 31, 2023."
G8825,"Patient not discharged to home by post-operative day #7Terminated December 31, 2023."
G8826,Patient discharged to home no later than post-operative day #2 following evar
G8833,Patient not discharged to home by post-operative day #2 following evar
G8834,Patient discharged to home no later than post-operative day #2 following cea
G8838,Patient not discharged to home by post-operative day #2 following cea
G8839,"Sleep apnea symptoms assessed, including presence or absence of snoring and daytime sleepiness"
G8840,"Documentation of reason(s) for not documenting an assessment of sleep symptoms (e.g., patient didn't have initial daytime sleepiness, patient visited between initial testing and initiation of therapy)"
G8841,"Sleep apnea symptoms not assessed, reason not given"
G8842,"Apnea hypopnea index (ahi), respiratory disturbance index (rdi) or respiratory event index (rei) documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea"
G8843,"Documentation of reason(s) for not measuring an apnea hypopnea index (ahi), a respiratory disturbance index (rdi), or a respiratory event index (rei) within 2 months after initial evaluation for suspected obstructive sleep apnea (e.g., medical, neurological, or psychiatric disease that prohibits successful completion of a sleep study, patients for whom a sleep study would present a bigger risk than benefit or would pose an undue burden, dementia, patients previously diagnosed with osa and severity assessed by another provider, patients who decline ahi/rdi/rei measurement, patients who had a financial reason for not completing testing, test was ordered but not completed, patients decline because their insurance (payer) does not cover the expense)"
G8844,"Apnea hypopnea index (ahi), respiratory disturbance index (rdi), or respiratory event index (rei) not documented or measured within 2 months after initial evaluation for suspected obstructive sleep apnea, reason not given"
G8845,Positive airway pressure therapy prescribed
G8846,Moderate or severe obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of 15 or greater)
G8848,"Mild obstructive sleep apnea (apnea hypopnea index (ahi) or respiratory disturbance index (rdi) of less than 15)Terminated December 31, 2016."
G8849,"Documentation of reason(s) for not prescribing positive airway pressure therapy (e.g., patient unable to tolerate, alternative therapies use, patient declined, financial, insurance coverage)"
G8850,"Positive airway pressure therapy not prescribed, reason not given"
G8851,"Adherence to therapy was assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available, documented)"
G8852,"Positive airway pressure therapy was prescribedTerminated December 31, 2023."
G8853,"Positive airway pressure therapy not prescribedTerminated December 31, 2016."
G8854,"Documentation of reason(s) for not objectively reporting adherence to evidence-based therapy (e.g., patients who have been diagnosed with a terminal or advanced disease with an expected life span of less than 6 months, patients who decline therapy, patients who do not return for follow-up at least annually, patients unable to access/afford therapy, patient's insurance will not cover therapy)"
G8855,"Adherence to therapy was not assessed at least annually through an objective informatics system or through self-reporting (if objective reporting is not available), reason not given"
G8856,Referral to a physician for an otologic evaluation performed
G8857,"Patient is not eligible for the referral for otologic evaluation measure (e.g., patients who are already under the care of a physician for acute or chronic dizziness)"
G8858,"Referral to a physician for an otologic evaluation not performed, reason not given"
G8859,"Patient receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive daysTerminated December 31, 2014."
G8860,"Patients who have received dose of corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive daysTerminated December 31, 2014."
G8861,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) ordered and documented, review of systems and medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribedTerminated December 31, 2019."
G8862,"Patients not receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive daysTerminated December 31, 2014."
G8863,"Patients not assessed for risk of bone loss, reason not given"
G8864,Pneumococcal vaccine administered or previously received
G8865,"Documentation of medical reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient allergic reaction, potential adverse drug reaction)"
G8866,"Documentation of patient reason(s) for not administering or previously receiving pneumococcal vaccine (e.g., patient refusal)"
G8867,"Pneumococcal vaccine not administered or previously received, reason not given"
G8868,"Patients receiving a first course of anti-tnf therapyTerminated December 31, 2016."
G8869,Patient has documented immunity to hepatitis b and initiating anti-tnf therapy
G8870,"Hepatitis b vaccine injection administered or previously received and is receiving a first course of anti-tnf therapyTerminated December 31, 2015."
G8871,"Patient not receiving a first course of anti-tnf therapyTerminated December 31, 2015."
G8872,"Excised tissue evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesionTerminated December 31, 2020."
G8873,"Patients with needle localization specimens which are not amenable to intraoperative imaging such as mri needle wire localization, or targets which are tentatively identified on mammogram or ultrasound which do not contain a biopsy marker but which can be verified on intraoperative inspection or pathology (e.g., needle biopsy site where the biopsy marker is remote from the actual biopsy site)Terminated December 31, 2020."
G8874,"Excised tissue not evaluated by imaging intraoperatively to confirm successful inclusion of targeted lesionTerminated December 31, 2020."
G8875,Clinician diagnosed breast cancer preoperatively by a minimally invasive biopsy method
G8876,"Documentation of reason(s) for not performing minimally invasive biopsy to diagnose breast cancer preoperatively (e.g., lesion too close to skin, implant, chest wall, etc., lesion could not be adequately visualized for needle biopsy, patient condition prevents needle biopsy [weight, breast thickness, etc.], duct excision without imaging abnormality, prophylactic mastectomy, reduction mammoplasty, excisional biopsy performed by another physician)"
G8877,"Clinician did not attempt to achieve the diagnosis of breast cancer preoperatively by a minimally invasive biopsy method, reason not given"
G8878,Sentinel lymph node biopsy procedure performed
G8879,"Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancerTerminated December 31, 2017."
G8880,"Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change)"
G8881,Stage of breast cancer is greater than t1n0m0 or t2n0m0
G8882,"Sentinel lymph node biopsy procedure not performed, reason not given"
G8883,"Biopsy results reviewed, communicated, tracked and documentedTerminated December 31, 2023."
G8884,"Clinician documented reason that patient's biopsy results were not reviewedTerminated December 31, 2023."
G8885,"Biopsy results not reviewed, communicated, tracked or documentedTerminated December 31, 2023."
G8886,"Most recent blood pressure under controlTerminated December 31, 2014."
G8887,"Documentation of medical reason(s) for most recent blood pressure not being under control (e.g., patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)Terminated December 31, 2014."
G8888,"Most recent blood pressure not under control, results documented and reviewedTerminated December 31, 2014."
G8889,"No documentation of blood pressure measurement, reason not givenTerminated December 31, 2014."
G8890,"Most recent ldl-c under control, results documented and reviewedTerminated December 31, 2014."
G8891,"Documentation of medical reason(s) for most recent ldl-c not under control (e.g., patients with palliative goals for whom treatment of hypertension with standard treatment goals is not clinically appropriate)Terminated December 31, 2014."
G8892,"Documentation of medical reason(s) for not performing ldl-c test (e.g. patients with palliative goals or for whom treatment of hypertension with standard treatment goals is not clinically appropriate)Terminated December 31, 2014."
G8893,"Most recent ldl-c not under control, results documented and reviewedTerminated December 31, 2014."
G8894,"Ldl-c not performed, reason not givenTerminated December 31, 2014."
G8895,"Oral aspirin or other antithrombotic therapy prescribedTerminated December 31, 2014."
G8896,"Documentation of medical reason(s) for not prescribing oral aspirin or other antithrombotic therapy (e.g., patient documented to be low risk or patient with terminal illness or treatment of hypertension with standard treatment goals is not clinically appropriate, or for whom risk of aspirin or other antithrombotic therapy exceeds potential benefits such as for individuals whose blood pressure is poorly controlled)Terminated December 31, 2014."
G8897,"Oral aspirin or other antithrombotic therapy was not prescribed, reason not givenTerminated December 31, 2014."
G8898,"I intend to report the chronic obstructive pulmonary disease (copd) measures groupTerminated December 31, 2016."
G8899,"I intend to report the inflammatory bowel disease (ibd) measures groupTerminated December 31, 2016."
G8900,"I intend to report the sleep apnea measures groupTerminated December 31, 2016."
G8902,"I intend to report the dementia measures groupTerminated December 31, 2016."
G8903,"I intend to report the parkinson's disease measures groupTerminated December 31, 2016."
G8904,"I intend to report the hypertension (htn) measures groupTerminated December 31, 2014."
G8905,"I intend to report the cardiovascular prevention measures groupTerminated December 31, 2014."
G8906,"I intend to report the cataract measures groupTerminated December 31, 2016."
G8907,Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility
G8908,Patient documented to have received a burn prior to discharge
G8909,Patient documented not to have received a burn prior to discharge
G8910,Patient documented to have experienced a fall within asc
G8911,Patient documented not to have experienced a fall within ambulatory surgical center
G8912,"Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event"
G8913,"Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event"
G8914,Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc
G8915,Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc
G8916,"Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time"
G8917,"Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time"
G8918,Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis
G8923,Current or prior left ventricular ejection fraction (lvef) <= 40% or documentation of moderately or severely depressed left ventricular systolic function
G8924,Spirometry results documented (fev1/fvc < 70%)
G8925,"Spirometry test results demonstrate fev1 >= 60% fev1/fvc >= 70%, predicted or patient does not have copd symptomsTerminated December 31, 2021."
G8926,"Spirometry test not performed or documented, reason not givenTerminated December 31, 2021."
G8927,"Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancerTerminated December 31, 2016."
G8928,"Adjuvant chemotherapy not prescribed or previously received, for documented reasons (e.g., medical co-morbidities, diagnosis date more than 5 years prior to the current visit date, patient's diagnosis date is within 120 days of the end of the 12 month reporting period, patient's cancer has metastasized, medical contraindication/allergy, poor performance status, other medical reasons, patient refusal, other patient reasons, patient is currently enrolled in a clinical trial that precludes prescription of chemotherapy, other system reasons)Terminated December 31, 2016."
G8929,"Adjuvant chemotherapy not prescribed or previously received, reason not givenTerminated December 31, 2016."
G8930,"Assessment of depression severity at the initial evaluationTerminated December 31, 2014."
G8931,"Assessment of depression severity not documented, reason not givenTerminated December 31, 2014."
G8932,"Suicide risk assessed at the initial evaluationTerminated December 31, 2014."
G8933,"Suicide risk not assessed at the initial evaluation, reason not givenTerminated December 31, 2014."
G8934,Current or prior left ventricular ejection fraction (lvef) <=40% or documentation of moderately or severely depressed left ventricular systolic function
G8935,Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
G8936,"Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy (eg, allergy, intolerance, pregnancy, renal failure due to ace inhibitor, diseases of the aortic or mitral valve, other medical reasons) or (eg, patient declined, other patient reasons)"
G8937,"Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given"
G8938,"Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligibleTerminated December 31, 2021."
G8939,"Pain assessment documented as positive, follow-up plan not documented, documentation the patient is not eligible at the time of the encounterTerminated December 31, 2020."
G8940,"Screening for depression documented as positive, a follow-up plan not completed, documented reasonTerminated December 31, 2016."
G8941,"Elder maltreatment screen documented as positive, follow-up plan not documented, documentation the patient is not eligible for follow-up plan at the time of the encounterTerminated December 31, 2023."
G8942,"Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment"
G8943,"Ldl-c result not present or not within 12 months priorTerminated December 31, 2014."
G8944,Ajcc melanoma cancer stage 0 through iic melanoma
G8946,"Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e.g., high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular hyperplasia, lobular carcinoma in situ, atypical columnar hyperplasia, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)"
G8947,"One or more neuropsychiatric symptomsTerminated December 31, 2017."
G8948,"No neuropsychiatric symptomsTerminated December 31, 2016."
G8949,"Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e.g., patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes)Terminated December 31, 2014."
G8950,"Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented"
G8951,"Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, documentation the patient is not eligibleTerminated December 31, 2015."
G8952,"Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given"
G8953,"All quality actions for the applicable measures in the oncology measures group have been performed for this patientTerminated December 31, 2016."
G8955,Most recent assessment of adequacy of volume management documented
G8956,Patient receiving maintenance hemodialysis in an outpatient dialysis facility
G8957,"Patient not receiving maintenance hemodialysis in an outpatient dialysis facilityTerminated December 31, 2014."
G8958,"Assessment of adequacy of volume management not documented, reason not given"
G8959,"Clinician treating major depressive disorder communicates to clinician treating comorbid conditionTerminated December 31, 2020."
G8960,"Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not givenTerminated December 31, 2020."
G8961,Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery
G8962,Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery
G8963,"Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 yearsTerminated December 31, 2023."
G8964,"Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.g., symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)Terminated December 31, 2023."
G8965,"Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessmentTerminated December 31, 2024."
G8966,"Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessmentTerminated December 31, 2024."
G8967,Fda approved oral anticoagulant is prescribed
G8968,"Documentation of medical reason(s) for not prescribing an fda-approved anticoagulant (e.g., present or planned atrial appendage occlusion or ligation or patient being currently enrolled in a clinical trial related to af/atrial flutter treatment)"
G8969,"Documentation of patient reason(s) for not prescribing an oral anticoagulant that is fda approved for the prevention of thromboembolism (e.g., patient preference for not receiving anticoagulation)"
G8970,No risk factors or one moderate risk factor for thromboembolism
G8971,"Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not givenTerminated December 31, 2017."
G8972,"One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolismTerminated December 31, 2017."
G8973,"Most recent hemoglobin (hgb) level < 10 g/dlTerminated December 31, 2020."
G8974,"Hemoglobin level measurement not documented, reason not givenTerminated December 31, 2020."
G8975,"Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e.g., patients who have non-renal etiologies of anemia [e.g., sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)Terminated December 31, 2020."
G8976,"Most recent hemoglobin (hgb) level >= 10 g/dlTerminated December 31, 2020."
G8977,"I intend to report the oncology measures groupTerminated December 31, 2016."
G8978,"Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G8979,"Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G8980,"Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G8981,"Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G8982,"Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G8983,"Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G8984,"Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G8985,"Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G8986,"Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G8987,"Self care functional limitation, current status, at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G8988,"Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G8989,"Self care functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G8990,"Other physical or occupational therapy primary functional limitation, current status, at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G8991,"Other physical or occupational therapy primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G8992,"Other physical or occupational therapy primary functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G8993,"Other physical or occupational therapy subsequent functional limitation, current status, at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G8994,"Other physical or occupational therapy subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G8995,"Other physical or occupational therapy subsequent functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G8996,"Swallowing functional limitation, current status at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G8997,"Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G8998,"Swallowing functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G8999,"Motor speech functional limitation, current status at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G9001,"Coordinated care fee, initial rate"
G9002,"Coordinated care fee, maintenance rate"
G9003,"Coordinated care fee, risk adjusted high, initial"
G9004,"Coordinated care fee, risk adjusted low, initial"
G9005,"Coordinated care fee, risk adjusted maintenance"
G9006,"Coordinated care fee, home monitoring"
G9007,"Coordinated care fee, scheduled team conference"
G9008,"Coordinated care fee, physician coordinated care oversight services"
G9009,"Coordinated care fee, risk adjusted maintenance, level 3"
G9010,"Coordinated care fee, risk adjusted maintenance, level 4"
G9011,"Coordinated care fee, risk adjusted maintenance, level 5"
G9012,Other specified case management service not elsewhere classified
G9013,Esrd demo basic bundle level i
G9014,Esrd demo expanded bundle including venous access and related services
G9016,"Smoking cessation counseling, individual, in the absence of or in addition to any other evaluation and management service, per session (6-10 minutes) [demo project code only]"
G9017,"Amantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)Terminated December 31, 2019."
G9018,"Zanamivir, inhalation powder, administered through inhaler, per 10 mg (for use in a medicare-approved demonstration project)Terminated December 31, 2019."
G9019,"Oseltamivir phosphate, oral, per 75 mg (for use in a medicare-approved demonstration project)Terminated December 31, 2019."
G9020,"Rimantadine hydrochloride, oral, per 100 mg (for use in a medicare-approved demonstration project)Terminated December 31, 2019."
G9033,"Amantadine hydrochloride, oral brand, per 100 mg (for use in a medicare-approved demonstration project)Terminated December 31, 2019."
G9034,"Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)Terminated December 31, 2019."
G9035,"Oseltamivir phosphate, oral, brand, per 75 mg (for use in a medicare-approved demonstration project)Terminated December 31, 2019."
G9036,"Rimantadine hydrochloride, oral, brand, per 100 mg (for use in a medicare-approved demonstration project)Terminated December 31, 2019."
G9037,"Interprofessional telephone/internet/electronic health record clinical question/request for specialty recommendations by a treating/requesting physician or other qualified health care professional for the care of the patient (i.e. not for professional education or scheduling) and may include subsequent follow up on the specialist's recommendations; 30 minutesTerminated June 30, 2025."
G9038,"Co-management services with the following elements: new diagnosis or acute exacerbation and stabilization of existing condition; condition which may benefit from joint care planning; condition for which specialist is taking a co-management role; condition expected to last at least 3 months; comprehensive care plan established, implemented, revised or monitored in partnership with co-managing clinicians; ongoing communication and care coordination between co-managing clinicians furnishing careTerminated June 30, 2025."
G9050,"Oncology; primary focus of visit; work-up, evaluation, or staging at the time of cancer diagnosis or recurrence (for use in a medicare-approved demonstration project)"
G9051,"Oncology; primary focus of visit; treatment decision-making after disease is staged or restaged, discussion of treatment options, supervising/coordinating active cancer directed therapy or managing consequences of cancer directed therapy (for use in a medicare-approved demonstration project)"
G9052,Oncology; primary focus of visit; surveillance for disease recurrence for patient who has completed definitive cancer-directed therapy and currently lacks evidence of recurrent disease; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)
G9053,Oncology; primary focus of visit; expectant management of patient with evidence of cancer for whom no cancer directed therapy is being administered or arranged at present; cancer directed therapy might be considered in the future (for use in a medicare-approved demonstration project)
G9054,"Oncology; primary focus of visit; supervising, coordinating or managing care of patient with terminal cancer or for whom other medical illness prevents further cancer treatment; includes symptom management, end-of-life care planning, management of palliative therapies (for use in a medicare-approved demonstration project)"
G9055,"Oncology; primary focus of visit; other, unspecified service not otherwise listed (for use in a medicare-approved demonstration project)"
G9056,Oncology; practice guidelines; management adheres to guidelines (for use in a medicare-approved demonstration project)
G9057,Oncology; practice guidelines; management differs from guidelines as a result of patient enrollment in an institutional review board approved clinical trial (for use in a medicare-approved demonstration project)
G9058,Oncology; practice guidelines; management differs from guidelines because the treating physician disagrees with guideline recommendations (for use in a medicare-approved demonstration project)
G9059,"Oncology; practice guidelines; management differs from guidelines because the patient, after being offered treatment consistent with guidelines, has opted for alternative treatment or management, including no treatment (for use in a medicare-approved demonstration project)"
G9060,Oncology; practice guidelines; management differs from guidelines for reason(s) associated with patient comorbid illness or performance status not factored into guidelines (for use in a medicare-approved demonstration project)
G9061,Oncology; practice guidelines; patient's condition not addressed by available guidelines (for use in a medicare-approved demonstration project)
G9062,Oncology; practice guidelines; management differs from guidelines for other reason(s) not listed (for use in a medicare-approved demonstration project)
G9063,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage i (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9064,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage ii (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9065,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease initially established as stage iii a (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9066,"Oncology; disease status; limited to non-small cell lung cancer; stage iii b- iv at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)"
G9067,"Oncology; disease status; limited to non-small cell lung cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9068,"Oncology; disease status; limited to small cell and combined small cell/non-small cell; extent of disease initially established as limited with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9069,"Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small cell; extensive stage at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)"
G9070,"Oncology; disease status; small cell lung cancer, limited to small cell and combined small cell/non-small; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9071,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i or stage iia-iib; or t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9072,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage i, or stage iia-iib; or t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9073,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and/or pr positive; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9074,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; stage iiia-iiib; and not t3, n1, m0; and er and pr negative; with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9075,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)"
G9077,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t1-t2c and gleason 2-7 and psa < or equal to 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9078,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9079,"Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t3b-t4, any n; any t, n1 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9080,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; after initial treatment with rising psa or failure of psa decline (for use in a medicare-approved demonstration project)"
G9083,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9084,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9085,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, n0, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9086,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-4, n1-2, m0 with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9087,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive with current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)"
G9088,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive without current clinical, radiologic, or biochemical evidence of disease (for use in a medicare-approved demonstration project)"
G9089,"Oncology; disease status; colon cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9090,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-2, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9091,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t3, n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9092,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)"
G9093,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9094,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)"
G9095,"Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9096,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t1-t3, n0-n1 or nx (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9097,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease initially established as t4, any n, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9098,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)"
G9099,"Oncology; disease status; esophageal cancer, limited to adenocarcinoma or squamous cell carcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9100,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r0 resection (with or without neoadjuvant therapy) with no evidence of disease recurrence, progression, or metastases (for use in a medicare-approved demonstration project)"
G9101,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; post r1 or r2 resection (with or without neoadjuvant therapy) with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)"
G9102,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m0, unresectable with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)"
G9103,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; clinical or pathologic m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)"
G9104,"Oncology; disease status; gastric cancer, limited to adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9105,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma as predominant cell type; post r0 resection without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9106,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; post r1 or r2 resection with no evidence of disease progression, or metastases (for use in a medicare-approved demonstration project)"
G9107,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; unresectable at diagnosis, m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)"
G9108,"Oncology; disease status; pancreatic cancer, limited to adenocarcinoma; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9109,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t1-t2 and n0, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9110,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease initially established as t3-4 and/or n1-3, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9111,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; m1 at diagnosis, metastatic, locally recurrent, or progressive (for use in a medicare-approved demonstration project)"
G9112,"Oncology; disease status; head and neck cancer, limited to cancers of oral cavity, pharynx and larynx with squamous cell as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9113,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 1) without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9114,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage ia-b (grade 2-3); or stage ic (all grades); or stage ii; without evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9115,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; pathologic stage iii-iv; without evidence of progression, recurrence, or metastases (for use in a medicare-approved demonstration project)"
G9116,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; evidence of disease progression, or recurrence, and/or platinum resistance (for use in a medicare-approved demonstration project)"
G9117,"Oncology; disease status; ovarian cancer, limited to epithelial cancer; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9123,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; chronic phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)"
G9124,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; accelerated phase not in hematologic cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)"
G9125,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; blast phase not in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)"
G9126,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; in hematologic, cytogenetic, or molecular remission (for use in a medicare-approved demonstration project)"
G9128,"Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project)"
G9129,"Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project)"
G9130,"Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9131,"Oncology; disease status; invasive female breast cancer (does not include ductal carcinoma in situ); adenocarcinoma as predominant cell type; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project)"
G9132,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-refractory/androgen-independent (e.g., rising psa on anti-androgen therapy or post-orchiectomy); clinical metastases (for use in a medicare-approved demonstration project)"
G9133,"Oncology; disease status; prostate cancer, limited to adenocarcinoma; hormone-responsive; clinical metastases or m1 at diagnosis (for use in a medicare-approved demonstration project)"
G9134,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage i, ii at diagnosis, not relapsed, not refractory (for use in a medicare-approved demonstration project)"
G9135,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; stage iii, iv, not relapsed, not refractory (for use in a medicare-approved demonstration project)"
G9136,"Oncology; disease status; non-hodgkin's lymphoma, transformed from original cellular diagnosis to a second cellular classification (for use in a medicare-approved demonstration project)"
G9137,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; relapsed/refractory (for use in a medicare-approved demonstration project)"
G9138,"Oncology; disease status; non-hodgkin's lymphoma, any cellular classification; diagnostic evaluation, stage not determined, evaluation of possible relapse or non-response to therapy, or not listed (for use in a medicare-approved demonstration project)"
G9139,"Oncology; disease status; chronic myelogenous leukemia, limited to philadelphia chromosome positive and/or bcr-abl positive; extent of disease unknown, staging in progress, not listed (for use in a medicare-approved demonstration project)"
G9140,"Frontier extended stay clinic demonstration; for a patient stay in a clinic approved for the cms demonstration project; the following measures should be present: the stay must be equal to or greater than 4 hours; weather or other conditions must prevent transfer or the case falls into a category of monitoring and observation cases that are permitted by the rules of the demonstration; there is a maximum frontier extended stay clinic (fesc) visit of 48 hours, except in the case when weather or other conditions prevent transfer; payment is made on each period up to 4 hours, after the first 4 hours"
G9143,"Warfarin responsiveness testing by genetic technique using any method, any number of specimen(s)"
G9147,"Outpatient intravenous insulin treatment (oivit) either pulsatile or continuous, by any means, guided by the results of measurements for: respiratory quotient; and/or, urine urea nitrogen (uun); and/or, arterial, venous or capillary glucose; and/or potassium concentration"
G9148,National committee for quality assurance - level 1 medical home
G9149,National committee for quality assurance - level 2 medical home
G9150,National committee for quality assurance - level 3 medical home
G9151,Mapcp demonstration - state provided services
G9152,Mapcp demonstration - community health teams
G9153,Mapcp demonstration - physician incentive pool
G9156,Evaluation for wheelchair requiring face to face visit with physician
G9157,"Transesophageal doppler measurement of cardiac output (including probe placement, image acquisition, and interpretation per course of treatment) for monitoring purposes"
G9158,"Motor speech functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G9159,"Spoken language comprehension functional limitation, current status at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G9160,"Spoken language comprehension functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G9161,"Spoken language comprehension functional limitation, discharge status, at discharge from therapy or to end reportingTerminated December 31, 2019."
G9162,"Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G9163,"Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G9164,"Spoken language expression functional limitation, discharge status at discharge from therapy or to end reportingTerminated December 31, 2019."
G9165,"Attention functional limitation, current status at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G9166,"Attention functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G9167,"Attention functional limitation, discharge status at discharge from therapy or to end reportingTerminated December 31, 2019."
G9168,"Memory functional limitation, current status at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G9169,"Memory functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G9170,"Memory functional limitation, discharge status at discharge from therapy or to end reportingTerminated December 31, 2019."
G9171,"Voice functional limitation, current status at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G9172,"Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G9173,"Voice functional limitation, discharge status at discharge from therapy or to end reportingTerminated December 31, 2019."
G9174,"Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervalsTerminated December 31, 2019."
G9175,"Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G9176,"Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reportingTerminated December 31, 2019."
G9186,"Motor speech functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reportingTerminated December 31, 2019."
G9187,"Bundled payments for care improvement initiative home visit for patient assessment performed by a qualified health care professional for individuals not considered homebound including, but not limited to, assessment of safety, falls, clinical status, fluid status, medication reconciliation/management, patient compliance with orders/plan of care, performance of activities of daily living, appropriateness of care setting; (for use only in the meidcare-approved bundled payments for care improvement initiative); may not be billed for a 30-day period covered by a transitional care management code"
G9188,"Beta-blocker therapy not prescribed, reason not given"
G9189,Beta-blocker therapy prescribed or currently being taken
G9190,"Documentation of medical reason(s) for not prescribing beta-blocker therapy (eg, allergy, intolerance, other medical reasons)"
G9191,"Documentation of patient reason(s) for not prescribing beta-blocker therapy (eg, patient declined, other patient reasons)"
G9192,"Documentation of system reason(s) for not prescribing beta-blocker therapy (eg, other reasons attributable to the health care system)Terminated December 31, 2023."
G9193,"Clinician documented that patient with a diagnosis of major depression was not an eligible candidate for antidepressant medication treatment or patient did not have a diagnosis of major depressionTerminated December 31, 2014."
G9194,"Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 180 day (6 month) continuation treatment phaseTerminated December 31, 2014."
G9195,"Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 180 day (6 months) continuation treatment phaseTerminated December 31, 2014."
G9196,"Documentation of medical reason(s) for not ordering a first or second generation cephalosporin for antimicrobial prophylaxis (e.g., patients enrolled in clinical trials, patients with documented infection prior to surgical procedure of interest, patients who were receiving antibiotics more than 24 hours prior to surgery [except colon surgery patients taking oral prophylactic antibiotics], patients who were receiving antibiotics within 24 hours prior to arrival [except colon surgery patients taking oral prophylactic antibiotics], other medical reason(s))Terminated December 31, 2022."
G9197,"Documentation of order for first or second generation cephalosporin for antimicrobial prophylaxisTerminated December 31, 2022."
G9198,"Order for first or second generation cephalosporin for antimicrobial prophylaxis was not documented, reason not givenTerminated December 31, 2022."
G9199,"Venous thromboembolism (vte) prophylaxis not administered the day of or the day after hospital admission for documented reasons (eg, patient is ambulatory, patient expired during inpatient stay, patient already on warfarin or another anticoagulant, other medical reason(s) or eg, patient left against medical advice, other patient reason(s))Terminated December 31, 2014."
G9200,"Venous thromboembolism (vte) prophylaxis was not administered the day of or the day after hospital admission, reason not givenTerminated December 31, 2014."
G9201,"Venous thromboembolism (vte) prophylaxis administered the day of or the day after hospital admissionTerminated December 31, 2014."
G9202,"Patients with a positive hepatitis c antibody testTerminated December 31, 2014."
G9203,"Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis cTerminated December 31, 2016."
G9204,"Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not givenTerminated December 31, 2016."
G9205,"Patient starting antiviral treatmentfor hepatitis c during the measurement periodTerminated December 31, 2016."
G9206,"Patient starting antiviral treatment for hepatitis c during the measurement periodTerminated December 31, 2016."
G9207,"Hepatitis c genotype testing documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis cTerminated December 31, 2016."
G9208,"Hepatitis c genotype testing was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not givenTerminated December 31, 2016."
G9209,"Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatmentTerminated December 31, 2016."
G9210,"Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)Terminated December 31, 2016."
G9211,"Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not givenTerminated December 31, 2016."
G9212,Dsm-ivtm criteria for major depressive disorder documented at the initial evaluation
G9213,"Dsm-iv-tr criteria for major depressive disorder not documented at the initial evaluation, reason not otherwise specified"
G9214,"Cd4+ cell count or cd4+ cell percentage results documentedTerminated December 31, 2014."
G9215,"Cd4+ cell count or percentage not documented as performed, reason not givenTerminated December 31, 2014."
G9216,"Pcp prophylaxis was not prescribed at time of diagnosis of hiv, reason not givenTerminated December 31, 2014."
G9217,"Pcp prophylaxis was not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3, reason not givenTerminated December 31, 2016."
G9218,"Pcp prophylaxis was not prescribed within 3 months oflow cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%, reason not givenTerminated December 31, 2014."
G9219,"Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 200 cells/mm3 for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)Terminated December 31, 2016."
G9220,"Pneumocystis jiroveci pneumonia prophylaxis not prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15% for medical reason (i.e., patient's cd4+ cell count above threshold within 3 months after cd4+ cell count below threshold, indicating that the patient's cd4+ levels are within an acceptable range and the patient does not require pcp prophylaxis)Terminated December 31, 2014."
G9221,"Pneumocystis jiroveci pneumonia prophlaxis prescribedTerminated December 31, 2014."
G9222,"Pneumocystis jiroveci pneumonia prophylaxis prescribed wthin 3 months of low cd4+ cell count below 200 cells/mm3Terminated December 31, 2016."
G9223,Pneumocystis jiroveci pneumonia prophylaxis prescribed within 3 months of low cd4+ cell count below 500 cells/mm3 or a cd4 percentage below 15%
G9224,"Documentation of medical reason for not performing foot exam (e.g., patient with bilateral foot/leg amputation)Terminated December 31, 2014."
G9225,"Foot exam was not performed, reason not given"
G9226,"Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed)"
G9227,"Functional outcome assessment documented, care plan not documented, documentation the patient is not eligible for a care plan at the time of the encounter"
G9228,"Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for all of the 3 screenings)"
G9229,"Chlamydia, gonorrhea, and syphilis screening results not documented (patient refusal is the only allowed exception)Terminated December 31, 2023."
G9230,"Chlamydia, gonorrhea, and syphilis not screened, reason not given"
G9231,"Documentation of end stage renal disease (esrd), dialysis, renal transplant before or during the measurement period or pregnancy during the measurement period"
G9232,"Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition for specified patient reason (e.g., patient is unable to communicate the diagnosis of a comorbid condition; the patient is unwilling to communicate the diagnosis of a comorbid condition; or the patient is unaware of the comorbid condition, or any other specified patient reason)Terminated December 31, 2020."
G9233,"All quality actions for the applicable measures in the total knee replacement measures group have been performed for this patientTerminated December 31, 2016."
G9234,"I intend to report the total knee replacement measures groupTerminated December 31, 2016."
G9235,"All quality actions for the applicable measures in the general surgery measures group have been performed for this patientTerminated December 31, 2016."
G9236,"All quality actions for the applicable measures in the optimizing patient exposure to ionizing radiation measures group have been performed for this patientTerminated December 31, 2016."
G9237,"I intend to report the general surgery measures groupTerminated December 31, 2016."
G9238,"I intend to report the optimizing patient exposure to ionizing radiation measures groupTerminated December 31, 2016."
G9239,"Documentation of reasons for patient initiating maintenance hemodialysis with a catheter as the mode of vascular access (e.g., patient has a maturing arteriovenous fistula (avf)/arteriovenous graft (avg), time-limited trial of hemodialysis, other medical reasons, patient declined avf/avg, other patient reasons, patient followed by reporting nephrologist for fewer than 90 days, other system reasons)Terminated December 31, 2020."
G9240,"Patient whose mode of vascular access is a catheter at the time maintenance hemodialysis is initiatedTerminated December 31, 2020."
G9241,"Patient whose mode of vascular access is not a catheter at the time maintenance hemodialysis is initiatedTerminated December 31, 2020."
G9242,Documentation of viral load equal to or greater than 200 copies/ml or viral load not performed
G9243,Documentation of viral load less than 200 copies/ml
G9244,"Antiretroviral thereapy not prescribedTerminated December 31, 2016."
G9245,"Antiretroviral therapy prescribedTerminated December 31, 2016."
G9246,Patient did not have two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart
G9247,Patient had two eligible encounters at least 90 days apart or one eligible encounter and one hiv viral load test at least 90 days apart
G9248,"Patient did not have a medical visit in the last 6 monthsTerminated December 31, 2014."
G9249,"Patient had a medical visit in the last 6 monthsTerminated December 31, 2014."
G9250,"Documentation of patient pain brought to a comfortable level within 48 hours from initial assessmentTerminated December 31, 2022."
G9251,"Documentation of patient with pain not brought to a comfortable level within 48 hours from initial assessmentTerminated December 31, 2022."
G9252,"Adenoma(s) or other neoplasm detected during screening colonoscopyTerminated December 31, 2014."
G9253,"Adenoma(s) or other neoplasm not detected during screening colonoscopyTerminated December 31, 2014."
G9254,Documentation of patient discharged to home later than post-operative day 2 following cea or cas
G9255,Documentation of patient discharged to home no later than post operative day 2 following cea or cas
G9256,"Documentation of patient death following casTerminated December 31, 2020."
G9257,"Documentation of patient stroke following casTerminated December 31, 2020."
G9258,"Documentation of patient stroke following ceaTerminated December 31, 2020."
G9259,"Documentation of patient survival and absence of stroke following casTerminated December 31, 2020."
G9260,"Documentation of patient death following ceaTerminated December 31, 2020."
G9261,"Documentation of patient survival and absence of stroke following ceaTerminated December 31, 2020."
G9262,"Documentation of patient death in the hospital following endovascular aaa repairTerminated December 31, 2020."
G9263,"Documentation of patient discharged alive following endovascular aaa repairTerminated December 31, 2020."
G9264,"Documentation of patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter for documented reasons (e.g., other medical reasons, patient declined arteriovenous fistula (avf)/arteriovenous graft (avg), other patient reasons)Terminated December 31, 2020."
G9265,"Patient receiving maintenance hemodialysis for greater than or equal to 90 days with a catheter as the mode of vascular accessTerminated December 31, 2020."
G9266,"Patient receiving maintenance hemodialysis for greater than or equal to 90 days without a catheter as the mode of vascular accessTerminated December 31, 2020."
G9267,"Documentation of patient with one or more complications or mortality within 30 daysTerminated December 31, 2021."
G9268,"Documentation of patient with one or more complications within 90 daysTerminated December 31, 2021."
G9269,"Documentation of patient without one or more complications and without mortality within 30 daysTerminated December 31, 2021."
G9270,"Documentation of patient without one or more complications within 90 daysTerminated December 31, 2021."
G9271,"Ldl value < 100Terminated December 31, 2014."
G9272,"Ldl value >= 100Terminated December 31, 2014."
G9273,Blood pressure has a systolic value of < 140 and a diastolic value of < 90
G9274,Blood pressure has a systolic value of =140 and a diastolic value of = 90 or systolic value < 140 and diastolic value = 90 or systolic value = 140 and diastolic value < 90
G9275,Documentation that patient is a current non-tobacco user
G9276,Documentation that patient is a current tobacco user
G9277,"Documentation that the patient is on daily aspirin or anti-platelet or has documentation of a valid contraindication or exception to aspirin/anti-platelet; contraindications/exceptions include anti-coagulant use, allergy to aspirin or anti-platelets, history of gastrointestinal bleed and bleeding disorder; additionally, the following exceptions documented by the physician as a reason for not taking daily aspirin or anti-platelet are acceptable (use of non-steroidal anti-inflammatory agents, documented risk for drug interaction, uncontrolled hypertension defined as >180 systolic or >110 diastolic or gastroesophageal reflux)"
G9278,Documentation that the patient is not on daily aspirin or anti-platelet regimen
G9279,Pneumococcal screening performed and documentation of vaccination received prior to discharge
G9280,"Pneumococcal vaccination not administered prior to discharge, reason not specified"
G9281,Screening performed and documentation that vaccination not indicated/patient refusal
G9282,"Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., biopsy taken for other purposes in a patient with a history of non-small cell lung cancer or other documented medical reasons)"
G9283,Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9284,Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9285,Specimen site other than anatomic location of lung or is not classified as non small cell lung cancer
G9286,Antibiotic regimen prescribed within 10 days after onset of symptoms
G9287,Antibiotic regimen not prescribed within 10 days after onset of symptoms
G9288,"Documentation of medical reason(s) for not reporting the histological type or nsclc-nos classification with an explanation (e.g., a solitary fibrous tumor in a person with a history of non-small cell carcinoma or other documented medical reasons)"
G9289,Non small cell lung cancer biopsy and cytology specimen report documents classification into specific histologic type or classified as nsclc-nos with an explanation
G9290,Non small cell lung cancer biopsy and cytology specimen report does not document classification into specific histologic type or classified as nsclc-nos with an explanation
G9291,"Specimen site other than anatomic location of lung, is not classified as non small cell lung cancer or classified as nsclc-nos"
G9292,"Documentation of medical reason(s) for not reporting pt category and a statement on thickness and ulceration and for pt1, mitotic rate (e.g., negative skin biopsies in a patient with a history of melanoma or other documented medical reasons)"
G9293,"Pathology report does not include the pt category and a statement on thickness and ulceration and for pt1, mitotic rate"
G9294,"Pathology report includes the pt category and a statement on thickness and ulceration and for pt1, mitotic rate"
G9295,Specimen site other than anatomic cutaneous location
G9296,"Patients with documented shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure"
G9297,"Shared decision-making including discussion of conservative (non-surgical) therapy (e.g., nsaids, analgesics, weight loss, exercise, injections) prior to the procedure, not documented, reason not given"
G9298,"Patients who are evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke)"
G9299,"Patients who are not evaluated for venous thromboembolic and cardiovascular risk factors within 30 days prior to the procedure (e.g., history of dvt, pe, mi, arrhythmia and stroke, reason not given)"
G9300,"Documentation of medical reason(s) for not completely infusing the prophylactic antibiotic prior to the inflation of the proximal tourniquet (e.g., a tourniquet was not used)Terminated December 31, 2020."
G9301,"Patients who had the prophylactic antibiotic completely infused prior to the inflation of the proximal tourniquetTerminated December 31, 2020."
G9302,"Prophylactic antibiotic not completely infused prior to the inflation of the proximal tourniquet, reason not givenTerminated December 31, 2020."
G9303,"Operative report does not identify the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implant, reason not givenTerminated December 31, 2020."
G9304,"Operative report identifies the prosthetic implant specifications including the prosthetic implant manufacturer, the brand name of the prosthetic implant and the size of each prosthetic implantTerminated December 31, 2020."
G9305,Intervention for presence of leak of endoluminal contents through an anastomosis not required
G9306,Intervention for presence of leak of endoluminal contents through an anastomosis required
G9307,"No return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure"
G9308,"Unplanned return to the operating room for a surgical procedure, for complications of the principal operative procedure, within 30 days of the principal operative procedure"
G9309,No unplanned hospital readmission within 30 days of principal procedure
G9310,Unplanned hospital readmission within 30 days of principal procedure
G9311,No surgical site infection
G9312,Surgical site infection
G9313,"Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason"
G9314,"Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given"
G9315,"Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis"
G9316,"Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family"
G9317,"Documentation of patient-specific risk assessment with a risk calculator based on multi-institutional clinical data, the specific risk calculator used, and communication of risk assessment from risk calculator with the patient or family not completed"
G9318,Imaging study named according to standardized nomenclature
G9319,"Imaging study not named according to standardized nomenclature, reason not given"
G9320,"Documentation of medical reason(s) for not naming ct studies according to a standardized nomenclature provided (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)Terminated December 31, 2015."
G9321,Count of previous ct (any type of ct) and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies documented in the 12-month period prior to the current study
G9322,"Count of previous ct and cardiac nuclear medicine (myocardial perfusion or infarct avid imaging) studies not documented in the 12-month period prior to the current study, reason not given"
G9323,"Documentation of medical reason(s) for not counting previous ct and cardiac nuclear medicine (myocardial perfusion) studies (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)Terminated December 31, 2015."
G9324,"All necessary data elements not included, reason not givenTerminated December 31, 2016."
G9325,"Ct studies not reported to a radiation dose index registry due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)Terminated December 31, 2015."
G9326,"Ct studies performed not reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements, reason not givenTerminated December 31, 2020."
G9327,"Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elementsTerminated December 31, 2020."
G9328,"Dicom format image data availability not documented in final report due to medical reasons (eg, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)Terminated December 31, 2015."
G9329,"Dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the study not documented in final report, reason not givenTerminated December 31, 2020."
G9340,"Final report documented that dicom format image data available to non-affiliated external healthcare facilities or entities on a secure, media free, reciprocally searchable basis with patient authorization for at least a 12-month period after the studyTerminated December 31, 2020."
G9341,"Search conducted for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive prior to an imaging study being performed"
G9342,"Search not conducted prior to an imaging study being performed for prior patient ct studies completed at non-affiliated external healthcare facilities or entities within the past 12-months and are available through a secure, authorized, media-free, shared archive, reason not given"
G9343,"Due to medical reasons, search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)Terminated December 31, 2015."
G9344,"Due to system reasons search not conducted for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., non-affiliated external healthcare facilities or entities does not have archival abilities through a shared archival system)"
G9345,"Follow-up recommendations documented according to recommended guidelines for incidentally detected pulmonary nodules (e.g., follow-up ct imaging studies needed or that no follow-up is needed) based at a minimum on nodule size and patient risk factors"
G9346,"Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules due to medical reasons (e.g., patients with known malignant disease, patients with unexplained fever, ct studies performed for radiation treatment planning or image-guided radiation treatment delivery)Terminated December 31, 2015."
G9347,"Follow-up recommendations not documented according to recommended guidelines for incidentally detected pulmonary nodules, reason not given"
G9348,"Ct scan of the paranasal sinuses ordered at the time of diagnosis for documented reasonsTerminated December 31, 2021."
G9349,"Ct scan of the paranasal sinuses ordered at the time of diagnosis or received within 28 days after date of diagnosisTerminated December 31, 2021."
G9350,"Ct scan of the paranasal sinuses not ordered at the time of diagnosis or received within 28 days after date of diagnosisTerminated December 31, 2021."
G9351,More than one ct scan of the paranasal sinuses ordered or received within 90 days after diagnosis
G9352,"More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis, reason not given"
G9353,"More than one ct scan of the paranasal sinuses ordered or received within 90 days after the date of diagnosis for documented reasons (eg, patients with complications, second ct obtained prior to surgery, other medical reasons)"
G9354,One ct scan or no ct scan of the paranasal sinuses ordered within 90 days after the date of diagnosis
G9355,Elective delivery (without medical indication) by cesarean birth or induction of labor not performed (<39 weeks of gestation)
G9356,Elective delivery (without medical indication) by cesarean birth or induction of labor performed (<39 weeks of gestation)
G9357,"Post-partum screenings, evaluations and education performed"
G9358,"Post-partum screenings, evaluations and education not performed"
G9359,"Documentation of negative or managed positive tb screen with further evidence that tb is not active prior to treatment with a biologic immune response modifierTerminated December 31, 2022."
G9360,"No documentation of negative or managed positive tb screenTerminated December 31, 2022."
G9361,"Medical indication for delivery by cesarean birth or induction of labor (<39 weeks of gestation) [documentation of reason(s) for elective delivery (e.g., hemorrhage and placental complications, hypertension, preeclampsia and eclampsia, rupture of membranes (premature or prolonged), maternal conditions complicating pregnancy/delivery, fetal conditions complicating pregnancy/delivery, late pregnancy, prior uterine surgery, or participation in clinical trial)]"
G9362,"Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure 60 minutes or longer, as documented in the anesthesia recordTerminated December 31, 2015."
G9363,"Duration of monitored anesthesia care (mac) or peripheral nerve block (pnb) without the use of general anesthesia during an applicable procedure or general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia recordTerminated December 31, 2015."
G9364,"Sinusitis caused by, or presumed to be caused by, bacterial infection"
G9365,"One high-risk medication orderedTerminated December 31, 2020."
G9366,"One high-risk medication not orderedTerminated December 31, 2020."
G9367,At least two orders for high-risk medications from the same drug class
G9368,At least two orders for high-risk medications from the same drug class not ordered
G9369,"Individual filled at least two prescriptions for any antipsychotic medication and had a pdc of 0.8 or greaterTerminated December 31, 2015."
G9370,"Individual who did not fill at least two prescriptions for any antipsychotic medication or did not have a pdc of 0.8 or greaterTerminated December 31, 2015."
G9376,"Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month) following only one surgeryTerminated December 31, 2015."
G9377,"Patient did not have the retina attached after 6 months following only one surgeryTerminated December 31, 2015."
G9378,"Patient continued to have the retina attached at the 6 months follow up visit (+/- 1 month)Terminated December 31, 2015."
G9379,"Patient did not achieve flat retinas six months post surgeryTerminated December 31, 2015."
G9380,Patient offered assistance with end of life issues or existing end of life plan was reviewed or updated during the measurement period
G9381,"Documentation of medical reason(s) for not offering assistance with end of life issues (e.g., patient in hospice care, patient in terminal phase) during the measurement periodTerminated December 31, 2017."
G9382,Patient not offered assistance with end of life issues or existing end of life plan was not reviewed or updated during the measurement period
G9383,Patient received screening for hcv infection within the 12 month reporting period
G9384,"Documentation of medical reason(s) for not receiving annual screening for hcv infection (e.g., decompensated cirrhosis indicating advanced disease [i.e., ascites, esophageal variceal bleeding, hepatic encephalopathy], hepatocellular carcinoma, waitlist for organ transplant, limited life expectancy, other medical reasons)"
G9385,"Documentation of patient reason(s) for not receiving annual screening for hcv infection (e.g., patient declined, other patient reasons)"
G9386,"Screening for hcv infection not received within the 12 month reporting period, reason not given"
G9389,"Unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgeryTerminated December 31, 2020."
G9390,"No unplanned rupture of the posterior capsule requiring vitrectomy during cataract surgeryTerminated December 31, 2020."
G9391,"Patient achieves refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visitTerminated December 31, 2015."
G9392,"Patient does not achieve refraction +-1 d for the eye that underwent cataract surgery, measured at the one month follow up visitTerminated December 31, 2015."
G9393,Patient with an initial phq-9 score greater than nine who achieves remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score of less than five
G9394,"Patient who had a diagnosis of bipolar disorder or personality disorder, death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement or assessment period"
G9395,Patient with an initial phq-9 score greater than nine who did not achieve remission at twelve months as demonstrated by a twelve month (+/- 30 days) phq-9 score greater than or equal to five
G9396,Patient with an initial phq-9 score greater than nine who was not assessed for remission at twelve months (+/- 30 days)
G9399,"Documentation in the patient record of a discussion between the physician/clinician and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward the outcome of the treatmentTerminated December 31, 2021."
G9400,"Documentation of medical or patient reason(s) for not discussing treatment options; medical reasons: patient is not a candidate for treatment due to advanced physical or mental health comorbidity (including active substance use); currently receiving antiviral treatment; successful antiviral treatment (with sustained virologic response) prior to reporting period; other documented medical reasons; patient reasons: patient unable or unwilling to participate in the discussion or other patient reasonsTerminated December 31, 2021."
G9401,"No documentation in the patient record of a discussion between the physician or other qualified healthcare professional and the patient that includes all of the following: treatment choices appropriate to genotype, risks and benefits, evidence of effectiveness, and patient preferences toward treatmentTerminated December 31, 2021."
G9402,"Patient received follow-up within 30 days after dischargeTerminated December 31, 2024."
G9403,"Clinician documented reason patient was not able to complete 30 day follow-up from acute inpatient setting discharge (e.g., patient death prior to follow-up visit, patient non-compliant for visit follow-up)Terminated December 31, 2024."
G9404,"Patient did not receive follow-up within 30 days after dischargeTerminated December 31, 2024."
G9405,"Patient received follow-up within 7 days after dischargeTerminated December 31, 2024."
G9406,"Clinician documented reason patient was not able to complete 7 day follow-up from acute inpatient setting discharge (i.e patient death prior to follow-up visit, patient non-compliance for visit follow-up)Terminated December 31, 2024."
G9407,"Patient did not receive follow-up within 7 days after dischargeTerminated December 31, 2024."
G9408,Patients with cardiac tamponade and/or pericardiocentesis occurring within 30 days
G9409,Patients without cardiac tamponade and/or pericardiocentesis occurring within 30 days
G9410,"Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision"
G9411,"Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision"
G9412,"Patient admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision"
G9413,"Patient not admitted within 180 days, status post cied implantation, replacement, or revision with an infection requiring device removal or surgical revision"
G9414,"Patient had one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient's 11th and 13th birthdays"
G9415,"Patient did not have one dose of meningococcal vaccine (serogroups a, c, w, y) on or between the patient's 11th and 13th birthdays"
G9416,"Patient had one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays"
G9417,"Patient did not have one tetanus, diphtheria toxoids and acellular pertussis vaccine (tdap) on or between the patient's 10th and 13th birthdays"
G9418,Primary non-small cell lung cancer lung biopsy and cytology specimen report documents classification into specific histologic type following iaslc guidance or classified as nsclc-nos with an explanation
G9419,"Documentation of medical reason(s) for not including the histological type or nsclc-nos classification with an explanation (e.g. specimen insufficient or non-diagnostic, specimen does not contain cancer, or other documented medical reasons)"
G9420,Specimen site other than anatomic location of lung or is not classified as primary non-small cell lung cancer
G9421,Primary non-small cell lung cancer lung biopsy and cytology specimen report does not document classification into specific histologic type or histologic type does not follow iaslc guidance or is classified as nsclc-nos but without an explanation
G9422,"Primary lung carcinoma resection report documents pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma and not nsclc-nos)"
G9423,"Documentation of medical reason for not including pt category, pn category and histologic type [for patient with appropriate exclusion criteria (e.g., metastatic disease, benign tumors, malignant tumors other than carcinomas, inadequate surgical specimens)]"
G9424,"Specimen site other than anatomic location of lung, or classified as nsclc-nos"
G9425,"Primary lung carcinoma resection report does not document pt category, pn category and for non-small cell lung cancer, histologic type (e.g., squamous cell carcinoma, adenocarcinoma)"
G9426,Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration performed for ed admitted patients
G9427,Improvement in median time from ed arrival to initial ed oral or parenteral pain medication administration not performed for ed admitted patients
G9428,"Pathology report includes the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors"
G9429,"Documentation of medical reason(s) for not including pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors (e.g., negative skin biopsies, insufficient tissue, or other documented medical reasons)"
G9430,Specimen site other than anatomic cutaneous location
G9431,"Pathology report does not include the pt category, thickness, ulceration and mitotic rate, peripheral and deep margin status and presence or absence of microsatellitosis for invasive tumors"
G9432,"Asthma well-controlled based on the act, c-act, acq, or ataq score and results documented"
G9433,"Death, permanent nursing home resident or receiving hospice or palliative care any time during the measurement periodTerminated December 31, 2015."
G9434,"Asthma not well-controlled based on the act, c-act, acq, or ataq score, or specified asthma control tool not used, reason not given"
G9435,"Aspirin prescribed at dischargeTerminated December 31, 2016."
G9436,"Aspirin not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)Terminated December 31, 2016."
G9437,"Aspirin not prescribed at dischargeTerminated December 31, 2016."
G9438,"P2y inhibitor prescribed at dischargeTerminated December 31, 2016."
G9439,"P2y inhibitor not prescribed for documented reasons (e.g., allergy, medical intolerance, history of bleed)Terminated December 31, 2016."
G9440,"P2y inhibitor not prescribed at dischargeTerminated December 31, 2016."
G9441,"Statin prescribed at dischargeTerminated December 31, 2016."
G9442,"Statin not prescribed for documented reasons (e.g., allergy, medical intolerance)Terminated December 31, 2016."
G9443,"Statin not prescribed at dischargeTerminated December 31, 2016."
G9448,"Patients who were born in the years 1945 to 1965Terminated December 31, 2021."
G9449,"History of receiving blood transfusions prior to 1992Terminated December 31, 2021."
G9450,"History of injection drug useTerminated December 31, 2021."
G9451,"Patient received one-time screening for hcv infectionTerminated December 31, 2023."
G9452,Documentation of medical reason(s) for not receiving hcv antibody test due to limited life expectancy
G9453,"Documentation of patient reason(s) for not receiving one-time screening for hcv infection (e.g., patient declined, other patient reasons)Terminated December 31, 2023."
G9454,"One-time screening for hcv infection not received within 12-month reporting period and no documentation of prior screening for hcv infection, reason not givenTerminated December 31, 2023."
G9455,"Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc"
G9456,"Documentation of medical or patient reason(s) for not ordering or performing screening for hcc. medical reason: comorbid medical conditions with expected survival < 5 years, hepatic decompensation and not a candidate for liver transplantation, or other medical reasons; patient reasons: patient declined or other patient reasons (e.g., cost of tests, time related to accessing testing equipment)"
G9457,Patient did not undergo abdominal imaging and did not have a documented reason for not undergoing abdominal imaging in the submission period
G9458,"Patient documented as tobacco user and received tobacco cessation intervention (must include at least one of the following: advice given to quit smoking or tobacco use, counseling on the benefits of quitting smoking or tobacco use, assistance with or referral to external smoking or tobacco cessation support programs, or current enrollment in smoking or tobacco use cessation program) if identified as a tobacco userTerminated December 31, 2024."
G9459,"Currently a tobacco non-userTerminated December 31, 2024."
G9460,"Tobacco assessment or tobacco cessation intervention not performed, reason not givenTerminated December 31, 2024."
G9463,"I intend to report the sinusitis measures groupTerminated December 31, 2016."
G9464,"All quality actions for the applicable measures in the sinusitis measures group have been performed for this patientTerminated December 31, 2016."
G9465,"I intend to report the acute otitis externa (aoe) measures groupTerminated December 31, 2016."
G9466,"All quality actions for the applicable measures in the aoe measures group have been performed for this patientTerminated December 31, 2016."
G9467,"Patient who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills within the last twelve monthsTerminated December 31, 2016."
G9468,Patient not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills
G9469,"Patients who have received or are receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 90 or greater consecutive days or a single prescription equating to 900 mg prednisone or greater for all fillsTerminated December 31, 2020."
G9470,Patients not receiving corticosteroids greater than or equal to 10 mg/day of prednisone equivalents for 60 or greater consecutive days or a single prescription equating to 600 mg prednisone or greater for all fills
G9471,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered or documented"
G9472,"Within the past 2 years, central dual-energy x-ray absorptiometry (dxa) not ordered and documented, no review of systems and no medication history or pharmacologic therapy (other than minerals/vitamins) for osteoporosis prescribedTerminated December 31, 2019."
G9473,"Services performed by chaplain in the hospice setting, each 15 minutes"
G9474,"Services performed by dietary counselor in the hospice setting, each 15 minutes"
G9475,"Services performed by other counselor in the hospice setting, each 15 minutes"
G9476,"Services performed by volunteer in the hospice setting, each 15 minutes"
G9477,"Services performed by care coordinator in the hospice setting, each 15 minutes"
G9478,"Services performed by other qualified therapist in the hospice setting, each 15 minutes"
G9479,"Services performed by qualified pharmacist in the hospice setting, each 15 minutes"
G9480,Admission to medicare care choice model program (mccm)
G9481,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a problem focused history;  a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor.  typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9482,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: an expanded problem focused history; an expanded problem focused examination;  straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of low to moderate severity.  typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9483,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate severity.  typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9484,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9485,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved cms innovation center demonstration project, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9486,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are self limited or minor.  typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9487,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of low to moderate severity.  typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9488,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved cms innovation center demonstration project, which requires at least 2 of the following 3 key components: a detailed history; a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9489,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved coms innovation center demonstration project, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both.  usually, the presenting problem(s) are of moderate to high severity.  typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9490,"Cms innovation center models, home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary connections to community and other services.  (for use only in medicare-approved cms innovation center models); may not be billed for a 30 day period covered by a transitional care management code"
G9496,"Documentation of reason for not detecting adenoma(s) or other neoplasm. (e.g., neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenomaTerminated December 31, 2017."
G9497,Received instruction from the anesthesiologist or proxy prior to the day of surgery to abstain from smoking on the day of surgery
G9498,Antibiotic regimen prescribed
G9499,"Patient did not start or is not receiving antiviral treatment for hepatitis c during the measurement periodTerminated December 31, 2016."
G9500,Radiation exposure indices documented in final report for procedure using fluoroscopy
G9501,"Radiation exposure indices not documented in final report for procedure using fluoroscopy, reason not given"
G9502,"Documentation of medical reason for not performing foot exam (i.e., patients who have had either a bilateral amputation above or below the knee, or both a left and right amputation above or below the knee before or during the measurement period)"
G9503,"Patient taking tamsulosin hydrochlorideTerminated December 31, 2020."
G9504,"Documented reason for not assessing hepatitis b virus (hbv) status (e.g., patient not initiating anti-tnf therapy, patient declined) prior to initiating anti-tnf therapy"
G9505,Antibiotic regimen prescribed within 10 days after onset of symptoms for documented medical reason
G9506,"Biologic immune response modifier prescribedTerminated December 31, 2022."
G9507,"Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs)"
G9508,Documentation that the patient is not on a statin medication
G9509,Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5
G9510,Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve  month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq- 9 or phq-9m score was not assessed or is greater than or equal to 5
G9511,Index event date phq-9 or phq-9m score greater than 9 documented during the twelve month denominator identification period
G9512,Individual had a pdc of 0.8 or greater
G9513,Individual did not have a pdc of 0.8 or greater
G9514,Patient required a return to the operating room within 90 days of surgery
G9515,Patient did not require a return to the operating room within 90 days of surgery
G9516,"Patient achieved an improvement in visual acuity, from their preoperative level, within 90 days of surgery"
G9517,"Patient did not achieve an improvement in visual acuity, from their preoperative level, within 90 days of surgery, reason not given"
G9518,Documentation of active injection drug use
G9519,Patient achieves final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery
G9520,Patient does not achieve final refraction (spherical equivalent) +/- 1.0 diopters of their planned refraction within 90 days of surgery
G9521,Total number of emergency department visits and inpatient hospitalizations less than two in the past 12 months
G9522,"Total number of emergency department visits and inpatient hospitalizations equal to or greater than two in the past 12 months or patient not screened, reason not given"
G9523,"Patient discontinued from hemodialysis or peritoneal dialysisTerminated December 31, 2020."
G9524,"Patient was referred to hospice careTerminated December 31, 2020."
G9525,"Documentation of patient reason(s) for not referring to hospice care (e.g., patient declined, other patient reasons)Terminated December 31, 2020."
G9526,"Patient was not referred to hospice care, reason not givenTerminated December 31, 2020."
G9529,Patient with minor blunt head trauma had an appropriate indication(s) for a head ct
G9530,Patient presented with a minor blunt head trauma  and had a head ct ordered for trauma by an emergency care provider
G9531,"Patient has documentation of ventricular shunt, brain tumor, multisystem trauma, or is currently taking an antiplatelet medication including: abciximab, anagrelide, cangrelor, cilostazol, clopidogrel, dipyridamole, eptifibatide, prasugrel, ticlopidine, ticagrelor, tirofiban, or vorapaxar"
G9532,"Patient had a head ct for trauma ordered by someone other than an emergency care provider  or was ordered for a reason other than traumaTerminated December 31, 2020."
G9533,Patient with minor blunt head trauma did not have an appropriate indication(s) for a head ct
G9534,"Advanced brain imaging (cta, ct, mra or mri) was not orderedTerminated December 31, 2018."
G9535,"Patients with a normal neurological examinationTerminated December 31, 2018."
G9536,"Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms)Terminated December 31, 2018."
G9537,Imaging needed as part of a clinical trial; or other clinician ordered the study
G9538,"Advanced brain imaging (cta, ct, mra or mri) was orderedTerminated December 31, 2018."
G9539,Intent for potential removal at time of placement
G9540,Patient alive 3 months post procedure
G9541,Filter removed within 3 months of placement
G9542,Documented re-assessment for the appropriateness of filter removal within 3 months of placement
G9543,Documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement
G9544,"Patients that do not have the filter removed, documented re-assessment for the appropriateness of filter removal, or documentation of at least two attempts to reach the patient to arrange a clinical re-assessment for the appropriateness of filter removal within 3 months of placement"
G9547,"Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion  less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols"
G9548,Final reports for imaging studies stating no  follow-up imaging is recommended
G9549,"Documentation of medical reason(s) that follow-up imaging is indicated (e.g., patient has lymphadenopathy, signs of metastasis or an active diagnosis or history of cancer, and other medical reason(s))"
G9550,"Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up"
G9551,Final reports for imaging studies without an incidentally found lesion noted
G9552,Incidental thyroid nodule < 1.0 cm noted in report
G9553,Prior thyroid disease diagnosis
G9554,"Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging recommended"
G9555,"Documentation of medical reason(s) for recommending follow up imaging (e.g., patient has multiple endocrine neoplasia, patient has cervical lymphadenopathy, other medical reason(s))"
G9556,"Final reports for ct, cta, mri or mra of the chest or neck with follow-up imaging not recommended"
G9557,"Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found"
G9558,"Patient treated with a beta-lactam antibiotic as definitive therapyTerminated December 31, 2020."
G9559,"Documentation of medical reason(s) for not prescribing a beta-lactam antibiotic (e.g., allergy, intolerance to beta-lactam antibiotics)Terminated December 31, 2020."
G9560,"Patient not treated with a beta-lactam antibiotic as definitive therapy, reason not givenTerminated December 31, 2020."
G9561,"Patients prescribed opiates for longer than six weeksTerminated December 31, 2021."
G9562,"Patients who had a follow-up evaluation conducted at least every three months during opioid therapyTerminated December 31, 2021."
G9563,"Patients who did not have a follow-up evaluation conducted at least every three months during opioid therapyTerminated December 31, 2021."
G9572,"Index date phq-score greater than 9 documented during the twelve month denominator identification periodTerminated December 31, 2016."
G9573,"Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than fiveTerminated December 31, 2020."
G9574,"Adult patients 18 years of age or older with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five; either phq-9 or phq-9m score was not assessed or is greater than or equal to fiveTerminated December 31, 2020."
G9577,"Patients prescribed opiates for longer than six weeksTerminated December 31, 2021."
G9578,"Documentation of signed opioid treatment agreement at least once during opioid therapyTerminated December 31, 2021."
G9579,"No documentation of signed an opioid treatment agreement at least once during opioid therapyTerminated December 31, 2021."
G9580,Door to puncture time of 90 minutes or less
G9581,"Door to puncture time of greater than 2 hours for reasons documented by clinician (e.g., patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment; hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment)Terminated December 31, 2016."
G9582,"Door to puncture time of greater than 90 minutes, no reason given"
G9583,"Patients prescribed opiates for longer than six weeksTerminated December 31, 2021."
G9584,"Patient evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient interviewed at least once during opioid therapyTerminated December 31, 2021."
G9585,"Patient not evaluated for risk of misuse of opiates by using a brief validated instrument (e.g., opioid risk tool, soapp-r) or patient not interviewed at least once during opioid therapyTerminated December 31, 2021."
G9593,Pediatric patient with minor blunt head trauma classified as low risk according to the pecarn prediction rules
G9594,Patient presented with a minor blunt head trauma and had a head ct ordered for trauma by an emergency care provider
G9595,"Patient has documentation of ventricular shunt, brain tumor, or coagulopathy"
G9596,"Pediatric patient had a head ct for trauma ordered by someone other than an emergency care provider or was ordered for a reason other than traumaTerminated December 31, 2023."
G9597,Pediatric patient with minor blunt head trauma not classified as low risk according to the pecarn prediction rules
G9598,Aortic aneurysm 5.5 - 5.9 cm maximum diameter on centerline formatted ct or minor diameter on axial formatted ct
G9599,Aortic aneurysm 6.0 cm or greater maximum diameter on centerline formatted ct or minor diameter on axial formatted ct
G9600,"Symptomatic aaas that required urgent/emergent (non-elective) repairTerminated December 31, 2020."
G9601,"Patient discharge to home no later than post-operative day #7Terminated December 31, 2020."
G9602,"Patient not discharged to home by post-operative day #7Terminated December 31, 2020."
G9603,Patient survey score improved from baseline following treatment
G9604,Patient survey results not available
G9605,Patient survey score did not improve from baseline following treatment
G9606,Intraoperative cystoscopy performed to evaluate for lower tract injury
G9607,"Documented medical reasons for not performing intraoperative cystoscopy (e.g., urethral pathology precluding cystoscopy, any patient who has a congenital or acquired absence of the urethra) or in the case of patient death"
G9608,Intraoperative cystoscopy not performed to evaluate for lower tract injury
G9609,Documentation of an order for anti-platelet agents
G9610,Documentation of medical reason(s) in the patient's record for not ordering anti-platelet agents
G9611,"Order for anti-platelet agents was not documented in the patient's record, reason not given"
G9612,"Photodocumentation of two or more cecal landmarks to establish a complete examinationTerminated December 31, 2023."
G9613,"Documentation of post-surgical anatomy (e.g., right hemicolectomy, ileocecal resection, etc.)Terminated December 31, 2023."
G9614,"Photodocumentation of less than two cecal landmarks (i.e., no cecal landmarks or only one cecal landmark) to establish a complete examinationTerminated December 31, 2023."
G9615,"Preoperative assessment documentedTerminated December 31, 2020."
G9616,"Documentation of reason(s) for not documenting a preoperative assessment (e.g., patient with a gynecologic or other pelvic malignancy noted at the time of surgery)Terminated December 31, 2020."
G9617,"Preoperative assessment not documented, reason not givenTerminated December 31, 2020."
G9618,"Documentation of screening for uterine malignancy or those that had an ultrasound and/or endometrial sampling of any kindTerminated December 31, 2022."
G9619,"Documentation of reason(s) for not screening for uterine malignancy (e.g., prior hysterectomy)Terminated December 31, 2016."
G9620,"Patient not screened for uterine malignancy, or those that have not had an ultrasound and/or endometrial sampling of any kind, reason not givenTerminated December 31, 2022."
G9621,Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling
G9622,Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method
G9623,"Documentation of medical reason(s) for not screening for unhealthy alcohol use (e.g., limited life expectancy, other medical reasons)Terminated December 31, 2022."
G9624,Patient not screened for unhealthy alcohol use using a systematic screening method or patient did not receive brief counseling if identified as an unhealthy alcohol user
G9625,Patient sustained bladder injury at the time of surgery or discovered subsequently up to 30 days post-surgery
G9626,"Documented medical reason for not reporting bladder injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bladder injury)"
G9627,Patient did not sustain bladder injury at the time of surgery nor discovered  subsequently up to 30 days post-surgery
G9628,Patient sustained bowel injury at the time of surgery or discovered subsequently up to 30 days  post-surgery
G9629,"Documented medical reasons for not reporting bowel injury (e.g., gynecologic or other pelvic malignancy documented, planned (e.g., not due to an unexpected bowel injury) resection and/or re-anastomosis of bowel, or patient death from non-medical causes not related to surgery, patient died during procedure without evidence of bowel injury)"
G9630,Patient did not sustain a bowel injury at the time of surgery nor discovered subsequently up to 30 days post-surgery
G9631,"Patient sustained ureter injury at the time of surgery or discovered subsequently up to 30 days post-surgeryTerminated December 31, 2022."
G9632,"Documented medical reasons for not reporting ureter injury (e.g., gynecologic or other pelvic malignancy documented, concurrent surgery involving bladder pathology, injury that occurs during a urinary incontinence procedure, patient death from non-medical causes not related to surgery, patient died during procedure without evidence of ureter injury)Terminated December 31, 2022."
G9633,"Patient did not sustain ureter injury at the time of surgery nor discovered subsequently up to 30 days post-surgeryTerminated December 31, 2022."
G9634,"Health-related quality of life assessed with tool during at least two visits and quality of life score remained the same or improvedTerminated December 31, 2021."
G9635,"Health-related quality of life not assessed with tool for documented reason(s) (e.g., patient has a cognitive or neuropsychiatric impairment that impairs his/her ability to complete the hrqol survey, patient has the inability to read and/or write in order to complete the hrqol questionnaire)Terminated December 31, 2021."
G9636,"Health-related quality of life not assessed with tool during at least two visits or quality of life score declinedTerminated December 31, 2021."
G9637,"Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)"
G9638,"Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique)"
G9639,"Major amputation or open surgical bypass not required within 48 hours of the index endovascular lower extremity revascularization procedureTerminated December 31, 2021."
G9640,"Documentation of planned hybrid or staged procedureTerminated December 31, 2021."
G9641,"Major amputation or open surgical bypass required within 48 hours of the index endovascular lower extremity revascularization procedureTerminated December 31, 2021."
G9642,"Current smoker (e.g., cigarette, cigar, pipe, e-cigarette or marijuana)"
G9643,Elective surgery
G9644,Patients who abstained from smoking prior to anesthesia on the day of surgery or procedure
G9645,Patients who did not abstain from smoking prior to anesthesia on the day of surgery or procedure
G9646,Patients with 90 day mrs score of 0 to 2
G9647,"Patients in whom mrs score could not be obtained at 90 day follow-upTerminated December 31, 2021."
G9648,Patients with 90 day mrs score greater than 2
G9649,"Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))"
G9650,"Documentation that the patient declined therapy change or has documented contraindications (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqiTerminated December 31, 2016."
G9651,"Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented"
G9652,"Patient has been treated with a systemic or biologic medication for psoriasis for at least six monthsTerminated December 31, 2016."
G9653,"Patient has not been treated with a systemic or biologic medication for psoriasis for at least six monthsTerminated December 31, 2016."
G9654,Monitored anesthesia care (mac)
G9655,A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is used
G9656,Patient transferred directly from anesthetizing location to pacu or other non-icu location
G9657,"Transfer of care during an anesthetic or to the intensive care unitTerminated December 31, 2016."
G9658,A transfer of care protocol or handoff tool/checklist that includes the required key handoff elements is not used
G9659,"Patients greater than or equal to 86 years of age who underwent a screening colonoscopy and did not have a history of colorectal cancer or other valid medical reason for the colonoscopy, including: iron deficiency anemia, lower gastrointestinal bleeding, familial adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits"
G9660,"Documentation of medical reason(s) for a colonoscopy performed on a patient greater than or equal to 86 years of age (e.g., iron deficiency anemia, lower gastrointestinal bleeding, familial history of adenomatous polyposis, lynch syndrome (i.e., hereditary non-polyposis colorectal cancer), inflammatory bowel disease (i.e., crohn's disease or ulcerative colitis), abnormal finding of gastrointestinal tract, weight loss, or changes in bowel habits)"
G9661,"Patients greater than or equal to 86 years of age who received a  colonoscopy for an assessment of signs/symptoms of gi tract illness, and/or because the patient meets high risk criteria, and/or to follow-up on previously diagnosed advanced lesions"
G9662,"Previously diagnosed or have a diagnosis of clinical ascvd, including ascvd procedure"
G9663,Any ldl-c laboratory result >= 190 mg/dl
G9664,Patients who are currently statin therapy users or received an order (prescription) for statin therapy
G9665,Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy
G9666,"Patient's highest fasting or direct ldl-c laboratory test result in the measurement period or two years prior to the beginning of the measurement period is 70-189 mg/dlTerminated December 31, 2021."
G9667,"Documentation of medical reason(s) for not currently being a statin   therapy user or receive an order (prescription) for statin therapy (e.g., patient with adverse effect, allergy or intolerance to statin medication therapy, patients who have an active diagnosis of pregnancy or who are breastfeeding, patients who are receiving palliative care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease (esrd), and patients with diabetes who have a fasting or direct ldl-c laboratory test result < 70 mg/dl and are not taking statin therapy)Terminated December 31, 2016."
G9669,"I intend to report the multiple chronic conditions measures groupTerminated December 31, 2016."
G9670,"All quality actions for the applicable measures in the multiple chronic conditions measures group have been performed for this patientTerminated December 31, 2016."
G9671,"I intend to report the diabetic retinopathy measures groupTerminated December 31, 2016."
G9672,"All quality actions for the applicable measures in the diabetic retinopathy measures group have been performed for this patientTerminated December 31, 2016."
G9673,"I intend to report the cardiovascular prevention measures groupTerminated December 31, 2016."
G9674,Patients with clinical ascvd diagnosis
G9675,Patients who have ever had a fasting or direct laboratory result of ldl-c = 190 mg/dl
G9676,Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes and with an ldl-c result of 70-189 mg/dl recorded as the highest fasting or direct laboratory test result in the measurement year or during the two years prior to the beginning of the measurement period
G9677,"All quality actions for the applicable measures in the cardiovascular prevention measures group have been performed for this patientTerminated December 31, 2016."
G9678,"Oncology care model (ocm) monthly enhanced oncology services (meos) payment for  ocm enhanced services.  g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation agreementTerminated June 30, 2022."
G9679,This code is for onsite acute care treatment of a nursing facility resident with pneumonia; may only be billed once per day per beneficiary
G9680,This code is for onsite acute care treatment of a nursing facility resident with chf; may only be billed once per day per beneficiary
G9681,This code is for onsite acute care treatment of a resident with copd or asthma; may only be billed once per day per beneficiary
G9682,This code is for the onsite acute care treatment a nursing facility resident with a skin infection; may only be billed once per day per beneficiary
G9683,Facility service(s) for the onsite acute care treatment of a nursing facility resident with fluid or electrolyte disorder. (may only be billed once per day per beneficiary). this service is for a demonstration project
G9684,This code is for the onsite acute care treatment of a nursing facility resident for a uti; may only be billed once per day per beneficiary
G9685,Physician service or other qualified health care professional for the evaluation and management of a beneficiary's acute change in condition in a nursing facility. this service is for a demonstration project
G9686,"Onsite nursing facility conference, that is separate and distinct from an evaluation and management visit, including qualified practitioner and at least one member of the nursing facility interdisciplinary care teamTerminated December 31, 2018."
G9687,Hospice services provided to patient any time during the measurement period
G9688,Patients using hospice services any time during the measurement period
G9689,Patient admitted for performance of elective carotid intervention
G9690,Patient receiving hospice services any time during the measurement period
G9691,Patient had hospice services any time during the measurement period
G9692,Hospice services received by patient any time during the measurement period
G9693,Patient use of hospice services any time during the measurement period
G9694,Hospice services utilized by patient any time during the measurement period
G9695,Long-acting inhaled bronchodilator prescribed
G9696,"Documentation of medical reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., patient intolerance or history of side effects)"
G9697,"Documentation of patient reason(s) for not prescribing a long-acting inhaled bronchodilatorTerminated December 31, 2023."
G9698,"Documentation of system reason(s) for not prescribing a long-acting inhaled bronchodilator (e.g., cost of treatment or lack of insurance)"
G9699,"Long-acting inhaled bronchodilator not prescribed, reason not otherwise specified"
G9700,Patients who use hospice services any time during the measurement period
G9701,"Children who are taking antibiotics in the 30 days prior to the date of the encounter during which the diagnosis was establishedTerminated December 31, 2020."
G9702,Patients who use hospice services any time during the measurement period
G9703,Episodes where the patient is taking antibiotics (table 1) in the 30 days prior to the episode date
G9704,Ajcc breast cancer stage i: t1 mic or t1a documented
G9705,Ajcc breast cancer stage i: t1b (tumor > 0.5 cm but <= 1 cm in greatest dimension) documented
G9706,"Low (or very low) risk of recurrence, prostate cancer"
G9707,"Patient received hospice services any time during the measurement periodTerminated December 31, 2024."
G9708,Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy
G9709,Hospice services used by patient any time during the measurement period
G9710,Patient was provided hospice services any time during the measurement period
G9711,Patients with a diagnosis or past history of total colectomy or colorectal cancer
G9712,"Documentation of medical reason(s) for prescribing or dispensing antibiotic (e.g., intestinal   infection, pertussis, bacterial infection, lyme disease, otitis media, acute sinusitis, acute pharyngitis, acute tonsillitis, chronic sinusitis, infection of the pharynx/larynx/tonsils/adenoids, prostatitis, cellulitis/ mastoiditis/bone infections, acute lymphadenitis, impetigo, skin staph infections, pneumonia, gonococcal infections/venereal disease (syphilis, chlamydia, inflammatory diseases [female reproductive organs]), infections of the kidney, cystitis/uti, acne, hiv disease/asymptomatic hiv, cystic fibrosis, disorders of the immune system, malignancy neoplasms, chronic bronchitis, emphysema, bronchiectasis, extrinsic allergic alveolitis, chronic airway obstruction, chronic obstructive asthma, pneumoconiosis and other lung disease due to external agents, other diseases of the respiratory system, and tuberculosis"
G9713,Patients who use hospice services any time during the measurement period
G9714,Patient is using hospice services any time during the measurement period
G9715,"Patients who use hospice services any time during the measurement periodTerminated December 31, 2023."
G9716,"Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason"
G9717,Documentation stating the patient has had a diagnosis of bipolar disorder
G9718,"Hospice services for patient provided any time during the measurement periodTerminated December 31, 2022."
G9719,"Patient is not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair"
G9720,Hospice services for patient occurred any time during the measurement period
G9721,"Patient not ambulatory, bed ridden, immobile, confined to chair, wheelchair bound, dependent on helper pushing wheelchair, independent in wheelchair or minimal help in wheelchair"
G9722,"Documented history of renal failure or baseline serum creatinine >= 4.0 mg/dl; renal transplant recipients are not considered to have preoperative renal failure, unless, since transplantation the cr has been or is 4.0 or higher"
G9723,Hospice services for patient received any time during the measurement period
G9724,Patients who had documentation of use of anticoagulant medications overlapping the measurement year
G9725,"Patients who use hospice services any time during the measurement periodTerminated December 31, 2023."
G9726,Patient refused to participate
G9727,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available"
G9728,Patient refused to participate
G9729,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available"
G9730,Patient refused to participate
G9731,"Patient unable to complete the lepf prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available"
G9732,Patient refused to participate
G9733,"Patient unable to complete the low back fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available"
G9734,Patient refused to participate
G9735,"Patient unable to complete the shoulder fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available"
G9736,Patient refused to participate
G9737,"Patient unable to complete the elbow/wrist/hand fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not available"
G9738,"Patient refused to participateTerminated December 31, 2020."
G9739,"Patient unable to complete the general orthopedic fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility and an adequate proxy is not availableTerminated December 31, 2020."
G9740,Hospice services given to patient any time during the measurement period
G9741,Patients who use hospice services any time during the measurement period
G9742,"Psychiatric symptoms assessedTerminated December 31, 2019."
G9743,"Psychiatric symptoms not assessed, reason not otherwise specifiedTerminated December 31, 2019."
G9744,Patient not eligible due to active diagnosis of hypertension
G9745,Documented reason for not screening or recommending a follow-up for high blood pressure
G9746,"Patient has mitral stenosis or prosthetic heart valves or patient has transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)"
G9747,"Patient is undergoing palliative dialysis with a catheterTerminated December 31, 2020."
G9748,"Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplantTerminated December 31, 2020."
G9749,"Patient is undergoing palliative dialysis with a catheterTerminated December 31, 2020."
G9750,"Patient approved by a qualified transplant program and scheduled to receive a living donor kidney transplantTerminated December 31, 2020."
G9751,"Patient died at any time during the 24-month measurement periodTerminated December 31, 2024."
G9752,Emergency surgery
G9753,"Documentation of medical reason for not conducting a search for dicom format images for prior patient ct imaging studies completed at non-affiliated external healthcare facilities or entities within the past 12 months that are available through a secure, authorized, media-free, shared archive (e.g., trauma, acute myocardial infarction, stroke, aortic aneurysm where time is of the essence)"
G9754,A finding of an incidental pulmonary nodule
G9755,"Documentation of medical reason(s) for not including a recommended interval and modality for follow-up or for no follow-up, and source of recommendations (e.g., patients with unexplained fever, immunocompromised patients who are at risk for infection)"
G9756,Surgical procedures that included the use of silicone oil
G9757,Surgical procedures that included the use of silicone oil
G9758,Patient in hospice at any time during the measurement period
G9759,"History of preoperative posterior capsule ruptureTerminated December 31, 2020."
G9760,"Patients who use hospice services any time during the measurement periodTerminated December 31, 2024."
G9761,Patients who use hospice services any time during the measurement period
G9762,Patient had at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays
G9763,Patient did not have at least two hpv vaccines (with at least 146 days between the two) or three hpv vaccines on or between the patient's 9th and 13th birthdays
G9764,Patient has been treated with a systemic medication for psoriasis vulgaris
G9765,"Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi"
G9766,Patients who are transferred from one institution to another with a known diagnosis of cva for endovascular stroke treatment
G9767,Hospitalized patients with newly diagnosed cva considered for endovascular stroke treatment
G9768,Patients who utilize hospice services any time during the measurement period
G9769,Patient had a bone mineral density test in the past two years or received osteoporosis medication or therapy in the past 12 months
G9770,Peripheral nerve block (pnb)
G9771,At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time
G9772,"Documentation of medical reason(s) for not achieving at least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time (e.g., emergency cases, intentional hypothermia, etc.)"
G9773,"At least 1 body temperature measurement equal to or greater than 35.5 degrees celsius (or 95.9 degrees fahrenheit) not achieved within the 30 minutes immediately before or 15 minutes immediately after anesthesia end time, reason not given"
G9774,"Patients who have had a hysterectomyTerminated December 31, 2022."
G9775,Patient received at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
G9776,"Documentation of medical reason for not receiving at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively  (e.g., intolerance or other medical reason)"
G9777,Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
G9778,"Patients who have a diagnosis of pregnancy at any time during the measurement periodTerminated December 31, 2022."
G9779,Patients who are breastfeeding at any time during the performance period
G9780,Patients who have a diagnosis of rhabdomyolysis at any time during the performance period
G9781,"Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)"
G9782,History of or active diagnosis of familial hypercholesterolemia
G9783,"Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapyTerminated December 31, 2021."
G9784,Pathologists/dermatopathologists providing a second opinion on a biopsy
G9785,"Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist"
G9786,"Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist"
G9787,Patient alive as of the last day of the measurement year
G9788,Most recent bp is less than or equal to 140/90 mm hg
G9789,"Blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits"
G9790,"Most recent bp is greater than 140/90 mm hg, or blood pressure not documented"
G9791,Most recent tobacco status is tobacco free
G9792,Most recent tobacco status is not tobacco free
G9793,Patient is currently on a daily aspirin or other antiplatelet
G9794,"Documentation of medical reason(s) for not on a daily aspirin or other antiplatelet (e.g., history of gastrointestinal bleed, intra-cranial bleed, idiopathic thrombocytopenic purpura (itp), gastric bypass or documentation of active anticoagulant use during the measurement period)"
G9795,Patient is not currently on a daily aspirin or other antiplatelet
G9796,Patient is currently on a statin therapy
G9797,Patient is not on a statin therapy
G9798,"Discharge(s) for ami between july 1 of the year prior measurement period to june 30 of the measurement periodTerminated December 31, 2020."
G9799,"Patients with a medication dispensing event indicator of a history of asthma any time during the patient's history through the end of the measure periodTerminated December 31, 2020."
G9800,"Patients who are identified as having an intolerance or allergy to beta-blocker therapyTerminated December 31, 2020."
G9801,"Hospitalizations in which the patient was transferred directly to a non-acute care facility for any diagnosisTerminated December 31, 2020."
G9802,"Patients who use hospice services any time during the measurement periodTerminated December 31, 2020."
G9803,"Patient prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for amiTerminated December 31, 2020."
G9804,"Patient was not prescribed at least a 135 day treatment within the 180-day measurement interval with beta-blockers post-discharge for amiTerminated December 31, 2020."
G9805,Patients who use hospice services any time during the measurement period
G9806,Patients who received cervical cytology or an hpv test
G9807,Patients who did not receive cervical cytology or an hpv test
G9808,"Any patients who had no asthma controller medications dispensed during the measurement yearTerminated December 31, 2022."
G9809,"Patients who use hospice services any time during the measurement periodTerminated December 31, 2022."
G9810,"Patient achieved a pdc of at least 75% for their asthma controller medicationTerminated December 31, 2022."
G9811,"Patient did not achieve a pdc of at least 75% for their asthma controller medicationTerminated December 31, 2022."
G9812,"Patient died including all deaths occurring during the hospitalization in which the operation was performed, even if after 30 days, and those deaths occurring after discharge from the hospital, but within 30 days of the procedure"
G9813,Patient did not die within 30 days of the procedure or during the index hospitalization
G9814,"Death occurring during the index acute care hospitalizationTerminated December 31, 2020."
G9815,"Death did not occur during the index acute care hospitalizationTerminated December 31, 2020."
G9816,"Death occurring after discharge from the hospital but within 30 days post procedureTerminated December 31, 2020."
G9817,"Death did not occur after discharge from the hospital within 30 days post procedureTerminated December 31, 2020."
G9818,Documentation of sexual activity
G9819,Patients who use hospice services any time during the measurement period
G9820,Documentation of a chlamydia screening test with proper follow-up
G9821,No documentation of a chlamydia screening test with proper follow-up
G9822,Patients who had an endometrial ablation procedure during the 12 months prior to the index date (exclusive of the index date)
G9823,Endometrial sampling or hysteroscopy with biopsy and results documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation
G9824,Endometrial sampling or hysteroscopy with biopsy and results not documented during the 12 months prior to the index date (exclusive of the index date) of the endometrial ablation
G9825,"Her-2/neu negative or undocumented/unknownTerminated December 31, 2020."
G9826,"Patient transferred to practice after initiation of chemotherapyTerminated December 31, 2020."
G9827,"Her2-targeted therapies not administered during the initial course of treatmentTerminated December 31, 2020."
G9828,"Her2-targeted therapies administered during the initial course of treatmentTerminated December 31, 2020."
G9829,"Breast adjuvant chemotherapy administeredTerminated December 31, 2020."
G9830,Her-2/neu positive
G9831,Ajcc stage at breast cancer diagnosis = ii or iii
G9832,"Ajcc stage at breast cancer diagnosis = i (ia or ib) and t-stage at breast cancer diagnosis does not equal = t1, t1a, t1b"
G9833,"Patient transfer to practice after initiation of chemotherapyTerminated December 31, 2020."
G9834,"Patient has metastatic disease at diagnosisTerminated December 31, 2020."
G9835,"Trastuzumab administered within 12 months of diagnosisTerminated December 31, 2020."
G9836,"Reason for not administering trastuzumab documented (e.g. patient declined, patient died, patient transferred, contraindication or other clinical exclusion, neoadjuvant chemotherapy or radiation not complete)Terminated December 31, 2020."
G9837,"Trastuzumab not administered within 12 months of diagnosisTerminated December 31, 2020."
G9838,Patient has metastatic disease at diagnosis
G9839,Anti-egfr monoclonal antibody therapy
G9840,Ras (kras and nras) gene mutation testing performed before initiation of anti-egfr moab
G9841,Ras (kras and nras) gene mutation testing not performed before initiation of anti-egfr moab
G9842,Patient has metastatic disease at diagnosis
G9843,Ras (kras or nras) gene mutation
G9844,Patient did not receive anti-egfr monoclonal antibody therapy
G9845,Patient received anti-egfr monoclonal antibody therapy
G9846,Patients who died from cancer
G9847,Patient received systemic cancer-directed therapy in the last 14 days of life
G9848,Patient did not receive systemic cancer-directed therapy in the last 14 days of life
G9849,"Patients who died from cancerTerminated December 31, 2020."
G9850,"Patient had more than one emergency department visit in the last 30 days of lifeTerminated December 31, 2020."
G9851,"Patient had one or less emergency department visits in the last 30 days of lifeTerminated December 31, 2020."
G9852,"Patients who died from cancerTerminated December 31, 2023."
G9853,"Patient admitted to the icu in the last 30 days of lifeTerminated December 31, 2023."
G9854,"Patient was not admitted to the icu in the last 30 days of lifeTerminated December 31, 2023."
G9855,"Patients who died from cancerTerminated December 31, 2020."
G9856,"Patient was not admitted to hospiceTerminated December 31, 2020."
G9857,"Patient admitted to hospiceTerminated December 31, 2020."
G9858,Patient enrolled in hospice
G9859,Patients who died from cancer
G9860,Patient spent less than three days in hospice care
G9861,Patient spent greater than or equal to three days in hospice care
G9862,"Documentation of medical reason(s) for not recommending at least a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is = 66 years old, or life expectancy < 10 years old, other medical reasons)"
G9868,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, less than 10 minutes"
G9869,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, 10-20 minutes"
G9870,"Receipt and analysis of remote, asynchronous images for dermatologic and/or ophthalmologic evaluation, for use only in a medicare-approved cmmi model, more than 20 minutes"
G9873,First medicare diabetes prevention program (mdpp) core session was attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions
G9874,Four total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions
G9875,Nine total medicare diabetes prevention program (mdpp) core sessions were attended by an mdpp beneficiary under the mdpp expanded model (em).  a core session is an mdpp service that: (1)  is furnished by an mdpp supplier during months 1 through 6 of the mdpp services period; (2)  is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for core sessions
G9876,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9"
G9877,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary did not achieve at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12"
G9878,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 7-9 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 7-9"
G9879,"Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 10-12 under the mdpp expanded model (em).  a core maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 7 through 12 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at a core maintenance session in months 10-12"
G9880,The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her baseline weight in months 1-12 of the mdpp services period under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 5% weight loss from baseline as measured by an in-person weight measurement at a core session or core maintenance session
G9881,"The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her baseline weight in months 1-24 under the mdpp expanded model (em).  this is a one-time payment available when a beneficiary first achieves at least 9% weight loss from baseline as measured by an in-person weight measurement at a core session, core maintenance session, or ongoing maintenance session"
G9882,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 13-15 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 13-15"
G9883,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 16-18 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 16-18"
G9884,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 19-21 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions. the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 19-21"
G9885,"Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions (ms) were attended by an mdpp beneficiary in months (mo) 22-24 under the mdpp expanded model (em).  an ongoing maintenance session is an mdpp service that: (1) is furnished by an mdpp supplier during months 13 through 24 of the mdpp services period; (2) is approximately 1 hour in length; and (3) adheres to a cdc-approved dpp curriculum for maintenance sessions.  the beneficiary maintained at least 5% weight loss (wl) from his/her baseline weight, as measured by at least one in-person weight measurement at an ongoing maintenance session in months 22-24"
G9886,"Behavioral counseling for diabetes prevention, in-person, group, 60 minutes"
G9887,"Behavioral counseling for diabetes prevention, distance learning, 60 minutes"
G9888,Maintenance 5% wl from baseline weight in months 7-12
G9890,"Bridge payment: a one-time payment for the first medicare diabetes prevention program (mdpp) core session, core maintenance session, or ongoing maintenance session furnished by an mdpp supplier to an mdpp beneficiary during months 1-24 of the mdpp expanded model (em) who has previously received mdpp services from a different mdpp supplier under the mdpp expanded model.  a supplier may only receive one bridge payment per mdpp beneficiary"
G9891,Mdpp session reported as a line-item on a claim for a payable mdpp expanded model (em)  hcpcs code for a session furnished by the billing supplier under the mdpp expanded model and counting toward achievement of the attendance performance goal for the payable mdpp expanded model hcpcs code (this code is for reporting purposes only)
G9892,"Documentation of patient reason(s) for not performing a dilated macular examinationTerminated December 31, 2024."
G9893,"Dilated macular exam was not performed, reason not otherwise specifiedTerminated December 31, 2024."
G9894,Androgen deprivation therapy prescribed/administered in combination with external beam radiotherapy to the prostate
G9895,"Documentation of medical reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate (e.g., salvage therapy)"
G9896,Documentation of patient reason(s) for not prescribing/administering androgen deprivation therapy in combination with external beam radiotherapy to the prostate
G9897,"Patients who were not prescribed/administered androgen deprivation therapy in combination with external beam radiotherapy to the prostate, reason not given"
G9898,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period"
G9899,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed"
G9900,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified"
G9901,"Patient age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period"
G9902,Patient screened for tobacco use and identified as a tobacco user
G9903,Patient screened for tobacco use and identified as a tobacco non-user
G9904,"Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reason)Terminated December 31, 2022."
G9905,Patient not screened for tobacco use
G9906,Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
G9907,"Documentation of medical reason(s) for not providing tobacco cessation intervention on the date of the encounter or within the previous 12 months (e.g., limited life expectancy, other medical reason)Terminated December 31, 2022."
G9908,Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
G9909,"Documentation of medical reason(s) for not  providing tobacco cessation intervention on the date of the encounter or within the previous 12 months if identified as a tobacco user (e.g., limited life expectancy, other medical reason)Terminated December 31, 2022."
G9910,"Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54 or 56 for more than 90 consecutive days during the measurement period"
G9911,Clinically node negative (t1n0m0 or t2n0m0) invasive breast cancer before or after neoadjuvant  systemic therapy
G9912,Hepatitis b virus (hbv) status assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy
G9913,"Hepatitis b virus (hbv) status not assessed and results interpreted prior to initiating anti-tnf (tumor necrosis factor) therapy, reason not otherwise specified"
G9914,Patient initiated an anti-tnf agent
G9915,No record of hbv results documented
G9916,Functional status  performed once in the last 12 months
G9917,Documentation of advanced stage dementia and caregiver knowledge is limited
G9918,"Functional status not performed, reason not otherwise specified"
G9919,Screening performed and positive and provision of recommendations
G9920,Screening performed and negative
G9921,"No screening performed, partial screening performed or positive screen without recommendations and reason is not given or otherwise specifiedTerminated December 31, 2024."
G9922,Safety concerns screen provided and if positive then documented mitigation recommendations
G9923,Safety concerns screen provided and negative
G9924,"Documentation of medical reason(s) for not providing safety concerns screen or for not providing recommendations, orders or referrals for positive screen (e.g., patient in palliative care, other medical reason)Terminated December 31, 2020."
G9925,"Safety concerns screening not provided, reason not otherwise specified"
G9926,"Safety concerns screening positive screen is without provision of mitigation recommendations, including but not limited to referral to other resources"
G9927,"Documentation of system reason(s) for not prescribing an fda-approved anticoagulation due to patient being currently enrolled in a clinical trial related to af/atrial flutter treatmentTerminated December 31, 2023."
G9928,"Fda-approved anticoagulant not prescribed, reason not given"
G9929,"Patient with transient or reversible cause of af (e.g., pneumonia, hyperthyroidism, pregnancy, cardiac surgery)"
G9930,Patients who are receiving comfort care only
G9931,"Documentation of cha2ds2-vasc risk score of 0 or 1 for men; or 0, 1, or 2 for women"
G9932,"Documentation of patient reason(s) for not having records of negative or managed positive tb screen (e.g., patient does not return for mantoux (ppd) skin test evaluation)Terminated December 31, 2022."
G9933,"Adenoma(s) or colorectal cancer detected during screening colonoscopyTerminated December 31, 2020."
G9934,"Documentation that neoplasm detected is only diagnosed as traditional serrated adenoma, sessile serrated polyp, or sessile serrated adenomaTerminated December 31, 2020."
G9935,"Adenoma(s) or colorectal cancer not detected during screening colonoscopyTerminated December 31, 2020."
G9936,"Surveillance colonoscopy - personal history of colonic polyps, colon cancer, or other malignant neoplasm of rectum, rectosigmoid junction, and anusTerminated December 31, 2020."
G9937,"Diagnostic colonoscopyTerminated December 31, 2020."
G9938,"Patients aged 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the six months prior to the measurement period through december 31 of the measurement period"
G9939,Pathologists/dermatopathologists is the same clinician who performed the biopsy
G9940,"Documentation of medical reason(s) for not on a statin (e.g., pregnancy, in vitro fertilization, clomiphene rx, esrd, cirrhosis, muscular pain and disease during the measurement period or prior year)"
G9941,"Back pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 - 20 weeks) postoperativelyTerminated December 31, 2019."
G9942,"Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomyTerminated December 31, 2022."
G9943,Back pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively
G9944,"Back pain was measured by the visual analog scale (vas) within three months preoperatively and at one year  (9 to 15 months) postoperativelyTerminated December 31, 2019."
G9945,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular,  idiopathic or congenital lumbar scoliosis"
G9946,Back pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively
G9947,"Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at three months (6 to 20 weeks) postoperativelyTerminated December 31, 2019."
G9948,"Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminectomyTerminated December 31, 2022."
G9949,Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at three months (6 - 20 weeks) postoperatively
G9954,Patient exhibits 2 or more risk factors for post-operative vomiting
G9955,Cases in which an inhalational anesthetic is used only for induction
G9956,Patient received combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
G9957,"Documentation of medical reason for not receiving combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively (e.g., intolerance or other medical reason)"
G9958,Patient did not receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
G9959,Systemic antimicrobials not prescribed
G9960,Documentation of medical reason(s) for prescribing systemic antimicrobials
G9961,Systemic antimicrobials prescribed
G9962,Embolization endpoints are documented separately for each embolized vessel and ovarian artery angiography or embolization performed in the presence of variant uterine artery anatomy
G9963,Embolization endpoints are not documented separately for each embolized vessel or ovarian artery angiography or embolization not performed in the presence of variant uterine artery anatomy
G9964,Patient received at least one well-child visit with a pcp during the performance period
G9965,Patient did not receive at least one well-child visit with a pcp during the performance period
G9966,"Children who were screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and reportTerminated December 31, 2020."
G9967,"Children who were not screened for risk of developmental, behavioral and social delays using a standardized tool with interpretation and reportTerminated December 31, 2020."
G9968,Patient was referred to another clinician or specialist during the measurement period
G9969,Clinician who referred the patient to another clinician received a report from the clinician to whom the patient was referred
G9970,Clinician who referred the patient to another clinician did not receive a report from the clinician to whom the patient was referred
G9974,"Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severityTerminated December 31, 2024."
G9975,"Documentation of medical reason(s) for not performing a dilated macular examinationTerminated December 31, 2024."
G9978,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a problem focused history; a problem focused examination; and straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9979,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: an expanded problem focused history;  an expanded problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 20 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9980,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a detailed history; a detailed examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting  problem(s) are of moderate severity. typically, 30 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9981,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 45 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9982,"Remote in-home visit for the evaluation and management of a new patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires these 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 60 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9983,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a problem focused history; a problem focused examination; straightforward medical decision making, furnished in real time using interactive audio and video technology. counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are self limited or minor. typically, 10 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9984,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: an expanded problem focused history; an expanded problem focused examination; medical decision making of low complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of low to moderate severity. typically, 15 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9985,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a detailed history;  a detailed examination; medical decision making of moderate complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 25 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9986,"Remote in-home visit for the evaluation and management of an established patient for use only in a medicare-approved bundled payments for care improvement advanced (bpci advanced) model episode of care, which requires at least 2 of the following 3 key components: a comprehensive history; a comprehensive examination; medical decision making of high complexity, furnished in real time using interactive audio and video technology.  counseling and coordination of care with other physicians, other qualified health care professionals or agencies are provided consistent with the nature of the problem(s) and the needs of the patient or the family or both. usually, the presenting problem(s) are of moderate to high severity. typically, 40 minutes are spent with the patient or family or both via real time, audio and video intercommunications technology"
G9987,"Bundled payments for care improvement advanced (bpci advanced) model home visit for patient assessment performed by clinical staff for an individual not considered homebound, including, but not necessarily limited to patient assessment of clinical status, safety/fall prevention, functional status/ambulation, medication reconciliation/management, compliance with orders/plan of care, performance of activities of daily living, and ensuring beneficiary  connections to community and other services; for use only for a bpci advanced model episode of care; may not be billed for a 30-day period covered by a transitional care management code"
G9988,Palliative care services provided to patient any time during the measurement period
G9989,"Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., adverse reaction to vaccine)Terminated December 31, 2022."
G9990,"Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement periodTerminated December 31, 2024."
G9991,"Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement periodTerminated December 31, 2024."
G9992,Palliative care services used by patient any time during the measurement period
G9993,Patient was provided palliative care services any time during the measurement period
G9994,Patient is using palliative care services any time during the measurement period
G9995,"Patients who use palliative care services any time during the measurement periodTerminated December 31, 2023."
G9996,Documentation stating the patient has received or is currently receiving palliative or hospice care
G9997,Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter
G9998,"Documentation of medical reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., last colonoscopy incomplete, last colonoscopy had inadequate prep, piecemeal removal of adenomas, or sessile serrated polyps >= 20 mm in size, last colonoscopy found greater than 10 adenomas, lower gastrointestinal bleeding, or patient at high risk for colon cancer due to underlying medical history ([i.e. crohn's disease, ulcerative colitis, personal or family history of colon cancer, hereditary colorectal cancer syndromes])"
G9999,"Documentation of system reason(s) for an interval of less than 3 years since the last colonoscopy (e.g., unable to locate previous colonoscopy report, patient cannot provide precise date or details from previous colonoscopy, previous colonoscopy report was incomplete)"
H0001,Alcohol and/or drug assessment
H0002,Behavioral health screening to determine eligibility for admission to treatment program
H0003,Alcohol and/or drug screening; laboratory analysis of specimens for presence of alcohol and/or drugs
H0004,"Behavioral health counseling and therapy, per 15 minutes"
H0005,Alcohol and/or drug services; group counseling by a clinician
H0006,Alcohol and/or drug services; case management
H0007,Alcohol and/or drug services; crisis intervention (outpatient)
H0008,Alcohol and/or drug services; sub-acute detoxification (hospital inpatient)
H0009,Alcohol and/or drug services; acute detoxification (hospital inpatient)
H0010,Alcohol and/or drug services; sub-acute detoxification (residential addiction program inpatient)
H0011,Alcohol and/or drug services; acute detoxification (residential addiction program inpatient)
H0012,Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient)
H0013,Alcohol and/or drug services; acute detoxification (residential addiction program outpatient)
H0014,Alcohol and/or drug services; ambulatory detoxification
H0015,"Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education"
H0016,Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting)
H0017,"Behavioral health; residential (hospital residential treatment program), without room and board, per diem"
H0018,"Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem"
H0019,"Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem"
H0020,Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program)
H0021,Alcohol and/or drug training service (for staff and personnel not employed by providers)
H0022,Alcohol and/or drug intervention service (planned facilitation)
H0023,Behavioral health outreach service (planned approach to reach a targeted population)
H0024,Behavioral health prevention information dissemination service (one-way direct or non-direct contact with service audiences to affect knowledge and attitude)
H0025,"Behavioral health prevention education service (delivery of services with target population to affect knowledge, attitude and/or behavior)"
H0026,"Alcohol and/or drug prevention process service, community-based (delivery of services to develop skills of impactors)"
H0027,Alcohol and/or drug prevention environmental service (broad range of external activities geared toward modifying systems in order to mainstream prevention through policy and law)
H0028,"Alcohol and/or drug prevention problem identification and referral service (e.g., student assistance and employee assistance programs), does not include assessment"
H0029,"Alcohol and/or drug prevention alternatives service (services for populations that exclude alcohol and other drug use e.g., alcohol free social events)"
H0030,Behavioral health hotline service
H0031,"Mental health assessment, by non-physician"
H0032,Mental health service plan development by non-physician
H0033,"Oral medication administration, direct observation"
H0034,"Medication training and support, per 15 minutes"
H0035,"Mental health partial hospitalization, treatment, less than 24 hours"
H0036,"Community psychiatric supportive treatment, face-to-face, per 15 minutes"
H0037,"Community psychiatric supportive treatment program, per diem"
H0038,"Self-help/peer services, per 15 minutes"
H0039,"Assertive community treatment, face-to-face, per 15 minutes"
H0040,"Assertive community treatment program, per diem"
H0041,"Foster care, child, non-therapeutic, per diem"
H0042,"Foster care, child, non-therapeutic, per month"
H0043,"Supported housing, per diem"
H0044,"Supported housing, per month"
H0045,"Respite care services, not in the home, per diem"
H0046,"Mental health services, not otherwise specified"
H0047,"Alcohol and/or other drug abuse services, not otherwise specified"
H0048,"Alcohol and/or other drug testing: collection and handling only, specimens other than blood"
H0049,Alcohol and/or drug screening
H0050,"Alcohol and/or drug services, brief intervention, per 15 minutes"
H0051,Traditional healing service
H0052,Missing and murdered indigenous persons (mmip) mental health and clinical care
H0053,Historical trauma (ht) mental health and clinical care for indigenous persons
H1000,"Prenatal care, at-risk assessment"
H1001,"Prenatal care, at-risk enhanced service; antepartum management"
H1002,"Prenatal care, at risk enhanced service; care coordination"
H1003,"Prenatal care, at-risk enhanced service; education"
H1004,"Prenatal care, at-risk enhanced service; follow-up home visit"
H1005,"Prenatal care, at-risk enhanced service package (includes h1001-h1004)"
H1010,"Non-medical family planning education, per session"
H1011,Family assessment by licensed behavioral health professional for state defined purposes
H2000,Comprehensive multidisciplinary evaluation
H2001,"Rehabilitation program, per 1/2 day"
H2010,"Comprehensive medication services, per 15 minutes"
H2011,"Crisis intervention service, per 15 minutes"
H2012,"Behavioral health day treatment, per hour"
H2013,"Psychiatric health facility service, per diem"
H2014,"Skills training and development, per 15 minutes"
H2015,"Comprehensive community support services, per 15 minutes"
H2016,"Comprehensive community support services, per diem"
H2017,"Psychosocial rehabilitation services, per 15 minutes"
H2018,"Psychosocial rehabilitation services, per diem"
H2019,"Therapeutic behavioral services, per 15 minutes"
H2020,"Therapeutic behavioral services, per diem"
H2021,"Community-based wrap-around services, per 15 minutes"
H2022,"Community-based wrap-around services, per diem"
H2023,"Supported employment, per 15 minutes"
H2024,"Supported employment, per diem"
H2025,"Ongoing support to maintain employment, per 15 minutes"
H2026,"Ongoing support to maintain employment, per diem"
H2027,"Psychoeducational service, per 15 minutes"
H2028,"Sexual offender treatment service, per 15 minutes"
H2029,"Sexual offender treatment service, per diem"
H2030,"Mental health clubhouse services, per 15 minutes"
H2031,"Mental health clubhouse services, per diem"
H2032,"Activity therapy, per 15 minutes"
H2033,"Multisystemic therapy for juveniles, per 15 minutes"
H2034,"Alcohol and/or drug abuse halfway house services, per diem"
H2035,"Alcohol and/or other drug treatment program, per hour"
H2036,"Alcohol and/or other drug treatment program, per diem"
H2037,"Developmental delay prevention activities, dependent child of client, per 15 minutes"
H2038,"Skills training and development, per diem"
H2040,"Coordinated specialty care, team-based, for first episode psychosis, per month"
H2041,"Coordinated specialty care, team-based, for first episode psychosis, per encounter"
J0120,"Injection, tetracycline, up to 250 mg"
J0121,"Injection, omadacycline, 1 mg"
J0122,"Injection, eravacycline, 1 mg"
J0129,"Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)"
J0130,"Injection abciximab, 10 mg"
J0131,"Injection, acetaminophen, not otherwise specified,10 mg"
J0132,"Injection, acetylcysteine, 100 mg"
J0133,"Injection, acyclovir, 5 mg"
J0134,"Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg"
J0135,"Injection, adalimumab, 20 mgTerminated December 31, 2024."
J0136,"Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg"
J0137,"Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg"
J0138,"Injection, acetaminophen 10 mg and ibuprofen 3 mg"
J0139,"Injection, adalimumab, 1 mg"
J0150,"Injection, adenosine for therapeutic use,  6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)Terminated December 31, 2014."
J0151,"Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)Terminated December 31, 2014."
J0153,"Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)"
J0163,"Injection, epinephrine in sodium chloride (endo), 0.1 mg"
J0164,"Injection, epinephrine in sodium chloride (baxter), 0.1 mg"
J0165,"Injection, epinephrine, not otherwise specified, 0.1 mg"
J0166,"Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mg"
J0167,"Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg"
J0168,"Injection, epinephrine (international medication systems), not therapeutically equivalent to j0165, 0.1 mg"
J0169,"Injection, epinephrine (adrenalin), not therapeutically equivalent to j0165, 0.1 mg"
J0171,"Injection, adrenalin, epinephrine, 0.1 mgTerminated June 30, 2025."
J0172,"Injection, aducanumab-avwa, 2 mg"
J0173,"Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mgTerminated June 30, 2025."
J0174,"Injection, lecanemab-irmb, 1 mg"
J0175,"Injection, donanemab-azbt, 2 mg"
J0177,"Injection, aflibercept hd, 1 mg"
J0178,"Injection, aflibercept, 1 mg"
J0179,"Injection, brolucizumab-dbll, 1 mg"
J0180,"Injection, agalsidase beta, 1 mg"
J0184,"Injection, amisulpride, 1 mg"
J0185,"Injection, aprepitant, 1 mg"
J0190,"Injection, biperiden lactate, per 5 mg"
J0200,"Injection, alatrofloxacin mesylate, 100 mg"
J0202,"Injection, alemtuzumab, 1 mg"
J0205,"Injection, alglucerase, per 10 units"
J0206,"Injection, allopurinol sodium, 1 mg"
J0207,"Injection, amifostine, 500 mg"
J0208,"Injection, sodium thiosulfate (pedmark), 100 mg"
J0209,"Injection, sodium thiosulfate (hope), 100 mg"
J0210,"Injection, methyldopate hcl, up to 250 mg"
J0211,"Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)"
J0215,"Injection, alefacept, 0.5 mg"
J0216,"Injection, alfentanil hydrochloride, 500 micrograms"
J0217,"Injection, velmanase alfa-tycv, 1 mg"
J0218,"Injection, olipudase alfa-rpcp, 1 mg"
J0219,"Injection, avalglucosidase alfa-ngpt, 4 mg"
J0220,"Injection, alglucosidase alfa, 10 mg, not otherwise specified"
J0221,"Injection, alglucosidase alfa, (lumizyme), 10 mg"
J0222,"Injection, patisiran, 0.1 mg"
J0223,"Injection, givosiran, 0.5 mg"
J0224,"Injection, lumasiran, 0.5 mg"
J0225,"Injection, vutrisiran, 1 mg"
J0248,"Injection, remdesivir, 1 mg"
J0256,"Injection, alpha 1 proteinase inhibitor (human), not otherwise specified, 10 mg"
J0257,"Injection, alpha 1 proteinase inhibitor (human), (glassia), 10 mg"
J0270,"Injection, alprostadil, 1.25 mcg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)"
J0275,"Alprostadil urethral suppository (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)"
J0278,"Injection, amikacin sulfate, 100 mg"
J0280,"Injection, aminophyllin, up to 250 mg"
J0281,"Injection, aminocaproic acid, 1 gram"
J0282,"Injection, amiodarone hydrochloride, 30 mg"
J0283,"Injection, amiodarone hydrochloride (nexterone), 30 mg"
J0285,"Injection, amphotericin b, 50 mg"
J0287,"Injection, amphotericin b lipid complex, 10 mg"
J0288,"Injection, amphotericin b cholesteryl sulfate complex, 10 mg"
J0289,"Injection, amphotericin b liposome, 10 mg"
J0290,"Injection, ampicillin sodium, 500 mg"
J0291,"Injection, plazomicin, 5 mg"
J0295,"Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm"
J0300,"Injection, amobarbital, up to 125 mg"
J0330,"Injection, succinylcholine chloride, up to 20 mg"
J0348,"Injection, anidulafungin, 1 mg"
J0349,"Injection, rezafungin, 1 mg"
J0350,"Injection, anistreplase, per 30 units"
J0360,"Injection, hydralazine hcl, up to 20 mg"
J0364,"Injection, apomorphine hydrochloride, 1 mg"
J0365,"Injection, aprotonin, 10,000 kiu"
J0380,"Injection, metaraminol bitartrate, per 10 mg"
J0390,"Injection, chloroquine hydrochloride, up to 250 mg"
J0391,"Injection, artesunate, 1 mg"
J0395,"Injection, arbutamine hcl, 1 mg"
J0400,"Injection, aripiprazole, intramuscular, 0.25 mg"
J0401,"Injection, aripiprazole (abilify maintena), 1 mg"
J0402,"Injection, aripiprazole (abilify asimtufii), 1 mg"
J0456,"Injection, azithromycin, 500 mg"
J0457,"Injection, aztreonam, 100 mg"
J0458,"Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)"
J0461,"Injection, atropine sulfate, 0.01 mg"
J0462,"Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg"
J0470,"Injection, dimercaprol, per 100 mg"
J0475,"Injection, baclofen, 10 mg"
J0476,"Injection, baclofen, 50 mcg for intrathecal trial"
J0480,"Injection, basiliximab, 20 mg"
J0485,"Injection, belatacept, 1 mg"
J0490,"Injection, belimumab, 10 mg"
J0491,"Injection, anifrolumab-fnia, 1 mg"
J0500,"Injection, dicyclomine hcl, up to 20 mg"
J0515,"Injection, benztropine mesylate, per 1 mg"
J0517,"Injection, benralizumab, 1 mg"
J0520,"Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg"
J0525,"Injection, cefotetan disodium, 10 mg"
J0558,"Injection, penicillin g benzathine and penicillin g procaine, 100,000 units"
J0561,"Injection, penicillin g benzathine, 100,000 units"
J0565,"Injection, bezlotoxumab, 10 mg"
J0567,"Injection, cerliponase alfa, 1 mg"
J0570,"Buprenorphine implant, 74.2 mg"
J0571,"Buprenorphine, oral, 1 mg"
J0572,"Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine"
J0573,"Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine"
J0574,"Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine"
J0575,"Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine"
J0576,"Injection, buprenorphine extended-release (brixadi), 1 mgTerminated March 31, 2024."
J0577,"Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy"
J0578,"Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy"
J0582,"Injection, bivalirudin (endo), not therapeutically equivalent to j0583, 1 mg"
J0583,"Injection, bivalirudin, 1 mg"
J0584,"Injection, burosumab-twza 1 mg"
J0585,"Injection, onabotulinumtoxina, 1 unit"
J0586,"Injection, abobotulinumtoxina, 5 units"
J0587,"Injection, rimabotulinumtoxinb, 100 units"
J0588,"Injection, incobotulinumtoxin a, 1 unit"
J0589,"Injection, daxibotulinumtoxina-lanm, 1 unit"
J0591,"Injection, deoxycholic acid, 1 mg"
J0592,"Injection, buprenorphine hydrochloride, 0.1 mg"
J0593,"Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)"
J0594,"injection, busulfan, 1 mg"
J0595,"Injection, butorphanol tartrate, 1 mg"
J0596,"Injection, c1 esterase inhibitor (recombinant), ruconest, 10 units"
J0597,"Injection, c-1 esterase inhibitor (human), berinert, 10 units"
J0598,"Injection, c-1 esterase inhibitor (human), cinryze, 10 units"
J0599,"Injection, c-1 esterase inhibitor (human), (haegarda), 10 units"
J0600,"Injection, edetate calcium disodium, up to 1000 mg"
J0601,"Sevelamer carbonate (renvela or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)"
J0602,"Sevelamer carbonate (renvela or therapeutically equivalent), oral, powder, 20 mg (for esrd on dialysis)"
J0603,"Sevelamer hydrochloride (renagel or therapeutically equivalent), oral, 20 mg (for esrd on dialysis)"
J0604,"Cinacalcet, oral, 1 mg, (for esrd on dialysis)"
J0605,"Sucroferric oxyhydroxide, oral, 5 mg (for esrd on dialysis)"
J0606,"Injection, etelcalcetide, 0.1 mg"
J0607,"Lanthanum carbonate, oral, 5 mg (for esrd on dialysis)"
J0608,"Lanthanum carbonate, oral, powder, 5 mg, not therapeutically equivalent to j0607 (for esrd on dialysis)"
J0609,"Ferric citrate, oral, 3 mg ferric iron, (for esrd on dialysis)"
J0610,"Injection, calcium gluconate (fresenius kabi), per 10 mlTerminated March 31, 2023."
J0611,"Injection, calcium gluconate (wg critical care), per 10 mlTerminated March 31, 2023."
J0612,"Injection, calcium gluconate, not otherwise specified, 10 mg"
J0613,"Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg"
J0614,"Injection, treosulfan, 50 mg"
J0615,"Calcium acetate, oral, 23 mg (for esrd on dialysis)"
J0616,"Injection, metoprolol tartrate, 1 mg"
J0618,"Injection, calcium chloride, 2 mg"
J0620,"Injection, calcium glycerophosphate and calcium lactate, per 10 ml"
J0630,"Injection, calcitonin salmon, up to 400 units"
J0636,"Injection, calcitriol, 0.1 mcg"
J0637,"Injection, caspofungin acetate, 5 mg"
J0638,"Injection, canakinumab, 1 mg"
J0640,"Injection, leucovorin calcium, per 50 mg"
J0641,"Injection, levoleucovorin, not otherwise specified, 0.5 mg"
J0642,"Injection, levoleucovorin (khapzory), 0.5 mg"
J0650,"Injection, levothyroxine sodium, not otherwise specified, 10 mcg"
J0651,"Injection, levothyroxine sodium (fresenius kabi), not therapeutically equivalent to j0650, 10 mcg"
J0652,"Injection, levothyroxine sodium (hikma), not therapeutically equivalent to j0650, 10 mcg"
J0665,"Injection, bupivicaine, not otherwise specified, 0.5 mg"
J0666,"Injection, bupivacaine liposome, 1 mg"
J0668,"Instillation, bupivacaine and meloxicam, 1 mg/0.03 mg"
J0670,"Injection, mepivacaine hydrochloride, per 10 ml"
J0675,"Injection, carboprost tromethamine, 0.1 mg"
J0681,"Injection, ceftobiprole medocaril sodium, 3 mg"
J0687,"Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg"
J0688,"Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg"
J0689,"Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg"
J0690,"Injection, cefazolin sodium, 500 mg"
J0691,"Injection, lefamulin, 1 mg"
J0692,"Injection, cefepime hydrochloride, 500 mg"
J0693,"Injection, cefiderocol, 5 mgTerminated September 30, 2021."
J0694,"Injection, cefoxitin sodium, 1 gm"
J0695,"Injection, ceftolozane 50 mg and tazobactam 25 mg"
J0696,"Injection, ceftriaxone sodium, per 250 mg"
J0697,"Injection, sterile cefuroxime sodium, per 750 mg"
J0698,"Injection, cefotaxime sodium, per gm"
J0699,"Injection, cefiderocol, 10 mg"
J0701,"Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg"
J0702,"Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg"
J0703,"Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg"
J0706,"Injection, caffeine citrate, 5 mg"
J0710,"Injection, cephapirin sodium, up to 1 gm"
J0712,"Injection, ceftaroline fosamil, 10 mg"
J0713,"Injection, ceftazidime, per 500 mg"
J0714,"Injection, ceftazidime and avibactam, 0.5 g/0.125 g"
J0715,"Injection, ceftizoxime sodium, per 500 mg"
J0716,"Injection, centruroides immune f(ab)2, up to 120 milligrams"
J0717,"Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)"
J0720,"Injection, chloramphenicol sodium succinate, up to 1 gm"
J0725,"Injection, chorionic gonadotropin, per 1,000 usp units"
J0735,"Injection, clonidine hydrochloride, 1 mg"
J0736,"Injection, clindamycin phosphate, 300 mg"
J0737,"Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg"
J0738,"Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)"
J0739,"Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)"
J0740,"Injection, cidofovir, 375 mg"
J0741,"Injection, cabotegravir and rilpivirine, 2mg/3mg"
J0742,"Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg"
J0743,"Injection, cilastatin sodium; imipenem, per 250 mg"
J0744,"Injection, ciprofloxacin for intravenous infusion, 200 mg"
J0745,"Injection, codeine phosphate, per 30 mg"
J0750,"Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)"
J0751,"Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)"
J0752,"Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)"
J0759,"Injection, clevidipine butyrate, 1 mg"
J0760,"Injection, colchicine, per 1 mgTerminated December 31, 2016."
J0770,"Injection, colistimethate sodium, up to 150 mg"
J0775,"Injection, collagenase, clostridium histolyticum, 0.01 mg"
J0780,"Injection, prochlorperazine, up to 10 mg"
J0791,"Injection, crizanlizumab-tmca, 5 mg"
J0795,"Injection, corticorelin ovine triflutate, 1 microgram"
J0799,"Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified"
J0800,"Injection, corticotropin, up to 40 unitsTerminated September 30, 2023."
J0801,"Injection, corticotropin (acthar gel), up to 40 units"
J0802,"Injection, corticotropin (ani), up to 40 units"
J0833,"Injection, cosyntropin, not otherwise specified, 0.25 mgTerminated December 31, 2018."
J0834,"Injection, cosyntropin, 0.25 mg"
J0840,"Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram"
J0841,"Injection, crotalidae immune f(ab')2 (equine), 120 mg"
J0850,"Injection, cytomegalovirus immune globulin intravenous (human), per vial"
J0870,"Injection, imetelstat, 1 mg"
J0872,"Injection, daptomycin (xellia), unrefrigerated, not therapeutically equivalent to j0878 or j0873, 1 mg"
J0873,"Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg"
J0874,"Injection, daptomycin (baxter), not therapeutically equivalent to j0878, 1 mg"
J0875,"Injection, dalbavancin, 5 mg"
J0877,"Injection, daptomycin (hospira), not therapeutically equivalent to j0878, 1 mg"
J0878,"Injection, daptomycin, 1 mg"
J0879,"Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)"
J0881,"Injection, darbepoetin alfa, 1 microgram (non-esrd use)"
J0882,"Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis)"
J0883,"Injection, argatroban, 1 mg (for non-esrd use)"
J0884,"Injection, argatroban, 1 mg (for esrd on dialysis)"
J0885,"Injection, epoetin alfa, (for non-esrd use), 1000 units"
J0886,"Injection, epoetin alfa, 1000 units (for esrd on dialysis)Terminated December 31, 2015."
J0887,"Injection, epoetin beta, 1 microgram, (for esrd on dialysis)"
J0888,"Injection, epoetin beta, 1 microgram, (for non esrd use)"
J0889,"Daprodustat, oral, 1 mg, (for esrd on dialysis)"
J0890,"Injection, peginesatide, 0.1 mg (for esrd on dialysis)"
J0891,"Injection, argatroban (accord), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)"
J0892,"Injection, argatroban (accord), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)"
J0893,"Injection, decitabine (sun pharma), not therapeutically equivalent to j0894, 1 mg"
J0894,"Injection, decitabine, 1 mg"
J0895,"Injection, deferoxamine mesylate, 500 mg"
J0896,"Injection, luspatercept-aamt, 0.25 mg"
J0897,"Injection, denosumab, 1 mg"
J0898,"Injection, argatroban (auromedics), not therapeutically equivalent to j0883, 1 mg (for non-esrd use)"
J0899,"Injection, argatroban (auromedics), not therapeutically equivalent to j0884, 1 mg (for esrd on dialysis)"
J0900,"Injection, testosterone enanthate and estradiol valerate, up to 1 ccTerminated December 31, 2014."
J0901,"Vadadustat, oral, 1 mg (for esrd on dialysis)"
J0911,"Instillation, taurolidine 1.35 mg and heparin sodium 100 units (central venous catheter lock for adult patients receiving chronic hemodialysis)"
J0945,"Injection, brompheniramine maleate, per 10 mg"
J1000,"Injection, depo-estradiol cypionate, up to 5 mg"
J1010,"Injection, methylprednisolone acetate, 1 mg"
J1020,"Injection, methylprednisolone acetate, 20 mgTerminated March 31, 2024."
J1030,"Injection, methylprednisolone acetate, 40 mgTerminated March 31, 2024."
J1040,"Injection, methylprednisolone acetate, 80 mgTerminated March 31, 2024."
J1050,"Injection, medroxyprogesterone acetate, 1 mg"
J1060,"Injection, testosterone cypionate and estradiol cypionate, up to 1 mlTerminated December 31, 2014."
J1070,"Injection, testosterone cypionate, up to 100 mgTerminated December 31, 2014."
J1071,"Injection, testosterone cypionate, 1 mg"
J1072,"Injection, testosterone cypionate (azmiro), 1 mg"
J1080,"Injection, testosterone cypionate, 1 cc, 200 mgTerminated December 31, 2014."
J1094,"Injection, dexamethasone acetate, 1 mgTerminated March 31, 2025."
J1095,"Injection, dexamethasone 9 percent, intraocular, 1 microgram"
J1096,"Dexamethasone, lacrimal ophthalmic insert, 0.1 mg"
J1097,"Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml"
J1100,"Injection, dexamethasone sodium phosphate, 1 mg"
J1105,"Dexmedetomidine, oral, 1 mcg"
J1110,"Injection, dihydroergotamine mesylate, per 1 mg"
J1120,"Injection, acetazolamide sodium, up to 500 mg"
J1130,"Injection, diclofenac sodium, 0.5 mg"
J1160,"Injection, digoxin, up to 0.5 mg"
J1162,"Injection, digoxin immune fab (ovine), per vial"
J1163,"Injection, diltiazem hydrochloride, 0.5 mg"
J1165,"Injection, phenytoin sodium, per 50 mg"
J1170,"Injection, hydromorphone, up to 4 mgTerminated September 30, 2024."
J1171,"Injection, hydromorphone, 0.1 mg"
J1180,"Injection, dyphylline, up to 500 mg"
J1190,"Injection, dexrazoxane hydrochloride, per 250 mg"
J1200,"Injection, diphenhydramine hcl, up to 50 mg"
J1201,"Injection, cetirizine hydrochloride, 0.5 mg"
J1202,"Miglustat, oral, 65 mg"
J1203,"Injection, cipaglucosidase alfa-atga, 5 mg"
J1205,"Injection, chlorothiazide sodium, per 500 mg"
J1212,"Injection, dmso, dimethyl sulfoxide, 50%, 50 ml"
J1230,"Injection, methadone hcl, up to 10 mg"
J1240,"Injection, dimenhydrinate, up to 50 mg"
J1245,"Injection, dipyridamole, per 10 mg"
J1250,"Injection, dobutamine hydrochloride, per 250 mg"
J1260,"Injection, dolasetron mesylate, 10 mg"
J1265,"Injection, dopamine hcl, 40 mg"
J1267,"Injection, doripenem, 10 mg"
J1270,"Injection, doxercalciferol, 1 mcg"
J1271,"Injection, doxycycline hyclate, 1 mg"
J1290,"Injection, ecallantide, 1 mg"
J1299,"Injection, eculizumab, 2 mg"
J1300,"Injection, eculizumab, 10 mgTerminated March 31, 2025."
J1301,"Injection, edaravone, 1 mg"
J1302,"Injection, sutimlimab-jome, 10 mg"
J1303,"Injection, ravulizumab-cwvz, 10 mg"
J1304,"Injection, tofersen, 1 mg"
J1305,"Injection, evinacumab-dgnb, 5mg"
J1306,"Injection, inclisiran, 1 mg"
J1307,"Injection, crovalimab-akkz, 10 mg"
J1308,"Injection, famotidine, 0.25 mg"
J1320,"Injection, amitriptyline hcl, up to 20 mg"
J1322,"Injection, elosulfase alfa, 1 mg"
J1323,"Injection, elranatamab-bcmm, 1 mg"
J1324,"Injection, enfuvirtide, 1 mg"
J1325,"Injection, epoprostenol, 0.5 mg"
J1326,"Injection, zolbetuximab-clzb, 2 mg"
J1327,"Injection, eptifibatide, 5 mg"
J1330,"Injection, ergonovine maleate, up to 0.2 mg"
J1335,"Injection, ertapenem sodium, 500 mg"
J1364,"Injection, erythromycin lactobionate, per 500 mg"
J1370,"Injection, esomeprazole sodium, 1 mg"
J1380,"Injection, estradiol valerate, up to 10 mg"
J1410,"Injection, estrogen conjugated, per 25 mg"
J1411,"Injection, etranacogene dezaparvovec-drlb, per therapeutic dose"
J1412,"Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes"
J1413,"Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose"
J1414,"Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose"
J1426,"Injection, casimersen, 10 mg"
J1427,"Injection, viltolarsen, 10 mg"
J1428,"Injection, eteplirsen, 10 mg"
J1429,"Injection, golodirsen, 10 mg"
J1430,"Injection, ethanolamine oleate, 100 mg"
J1434,"Injection, fosaprepitant (focinvez), 1 mg"
J1435,"Injection, estrone, per 1 mg"
J1436,"Injection, etidronate disodium, per 300 mg"
J1437,"Injection, ferric derisomaltose, 10 mg"
J1438,"Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)"
J1439,"Injection, ferric carboxymaltose, 1 mg"
J1440,"Fecal microbiota, live - jslm, 1 ml"
J1442,"Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram"
J1443,"Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron"
J1444,"Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron"
J1445,"Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of iron"
J1446,"Injection, tbo-filgrastim, 5 microgramsTerminated December 31, 2015."
J1447,"Injection, tbo-filgrastim, 1 microgram"
J1448,"Injection, trilaciclib, 1mg"
J1449,"Injection, eflapegrastim-xnst, 0.1 mg"
J1450,"Injection fluconazole, 200 mg"
J1451,"Injection, fomepizole, 15 mg"
J1452,"Injection, fomivirsen sodium, intraocular, 1.65 mg"
J1453,"Injection, fosaprepitant, 1 mg"
J1454,"Injection, fosnetupitant 235 mg and palonosetron 0.25 mg"
J1455,"Injection, foscarnet sodium, per 1000 mg"
J1456,"Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg"
J1457,"Injection, gallium nitrate, 1 mg"
J1458,"Injection, galsulfase, 1 mg"
J1459,"Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg"
J1460,"Injection, gamma globulin, intramuscular, 1 cc"
J1551,"Injection, immune globulin (cutaquig), 100 mg"
J1552,"Injection, immune globulin (alyglo), 500 mg"
J1554,"Injection, immune globulin (asceniv), 500 mg"
J1555,"Injection, immune globulin (cuvitru), 100 mg"
J1556,"Injection, immune globulin (bivigam), 500 mg"
J1557,"Injection, immune globulin, (gammaplex), intravenous, non-lyophilized (e.g., liquid), 500 mg"
J1558,"Injection, immune globulin (xembify), 100 mg"
J1559,"Injection, immune globulin (hizentra), 100 mg"
J1560,"Injection, gamma globulin, intramuscular, over 10 cc"
J1561,"Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg"
J1562,"Injection, immune globulin (vivaglobin), 100 mg"
J1566,"Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg"
J1568,"Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg"
J1569,"Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg"
J1570,"Injection, ganciclovir sodium, 500 mg"
J1571,"Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml"
J1572,"Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg"
J1573,"Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml"
J1574,"Injection, ganciclovir sodium (exela), not therapeutically equivalent to j1570, 500 mg"
J1575,"Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin"
J1576,"Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg"
J1580,"Injection, garamycin, gentamicin, up to 80 mg"
J1590,"Injection, gatifloxacin, 10 mgTerminated December 31, 2016."
J1595,"Injection, glatiramer acetate, 20 mg"
J1596,"Injection, glycopyrrolate, 0.1 mg"
J1597,"Injection, glycopyrrolate (glyrx-pf), 0.1 mg"
J1598,"Injection, glycopyrrolate (fresenius kabi), not therapeutically equivalent to j1596, 0.1 mg"
J1599,"Injection, immune globulin, intravenous, non-lyophilized (e.g., liquid), not otherwise specified, 500 mg"
J1600,"Injection, gold sodium thiomalate, up to 50 mg"
J1602,"Injection, golimumab, 1 mg, for intravenous use"
J1610,"Injection, glucagon hydrochloride, per 1 mg"
J1611,"Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg"
J1612,"Injection, glucagon (gvoke), 0.01 mg"
J1620,"Injection, gonadorelin hydrochloride, per 100 mcg"
J1626,"Injection, granisetron hydrochloride, 100 mcg"
J1627,"Injection, granisetron, extended-release, 0.1 mg"
J1628,"Injection, guselkumab, 1 mg"
J1630,"Injection, haloperidol, up to 5 mg"
J1631,"Injection, haloperidol decanoate, per 50 mg"
J1632,"Injection, brexanolone, 1 mg"
J1640,"Injection, hemin, 1 mg"
J1642,"Injection, heparin sodium, (heparin lock flush), per 10 units"
J1643,"Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units"
J1644,"Injection, heparin sodium, per 1000 units"
J1645,"Injection, dalteparin sodium, per 2500 iu"
J1650,"Injection, enoxaparin sodium, 10 mg"
J1652,"Injection, fondaparinux sodium, 0.5 mg"
J1655,"Injection, tinzaparin sodium, 1000 iu"
J1670,"Injection, tetanus immune globulin, human, up to 250 units"
J1675,"Injection, histrelin acetate, 10 micrograms"
J1700,"Injection, hydrocortisone acetate, up to 25 mg"
J1710,"Injection, hydrocortisone sodium phosphate, up to 50 mg"
J1720,"Injection, hydrocortisone sodium succinate, up to 100 mg"
J1725,"Injection, hydroxyprogesterone caproate, 1 mgTerminated December 31, 2017."
J1726,"Injection, hydroxyprogesterone caproate, (makena), 10 mg"
J1729,"Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg"
J1730,"Injection, diazoxide, up to 300 mg"
J1738,"Injection, meloxicam, 1 mg"
J1740,"Injection, ibandronate sodium, 1 mg"
J1741,"Injection, ibuprofen, 100 mg"
J1742,"Injection, ibutilide fumarate, 1 mg"
J1743,"Injection, idursulfase, 1 mg"
J1744,"Injection, icatibant, 1 mg"
J1745,"Injection, infliximab, excludes biosimilar, 10 mg"
J1746,"Injection, ibalizumab-uiyk, 10 mg"
J1747,"Injection, spesolimab-sbzo, 1 mg"
J1748,"Injection, infliximab-dyyb (zymfentra), 10 mg"
J1749,"Injection, iloprost, 0.1 mcg"
J1750,"Injection, iron dextran, 50 mg"
J1756,"Injection, iron sucrose, 1 mg"
J1786,"Injection, imiglucerase, 10 units"
J1790,"Injection, droperidol, up to 5 mg"
J1800,"Injection, propranolol hcl, up to 1 mg"
J1805,"Injection, esmolol hydrochloride, 10 mg"
J1806,"Injection, esmolol hydrochloride (wg critical care), not therapeutically equivalent to j1805, 10 mg"
J1807,"Injection, ethacrynate sodium, 1 mg"
J1808,"Injection, folic acid, 0.1 mg"
J1809,"Injection, fosdenopterin, 0.1 mg"
J1810,"Injection, droperidol and fentanyl citrate, up to 2 ml ampuleTerminated March 31, 2025."
J1811,"Insulin (fiasp) for administration through dme (i.e., insulin pump) per 50 units"
J1812,"Insulin (fiasp), per 5 units"
J1813,"Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units"
J1814,"Insulin (lyumjev), per 5 units"
J1815,"Injection, insulin, per 5 units"
J1817,"Insulin for administration through dme (i.e., insulin pump) per 50 units"
J1823,"Injection, inebilizumab-cdon, 1 mg"
J1826,"Injection, interferon beta-1a, 30 mcg"
J1830,"Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)"
J1833,"Injection, isavuconazonium, 1 mg"
J1834,"Injection, isoniazid, 1 mg"
J1835,"Injection, itraconazole, 50 mg"
J1836,"Injection, metronidazole, 10 mg"
J1840,"Injection, kanamycin sulfate, up to 500 mgTerminated March 31, 2024."
J1850,"Injection, kanamycin sulfate, up to 75 mgTerminated March 31, 2024."
J1885,"Injection, ketorolac tromethamine, per 15 mg"
J1890,"Injection, cephalothin sodium, up to 1 gramTerminated March 31, 2025."
J1920,"Injection, labetalol hydrochloride, 5 mg"
J1921,"Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg"
J1930,"Injection, lanreotide, 1 mg"
J1931,"Injection, laronidase, 0.1 mg"
J1932,"Injection, lanreotide, (cipla), 1 mg"
J1938,"Injection, furosemide, 1 mg"
J1939,"Injection, bumetanide, 0.5 mg"
J1940,"Injection, furosemide, up to 20 mgTerminated March 31, 2025."
J1941,"Injection, furosemide (furoscix), 20 mg"
J1942,"Injection, aripiprazole lauroxil, 1 mgTerminated September 30, 2019."
J1943,"Injection, aripiprazole lauroxil, (aristada initio), 1 mg"
J1944,"Injection, aripiprazole lauroxil, (aristada), 1 mg"
J1945,"Injection, lepirudin, 50 mg"
J1950,"Injection, leuprolide acetate (for depot suspension), per 3.75 mg"
J1951,"Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg"
J1952,"Leuprolide injectable, camcevi, 1 mg"
J1953,"Injection, levetiracetam, 10 mg"
J1954,"Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg"
J1955,"Injection, levocarnitine, per 1 gm"
J1956,"Injection, levofloxacin, 250 mg"
J1960,"Injection, levorphanol tartrate, up to 2 mg"
J1961,"Injection, lenacapavir (only for use as hiv treatment), 1 mg"
J1980,"Injection, hyoscyamine sulfate, up to 0.25 mg"
J1990,"Injection, chlordiazepoxide hcl, up to 100 mg"
J2001,"Injection, lidocaine hcl for intravenous infusion, 10 mgTerminated September 30, 2024."
J2002,"Injection, lidocaine hcl in 5% dextrose, 1 mg"
J2003,"Injection, lidocaine hydrochloride, 1 mg"
J2004,"Injection, lidocaine hcl with epinephrine, 1 mg"
J2010,"Injection, lincomycin hcl, up to 300 mg"
J2020,"Injection, linezolid, 200 mg"
J2021,"Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg"
J2060,"Injection, lorazepam, 2 mg"
J2062,"Loxapine for inhalation, 1 mg"
J2150,"Injection, mannitol, 25% in 50 mlTerminated September 30, 2025."
J2151,"Injection, mannitol, 250 mg"
J2170,"Injection, mecasermin, 1 mg"
J2175,"Injection, meperidine hydrochloride, per 100 mg"
J2180,"Injection, meperidine and promethazine hcl, up to 50 mg"
J2182,"Injection, mepolizumab, 1 mg"
J2183,"Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg"
J2184,"Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg"
J2185,"Injection, meropenem, 100 mg"
J2186,"Injection, meropenem and vaborbactam, 10mg/10mg (20mg)"
J2210,"Injection, methylergonovine maleate, up to 0.2 mg"
J2212,"Injection, methylnaltrexone, 0.1 mg"
J2246,"Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg"
J2247,"Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg"
J2248,"Injection, micafungin sodium, 1 mg"
J2249,"Injection, remimazolam, 1 mg"
J2250,"Injection, midazolam hydrochloride, per 1 mg"
J2251,"Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg"
J2252,"Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg"
J2253,"Injection, midazolam (seizalam), 1 mg"
J2260,"Injection, milrinone lactate, 5 mg"
J2265,"Injection, minocycline hydrochloride, 1 mg"
J2267,"Injection, mirikizumab-mrkz, 1 mg"
J2270,"Injection, morphine sulfate, up to 10 mg"
J2271,"Injection, morphine sulfate, 100mgTerminated December 31, 2014."
J2272,"Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg"
J2274,"Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg"
J2275,"Injection, morphine sulfate (preservative-free sterile solution), per 10 mgTerminated December 31, 2014."
J2277,"Injection, motixafortide, 0.25 mg"
J2278,"Injection, ziconotide, 1 microgram"
J2280,"Injection, moxifloxacin, 100 mg"
J2281,"Injection, moxifloxacin (fresenius kabi), not therapeutically equivalent to j2280, 100 mg"
J2290,"Injection, nafcillin sodium, 20 mg"
J2291,"Injection, nafcillin sodium (baxter), 20 mg"
J2300,"Injection, nalbuphine hydrochloride, per 10 mg"
J2305,"Injection, nitroglycerin, 5 mg"
J2310,"Injection, naloxone hydrochloride, per 1 mgTerminated June 30, 2025."
J2311,"Injection, naloxone hydrochloride (zimhi), 1 mgTerminated June 30, 2025."
J2312,"Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg"
J2313,"Injection, naloxone hydrochloride (zimhi), 0.01 mg"
J2315,"Injection, naltrexone, depot form, 1 mg"
J2320,"Injection, nandrolone decanoate, up to 50 mg"
J2323,"Injection, natalizumab, 1 mg"
J2325,"Injection, nesiritide, 0.1 mg"
J2326,"Injection, nusinersen, 0.1 mg"
J2327,"Injection, risankizumab-rzaa, intravenous, 1 mg"
J2329,"Injection, ublituximab-xiiy, 1mg"
J2350,"Injection, ocrelizumab, 1 mg"
J2351,"Injection, ocrelizumab, 1 mg and hyaluronidase-ocsq"
J2353,"Injection, octreotide, depot form for intramuscular injection, 1 mg"
J2354,"Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg"
J2355,"Injection, oprelvekin, 5 mg"
J2356,"Injection, tezepelumab-ekko, 1 mg"
J2357,"Injection, omalizumab, 5 mg"
J2358,"Injection, olanzapine, long-acting, 1 mg"
J2359,"Injection, olanzapine, 0.5 mg"
J2360,"Injection, orphenadrine citrate, up to 60 mg"
J2370,"Injection, phenylephrine hcl, up to 1 mlTerminated June 30, 2023."
J2371,"Injection, phenylephrine hydrochloride, 20 micrograms"
J2372,"Injection, phenylephrine hydrochloride (biorphen), 20 micrograms"
J2373,"Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms"
J2400,"Injection, chloroprocaine hydrochloride, per 30 mlTerminated December 31, 2022."
J2401,"Injection, chloroprocaine hydrochloride, per 1 mg"
J2402,"Injection, chloroprocaine hydrochloride (clorotekal), per 1 mg"
J2403,"Chloroprocaine hcl ophthalmic, 3% gel, 1 mg"
J2404,"Injection, nicardipine, 0.1 mg"
J2405,"Injection, ondansetron hydrochloride, per 1 mg"
J2406,"Injection, oritavancin (kimyrsa), 10 mg"
J2407,"Injection, oritavancin (orbactiv), 10 mg"
J2410,"Injection, oxymorphone hcl, up to 1 mg"
J2425,"Injection, palifermin, 50 micrograms"
J2426,"Injection, paliperidone palmitate extended release (invega sustenna), 1 mg"
J2427,"Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg"
J2428,"Injection, paliperidone palmitate extended release (erzofri), 1 mg"
J2430,"Injection, pamidronate disodium, per 30 mg"
J2440,"Injection, papaverine hcl, up to 60 mg"
J2460,"Injection, oxytetracycline hcl, up to 50 mg"
J2468,"Injection, palonosetron hydrochloride (posfrea), 25 micrograms"
J2469,"Injection, palonosetron hcl, 25 mcg"
J2470,"Injection, pantoprazole sodium, 40 mg"
J2471,"Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg"
J2472,"Injection, pantoprazole sodium in sodium chloride (baxter), 40 mg"
J2501,"Injection, paricalcitol, 1 mcg"
J2502,"Injection, pasireotide long acting, 1 mg"
J2503,"Injection, pegaptanib sodium, 0.3 mgTerminated September 30, 2025."
J2504,"Injection, pegademase bovine, 25 iu"
J2505,"Injection, pegfilgrastim, 6 mgTerminated December 31, 2021."
J2506,"Injection, pegfilgrastim, excludes biosimilar, 0.5 mg"
J2507,"Injection, pegloticase, 1 mg"
J2508,"Injection, pegunigalsidase alfa-iwxj, 1 mg"
J2510,"Injection, penicillin g procaine, aqueous, up to 600,000 units"
J2513,"Injection, pentastarch, 10% solution, 100 ml"
J2515,"Injection, pentobarbital sodium, per 50 mg"
J2540,"Injection, penicillin g potassium, up to 600,000 units"
J2543,"Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)"
J2545,"Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg"
J2547,"Injection, peramivir, 1 mg"
J2550,"Injection, promethazine hcl, up to 50 mg"
J2560,"Injection, phenobarbital sodium, up to 120 mg"
J2561,"Injection, phenobarbital sodium (sezaby), 1 mg"
J2562,"Injection, plerixafor, 1 mg"
J2590,"Injection, oxytocin, up to 10 units"
J2597,"Injection, desmopressin acetate, per 1 mcg"
J2598,"Injection, vasopressin, 1 unit"
J2599,"Injection, vasopressin (american regent), not therapeutically equivalent to j2598, 1 unit"
J2601,"Injection, vasopressin (baxter), 1 unit"
J2650,"Injection, prednisolone acetate, up to 1 ml"
J2670,"Injection, tolazoline hcl, up to 25 mg"
J2675,"Injection, progesterone, per 50 mg"
J2679,"Injection, fluphenazine hcl, 1.25 mg"
J2680,"Injection, fluphenazine decanoate, up to 25 mg"
J2690,"Injection, procainamide hcl, up to 1 gm"
J2700,"Injection, oxacillin sodium, up to 250 mg"
J2704,"Injection, propofol, 10 mg"
J2710,"Injection, neostigmine methylsulfate, up to 0.5 mg"
J2720,"Injection, protamine sulfate, per 10 mg"
J2724,"Injection, protein c concentrate, intravenous, human, 10 iu"
J2725,"Injection, protirelin, per 250 mcg"
J2730,"Injection, pralidoxime chloride, up to 1 gm"
J2760,"Injection, phentolamine mesylate, up to 5 mg"
J2765,"Injection, metoclopramide hcl, up to 10 mg"
J2770,"Injection, quinupristin/dalfopristin, 500 mg (150/350)"
J2777,"Injection, faricimab-svoa, 0.1 mg"
J2778,"Injection, ranibizumab, 0.1 mg"
J2779,"Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg"
J2780,"Injection, ranitidine hydrochloride, 25 mgTerminated June 30, 2024."
J2781,"Injection, pegcetacoplan, intravitreal, 1 mg"
J2782,"Injection, avacincaptad pegol, 0.1 mg"
J2783,"Injection, rasburicase, 0.5 mg"
J2785,"Injection, regadenoson, 0.1 mg"
J2786,"Injection, reslizumab, 1 mg"
J2787,"Riboflavin 5'-phosphate, ophthalmic solution, up to 3 ml"
J2788,"Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)"
J2790,"Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.)"
J2791,"Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu"
J2792,"Injection, rho d immune globulin, intravenous, human, solvent detergent, 100 iu"
J2793,"Injection, rilonacept, 1 mg"
J2794,"Injection, risperidone (risperdal consta), 0.5 mg"
J2795,"Injection, ropivacaine hydrochloride, 1 mg"
J2796,"Injection, romiplostim, 10 microgramsTerminated December 31, 2024."
J2797,"Injection, rolapitant, 0.5 mg"
J2798,"Injection, risperidone, (perseris), 0.5 mg"
J2799,"Injection, risperidone (uzedy), 1 mg"
J2800,"Injection, methocarbamol, up to 10 ml"
J2801,"Injection, risperidone (rykindo), 0.5 mg"
J2802,"Injection, romiplostim, 1 microgram"
J2804,"Injection, rifampin, 1 mg"
J2805,"Injection, sincalide, 5 micrograms"
J2806,"Injection, sincalide (maia), not therapeutically equivalent to j2805, 5 microgramsTerminated December 31, 2024."
J2810,"Injection, theophylline, per 40 mg"
J2820,"Injection, sargramostim (gm-csf), 50 mcg"
J2840,"Injection, sebelipase alfa, 1 mg"
J2850,"Injection, secretin, synthetic, human, 1 microgram"
J2860,"Injection, siltuximab, 10 mg"
J2865,"Injection, sulfamethoxazole 5 mg and trimethoprim 1 mg"
J2910,"Injection, aurothioglucose, up to 50 mg"
J2916,"Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg"
J2919,"Injection, methylprednisolone sodium succinate, 5 mg"
J2920,"Injection, methylprednisolone sodium succinate, up to 40 mgTerminated March 31, 2024."
J2930,"Injection, methylprednisolone sodium succinate, up to 125 mgTerminated March 31, 2024."
J2940,"Injection, somatrem, 1 mg"
J2941,"Injection, somatropin, 1 mg"
J2950,"Injection, promazine hcl, up to 25 mg"
J2993,"Injection, reteplase, 18.1 mg"
J2995,"Injection, streptokinase, per 250,000 iu"
J2997,"Injection, alteplase recombinant, 1 mg"
J2998,"Injection, plasminogen, human-tvmh, 1 mg"
J3000,"Injection, streptomycin, up to 1 gm"
J3010,"Injection, fentanyl citrate, 0.1 mg"
J3030,"Injection, sumatriptan succinate, 6 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)"
J3031,"Injection, fremanezumab-vfrm, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered)"
J3032,"Injection, eptinezumab-jjmr, 1 mg"
J3055,"Injection, talquetamab-tgvs, 0.25 mg"
J3060,"Injection, taliglucerase alfa, 10 units"
J3070,"Injection, pentazocine, 30 mg"
J3090,"Injection, tedizolid phosphate, 1 mg"
J3095,"Injection, telavancin, 10 mg"
J3101,"Injection, tenecteplase, 1 mg"
J3105,"Injection, terbutaline sulfate, up to 1 mg"
J3110,"Injection, teriparatide, 10 mcg"
J3111,"Injection, romosozumab-aqqg, 1 mg"
J3120,"Injection, testosterone enanthate, up to 100 mgTerminated December 31, 2014."
J3121,"Injection, testosterone enanthate, 1 mg"
J3130,"Injection, testosterone enanthate, up to 200 mgTerminated December 31, 2014."
J3140,"Injection, testosterone suspension, up to 50 mgTerminated December 31, 2014."
J3145,"Injection, testosterone undecanoate, 1 mg"
J3150,"Injection, testosterone propionate, up to 100 mgTerminated December 31, 2014."
J3230,"Injection, chlorpromazine hcl, up to 50 mg"
J3240,"Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial"
J3241,"Injection, teprotumumab-trbw, 10 mg"
J3243,"Injection, tigecycline, 1 mg"
J3244,"Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg"
J3245,"Injection, tildrakizumab, 1 mg"
J3246,"Injection, tirofiban hcl, 0.25 mg"
J3247,"Injection, secukinumab, intravenous, 1 mg"
J3250,"Injection, trimethobenzamide hcl, up to 200 mg"
J3260,"Injection, tobramycin sulfate, up to 80 mg"
J3262,"Injection, tocilizumab, 1 mg"
J3263,"Injection, toripalimab-tpzi, 1 mg"
J3265,"Injection, torsemide, 10 mg/ml"
J3280,"Injection, thiethylperazine maleate, up to 10 mg"
J3285,"Injection, treprostinil, 1 mg"
J3290,"Injection, tranexamic acid, 5 mg"
J3299,"Injection, triamcinolone acetonide (xipere), 1 mg"
J3300,"Injection, triamcinolone acetonide, preservative free, 1 mg"
J3301,"Injection, triamcinolone acetonide, not otherwise specified, 10 mg"
J3302,"Injection, triamcinolone diacetate, per 5 mg"
J3303,"Injection, triamcinolone hexacetonide, per 5 mg"
J3304,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg"
J3305,"Injection, trimetrexate glucuronate, per 25 mg"
J3310,"Injection, perphenazine, up to 5 mg"
J3315,"Injection, triptorelin pamoate, 3.75 mg"
J3316,"Injection, triptorelin, extended-release, 3.75 mg"
J3320,"Injection, spectinomycin dihydrochloride, up to 2 gm"
J3350,"Injection, urea, up to 40 gm"
J3355,"Injection, urofollitropin, 75 iu"
J3357,"Ustekinumab, for subcutaneous injection, 1 mg"
J3358,"Ustekinumab, for intravenous injection, 1 mg"
J3360,"Injection, diazepam, up to 5 mg"
J3364,"Injection, urokinase, 5000 iu vial"
J3365,"Injection, iv, urokinase, 250,000 i.u. vial"
J3370,"Injection, vancomycin hcl, 500 mgTerminated June 30, 2025."
J3371,"Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mgTerminated June 30, 2025."
J3372,"Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mgTerminated June 30, 2025."
J3373,"Injection, vancomycin hydrochloride, 10 mg"
J3374,"Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg"
J3375,"Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg"
J3380,"Injection, vedolizumab, intravenous, 1 mg"
J3385,"Injection, velaglucerase alfa, 100 units"
J3391,"Injection, atidarsagene autotemcel, per treatment"
J3392,"Injection, exagamglogene autotemcel, per treatment"
J3393,"Injection, betibeglogene autotemcel, per treatment"
J3394,"Injection, lovotibeglogene autotemcel, per treatment"
J3396,"Injection, verteporfin, 0.1 mg"
J3397,"Injection, vestronidase alfa-vjbk, 1 mg"
J3398,"Injection, voretigene neparvovec-rzyl, 1 billion vector genomes"
J3399,"Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes"
J3400,"Injection, triflupromazine hcl, up to 20 mg"
J3401,"Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml"
J3402,"Injection, remestemcel-l-rknd, per therapeutic dose"
J3403,"Revakinagene taroretcel-lwey, per implant"
J3410,"Injection, hydroxyzine hcl, up to 25 mg"
J3411,"Injection, thiamine hcl, 100 mg"
J3415,"Injection, pyridoxine hcl, 100 mg"
J3420,"Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg"
J3424,"Injection, hydroxocobalamin, intravenous, 25 mg"
J3425,"Injection, hydroxocobalamin, intramuscular, 10 mcg"
J3430,"Injection, phytonadione (vitamin k), per 1 mg"
J3465,"Injection, voriconazole, 10 mg"
J3470,"Injection, hyaluronidase, up to 150 units"
J3471,"Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units)"
J3472,"Injection, hyaluronidase, ovine, preservative free, per 1000 usp units"
J3473,"Injection, hyaluronidase, recombinant, 1 usp unit"
J3475,"Injection, magnesium sulfate, per 500 mg"
J3480,"Injection, potassium chloride, per 2 meq"
J3485,"Injection, zidovudine, 10 mg"
J3486,"Injection, ziprasidone mesylate, 10 mg"
J3489,"Injection, zoledronic acid, 1 mg"
J3490,Unclassified drugs
J3520,"Edetate disodium, per 150 mg"
J3530,Nasal vaccine inhalation
J3535,Drug administered through a metered dose inhaler
J3570,"Laetrile, amygdalin, vitamin b17"
J3590,Unclassified biologics
J3591,Unclassified drug or biological used for esrd on dialysis
J7030,"Infusion, normal saline solution , 1000 cc"
J7040,"Infusion, normal saline solution, sterile (500 ml = 1 unit)"
J7042,5% dextrose/normal saline (500 ml = 1 unit)
J7050,"Infusion, normal saline solution, 250 cc"
J7060,5% dextrose/water (500 ml = 1 unit)
J7070,"Infusion, d5w, 1000 cc"
J7100,"Infusion, dextran 40, 500 ml"
J7110,"Infusion, dextran 75, 500 ml"
J7120,"Ringers lactate infusion, up to 1000 cc"
J7121,"5% dextrose in lactated ringers infusion, up to 1000 cc"
J7131,"Hypertonic saline solution, 1 ml"
J7165,"Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity"
J7168,"Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity"
J7169,"Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg"
J7170,"Injection, emicizumab-kxwh, 0.5 mg"
J7171,"Injection, adamts13, recombinant-krhn, 10 iu"
J7172,"Injection, marstacimab-hncq, 0.5 mg"
J7173,"Injection, concizumab-mtci, 0.5 mg"
J7174,"Injection, fitusiran, 0.04 mg"
J7175,"Injection, factor x, (human), 1 i.u."
J7177,"Injection, human fibrinogen concentrate (fibryga), 1 mg"
J7178,"Injection, human fibrinogen concentrate, not otherwise specified, 1 mg"
J7179,"Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco"
J7180,"Injection, factor xiii (antihemophilic factor, human), 1 i.u."
J7181,"Injection, factor xiii a-subunit, (recombinant), per iu"
J7182,"Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iu"
J7183,"Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rco"
J7185,"Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u."
J7186,"Injection, antihemophilic factor viii/von willebrand factor complex (human), per factor viii i.u."
J7187,"Injection, von willebrand factor complex (humate-p), per iu vwf:rco"
J7188,"Injection, factor viii (antihemophilic factor, recombinant), (obizur), per i.u."
J7189,"Factor viia (antihemophilic factor, recombinant), (novoseven rt), 1 microgram"
J7190,"Factor viii (antihemophilic factor, human) per i.u."
J7191,"Factor viii (antihemophilic factor (porcine)), per i.u."
J7192,"Factor viii (antihemophilic factor, recombinant) per i.u., not otherwise specified"
J7193,"Factor ix (antihemophilic factor, purified, non-recombinant) per i.u."
J7194,"Factor ix, complex, per i.u."
J7195,"Injection, factor ix (antihemophilic factor, recombinant) per iu, not otherwise specified"
J7196,"Injection, antithrombin recombinant, 50 i.u."
J7197,"Antithrombin iii (human), per i.u."
J7198,"Anti-inhibitor, per i.u."
J7199,"Hemophilia clotting factor, not otherwise classified"
J7200,"Injection, factor ix, (antihemophilic factor, recombinant), rixubis, per iu"
J7201,"Injection, factor ix, fc fusion protein, (recombinant), alprolix, 1 i.u."
J7202,"Injection, factor ix, albumin fusion protein, (recombinant), idelvion, 1 i.u."
J7203,"Injection factor ix, (antihemophilic factor, recombinant), glycopegylated, (rebinyn), 1 iu"
J7204,"Injection, factor viii, antihemophilic factor (recombinant), (esperoct), glycopegylated-exei, per iu"
J7205,"Injection, factor viii fc fusion protein (recombinant), per iu"
J7207,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated, 1 i.u."
J7208,"Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl, (jivi), 1 i.u."
J7209,"Injection, factor viii, (antihemophilic factor, recombinant), (nuwiq), 1 i.u."
J7210,"Injection, factor viii, (antihemophilic factor, recombinant), (afstyla), 1 i.u."
J7211,"Injection, factor viii, (antihemophilic factor, recombinant), (kovaltry), 1 i.u."
J7212,"Factor viia (antihemophilic factor, recombinant)-jncw (sevenfact), 1 microgram"
J7213,"Injection, coagulation factor ix (recombinant), ixinity, 1 i.u."
J7214,"Injection, factor viii/von willebrand factor complex, recombinant (altuviiio), per factor viii i.u."
J7294,"Segesterone acetate and ethinyl estradiol 0.15mg, 0.013mg per 24 hours; yearly vaginal system, each"
J7295,"Ethinyl estradiol and etonogestrel 0.015mg, 0.12mg per 24 hours; monthly vaginal ring, each"
J7296,"Levonorgestrel-releasing intrauterine contraceptive system, (kyleena), 19.5 mg"
J7297,"Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg"
J7298,"Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg"
J7300,Intrauterine copper contraceptive (paragard)
J7301,"Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg"
J7302,"Levonorgestrel-releasing intrauterine contraceptive system, 52 mgTerminated December 31, 2015."
J7303,"Contraceptive supply, hormone containing vaginal ring, eachTerminated September 30, 2021."
J7304,"Contraceptive supply, hormone containing patch, each"
J7306,"Levonorgestrel (contraceptive) implant system, including implants and supplies"
J7307,"Etonogestrel (contraceptive) implant system, including implant and supplies"
J7308,"Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)"
J7309,"Methyl aminolevulinate (mal) for topical administration, 16.8%, 1 gram"
J7310,"Ganciclovir, 4.5 mg, long-acting implant"
J7311,"Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg"
J7312,"Injection, dexamethasone, intravitreal implant, 0.1 mg"
J7313,"Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg"
J7314,"Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg"
J7315,"Mitomycin, ophthalmic, 0.2 mg"
J7316,"Injection, ocriplasmin, 0.125 mg"
J7318,"Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg"
J7320,"Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg"
J7321,"Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose"
J7322,"Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg"
J7323,"Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose"
J7324,"Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose"
J7325,"Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg"
J7326,"Hyaluronan or derivative, gel-one, for intra-articular injection, per dose"
J7327,"Hyaluronan or derivative, monovisc, for intra-articular injection, per dose"
J7328,"Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg"
J7329,"Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg"
J7330,"Autologous cultured chondrocytes, implant"
J7331,"Hyaluronan or derivative, synojoynt, for intra-articular injection, 1 mg"
J7332,"Hyaluronan or derivative, triluron, for intra-articular injection, 1 mg"
J7333,"Hyaluronan or derivative, visco-3, for intra-articular injection, per doseTerminated March 31, 2021."
J7335,"Capsaicin 8% patch, per 10 square centimetersTerminated December 31, 2014."
J7336,"Capsaicin 8% patch, per square centimeter"
J7340,"Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml"
J7342,"Instillation, ciprofloxacin otic suspension, 6 mg"
J7345,"Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg"
J7351,"Injection, bimatoprost, intracameral implant, 1 microgram"
J7352,"Afamelanotide implant, 1 mg"
J7353,"Anacaulase-bcdb, 8.8% gel, 1 gram"
J7354,"Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)"
J7355,"Injection, travoprost, intracameral implant, 1 microgram"
J7356,"Injection, foscarbidopa 0.25 mg/foslevodopa 5 mg"
J7401,"Mometasone furoate sinus implant, 10 microgramsTerminated March 31, 2021."
J7402,"Mometasone furoate sinus implant, (sinuva), 10 micrograms"
J7500,"Azathioprine, oral, 50 mg"
J7501,"Azathioprine, parenteral, 100 mg"
J7502,"Cyclosporine, oral, 100 mg"
J7503,"Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg"
J7504,"Lymphocyte immune globulin, antithymocyte globulin, equine, parenteral, 250 mg"
J7505,"Muromonab-cd3, parenteral, 5 mg"
J7506,"Prednisone, oral, per 5 mgTerminated December 31, 2015."
J7507,"Tacrolimus, immediate release, oral, 1 mg"
J7508,"Tacrolimus, extended release, (astagraf xl), oral, 0.1 mg"
J7509,"Methylprednisolone oral, per 4 mg"
J7510,"Prednisolone oral, per 5 mg"
J7511,"Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mg"
J7512,"Prednisone, immediate release or delayed release, oral, 1 mg"
J7513,"Daclizumab, parenteral, 25 mg"
J7514,"Mycophenolate mofetil (myhibbin), oral suspension, 100 mg"
J7515,"Cyclosporine, oral, 25 mg"
J7516,"Injection, cyclosporine, 250 mg"
J7517,"Mycophenolate mofetil, oral, 250 mg"
J7518,"Mycophenolic acid, oral, 180 mg"
J7519,"Injection, mycophenolate mofetil, 10 mg"
J7520,"Sirolimus, oral, 1 mg"
J7521,"Tacrolimus, granules, oral suspension, 0.1 mg"
J7525,"Tacrolimus, parenteral, 5 mg"
J7527,"Everolimus, oral, 0.25 mg"
J7599,"Immunosuppressive drug, not otherwise classified"
J7601,"Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg"
J7604,"Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram"
J7605,"Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms"
J7606,"Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms"
J7607,"Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg"
J7608,"Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram"
J7609,"Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg"
J7610,"Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg"
J7611,"Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg"
J7612,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg"
J7613,"Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg"
J7614,"Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg"
J7615,"Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg"
J7620,"Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme"
J7622,"Beclomethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7624,"Betamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7626,"Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg"
J7627,"Budesonide, inhalation solution, compounded product, administered through dme, unit dose form, up to 0.5 mg"
J7628,"Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram"
J7629,"Bitolterol mesylate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7631,"Cromolyn sodium, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams"
J7632,"Cromolyn sodium, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams"
J7633,"Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram"
J7634,"Budesonide, inhalation solution, compounded product, administered through dme, concentrated form, per 0.25 milligram"
J7635,"Atropine, inhalation solution, compounded product, administered through dme, concentrated form, per milligram"
J7636,"Atropine, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7637,"Dexamethasone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram"
J7638,"Dexamethasone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7639,"Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram"
J7640,"Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms"
J7641,"Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram"
J7642,"Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram"
J7643,"Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7644,"Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram"
J7645,"Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7647,"Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram"
J7648,"Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram"
J7649,"Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram"
J7650,"Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7657,"Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram"
J7658,"Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram"
J7659,"Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram"
J7660,"Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7665,"Mannitol, administered through an inhaler, 5 mg"
J7667,"Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligrams"
J7668,"Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams"
J7669,"Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 10 milligrams"
J7670,"Metaproterenol sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per 10 milligrams"
J7674,"Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg"
J7676,"Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg"
J7677,"Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram"
J7680,"Terbutaline sulfate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram"
J7681,"Terbutaline sulfate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7682,"Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams"
J7683,"Triamcinolone, inhalation solution, compounded product, administered through dme, concentrated form, per milligram"
J7684,"Triamcinolone, inhalation solution, compounded product, administered through dme, unit dose form, per milligram"
J7685,"Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams"
J7686,"Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg"
J7699,"Noc drugs, inhalation solution administered through dme"
J7799,"Noc drugs, other than inhalation drugs, administered through dme"
J7999,"Compounded drug, not otherwise classified"
J8498,"Antiemetic drug, rectal/suppository, not otherwise specified"
J8499,"Prescription drug, oral, non chemotherapeutic, nos"
J8501,"Aprepitant, oral, 5 mg"
J8510,"Busulfan; oral, 2 mg"
J8515,"Cabergoline, oral, 0.25 mg"
J8520,"Capecitabine, oral, 150 mgTerminated September 30, 2024."
J8521,"Capecitabine, oral, 500 mgTerminated September 30, 2024."
J8522,"Capecitabine, oral, 50 mg"
J8530,"Cyclophosphamide; oral, 25 mg"
J8540,"Dexamethasone, oral, 0.25 mg"
J8541,"Dexamethasone (hemady), oral, 0.25 mg"
J8560,"Etoposide; oral, 50 mg"
J8562,"Fludarabine phosphate, oral, 10 mg"
J8565,"Gefitinib, oral, 250 mg"
J8597,"Antiemetic drug, oral, not otherwise specified"
J8600,"Melphalan; oral, 2 mg"
J8610,"Methotrexate; oral, 2.5 mg"
J8611,"Methotrexate (jylamvo), oral, 2.5 mg"
J8612,"Methotrexate (xatmep), oral, 2.5 mg"
J8650,"Nabilone, oral, 1 mg"
J8655,"Netupitant 300 mg and palonosetron 0.5 mg, oral"
J8670,"Rolapitant, oral, 1 mg"
J8700,"Temozolomide, oral, 5 mg"
J8705,"Topotecan, oral, 0.25 mg"
J8999,"Prescription drug, oral, chemotherapeutic, nos"
J9000,"Injection, doxorubicin hydrochloride, 10 mg"
J9010,"Injection, alemtuzumab, 10 mgTerminated December 31, 2015."
J9011,"Injection, datopotamab deruxtecan-dlnk, 1 mg"
J9015,"Injection, aldesleukin, per single use vial"
J9017,"Injection, arsenic trioxide, 1 mg"
J9019,"Injection, asparaginase (erwinaze), 1,000 iu"
J9020,"Injection, asparaginase, not otherwise specified, 10,000 units"
J9021,"Injection, asparaginase, recombinant, (rylaze), 0.1 mg"
J9022,"Injection, atezolizumab, 10 mg"
J9023,"Injection, avelumab, 10 mg"
J9024,"Injection, atezolizumab, 5 mg and hyaluronidase-tqjs"
J9025,"Injection, azacitidine, 1 mg"
J9026,"Injection, tarlatamab-dlle, 1 mg"
J9027,"Injection, clofarabine, 1 mg"
J9028,"Injection, nogapendekin alfa inbakicept-pmln, for intravesical use, 1 microgram"
J9029,"Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose"
J9030,"Bcg live intravesical instillation, 1 mg"
J9031,"Bcg (intravesical) per instillationTerminated June 30, 2019."
J9032,"Injection, belinostat, 10 mg"
J9033,"Injection, bendamustine hydrochloride, 1 mg"
J9034,"Injection, bendamustine hcl (bendeka), 1 mg"
J9035,"Injection, bevacizumab, 10 mg"
J9036,"Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg"
J9037,"Injection, belantamab mafodotin-blmf, 0.5 mgTerminated March 31, 2025."
J9038,"Injection, axatilimab-csfr, 0.1 mg"
J9039,"Injection, blinatumomab, 1 microgram"
J9040,"Injection, bleomycin sulfate, 15 units"
J9041,"Injection, bortezomib, 0.1 mg"
J9042,"Injection, brentuximab vedotin, 1 mg"
J9043,"Injection, cabazitaxel, 1 mg"
J9044,"Injection, bortezomib, not otherwise specified, 0.1 mgTerminated December 31, 2022."
J9045,"Injection, carboplatin, 50 mg"
J9046,"Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg"
J9047,"Injection, carfilzomib, 1 mg"
J9048,"Injection, bortezomib (fresenius kabi), not therapeutically equivalent to j9041, 0.1 mg"
J9049,"Injection, bortezomib (hospira), not therapeutically equivalent to j9041, 0.1 mg"
J9050,"Injection, carmustine, 100 mg"
J9051,"Injection, bortezomib (maia), not therapeutically equivalent to j9041, 0.1 mg"
J9052,"Injection, carmustine (accord), not therapeutically equivalent to j9050, 100 mg"
J9054,"Injection, bortezomib (boruzu), 0.1 mg"
J9055,"Injection, cetuximab, 10 mg"
J9056,"Injection, bendamustine hydrochloride (vivimusta), 1 mg"
J9057,"Injection, copanlisib, 1 mg"
J9058,"Injection, bendamustine hydrochloride (apotex), 1 mgTerminated December 31, 2024."
J9059,"Injection, bendamustine hydrochloride (baxter), 1 mgTerminated December 31, 2024."
J9060,"Injection, cisplatin, powder or solution, 10 mg"
J9061,"Injection, amivantamab-vmjw, 2 mg"
J9063,"Injection, mirvetuximab soravtansine-gynx, 1 mg"
J9064,"Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg"
J9065,"Injection, cladribine, per 1 mg"
J9070,"Cyclophosphamide, 100 mgTerminated March 31, 2024."
J9071,"Injection, cyclophosphamide (auromedics), 5 mg"
J9072,"Injection, cyclophosphamide (frindovyx), 5 mg"
J9073,"Injection, cyclophosphamide (dr. reddy's), 5 mg"
J9074,"Injection, cyclophosphamide (sandoz), 5 mg"
J9075,"Injection, cyclophosphamide, not otherwise specified, 5 mg"
J9076,"Injection, cyclophosphamide (baxter), 5 mg"
J9098,"Injection, cytarabine liposome, 10 mg"
J9100,"Injection, cytarabine, 100 mg"
J9118,"Injection, calaspargase pegol-mknl, 10 units"
J9119,"Injection, cemiplimab-rwlc, 1 mg"
J9120,"Injection, dactinomycin, 0.5 mg"
J9130,"Dacarbazine, 100 mg"
J9144,"Injection, daratumumab, 10 mg and hyaluronidase-fihj"
J9145,"Injection, daratumumab, 10 mg"
J9150,"Injection, daunorubicin, 10 mg"
J9151,"Injection, daunorubicin citrate, liposomal formulation, 10 mg"
J9153,"Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine"
J9155,"Injection, degarelix, 1 mg"
J9160,"Injection, denileukin diftitox, 300 microgramsTerminated December 31, 2023."
J9161,"Injection, denileukin diftitox-cxdl, 1 mcg"
J9165,"Injection, diethylstilbestrol diphosphate, 250 mg"
J9171,"Injection, docetaxel, 1 mg"
J9172,"Injection, docetaxel (docivyx), 1 mg"
J9173,"Injection, durvalumab, 10 mg"
J9174,"Injection, docetaxel (beizray), 1 mg"
J9175,"Injection, elliotts' b solution, 1 ml"
J9176,"Injection, elotuzumab, 1 mg"
J9177,"Injection, enfortumab vedotin-ejfv, 0.25 mg"
J9178,"Injection, epirubicin hcl, 2 mg"
J9179,"Injection, eribulin mesylate, 0.1 mg"
J9181,"Injection, etoposide, 10 mg"
J9185,"Injection, fludarabine phosphate, 50 mg"
J9190,"Injection, fluorouracil, 500 mg"
J9196,"Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg"
J9198,"Injection, gemcitabine hydrochloride, (infugem), 100 mg"
J9199,"Injection, gemcitabine hydrochloride (infugem), 200 mgTerminated June 30, 2020."
J9200,"Injection, floxuridine, 500 mg"
J9201,"Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg"
J9202,"Goserelin acetate implant, per 3.6 mg"
J9203,"Injection, gemtuzumab ozogamicin, 0.1 mg"
J9204,"Injection, mogamulizumab-kpkc, 1 mg"
J9205,"Injection, irinotecan liposome, 1 mg"
J9206,"Injection, irinotecan, 20 mg"
J9207,"Injection, ixabepilone, 1 mg"
J9208,"Injection, ifosfamide, 1 gram"
J9209,"Injection, mesna, 200 mg"
J9210,"Injection, emapalumab-lzsg, 1 mg"
J9211,"Injection, idarubicin hydrochloride, 5 mg"
J9212,"Injection, interferon alfacon-1, recombinant, 1 microgram"
J9213,"Injection, interferon, alfa-2a, recombinant, 3 million units"
J9214,"Injection, interferon, alfa-2b, recombinant, 1 million units"
J9215,"Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu"
J9216,"Injection, interferon, gamma 1-b, 3 million units"
J9217,"Leuprolide acetate (for depot suspension), 7.5 mg"
J9218,"Leuprolide acetate, per 1 mg"
J9219,"Leuprolide acetate implant, 65 mg"
J9220,"Injection, indigotindisulfonate sodium, 1 mg"
J9223,"Injection, lurbinectedin, 0.1 mg"
J9225,"Histrelin implant (vantas), 50 mg"
J9226,"Histrelin implant (supprelin la), 50 mg"
J9227,"Injection, isatuximab-irfc, 10 mg"
J9228,"Injection, ipilimumab, 1 mg"
J9229,"Injection, inotuzumab ozogamicin, 0.1 mg"
J9230,"Injection, mechlorethamine hydrochloride, (nitrogen mustard), 10 mg"
J9245,"Injection, melphalan hydrochloride, not otherwise specified, 50 mg"
J9246,"Injection, melphalan (evomela), 1 mg"
J9247,"Injection, melphalan flufenamide, 1mgTerminated March 31, 2025."
J9248,"Injection, melphalan (hepzato), 1 mg"
J9249,"Injection, melphalan (apotex), 1 mg"
J9250,"Methotrexate sodium, 5 mgTerminated March 31, 2024."
J9255,"Injection, methotrexate (accord), not therapeutically equivalent to j9260, 50 mg"
J9258,"Injection, paclitaxel protein-bound particles (teva), not therapeutically equivalent to j9264, 1 mgTerminated September 30, 2024."
J9259,"Injection, paclitaxel protein-bound particles (american regent), not therapeutically equivalent to j9264, 1 mgTerminated December 31, 2024."
J9260,"Injection, methotrexate sodium, 50 mg"
J9261,"Injection, nelarabine, 50 mg"
J9262,"Injection, omacetaxine mepesuccinate, 0.01 mg"
J9263,"Injection, oxaliplatin, 0.5 mg"
J9264,"Injection, paclitaxel protein-bound particles, 1 mg"
J9265,"Injection, paclitaxel, 30 mgTerminated December 31, 2014."
J9266,"Injection, pegaspargase, per single dose vial"
J9267,"Injection, paclitaxel, 1 mg"
J9268,"Injection, pentostatin, 10 mg"
J9269,"Injection, tagraxofusp-erzs, 10 micrograms"
J9270,"Injection, plicamycin, 2.5 mg"
J9271,"Injection, pembrolizumab, 1 mg"
J9272,"Injection, dostarlimab-gxly, 10 mg"
J9273,"Injection, tisotumab vedotin-tftv, 1 mg"
J9274,"Injection, tebentafusp-tebn, 1 microgram"
J9275,"Injection, cosibelimab-ipdl, 2 mg"
J9276,"Injection, zanidatamab-hrii, 2 mg"
J9280,"Injection, mitomycin, 5 mg"
J9281,"Mitomycin pyelocalyceal instillation, 1 mg"
J9285,"Injection, olaratumab, 10 mg"
J9286,"Injection, glofitamab-gxbm, 2.5 mg"
J9289,"Injection, nivolumab, 2 mg and hyaluronidase-nvhy"
J9292,"Injection, pemetrexed dipotassium, 10 mg"
J9293,"Injection, mitoxantrone hydrochloride, per 5 mg"
J9294,"Injection, pemetrexed (hospira), not therapeutically equivalent to j9305, 10 mg"
J9295,"Injection, necitumumab, 1 mg"
J9296,"Injection, pemetrexed (accord), not therapeutically equivalent to j9305, 10 mg"
J9297,"Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg"
J9298,"Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg"
J9299,"Injection, nivolumab, 1 mg"
J9300,"Injection, gemtuzumab ozogamicin, 5 mgTerminated December 31, 2017."
J9301,"Injection, obinutuzumab, 10 mg"
J9302,"Injection, ofatumumab, 10 mg"
J9303,"Injection, panitumumab, 10 mg"
J9304,"Injection, pemetrexed (pemfexy), 10 mg"
J9305,"Injection, pemetrexed, not otherwise specified, 10 mg"
J9306,"Injection, pertuzumab, 1 mg"
J9307,"Injection, pralatrexate, 1 mg"
J9308,"Injection, ramucirumab, 5 mg"
J9309,"Injection, polatuzumab vedotin-piiq, 1 mg"
J9310,"Injection, rituximab, 100 mgTerminated December 31, 2018."
J9311,"Injection, rituximab 10 mg and hyaluronidase"
J9312,"Injection, rituximab, 10 mg"
J9313,"Injection, moxetumomab pasudotox-tdfk, 0.01 mg"
J9314,"Injection, pemetrexed (teva), not therapeutically equivalent to j9305, 10 mg"
J9315,"Injection, romidepsin, 1 mgTerminated September 30, 2021."
J9316,"Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg"
J9317,"Injection, sacituzumab govitecan-hziy, 2.5 mg"
J9318,"Injection, romidepsin, non-lyophilized, 0.1 mg"
J9319,"Injection, romidepsin, lyophilized, 0.1 mg"
J9320,"Injection, streptozocin, 1 gram"
J9321,"Injection, epcoritamab-bysp, 0.16 mg"
J9322,"Injection, pemetrexed (bluepoint), not therapeutically equivalent to j9305, 10 mg"
J9323,"Injection, pemetrexed ditromethamine, 10 mg"
J9324,"Injection, pemetrexed (pemrydi rtu), 10 mg"
J9325,"Injection, talimogene laherparepvec, per 1 million plaque forming units"
J9328,"Injection, temozolomide, 1 mg"
J9329,"Injection, tislelizumab-jsgr, 1mg"
J9330,"Injection, temsirolimus, 1 mg"
J9331,"Injection, sirolimus protein-bound particles, 1 mg"
J9332,"Injection, efgartigimod alfa-fcab, 2mg"
J9333,"Injection, rozanolixizumab-noli, 1 mg"
J9334,"Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc"
J9340,"Injection, thiotepa, 15 mgTerminated June 30, 2025."
J9341,"Injection, thiotepa (tepylute), 1 mg"
J9342,"Injection, thiotepa, not otherwise specified, 1 mg"
J9345,"Injection, retifanlimab-dlwr, 1 mg"
J9347,"Injection, tremelimumab-actl, 1 mg"
J9348,"Injection, naxitamab-gqgk, 1 mg"
J9349,"Injection, tafasitamab-cxix, 2 mg"
J9350,"Injection, mosunetuzumab-axgb, 1 mg"
J9351,"Injection, topotecan, 0.1 mg"
J9352,"Injection, trabectedin, 0.1 mg"
J9353,"Injection, margetuximab-cmkb, 5 mg"
J9354,"Injection, ado-trastuzumab emtansine, 1 mg"
J9355,"Injection, trastuzumab, excludes biosimilar, 10 mg"
J9356,"Injection, trastuzumab, 10 mg and hyaluronidase-oysk"
J9357,"Injection, valrubicin, intravesical, 200 mg"
J9358,"Injection, fam-trastuzumab deruxtecan-nxki, 1 mg"
J9359,"Injection, loncastuximab tesirine-lpyl, 0.075 mg"
J9360,"Injection, vinblastine sulfate, 1 mg"
J9361,"Injection, efbemalenograstim alfa-vuxw, 0.5 mg"
J9370,"Vincristine sulfate, 1 mg"
J9371,"Injection, vincristine sulfate liposome, 1 mgTerminated June 30, 2024."
J9376,"Injection, pozelimab-bbfg, 1 mg"
J9380,"Injection, teclistamab-cqyv, 0.5 mg"
J9381,"Injection, teplizumab-mzwv, 5 mcg"
J9382,"Injection, zenocutuzumab-zbco, 1 mg"
J9390,"Injection, vinorelbine tartrate, 10 mg"
J9393,"Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg"
J9394,"Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg"
J9395,"Injection, fulvestrant, 25 mg"
J9400,"Injection, ziv-aflibercept, 1 mg"
J9600,"Injection, porfimer sodium, 75 mg"
J9999,"Not otherwise classified, antineoplastic drugs"
K0001,Standard wheelchair
K0002,Standard hemi (low seat) wheelchair
K0003,Lightweight wheelchair
K0004,"High strength, lightweight wheelchair"
K0005,Ultralightweight wheelchair
K0006,Heavy duty wheelchair
K0007,Extra heavy duty wheelchair
K0008,Custom manual wheelchair/base
K0009,Other manual wheelchair/base
K0010,Standard - weight frame motorized/power wheelchair
K0011,"Standard - weight frame motorized/power wheelchair with programmable control parameters for speed adjustment, tremor dampening, acceleration control and braking"
K0012,Lightweight portable motorized/power wheelchair
K0013,Custom motorized/power wheelchair base
K0014,Other motorized/power wheelchair base
K0015,"Detachable, non-adjustable height armrest, replacement only, each"
K0017,"Detachable, adjustable height armrest, base, replacement only, each"
K0018,"Detachable, adjustable height armrest, upper portion, replacement only, each"
K0019,"Arm pad, replacement only, each"
K0020,"Fixed, adjustable height armrest, pair"
K0037,"High mount flip-up footrest, each"
K0038,"Leg strap, each"
K0039,"Leg strap, h style, each"
K0040,"Adjustable angle footplate, each"
K0041,"Large size footplate, each"
K0042,"Standard size footplate, replacement only, each"
K0043,"Footrest, lower extension tube, replacement only, each"
K0044,"Footrest, upper hanger bracket, replacement only, each"
K0045,"Footrest, complete assembly, replacement only, each"
K0046,"Elevating legrest, lower extension tube, replacement only, each"
K0047,"Elevating legrest, upper hanger bracket, replacement only, each"
K0050,"Ratchet assembly, replacement only"
K0051,"Cam release assembly, footrest or legrest, replacement only, each"
K0052,"Swingaway, detachable footrests, replacement only, each"
K0053,"Elevating footrests, articulating (telescoping), each"
K0056,"Seat height less than 17"" or equal to or greater than 21"" for a high strength, lightweight, or ultralightweight wheelchair"
K0065,"Spoke protectors, each"
K0069,"Rear wheel assembly, complete, with solid tire, spokes or molded, replacement only, each"
K0070,"Rear wheel assembly, complete, with pneumatic tire, spokes or molded, replacement only, each"
K0071,"Front caster assembly, complete, with pneumatic tire, replacement only, each"
K0072,"Front caster assembly, complete, with semi-pneumatic tire, replacement only, each"
K0073,"Caster pin lock, each"
K0077,"Front caster assembly, complete, with solid tire, replacement only, each"
K0098,"Drive belt for power wheelchair, replacement only"
K0105,"Iv hanger, each"
K0108,"Wheelchair component or accessory, not otherwise specified"
K0195,"Elevating leg rests, pair (for use with capped rental wheelchair base)"
K0455,"Infusion pump used for uninterrupted parenteral administration of medication, (e.g., epoprostenol or treprostinol)"
K0462,"Temporary replacement for patient owned equipment being repaired, any type"
K0552,"Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each"
K0553,"Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of serviceTerminated December 31, 2022."
K0554,"Receiver (monitor), dedicated, for use with therapeutic glucose continuous monitor systemTerminated December 31, 2022."
K0601,"Replacement battery for external infusion pump owned by patient, silver oxide, 1.5 volt, each"
K0602,"Replacement battery for external infusion pump owned by patient, silver oxide, 3 volt, each"
K0603,"Replacement battery for external infusion pump owned by patient, alkaline, 1.5 volt, each"
K0604,"Replacement battery for external infusion pump owned by patient, lithium, 3.6 volt, each"
K0605,"Replacement battery for external infusion pump owned by patient, lithium, 4.5 volt, each"
K0606,"Automatic external defibrillator, with integrated electrocardiogram analysis, garment type"
K0607,"Replacement battery for automated external defibrillator, garment type only, each"
K0608,"Replacement garment for use with automated external defibrillator, each"
K0609,"Replacement electrodes for use with automated external defibrillator, garment type only, each"
K0669,"Wheelchair accessory, wheelchair seat or back cushion, does not meet specific code criteria or no written coding verification from dme pdac"
K0672,"Addition to lower extremity orthosis, removable soft interface, all components, replacement only, each"
K0730,Controlled dose inhalation drug delivery system
K0733,"Power wheelchair accessory, 12 to 24 amp hour sealed lead acid battery, each (e.g., gel cell, absorbed glassmat)"
K0738,"Portable gaseous oxygen system, rental; home compressor used to fill portable oxygen cylinders; includes portable containers, regulator, flowmeter, humidifier, cannula or mask, and tubing"
K0739,"Repair or nonroutine service for durable medical equipment other than oxygen equipment requiring the skill of a technician, labor component, per 15 minutes"
K0740,"Repair or nonroutine service for oxygen equipment requiring the skill of a technician, labor component, per 15 minutes"
K0743,"Suction pump, home model, portable, for use on wounds"
K0744,"Absorptive wound dressing for use with suction pump, home model, portable, pad size 16 square inches or less"
K0745,"Absorptive wound dressing for use with suction pump, home model, portable, pad size more than 16 square inches but less than or equal to 48 square inches"
K0746,"Absorptive wound dressing for use with suction pump, home model, portable, pad size greater than 48 square inches"
K0800,"Power operated vehicle, group 1 standard, patient weight capacity up to and including 300 pounds"
K0801,"Power operated vehicle, group 1 heavy duty, patient weight capacity 301 to 450 pounds"
K0802,"Power operated vehicle, group 1 very heavy duty, patient weight capacity 451 to 600 pounds"
K0806,"Power operated vehicle, group 2 standard, patient weight capacity up to and including 300 pounds"
K0807,"Power operated vehicle, group 2 heavy duty, patient weight capacity 301 to 450 pounds"
K0808,"Power operated vehicle, group 2 very heavy duty, patient weight capacity 451 to 600 pounds"
K0812,"Power operated vehicle, not otherwise classified"
K0813,"Power wheelchair, group 1 standard, portable, sling/solid seat and back, patient weight capacity up to and including 300 pounds"
K0814,"Power wheelchair, group 1 standard, portable, captains chair, patient weight capacity up to and including 300 pounds"
K0815,"Power wheelchair, group 1 standard, sling/solid seat and back, patient weight capacity up to and including 300 pounds"
K0816,"Power wheelchair, group 1 standard, captains chair, patient weight capacity up to and including 300 pounds"
K0820,"Power wheelchair, group 2 standard, portable, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0821,"Power wheelchair, group 2 standard, portable, captains chair, patient weight capacity up to and including 300 pounds"
K0822,"Power wheelchair, group 2 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0823,"Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds"
K0824,"Power wheelchair, group 2 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds"
K0825,"Power wheelchair, group 2 heavy duty, captains chair, patient weight capacity 301 to 450 pounds"
K0826,"Power wheelchair, group 2 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds"
K0827,"Power wheelchair, group 2 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds"
K0828,"Power wheelchair, group 2 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more"
K0829,"Power wheelchair, group 2 extra heavy duty, captains chair, patient weight 601 pounds or more"
K0830,"Power wheelchair, group 2 standard, seat elevator, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0831,"Power wheelchair, group 2 standard, seat elevator, captains chair, patient weight capacity up to and including 300 pounds"
K0835,"Power wheelchair, group 2 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0836,"Power wheelchair, group 2 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds"
K0837,"Power wheelchair, group 2 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds"
K0838,"Power wheelchair, group 2 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds"
K0839,"Power wheelchair, group 2 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds"
K0840,"Power wheelchair, group 2 extra heavy duty, single power option, sling/solid seat/back, patient weight capacity 601 pounds or more"
K0841,"Power wheelchair, group 2 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0842,"Power wheelchair, group 2 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds"
K0843,"Power wheelchair, group 2 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds"
K0848,"Power wheelchair, group 3 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0849,"Power wheelchair, group 3 standard, captains chair, patient weight capacity up to and including 300 pounds"
K0850,"Power wheelchair, group 3 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds"
K0851,"Power wheelchair, group 3 heavy duty, captains chair, patient weight capacity 301 to 450 pounds"
K0852,"Power wheelchair, group 3 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds"
K0853,"Power wheelchair, group 3 very heavy duty, captains chair, patient weight capacity 451 to 600 pounds"
K0854,"Power wheelchair, group 3 extra heavy duty, sling/solid seat/back, patient weight capacity 601 pounds or more"
K0855,"Power wheelchair, group 3 extra heavy duty, captains chair, patient weight capacity 601 pounds or more"
K0856,"Power wheelchair, group 3 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0857,"Power wheelchair, group 3 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds"
K0858,"Power wheelchair, group 3 heavy duty, single power option, sling/solid seat/back, patient weight 301 to 450 pounds"
K0859,"Power wheelchair, group 3 heavy duty, single power option, captains chair, patient weight capacity 301 to 450 pounds"
K0860,"Power wheelchair, group 3 very heavy duty, single power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds"
K0861,"Power wheelchair, group 3 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0862,"Power wheelchair, group 3 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds"
K0863,"Power wheelchair, group 3 very heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 451 to 600 pounds"
K0864,"Power wheelchair, group 3 extra heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 601 pounds or more"
K0868,"Power wheelchair, group 4 standard, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0869,"Power wheelchair, group 4 standard, captains chair, patient weight capacity up to and including 300 pounds"
K0870,"Power wheelchair, group 4 heavy duty, sling/solid seat/back, patient weight capacity 301 to 450 pounds"
K0871,"Power wheelchair, group 4 very heavy duty, sling/solid seat/back, patient weight capacity 451 to 600 pounds"
K0877,"Power wheelchair, group 4 standard, single power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0878,"Power wheelchair, group 4 standard, single power option, captains chair, patient weight capacity up to and including 300 pounds"
K0879,"Power wheelchair, group 4 heavy duty, single power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds"
K0880,"Power wheelchair, group 4 very heavy duty, single power option, sling/solid seat/back, patient weight 451 to 600 pounds"
K0884,"Power wheelchair, group 4 standard, multiple power option, sling/solid seat/back, patient weight capacity up to and including 300 pounds"
K0885,"Power wheelchair, group 4 standard, multiple power option, captains chair, patient weight capacity up to and including 300 pounds"
K0886,"Power wheelchair, group 4 heavy duty, multiple power option, sling/solid seat/back, patient weight capacity 301 to 450 pounds"
K0890,"Power wheelchair, group 5 pediatric, single power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds"
K0891,"Power wheelchair, group 5 pediatric, multiple power option, sling/solid seat/back, patient weight capacity up to and including 125 pounds"
K0898,"Power wheelchair, not otherwise classified"
K0899,"Power mobility device, not coded by dme pdac or does not meet criteria"
K0900,"Customized durable medical equipment, other than wheelchair"
K0901,"Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelfTerminated December 31, 2016."
K0902,"Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelfTerminated December 31, 2016."
K0903,"For diabetics only, multiple density insert, made by direct carving with cam technology from a rectified cad model created from a digitized scan of the patient, total contact with patient's foot, including arch, base layer minimum of 3/16 inch material of shore a 35 durometer (or higher), includes arch filler and other shaping material, custom fabricated, eachTerminated December 31, 2018."
K1001,"Electronic positional obstructive sleep apnea treatment, with sensor, includes all components and accessories, any typeTerminated December 31, 2023."
K1002,"Cranial electrotherapy stimulation (ces) system, any typeTerminated December 31, 2023."
K1003,"Whirlpool tub, walk-in, portableTerminated December 31, 2023."
K1004,Low frequency ultrasonic diathermy treatment device for home use
K1005,"Disposable collection and storage bag for breast milk, any size, any type, eachTerminated December 31, 2023."
K1006,"Suction pump, home model, portable or stationary, electric, any type, for use with external urine management systemTerminated December 31, 2023."
K1007,"Bilateral hip, knee, ankle, foot device, powered, includes pelvic component, single or double upright(s), knee joints any type, with or without ankle joints any type, includes all components and accessories, motors, microprocessors, sensors"
K1009,"Speech volume modulation system, any type, including all components and accessoriesTerminated December 31, 2023."
K1010,"Indwelling intraurethral drainage device with valve, patient inserted, replacement only, eachTerminated March 31, 2021."
K1011,"Activation device for intraurethral drainage device with valve, replacement only, eachTerminated March 31, 2021."
K1012,"Charger and base station for intraurethral activation device, replacement onlyTerminated March 31, 2021."
K1013,"Enema tube, with or without adapter, any type, replacement only, eachTerminated December 31, 2023."
K1014,"Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase controlTerminated December 31, 2023."
K1015,"Foot, adductus positioning device, adjustableTerminated December 31, 2023."
K1016,"Transcutaneous electrical nerve stimulator for electrical stimulation of the trigeminal nerveTerminated December 31, 2023."
K1017,"Monthly supplies for use of device coded at k1016Terminated December 31, 2023."
K1018,"External upper limb tremor stimulator of the peripheral nerves of the wristTerminated December 31, 2023."
K1019,"Supplies and accessories for external upper limb tremor stimulator of the peripheral nerves of the wristTerminated December 31, 2023."
K1020,"Non-invasive vagus nerve stimulatorTerminated December 31, 2023."
K1021,"Exsufflation belt, includes all supplies and accessoriesTerminated December 31, 2023."
K1022,"Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any typeTerminated December 31, 2023."
K1023,"Distal transcutaneous electrical nerve stimulator, stimulates peripheral nerves of the upper armTerminated December 31, 2023."
K1024,"Non-pneumatic compression controller with sequential calibrated gradient pressureTerminated December 31, 2023."
K1025,"Non-pneumatic sequential compression garment, full armTerminated December 31, 2023."
K1026,"Mechanical allergen particle barrier/inhalation filter, cream, nasal, topicalTerminated December 31, 2023."
K1027,"Oral device/appliance used to reduce upper airway collapsibility, without fixed mechanical hinge, custom fabricated, includes fitting and adjustment"
K1028,"Power source and control electronics unit for oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, controlled by phone applicationTerminated December 31, 2023."
K1029,"Oral device/appliance for neuromuscular electrical stimulation of the tongue muscle, used in conjunction with the power source and control electronics unit, controlled by phone application, 90-day supplyTerminated December 31, 2023."
K1030,"External recharging system for battery (internal) for use with implanted cardiac contractility modulation generator, replacement only"
K1031,"Non-pneumatic compression controller without calibrated gradient pressureTerminated December 31, 2023."
K1032,"Non-pneumatic sequential compression garment, full legTerminated December 31, 2023."
K1033,"Non-pneumatic sequential compression garment, half legTerminated December 31, 2023."
K1034,"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count"
K1035,"Molecular diagnostic test reader, nonprescription self-administered and self-collected use, fda approved, authorized or cleared"
K1036,"Supplies and accessories (e.g., transducer) for low frequency ultrasonic diathermy treatment device, per month"
K1037,Docking station for use with oral device/appliance used to reduce upper airway collapsibility
L0112,"Cranial cervical orthosis, congenital torticollis type, with or without soft interface material, adjustable range of motion joint, custom fabricated"
L0113,"Cranial cervical orthosis, torticollis type, with or without joint, with or without soft interface material, prefabricated, includes fitting and adjustment"
L0120,"Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar)"
L0130,"Cervical, flexible, thermoplastic collar, molded to patient"
L0140,"Cervical, semi-rigid, adjustable (plastic collar)"
L0150,"Cervical, semi-rigid, adjustable molded chin cup (plastic collar with mandibular/occipital piece)"
L0160,"Cervical, semi-rigid, wire frame occipital/mandibular support, prefabricated, off-the-shelf"
L0170,"Cervical, collar, molded to patient model"
L0172,"Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf"
L0174,"Cervical, collar, semi-rigid, thermoplastic foam, two piece with thoracic extension, prefabricated, off-the-shelf"
L0180,"Cervical, multiple post collar, occipital/mandibular supports, adjustable"
L0190,"Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars (somi, guilford, taylor types)"
L0200,"Cervical, multiple post collar, occipital/mandibular supports, adjustable cervical bars, and thoracic extension"
L0220,"Thoracic, rib belt, custom fabricated"
L0450,"Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf"
L0452,"Tlso, flexible, provides trunk support, upper thoracic region, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, custom fabricated"
L0454,"Tlso flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0455,"Tlso, flexible, provides trunk support, extends from sacrococcygeal junction to above t-9 vertebra, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks with rigid stays or panel(s), includes shoulder straps and closures, prefabricated, off-the-shelf"
L0456,"Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0457,"Tlso, flexible, provides trunk support, thoracic region, rigid posterior panel and soft anterior apron, extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, restricts gross trunk motion in the sagittal plane, produces intracavitary pressure to reduce load on the intervertebral disks, includes straps and closures, prefabricated, off-the-shelf"
L0458,"Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment"
L0460,"Tlso, triplanar control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0462,"Tlso, triplanar control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in the sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment"
L0464,"Tlso, triplanar control, modular segmented spinal system, four rigid plastic shells, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to the sternal notch, soft liner, restricts gross trunk motion in sagittal, coronal, and transverse planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment"
L0466,"Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0467,"Tlso, sagittal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, restricts gross trunk motion in sagittal plane, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf"
L0468,"Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal, and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0469,"Tlso, sagittal-coronal control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction over scapulae, lateral strength provided by pelvic, thoracic, and lateral frame pieces, restricts gross trunk motion in sagittal and coronal planes, produces intracavitary pressure to reduce load on intervertebral disks, prefabricated, off-the-shelf"
L0470,"Tlso, triplanar control, rigid posterior frame and flexible soft anterior apron with straps, closures and padding, extends from sacrococcygeal junction to scapula, lateral strength provided by pelvic, thoracic, and lateral frame pieces, rotational strength provided by subclavicular extensions, restricts gross trunk motion in sagittal, coronal, and transverse planes, provides intracavitary pressure to reduce load on the intervertebral disks, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment"
L0472,"Tlso, triplanar control, hyperextension, rigid anterior and lateral frame extends from symphysis pubis to sternal notch with two anterior components (one pubic and one sternal), posterior and lateral pads with straps and closures, limits spinal flexion, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes fitting and shaping the frame, prefabricated, includes fitting and adjustment"
L0480,"Tlso, triplanar control, one piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated"
L0482,"Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated"
L0484,"Tlso, triplanar control, two piece rigid plastic shell without interface liner, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated"
L0486,"Tlso, triplanar control, two piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, lateral strength is enhanced by overlapping plastic, restricts gross trunk motion in the sagittal, coronal, and transverse planes, includes a carved plaster or cad-cam model, custom fabricated"
L0488,"Tlso, triplanar control, one piece rigid plastic shell with interface liner, multiple straps and closures, posterior extends from sacrococcygeal junction and terminates just inferior to scapular spine, anterior extends from symphysis pubis to sternal notch, anterior or posterior opening, restricts gross trunk motion in sagittal, coronal, and transverse planes, prefabricated, includes fitting and adjustment"
L0490,"Tlso, sagittal-coronal control, one piece rigid plastic shell, with overlapping reinforced anterior, with multiple straps and closures, posterior extends from sacrococcygeal junction and terminates at or before the t-9 vertebra, anterior extends from symphysis pubis to xiphoid, anterior opening, restricts gross trunk motion in sagittal and coronal planes, prefabricated, includes fitting and adjustment"
L0491,"Tlso, sagittal-coronal control, modular segmented spinal system, two rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment"
L0492,"Tlso, sagittal-coronal control, modular segmented spinal system, three rigid plastic shells, posterior extends from the sacrococcygeal junction and terminates just inferior to the scapular spine, anterior extends from the symphysis pubis to the xiphoid, soft liner, restricts gross trunk motion in the sagittal and coronal planes, lateral strength is provided by overlapping plastic and stabilizing closures, includes straps and closures, prefabricated, includes fitting and adjustment"
L0621,"Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf"
L0622,"Sacroiliac orthosis, flexible, provides pelvic-sacral support, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated"
L0623,"Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, prefabricated, off-the-shelf"
L0624,"Sacroiliac orthosis, provides pelvic-sacral support, with rigid or semi-rigid panels placed over the sacrum and abdomen, reduces motion about the sacroiliac joint, includes straps, closures, may include pendulous abdomen design, custom fabricated"
L0625,"Lumbar orthosis, flexible, provides lumbar support, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include pendulous abdomen design, shoulder straps, stays, prefabricated, off-the-shelf"
L0626,"Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0627,"Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0628,"Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf"
L0629,"Lumbar-sacral orthosis, flexible, provides lumbo-sacral support, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include stays, shoulder straps, pendulous abdomen design, custom fabricated"
L0630,"Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0631,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0632,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated"
L0633,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0634,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, custom fabricated"
L0635,"Lumbar-sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panel(s), lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, prefabricated, includes fitting and adjustment"
L0636,"Lumbar sacral orthosis, sagittal-coronal control, lumbar flexion, rigid posterior frame/panels, lateral articulating design to flex the lumbar spine, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, anterior panel, pendulous abdomen design, custom fabricated"
L0637,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0638,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panels, posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, custom fabricated"
L0639,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0640,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, custom fabricated"
L0641,"Lumbar orthosis, sagittal control, with rigid posterior panel(s), posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf"
L0642,"Lumbar orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from l-1 to below l-5 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf"
L0643,"Lumbar-sacral orthosis, sagittal control, with rigid posterior panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf"
L0648,"Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf"
L0649,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panels, produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, stays, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf"
L0650,"Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf"
L0651,"Lumbar-sacral orthosis, sagittal-coronal control, rigid shell(s)/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, anterior extends from symphysis pubis to xyphoid, produces intracavitary pressure to reduce load on the intervertebral discs, overall strength is provided by overlapping rigid material and stabilizing closures, includes straps, closures, may include soft interface, pendulous abdomen design, prefabricated, off-the-shelf"
L0700,"Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, molded to patient model, (minerva type)"
L0710,"Ctlso, anterior-posterior-lateral-control, molded to patient model, with interface material, (minerva type)"
L0720,"Cervical-thoracic-lumbar-sacral-orthoses (ctlso), anterior-posterior-lateral control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L0810,"Halo procedure, cervical halo incorporated into jacket vest"
L0820,"Halo procedure, cervical halo incorporated into plaster body jacket"
L0830,"Halo procedure, cervical halo incorporated into milwaukee type orthosis"
L0859,"Addition to halo procedure, magnetic resonance image compatible systems, rings and pins, any material"
L0861,"Addition to halo procedure, replacement liner/interface material"
L0970,"Tlso, corset front"
L0972,"Lso, corset front"
L0974,"Tlso, full corset"
L0976,"Lso, full corset"
L0978,Axillary crutch extension
L0980,"Peroneal straps, prefabricated, off-the-shelf, pair"
L0982,"Stocking supporter grips, prefabricated, off-the-shelf, set of four (4)"
L0984,"Protective body sock, prefabricated, off-the-shelf, each"
L0999,"Addition to spinal orthosis, not otherwise specified"
L1000,"Cervical-thoracic-lumbar-sacral orthosis (ctlso) (milwaukee), inclusive of furnishing initial orthosis, including model"
L1001,"Cervical thoracic lumbar sacral orthosis, immobilizer, infant size, prefabricated, includes fitting and adjustment"
L1005,"Tension based scoliosis orthosis and accessory pads, includes fitting and adjustment"
L1006,"Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla to trochanter, includes all accessory pads, straps and interface, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1007,"Scoliosis orthosis, sagittal-coronal control provided by a rigid lateral frame, extends from axilla, to trochanter, includes all accessory pads, straps, and interface, custom fabricated"
L1010,"Addition to cervical-thoracic-lumbar-sacral orthosis (ctlso) or scoliosis orthosis, axilla sling"
L1020,"Addition to ctlso or scoliosis orthosis, kyphosis pad"
L1025,"Addition to ctlso or scoliosis orthosis, kyphosis pad, floating"
L1030,"Addition to ctlso or scoliosis orthosis, lumbar bolster pad"
L1040,"Addition to ctlso or scoliosis orthosis, lumbar or lumbar rib pad"
L1050,"Addition to ctlso or scoliosis orthosis, sternal pad"
L1060,"Addition to ctlso or scoliosis orthosis, thoracic pad"
L1070,"Addition to ctlso or scoliosis orthosis, trapezius sling"
L1080,"Addition to ctlso or scoliosis orthosis, outrigger"
L1085,"Addition to ctlso or scoliosis orthosis, outrigger, bilateral with vertical extensions"
L1090,"Addition to ctlso or scoliosis orthosis, lumbar sling"
L1100,"Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather"
L1110,"Addition to ctlso or scoliosis orthosis, ring flange, plastic or leather, molded to patient model"
L1120,"Addition to ctlso, scoliosis orthosis, cover for upright, each"
L1200,"Thoracic-lumbar-sacral-orthosis (tlso), inclusive of furnishing initial orthosis only"
L1210,"Addition to tlso, (low profile), lateral thoracic extension"
L1220,"Addition to tlso, (low profile), anterior thoracic extension"
L1230,"Addition to tlso, (low profile), milwaukee type superstructure"
L1240,"Addition to tlso, (low profile), lumbar derotation pad"
L1250,"Addition to tlso, (low profile), anterior asis pad"
L1260,"Addition to tlso, (low profile), anterior thoracic derotation pad"
L1270,"Addition to tlso, (low profile), abdominal pad"
L1280,"Addition to tlso, (low profile), rib gusset (elastic), each"
L1290,"Addition to tlso, (low profile), lateral trochanteric pad"
L1300,"Other scoliosis procedure, body jacket molded to patient model"
L1310,"Other scoliosis procedure, post-operative body jacket"
L1320,"Thoracic, pectus carinatum orthosis, sternal compression, rigid circumferential frame with anterior and posterior rigid pads, custom fabricated"
L1499,"Spinal orthosis, not otherwise specified"
L1600,"Hip orthosis, abduction control of hip joints, flexible, frejka type with cover, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an inidividual with expertise"
L1610,"Hip orthosis, abduction control of hip joints, flexible, (frejka cover only), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1620,"Hip orthosis, abduction control of hip joints, flexible, (pavlik harness), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1630,"Hip orthosis, abduction control of hip joints, semi-flexible (von rosen type), custom fabricated"
L1640,"Hip orthosis, abduction control of hip joints, static, pelvic band or spreader bar, thigh cuffs, custom fabricated"
L1650,"Hip orthosis, abduction control of hip joints, static, adjustable, (ilfled type), prefabricated, includes fitting and adjustment"
L1652,"Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, includes fitting and adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1653,"Hip orthosis, bilateral thigh cuffs with adjustable abductor spreader bar, adult size, prefabricated, off the shelf"
L1660,"Hip orthosis, abduction control of hip joints, static, plastic, prefabricated, includes fitting and adjustment"
L1680,"Hip orthosis, abduction control of hip joints, dynamic, pelvic control, adjustable hip motion control, thigh cuffs (rancho hip action type), custom fabricated"
L1681,"Hip orthosis, bilateral hip joints and thigh cuffs, adjustable flexion, extension, abduction control of hip joint, postoperative hip abduction type, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1685,"Hip orthosis, abduction control of hip joint, postoperative hip abduction type, custom fabricated"
L1686,"Hip orthosis, abduction control of hip joint, postoperative hip abduction type, prefabricated, includes fitting and adjustment"
L1690,"Combination, bilateral, lumbo-sacral, hip, femur orthosis providing adduction and internal rotation control, prefabricated, includes fitting and adjustment"
L1700,"Legg perthes orthosis, (toronto type), custom fabricated"
L1710,"Legg perthes orthosis, (newington type), custom fabricated"
L1720,"Legg perthes orthosis, trilateral, (tachdijan type), custom fabricated"
L1730,"Legg perthes orthosis, (scottish rite type), custom fabricated"
L1755,"Legg perthes orthosis, (patten bottom type), custom fabricated"
L1810,"Knee orthosis, elastic with joints, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1812,"Knee orthosis, elastic with joints, prefabricated, off-the-shelf"
L1820,"Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1821,"Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated, off the shelf"
L1830,"Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf"
L1831,"Knee orthosis, locking knee joint(s), positional orthosis, prefabricated, includes fitting and adjustment"
L1832,"Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1833,"Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated, off-the shelf"
L1834,"Knee orthosis, without knee joint, rigid, custom fabricated"
L1836,"Knee orthosis, rigid, without joint(s), includes soft interface material, prefabricated, off-the-shelf"
L1840,"Knee orthosis, derotation, medial-lateral, anterior cruciate ligament, custom fabricated"
L1843,"Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1844,"Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated"
L1845,"Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1846,"Knee orthosis, double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated"
L1847,"Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1848,"Knee orthosis, double upright with adjustable joint, with inflatable air support chamber(s), prefabricated, off-the-shelf"
L1850,"Knee orthosis, swedish type, prefabricated, off-the-shelf"
L1851,"Knee orthosis (ko), single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf"
L1852,"Knee orthosis (ko), double upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated, off-the-shelf"
L1860,"Knee orthosis, modification of supracondylar prosthetic socket, custom fabricated (sk)"
L1900,"Ankle foot orthosis, spring wire, dorsiflexion assist calf band, custom fabricated"
L1902,"Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf"
L1904,"Ankle orthosis, ankle gauntlet or similar, with or without joints, custom fabricated"
L1906,"Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf"
L1907,"Ankle orthosis, supramalleolar with straps, with or without interface/pads, custom fabricated"
L1910,"Ankle foot orthosis, posterior, single bar, clasp attachment to shoe counter, prefabricated, includes fitting and adjustment"
L1920,"Ankle foot orthosis, single upright with static or adjustable stop (phelps or perlstein type), custom fabricated"
L1930,"Ankle foot orthosis, plastic or other material, prefabricated, includes fitting and adjustment"
L1932,"Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1933,"Ankle foot orthosis, rigid anterior tibial section, total carbon fiber or equal material, prefabricated, off-the-shelf"
L1940,"Ankle foot orthosis, plastic or other material, custom fabricated"
L1945,"Ankle foot orthosis, plastic, rigid anterior tibial section (floor reaction), custom fabricated"
L1950,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic, custom fabricated"
L1951,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L1952,"Ankle foot orthosis, spiral, (institute of rehabilitative medicine type), plastic or other material, prefabricated, off-the-shelf"
L1960,"Ankle foot orthosis, posterior solid ankle, plastic, custom fabricated"
L1970,"Ankle foot orthosis, plastic with ankle joint, custom fabricated"
L1971,"Ankle foot orthosis, plastic or other material with ankle joint, with or without dorsiflexion assist, prefabricated, includes fitting and adjustment"
L1980,"Ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup, calf band/cuff (single bar 'bk' orthosis), custom fabricated"
L1990,"Ankle foot orthosis, double upright free plantar dorsiflexion, solid stirrup, calf band/cuff (double bar 'bk' orthosis), custom fabricated"
L2000,"Knee ankle foot orthosis, single upright, free knee, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), custom fabricated"
L2005,"Knee ankle foot orthosis, any material, single or double upright, stance control, automatic lock and swing phase release, any type activation, includes ankle joint, any type, custom fabricated"
L2006,"Knee ankle foot device, any material, single or double upright, swing and stance phase microprocessor control with adjustability, includes all components (e.g., sensors, batteries, charger), any type activation, with or without ankle joint(s), custom fabricated"
L2010,"Knee ankle foot orthosis, single upright, free ankle, solid stirrup, thigh and calf bands/cuffs (single bar 'ak' orthosis), without knee joint, custom fabricated"
L2020,"Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs (double bar 'ak' orthosis), custom fabricated"
L2030,"Knee ankle foot orthosis, double upright, free ankle, solid stirrup, thigh and calf bands/cuffs, (double bar 'ak' orthosis), without knee joint, custom fabricated"
L2034,"Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, medial lateral rotation control, with or without free motion ankle, custom fabricated"
L2035,"Knee ankle foot orthosis, full plastic, static (pediatric size), without free motion ankle, prefabricated, includes fitting and adjustment"
L2036,"Knee ankle foot orthosis, full plastic, double upright, with or without free motion knee, with or without free motion ankle, custom fabricated"
L2037,"Knee ankle foot orthosis, full plastic, single upright, with or without free motion knee, with or without free motion ankle, custom fabricated"
L2038,"Knee ankle foot orthosis, full plastic, with or without free motion knee, multi-axis ankle, custom fabricated"
L2040,"Hip knee ankle foot orthosis, torsion control, bilateral rotation straps, pelvic band/belt, custom fabricated"
L2050,"Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, hip joint, pelvic band/belt, custom fabricated"
L2060,"Hip knee ankle foot orthosis, torsion control, bilateral torsion cables, ball bearing hip joint, pelvic band/ belt, custom fabricated"
L2070,"Hip knee ankle foot orthosis, torsion control, unilateral rotation straps, pelvic band/belt, custom fabricated"
L2080,"Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, hip joint, pelvic band/belt, custom fabricated"
L2090,"Hip knee ankle foot orthosis, torsion control, unilateral torsion cable, ball bearing hip joint, pelvic band/ belt, custom fabricated"
L2106,"Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, thermoplastic type casting material, custom fabricated"
L2108,"Ankle foot orthosis, fracture orthosis, tibial fracture cast orthosis, custom fabricated"
L2112,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, soft, prefabricated, includes fitting and adjustment"
L2114,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, semi-rigid, prefabricated, includes fitting and adjustment"
L2116,"Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid, prefabricated, includes fitting and adjustment"
L2126,"Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, thermoplastic type casting material, custom fabricated"
L2128,"Knee ankle foot orthosis, fracture orthosis, femoral fracture cast orthosis, custom fabricated"
L2132,"Kafo, fracture orthosis, femoral fracture cast orthosis, soft, prefabricated, includes fitting and adjustment"
L2134,"Kafo, fracture orthosis, femoral fracture cast orthosis, semi-rigid, prefabricated, includes fitting and adjustment"
L2136,"Kafo, fracture orthosis, femoral fracture cast orthosis, rigid, prefabricated, includes fitting and adjustment"
L2180,"Addition to lower extremity fracture orthosis, plastic shoe insert with ankle joints"
L2182,"Addition to lower extremity fracture orthosis, drop lock knee joint"
L2184,"Addition to lower extremity fracture orthosis, limited motion knee joint"
L2186,"Addition to lower extremity fracture orthosis, adjustable motion knee joint, lerman type"
L2188,"Addition to lower extremity fracture orthosis, quadrilateral brim"
L2190,"Addition to lower extremity fracture orthosis, waist belt"
L2192,"Addition to lower extremity fracture orthosis, hip joint, pelvic band, thigh flange, and pelvic belt"
L2200,"Addition to lower extremity, limited ankle motion, each joint"
L2210,"Addition to lower extremity, dorsiflexion assist (plantar flexion resist), each joint"
L2220,"Addition to lower extremity, dorsiflexion and plantar flexion assist/resist, each joint"
L2230,"Addition to lower extremity, split flat caliper stirrups and plate attachment"
L2232,"Addition to lower extremity orthosis, rocker bottom for total contact ankle foot orthosis, for custom fabricated orthosis only"
L2240,"Addition to lower extremity, round caliper and plate attachment"
L2250,"Addition to lower extremity, foot plate, molded to patient model, stirrup attachment"
L2260,"Addition to lower extremity, reinforced solid stirrup (scott-craig type)"
L2265,"Addition to lower extremity, long tongue stirrup"
L2270,"Addition to lower extremity, varus/valgus correction ('t') strap, padded/lined or malleolus pad"
L2275,"Addition to lower extremity, varus/valgus correction, plastic modification, padded/lined"
L2280,"Addition to lower extremity, molded inner boot"
L2300,"Addition to lower extremity, abduction bar (bilateral hip involvement), jointed, adjustable"
L2310,"Addition to lower extremity, abduction bar-straight"
L2320,"Addition to lower extremity, non-molded lacer, for custom fabricated orthosis only"
L2330,"Addition to lower extremity, lacer molded to patient model, for custom fabricated orthosis only"
L2335,"Addition to lower extremity, anterior swing band"
L2340,"Addition to lower extremity, pre-tibial shell, molded to patient model"
L2350,"Addition to lower extremity, prosthetic type, (bk) socket, molded to patient model, (used for 'ptb' 'afo' orthoses)"
L2360,"Addition to lower extremity, extended steel shank"
L2370,"Addition to lower extremity, patten bottom"
L2375,"Addition to lower extremity, torsion control, ankle joint and half solid stirrup"
L2380,"Addition to lower extremity, torsion control, straight knee joint, each joint"
L2385,"Addition to lower extremity, straight knee joint, heavy duty, each joint"
L2387,"Addition to lower extremity, polycentric knee joint, for custom fabricated knee ankle foot orthosis, each joint"
L2390,"Addition to lower extremity, offset knee joint, each joint"
L2395,"Addition to lower extremity, offset knee joint, heavy duty, each joint"
L2397,"Addition to lower extremity orthosis, suspension sleeve"
L2405,"Addition to knee joint, drop lock, each"
L2415,"Addition to knee lock with integrated release mechanism (bail, cable, or equal), any material, each joint"
L2425,"Addition to knee joint, disc or dial lock for adjustable knee flexion, each joint"
L2430,"Addition to knee joint, ratchet lock for active and progressive knee extension, each joint"
L2492,"Addition to knee joint, lift loop for drop lock ring"
L2500,"Addition to lower extremity, thigh/weight bearing, gluteal/ ischial weight bearing, ring"
L2510,"Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, molded to patient model"
L2520,"Addition to lower extremity, thigh/weight bearing, quadri- lateral brim, custom fitted"
L2525,"Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim molded to patient model"
L2526,"Addition to lower extremity, thigh/weight bearing, ischial containment/narrow m-l brim, custom fitted"
L2530,"Addition to lower extremity, thigh-weight bearing, lacer, non-molded"
L2540,"Addition to lower extremity, thigh/weight bearing, lacer, molded to patient model"
L2550,"Addition to lower extremity, thigh/weight bearing, high roll cuff"
L2570,"Addition to lower extremity, pelvic control, hip joint, clevis type two position joint, each"
L2580,"Addition to lower extremity, pelvic control, pelvic sling"
L2600,"Addition to lower extremity, pelvic control, hip joint, clevis type, or thrust bearing, free, each"
L2610,"Addition to lower extremity, pelvic control, hip joint, clevis or thrust bearing, lock, each"
L2620,"Addition to lower extremity, pelvic control, hip joint, heavy duty, each"
L2622,"Addition to lower extremity, pelvic control, hip joint, adjustable flexion, each"
L2624,"Addition to lower extremity, pelvic control, hip joint, adjustable flexion, extension, abduction control, each"
L2627,"Addition to lower extremity, pelvic control, plastic, molded to patient model, reciprocating hip joint and cables"
L2628,"Addition to lower extremity, pelvic control, metal frame, reciprocating hip joint and cables"
L2630,"Addition to lower extremity, pelvic control, band and belt, unilateral"
L2640,"Addition to lower extremity, pelvic control, band and belt, bilateral"
L2650,"Addition to lower extremity, pelvic and thoracic control, gluteal pad, each"
L2660,"Addition to lower extremity, thoracic control, thoracic band"
L2670,"Addition to lower extremity, thoracic control, paraspinal uprights"
L2680,"Addition to lower extremity, thoracic control, lateral support uprights"
L2750,"Addition to lower extremity orthosis, plating chrome or nickel, per bar"
L2755,"Addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, per segment, for custom fabricated orthosis only"
L2760,"Addition to lower extremity orthosis, extension, per extension, per bar (for lineal adjustment for growth)"
L2768,"Orthotic side bar disconnect device, per bar"
L2780,"Addition to lower extremity orthosis, non-corrosive finish, per bar"
L2785,"Addition to lower extremity orthosis, drop lock retainer, each"
L2795,"Addition to lower extremity orthosis, knee control, full kneecap"
L2800,"Addition to lower extremity orthosis, knee control, knee cap, medial or lateral pull, for use with custom fabricated orthosis only"
L2810,"Addition to lower extremity orthosis, knee control, condylar pad"
L2820,"Addition to lower extremity orthosis, soft interface for molded plastic, below knee section"
L2830,"Addition to lower extremity orthosis, soft interface for molded plastic, above knee section"
L2840,"Addition to lower extremity orthosis, tibial length sock, fracture or equal, each"
L2850,"Addition to lower extremity orthosis, femoral length sock, fracture or equal, each"
L2861,"Addition to lower extremity joint, knee or ankle, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each"
L2999,"Lower extremity orthoses, not otherwise specified"
L3000,"Foot, insert, removable, molded to patient model, 'ucb' type, berkeley shell, each"
L3001,"Foot, insert, removable, molded to patient model, spenco, each"
L3002,"Foot, insert, removable, molded to patient model, plastazote or equal, each"
L3003,"Foot, insert, removable, molded to patient model, silicone gel, each"
L3010,"Foot, insert, removable, molded to patient model, longitudinal arch support, each"
L3020,"Foot, insert, removable, molded to patient model, longitudinal/ metatarsal support, each"
L3030,"Foot, insert, removable, formed to patient foot, each"
L3031,"Foot, insert/plate, removable, addition to lower extremity orthosis, high strength, lightweight material, all hybrid lamination/prepreg composite, each"
L3040,"Foot, arch support, removable, premolded, longitudinal, each"
L3050,"Foot, arch support, removable, premolded, metatarsal, each"
L3060,"Foot, arch support, removable, premolded, longitudinal/ metatarsal, each"
L3070,"Foot, arch support, non-removable attached to shoe, longitudinal, each"
L3080,"Foot, arch support, non-removable attached to shoe, metatarsal, each"
L3090,"Foot, arch support, non-removable attached to shoe, longitudinal/metatarsal, each"
L3100,"Hallus-valgus night dynamic splint, prefabricated, off-the-shelf"
L3140,"Foot, abduction rotation bar, including shoes"
L3150,"Foot, abduction rotation bar, without shoes"
L3160,"Foot, adjustable shoe-styled positioning device"
L3161,"Foot, adductus positioning device, adjustable"
L3170,"Foot, plastic, silicone or equal, heel stabilizer, prefabricated, off-the-shelf, each"
L3201,"Orthopedic shoe, oxford with supinator or pronator, infant"
L3202,"Orthopedic shoe, oxford with supinator or pronator, child"
L3203,"Orthopedic shoe, oxford with supinator or pronator, junior"
L3204,"Orthopedic shoe, hightop with supinator or pronator, infant"
L3206,"Orthopedic shoe, hightop with supinator or pronator, child"
L3207,"Orthopedic shoe, hightop with supinator or pronator, junior"
L3208,"Surgical boot, each, infant"
L3209,"Surgical boot, each, child"
L3211,"Surgical boot, each, junior"
L3212,"Benesch boot, pair, infant"
L3213,"Benesch boot, pair, child"
L3214,"Benesch boot, pair, junior"
L3215,"Orthopedic footwear, ladies shoe, oxford, each"
L3216,"Orthopedic footwear, ladies shoe, depth inlay, each"
L3217,"Orthopedic footwear, ladies shoe, hightop, depth inlay, each"
L3219,"Orthopedic footwear, mens shoe, oxford, each"
L3221,"Orthopedic footwear, mens shoe, depth inlay, each"
L3222,"Orthopedic footwear, mens shoe, hightop, depth inlay, each"
L3224,"Orthopedic footwear, woman's shoe, oxford, used as an integral part of a brace (orthosis)"
L3225,"Orthopedic footwear, man's shoe, oxford, used as an integral part of a brace (orthosis)"
L3230,"Orthopedic footwear, custom shoe, depth inlay, each"
L3250,"Orthopedic footwear, custom molded shoe, removable inner mold, prosthetic shoe, each"
L3251,"Foot, shoe molded to patient model, silicone shoe, each"
L3252,"Foot, shoe molded to patient model, plastazote (or similar), custom fabricated, each"
L3253,"Foot, molded shoe plastazote (or similar) custom fitted, each"
L3254,Non-standard size or width
L3255,Non-standard size or length
L3257,"Orthopedic footwear, additional charge for split size"
L3260,"Surgical boot/shoe, each"
L3265,"Plastazote sandal, each"
L3300,"Lift, elevation, heel, tapered to metatarsals, per inch"
L3310,"Lift, elevation, heel and sole, neoprene, per inch"
L3320,"Lift, elevation, heel and sole, cork, per inch"
L3330,"Lift, elevation, metal extension (skate)"
L3332,"Lift, elevation, inside shoe, tapered, up to one-half inch"
L3334,"Lift, elevation, heel, per inch"
L3340,"Heel wedge, sach"
L3350,Heel wedge
L3360,"Sole wedge, outside sole"
L3370,"Sole wedge, between sole"
L3380,Clubfoot wedge
L3390,Outflare wedge
L3400,"Metatarsal bar wedge, rocker"
L3410,"Metatarsal bar wedge, between sole"
L3420,"Full sole and heel wedge, between sole"
L3430,"Heel, counter, plastic reinforced"
L3440,"Heel, counter, leather reinforced"
L3450,"Heel, sach cushion type"
L3455,"Heel, new leather, standard"
L3460,"Heel, new rubber, standard"
L3465,"Heel, thomas with wedge"
L3470,"Heel, thomas extended to ball"
L3480,"Heel, pad and depression for spur"
L3485,"Heel, pad, removable for spur"
L3500,"Orthopedic shoe addition, insole, leather"
L3510,"Orthopedic shoe addition, insole, rubber"
L3520,"Orthopedic shoe addition, insole, felt covered with leather"
L3530,"Orthopedic shoe addition, sole, half"
L3540,"Orthopedic shoe addition, sole, full"
L3550,"Orthopedic shoe addition, toe tap standard"
L3560,"Orthopedic shoe addition, toe tap, horseshoe"
L3570,"Orthopedic shoe addition, special extension to instep (leather with eyelets)"
L3580,"Orthopedic shoe addition, convert instep to velcro closure"
L3590,"Orthopedic shoe addition, convert firm shoe counter to soft counter"
L3595,"Orthopedic shoe addition, march bar"
L3600,"Transfer of an orthosis from one shoe to another, caliper plate, existing"
L3610,"Transfer of an orthosis from one shoe to another, caliper plate, new"
L3620,"Transfer of an orthosis from one shoe to another, solid stirrup, existing"
L3630,"Transfer of an orthosis from one shoe to another, solid stirrup, new"
L3640,"Transfer of an orthosis from one shoe to another, dennis browne splint (riveton), both shoes"
L3649,"Orthopedic shoe, modification, addition or transfer, not otherwise specified"
L3650,"Shoulder orthosis, figure of eight design abduction restrainer, prefabricated, off-the-shelf"
L3660,"Shoulder orthosis, figure of eight design abduction restrainer, canvas and webbing, prefabricated, off-the-shelf"
L3670,"Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf"
L3671,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3674,"Shoulder orthosis, abduction positioning (airplane design), thoracic component and support bar, with or without nontorsion joint/turnbuckle, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3675,"Shoulder orthosis, vest type abduction restrainer, canvas webbing type or equal, prefabricated, off-the-shelf"
L3677,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L3678,"Shoulder orthosis, shoulder joint design, without joints, may include soft interface, straps, prefabricated, off-the-shelf"
L3702,"Elbow orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3710,"Elbow orthosis, elastic with metal joints, prefabricated, off-the-shelf"
L3720,"Elbow orthosis, double upright with forearm/arm cuffs, free motion, custom fabricated"
L3730,"Elbow orthosis, double upright with forearm/arm cuffs, extension/ flexion assist, custom fabricated"
L3740,"Elbow orthosis, double upright with forearm/arm cuffs, adjustable position lock with active control, custom fabricated"
L3760,"Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific  patient by an individual with expertise"
L3761,"Elbow orthosis (eo), with adjustable position locking joint(s), prefabricated, off-the-shelf"
L3762,"Elbow orthosis, rigid, without joints, includes soft interface material, prefabricated, off-the-shelf"
L3763,"Elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3764,"Elbow wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3765,"Elbow wrist hand finger orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3766,"Elbow wrist hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3806,"Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, custom fabricated, includes fitting and adjustment"
L3807,"Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L3808,"Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment"
L3809,"Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type"
L3891,"Addition to upper extremity joint, wrist or elbow, concentric adjustable torsion style mechanism for custom fabricated orthotics only, each"
L3900,"Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, wrist or finger driven, custom fabricated"
L3901,"Wrist hand finger orthosis, dynamic flexor hinge, reciprocal wrist extension/ flexion, finger flexion/extension, cable driven, custom fabricated"
L3904,"Wrist hand finger orthosis, external powered, electric, custom fabricated"
L3905,"Wrist hand orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3906,"Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3908,"Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf"
L3912,"Hand finger orthosis (hfo), flexion glove with elastic finger control, prefabricated, off-the-shelf"
L3913,"Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3915,"Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L3916,"Wrist hand orthosis, includes one or more nontorsion joint(s), elastic bands, turnbuckles, may include soft interface, straps, prefabricated, off-the-shelf"
L3917,"Hand orthosis, metacarpal fracture orthosis, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L3918,"Hand orthosis, metacarpal fracture orthosis, prefabricated, off-the-shelf"
L3919,"Hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3921,"Hand finger orthosis, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3923,"Hand finger orthosis, without joints, may include soft interface, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L3924,"Hand finger orthosis, without joints, may include soft interface, straps, prefabricated, off-the-shelf"
L3925,"Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), non torsion joint/spring, extension/flexion, may include soft interface material, prefabricated, off-the-shelf"
L3927,"Finger orthosis, proximal interphalangeal (pip)/distal interphalangeal (dip), without joint/spring, extension/flexion (e.g., static or ring type), may include soft interface material, prefabricated, off-the-shelf"
L3929,"Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L3930,"Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, off-the-shelf"
L3931,"Wrist hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated, includes fitting and adjustment"
L3933,"Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment"
L3935,"Finger orthosis, nontorsion joint, may include soft interface, custom fabricated, includes fitting and adjustment"
L3956,"Addition of joint to upper extremity orthosis, any material; per joint"
L3960,"Shoulder elbow wrist hand orthosis, abduction positioning, airplane design, prefabricated, includes fitting and adjustment"
L3961,"Shoulder elbow wrist hand orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3962,"Shoulder elbow wrist hand orthosis, abduction positioning, erb's palsey design, prefabricated, includes fitting and adjustment"
L3967,"Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3971,"Shoulder elbow wrist hand orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3973,"Shoulder elbow wrist hand orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3975,"Shoulder elbow wrist hand finger orthosis, shoulder cap design, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3976,"Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3977,"Shoulder elbow wrist hand finger orthosis, shoulder cap design, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3978,"Shoulder elbow wrist hand finger orthosis, abduction positioning (airplane design), thoracic component and support bar, includes one or more nontorsion joints, elastic bands, turnbuckles, may include soft interface, straps, custom fabricated, includes fitting and adjustment"
L3980,"Upper extremity fracture orthosis, humeral, prefabricated, includes fitting and adjustment"
L3981,"Upper extremity fracture orthosis, humeral, prefabricated, includes shoulder cap design, with or without joints, forearm section, may include soft interface, straps, includes fitting and adjustments"
L3982,"Upper extremity fracture orthosis, radius/ulnar, prefabricated, includes fitting and adjustment"
L3984,"Upper extremity fracture orthosis, wrist, prefabricated, includes fitting and adjustment"
L3995,"Addition to upper extremity orthosis, sock, fracture or equal, each"
L3999,"Upper limb orthosis, not otherwise specified"
L4000,Replace girdle for spinal orthosis (ctlso or so)
L4002,"Replacement strap, any orthosis, includes all components, any length, any type"
L4010,Replace trilateral socket brim
L4020,"Replace quadrilateral socket brim, molded to patient model"
L4030,"Replace quadrilateral socket brim, custom fitted"
L4040,"Replace molded thigh lacer, for custom fabricated orthosis only"
L4045,"Replace non-molded thigh lacer, for custom fabricated orthosis only"
L4050,"Replace molded calf lacer, for custom fabricated orthosis only"
L4055,"Replace non-molded calf lacer, for custom fabricated orthosis only"
L4060,Replace high roll cuff
L4070,Replace proximal and distal upright for kafo
L4080,"Replace metal bands kafo, proximal thigh"
L4090,"Replace metal bands kafo-afo, calf or distal thigh"
L4100,"Replace leather cuff kafo, proximal thigh"
L4110,"Replace leather cuff kafo-afo, calf or distal thigh"
L4130,Replace pretibial shell
L4205,"Repair of orthotic device, labor component, per 15 minutes"
L4210,"Repair of orthotic device, repair or replace minor parts"
L4350,"Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf"
L4360,"Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L4361,"Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf"
L4370,"Pneumatic full leg splint, prefabricated, off-the-shelf"
L4386,"Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L4387,"Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf"
L4392,"Replacement, soft interface material, static afo"
L4394,"Replace soft interface material, foot drop splint"
L4396,"Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise"
L4397,"Static or dynamic ankle foot orthosis, including soft interface material, adjustable for fit, for positioning, may be used for minimal ambulation, prefabricated, off-the-shelf"
L4398,"Foot drop splint, recumbent positioning device, prefabricated, off-the-shelf"
L4631,"Ankle foot orthosis, walking boot type, varus/valgus correction, rocker bottom, anterior tibial shell, soft interface, custom arch support, plastic or other material, includes straps and closures, custom fabricated"
L5000,"Partial foot, shoe insert with longitudinal arch, toe filler"
L5010,"Partial foot, molded socket, ankle height, with toe filler"
L5020,"Partial foot, molded socket, tibial tubercle height, with toe filler"
L5050,"Ankle, symes, molded socket, sach foot"
L5060,"Ankle, symes, metal frame, molded leather socket, articulated ankle/foot"
L5100,"Below knee, molded socket, shin, sach foot"
L5105,"Below knee, plastic socket, joints and thigh lacer, sach foot"
L5150,"Knee disarticulation (or through knee), molded socket, external knee joints, shin, sach foot"
L5160,"Knee disarticulation (or through knee), molded socket, bent knee configuration, external knee joints, shin, sach foot"
L5200,"Above knee, molded socket, single axis constant friction knee, shin, sach foot"
L5210,"Above knee, short prosthesis, no knee joint ('stubbies'), with foot blocks, no ankle joints, each"
L5220,"Above knee, short prosthesis, no knee joint ('stubbies'), with articulated ankle/foot, dynamically aligned, each"
L5230,"Above knee, for proximal femoral focal deficiency, constant friction knee, shin, sach foot"
L5250,"Hip disarticulation, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot"
L5270,"Hip disarticulation, tilt table type; molded socket, locking hip joint, single axis constant friction knee, shin, sach foot"
L5280,"Hemipelvectomy, canadian type; molded socket, hip joint, single axis constant friction knee, shin, sach foot"
L5301,"Below knee, molded socket, shin, sach foot, endoskeletal system"
L5312,"Knee disarticulation (or through knee), molded socket, single axis knee, pylon, sach foot, endoskeletal system"
L5321,"Above knee, molded socket, open end, sach foot, endoskeletal system, single axis knee"
L5331,"Hip disarticulation, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot"
L5341,"Hemipelvectomy, canadian type, molded socket, endoskeletal system, hip joint, single axis knee, sach foot"
L5400,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment, suspension, and one cast change, below knee"
L5410,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension, below knee, each additional cast change and realignment"
L5420,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting, alignment and suspension and one cast change 'ak' or knee disarticulation"
L5430,"Immediate post surgical or early fitting, application of initial rigid dressing, incl. fitting, alignment and supension, 'ak' or knee disarticulation, each additional cast change and realignment"
L5450,"Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, below knee"
L5460,"Immediate post surgical or early fitting, application of non-weight bearing rigid dressing, above knee"
L5500,"Initial, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed"
L5505,"Initial, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, direct formed"
L5510,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model"
L5520,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed"
L5530,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model"
L5535,"Preparatory, below knee 'ptb' type socket, non-alignable system, no cover, sach foot, prefabricated, adjustable open end socket"
L5540,"Preparatory, below knee 'ptb' type socket, non-alignable system, pylon, no cover, sach foot, laminated socket, molded to model"
L5560,"Preparatory, above knee- knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, plaster socket, molded to model"
L5570,"Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, direct formed"
L5580,"Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon, no cover, sach foot, thermoplastic or equal, molded to model"
L5585,"Preparatory, above knee - knee disarticulation, ischial level socket, non-alignable system, pylon, no cover, sach foot, prefabricated adjustable open end socket"
L5590,"Preparatory, above knee - knee disarticulation ischial level socket, non-alignable system, pylon no cover, sach foot, laminated socket, molded to model"
L5595,"Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, thermoplastic or equal, molded to patient model"
L5600,"Preparatory, hip disarticulation-hemipelvectomy, pylon, no cover, sach foot, laminated socket, molded to patient model"
L5610,"Addition to lower extremity, endoskeletal system, above knee, hydracadence system"
L5611,"Addition to lower extremity, endoskeletal system, above knee - knee disarticulation, 4 bar linkage, with friction swing phase control"
L5613,"Addition to lower extremity, endoskeletal system, above knee-knee disarticulation, 4 bar linkage, with hydraulic swing phase control"
L5614,"Addition to lower extremity, exoskeletal system, above knee-knee disarticulation, 4 bar linkage, with pneumatic swing phase control"
L5615,"Addition, endoskeletal knee-shin system, 4 bar linkage or multiaxial, fluid swing and stance phase control"
L5616,"Addition to lower extremity, endoskeletal system, above knee, universal multiplex system, friction swing phase control"
L5617,"Addition to lower extremity, quick change self-aligning unit, above knee or below knee, each"
L5618,"Addition to lower extremity, test socket, symes"
L5620,"Addition to lower extremity, test socket, below knee"
L5622,"Addition to lower extremity, test socket, knee disarticulation"
L5624,"Addition to lower extremity, test socket, above knee"
L5626,"Addition to lower extremity, test socket, hip disarticulation"
L5628,"Addition to lower extremity, test socket, hemipelvectomy"
L5629,"Addition to lower extremity, below knee, acrylic socket"
L5630,"Addition to lower extremity, symes type, expandable wall socket"
L5631,"Addition to lower extremity, above knee or knee disarticulation, acrylic socket"
L5632,"Addition to lower extremity, symes type, 'ptb' brim design socket"
L5634,"Addition to lower extremity, symes type, posterior opening (canadian) socket"
L5636,"Addition to lower extremity, symes type, medial opening socket"
L5637,"Addition to lower extremity, below knee, total contact"
L5638,"Addition to lower extremity, below knee, leather socket"
L5639,"Addition to lower extremity, below knee, wood socket"
L5640,"Addition to lower extremity, knee disarticulation, leather socket"
L5642,"Addition to lower extremity, above knee, leather socket"
L5643,"Addition to lower extremity, hip disarticulation, flexible inner socket, external frame"
L5644,"Addition to lower extremity, above knee, wood socket"
L5645,"Addition to lower extremity, below knee, flexible inner socket, external frame"
L5646,"Addition to lower extremity, below knee, air, fluid, gel or equal, cushion socket"
L5647,"Addition to lower extremity, below knee suction socket"
L5648,"Addition to lower extremity, above knee, air, fluid, gel or equal, cushion socket"
L5649,"Addition to lower extremity, ischial containment/narrow m-l socket"
L5650,"Additions to lower extremity, total contact, above knee or knee disarticulation socket"
L5651,"Addition to lower extremity, above knee, flexible inner socket, external frame"
L5652,"Addition to lower extremity, suction suspension, above knee or knee disarticulation socket"
L5653,"Addition to lower extremity, knee disarticulation, expandable wall socket"
L5654,"Addition to lower extremity, socket insert, symes, (kemblo, pelite, aliplast, plastazote or equal)"
L5655,"Addition to lower extremity, socket insert, below knee (kemblo, pelite, aliplast, plastazote or equal)"
L5656,"Addition to lower extremity, socket insert, knee disarticulation (kemblo, pelite, aliplast, plastazote or equal)"
L5657,"Addition to lower extremity prosthesis, manual/automated adjustable air, fluid, gel or equal socket insert for limb volume management, any materials"
L5658,"Addition to lower extremity, socket insert, above knee (kemblo, pelite, aliplast, plastazote or equal)"
L5661,"Addition to lower extremity, socket insert, multi-durometer symes"
L5665,"Addition to lower extremity, socket insert, multi-durometer, below knee"
L5666,"Addition to lower extremity, below knee, cuff suspension"
L5668,"Addition  to lower extremity, below knee, molded distal cushion"
L5670,"Addition to lower extremity, below knee, molded supracondylar suspension ('pts' or similar)"
L5671,"Addition to lower extremity, below knee / above knee suspension locking mechanism (shuttle, lanyard or equal), excludes socket insert"
L5672,"Addition to lower extremity, below knee, removable medial brim suspension"
L5673,"Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric, or equal, with or without perforations, with or without breathable material, for use with locking mechanism"
L5676,"Additions to lower extremity, below knee, knee joints, single axis, pair"
L5677,"Additions to lower extremity, below knee, knee joints, polycentric, pair"
L5678,"Additions to lower extremity, below knee, joint covers, pair"
L5679,"Addition to lower extremity, below knee/above knee, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric, or equal, with or without perforations, with or without breathable material, not for use with locking mechanism"
L5680,"Addition to lower extremity, below knee, thigh lacer, nonmolded"
L5681,"Addition to lower extremity, below knee/above knee, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)"
L5682,"Addition to lower extremity, below knee, thigh lacer, gluteal/ischial, molded"
L5683,"Addition to lower extremity, below knee/above knee, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l5673 or l5679)"
L5684,"Addition to lower extremity, below knee, fork strap"
L5685,"Addition to lower extremity prosthesis, below knee, suspension/sealing sleeve, with or without valve, any material, each"
L5686,"Addition to lower extremity, below knee, back check (extension control)"
L5688,"Addition to lower extremity, below knee, waist belt, webbing"
L5690,"Addition to lower extremity, below knee, waist belt, padded and lined"
L5692,"Addition to lower extremity, above knee, pelvic control belt, light"
L5694,"Addition to lower extremity, above knee, pelvic control belt, padded and lined"
L5695,"Addition to lower extremity, above knee, pelvic control, sleeve suspension, neoprene or equal, each"
L5696,"Addition to lower extremity, above knee or knee disarticulation, pelvic joint"
L5697,"Addition to lower extremity, above knee or knee disarticulation, pelvic band"
L5698,"Addition to lower extremity, above knee or knee disarticulation, silesian bandage"
L5699,"All lower extremity prostheses, shoulder harness"
L5700,"Replacement, socket, below knee, molded to patient model"
L5701,"Replacement, socket, above knee/knee disarticulation, including attachment plate, molded to patient model"
L5702,"Replacement, socket, hip disarticulation, including hip joint, molded to patient model"
L5703,"Ankle, symes, molded to patient model, socket without solid ankle cushion heel (sach) foot, replacement only"
L5704,"Custom shaped protective cover, below knee"
L5705,"Custom shaped protective cover, above knee"
L5706,"Custom shaped protective cover, knee disarticulation"
L5707,"Custom shaped protective cover, hip disarticulation"
L5710,"Addition, exoskeletal knee-shin system, single axis, manual lock"
L5711,"Additions exoskeletal knee-shin system, single axis, manual lock, ultra-light material"
L5712,"Addition, exoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)"
L5714,"Addition, exoskeletal knee-shin system, single axis, variable friction swing phase control"
L5716,"Addition, exoskeletal knee-shin system, polycentric, mechanical stance phase lock"
L5718,"Addition, exoskeletal knee-shin system, polycentric, friction swing and stance phase control"
L5722,"Addition, exoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control"
L5724,"Addition, exoskeletal knee-shin system, single axis, fluid swing phase control"
L5726,"Addition, exoskeletal knee-shin system, single axis, external joints fluid swing phase control"
L5728,"Addition, exoskeletal knee-shin system, single axis, fluid swing and stance phase control"
L5780,"Addition, exoskeletal knee-shin system, single axis, pneumatic/hydra pneumatic swing phase control"
L5781,"Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system"
L5782,"Addition to lower limb prosthesis, vacuum pump, residual limb volume management and moisture evacuation system, heavy duty"
L5783,"Addition to lower extremity, user adjustable, mechanical, residual limb volume management system (with or without lamination kit)"
L5785,"Addition, exoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)"
L5790,"Addition, exoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)"
L5795,"Addition, exoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)"
L5810,"Addition, endoskeletal knee-shin system, single axis, manual lock"
L5811,"Addition, endoskeletal knee-shin system, single axis, manual lock, ultra-light material"
L5812,"Addition, endoskeletal knee-shin system, single axis, friction swing and stance phase control (safety knee)"
L5814,"Addition, endoskeletal knee-shin system, polycentric, hydraulic swing phase control, mechanical stance phase lock"
L5816,"Addition, endoskeletal knee-shin system, polycentric, mechanical stance phase lock"
L5818,"Addition, endoskeletal knee-shin system, polycentric, friction swing, and stance phase control"
L5822,"Addition, endoskeletal knee-shin system, single axis, pneumatic swing, friction stance phase control"
L5824,"Addition, endoskeletal knee-shin system, single axis, fluid swing phase control"
L5826,"Addition, endoskeletal knee-shin system, single axis, hydraulic swing phase control, with miniature high activity frame"
L5827,"Endoskeletal knee-shin system, single axis, electromechanical swing and stance phase control, with or without shock absorption and stance extension damping"
L5828,"Addition, endoskeletal knee-shin system, single axis, fluid swing and stance phase control"
L5830,"Addition, endoskeletal knee-shin system, single axis, pneumatic/ swing phase control"
L5840,"Addition, endoskeletal knee/shin system, 4-bar linkage or multiaxial, pneumatic swing phase control"
L5841,"Addition, endoskeletal knee-shin system, polycentric, pneumatic swing, and stance phase control"
L5845,"Addition, endoskeletal, knee-shin system, stance flexion feature, adjustable"
L5848,"Addition to endoskeletal knee-shin system, fluid stance extension, dampening feature, with or without adjustability"
L5850,"Addition, endoskeletal system, above knee or hip disarticulation, knee extension assist"
L5855,"Addition, endoskeletal system, hip disarticulation, mechanical hip extension assist"
L5856,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing and stance phase, includes electronic sensor(s), any type"
L5857,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, microprocessor control feature, swing phase only, includes electronic sensor(s), any type"
L5858,"Addition to lower extremity prosthesis, endoskeletal knee shin system, microprocessor control feature, stance phase only, includes electronic sensor(s), any type"
L5859,"Addition to lower extremity prosthesis, endoskeletal knee-shin system, powered and programmable flexion/extension assist control, includes any type motor(s)"
L5910,"Addition, endoskeletal system, below knee, alignable system"
L5920,"Addition, endoskeletal system, above knee or hip disarticulation, alignable system"
L5925,"Addition, endoskeletal system, above knee, knee disarticulation or hip disarticulation, manual lock"
L5926,"Addition to lower extremity prosthesis, endoskeletal, knee disarticulation, above knee, hip disarticulation, positional rotation unit, any type"
L5930,"Addition, endoskeletal system, high activity knee control frame"
L5940,"Addition, endoskeletal system, below knee, ultra-light material (titanium, carbon fiber or equal)"
L5950,"Addition, endoskeletal system, above knee, ultra-light material (titanium, carbon fiber or equal)"
L5960,"Addition, endoskeletal system, hip disarticulation, ultra-light material (titanium, carbon fiber or equal)"
L5961,"Addition, endoskeletal system, polycentric hip joint, pneumatic or hydraulic control, rotation control, with or without flexion and/or extension control"
L5962,"Addition, endoskeletal system, below knee, flexible protective outer surface covering system"
L5964,"Addition, endoskeletal system, above knee, flexible protective outer surface covering system"
L5966,"Addition, endoskeletal system, hip disarticulation, flexible protective outer surface covering system"
L5968,"Addition to lower limb prosthesis, multiaxial ankle with swing phase active dorsiflexion feature"
L5969,"Addition, endoskeletal ankle-foot or ankle system, power assist, includes any type motor(s)"
L5970,"All lower extremity prostheses, foot, external keel, sach foot"
L5971,"All lower extremity prosthesis, solid ankle cushion heel (sach) foot, replacement only"
L5972,"All lower extremity prostheses, foot, flexible keel"
L5973,"Endoskeletal ankle foot system, microprocessor controlled feature, dorsiflexion and/or plantar flexion control, includes power source"
L5974,"All lower extremity prostheses, foot, single axis ankle/foot"
L5975,"All lower extremity prosthesis, combination single axis ankle and flexible keel foot"
L5976,"All lower extremity prostheses, energy storing foot (seattle carbon copy ii or equal)"
L5978,"All lower extremity prostheses, foot, multiaxial ankle/foot"
L5979,"All lower extremity prosthesis, multi-axial ankle, dynamic response foot, one piece system"
L5980,"All lower extremity prostheses, flex foot system"
L5981,"All lower extremity prostheses, flex-walk system or equal"
L5982,"All exoskeletal lower extremity prostheses, axial rotation unit"
L5984,"All endoskeletal lower extremity prosthesis, axial rotation unit, with or without adjustability"
L5985,"All endoskeletal lower extremity prostheses, dynamic prosthetic pylon"
L5986,"All lower extremity prostheses, multi-axial rotation unit ('mcp' or equal)"
L5987,"All lower extremity prosthesis, shank foot system with vertical loading pylon"
L5988,"Addition to lower limb prosthesis, vertical shock reducing pylon feature"
L5990,"Addition to lower extremity prosthesis, user adjustable heel height"
L5991,"Addition to lower extremity prostheses, osseointegrated external prosthetic connector"
L5999,"Lower extremity prosthesis, not otherwise specified"
L6000,"Partial hand, thumb remaining"
L6010,"Partial hand, little and/or ring finger remaining"
L6020,"Partial hand, no finger remaining"
L6025,"Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal deviceTerminated December 31, 2014."
L6026,"Transcarpal/metacarpal or partial hand disarticulation prosthesis, external power, self-suspended, inner socket with removable forearm section, electrodes and cables, two batteries, charger, myoelectric control of terminal device, excludes terminal device(s)"
L6028,"Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at metacarpal level, including flexible or non-flexible interface, molded to patient model, including palm, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692"
L6029,"Upper extremity addition, test socket/interface, partial hand including fingers"
L6030,"Upper extremity addition, external frame, partial hand including fingers"
L6031,"Replacement socket/interface, partial hand including fingers, molded to patient model, for use with or without external power"
L6032,"Addition to upper extremity prosthesis, partial hand including fingers, ultralight material (titanium, carbon fiber or equal)"
L6033,"Addition to upper extremity prosthesis, partial hand including fingers, acrylic material"
L6034,"Partial hand, finger, and thumb prosthesis without prosthetic digit(s)/thumb, amputation at distal to metacarpal joint, including flexible or non-flexible interface, molded to patient model, for use without external power and/or passive prosthetic digit/thumb, not including inserts described by l6692"
L6035,"Single prosthetic digit, mechanical, can include metacarpophalangeal (mcp), proximal interphalangeal (pip), and/or distal interphalangeal (dip) joint(s), with or without locking mechanism, can include flexion or extension assist, any material, attachment, initial issue or replacement"
L6036,"Prosthetic thumb, mechanical, can include metacarpophalangeal (mcp), interphalangeal (ip) joint(s), with or without locking mechanism, can include flexion or extension assist, any material, attachment, initial issue or replacement"
L6037,"Immediate post-surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, partial hand including fingers"
L6038,"Addition to single prosthetic digit or thumb, mechanical, attachment, multiaxial and/or internal/external rotation/abduction/adduction mechanism, with or without locking feature, any material"
L6039,"Passive prosthetic digit or thumb prosthesis not including hand restoration partial hand, full or partial, custom made, any material, initial or replacement, per single passive prosthetic digit or thumb"
L6050,"Wrist disarticulation, molded socket, flexible elbow hinges, triceps pad"
L6055,"Wrist disarticulation, molded socket with expandable interface, flexible elbow hinges, triceps pad"
L6100,"Below elbow, molded socket, flexible elbow hinge, triceps pad"
L6110,"Below elbow, molded socket, (muenster or northwestern suspension types)"
L6120,"Below elbow, molded double wall split socket, step-up hinges, half cuff"
L6130,"Below elbow, molded double wall split socket, stump activated locking hinge, half cuff"
L6200,"Elbow disarticulation, molded socket, outside locking hinge, forearm"
L6205,"Elbow disarticulation, molded socket with expandable interface, outside locking hinges, forearm"
L6250,"Above elbow, molded double wall socket, internal locking elbow, forearm"
L6300,"Shoulder disarticulation, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm"
L6310,"Shoulder disarticulation, passive restoration (complete prosthesis)"
L6320,"Shoulder disarticulation, passive restoration (shoulder cap only)"
L6350,"Interscapular thoracic, molded socket, shoulder bulkhead, humeral section, internal locking elbow, forearm"
L6360,"Interscapular thoracic, passive restoration (complete prosthesis)"
L6370,"Interscapular thoracic, passive restoration (shoulder cap only)"
L6380,"Immediate post surgical or early fitting, application of initial rigid dressing, including fitting alignment and suspension of components, and one cast change, wrist disarticulation or below elbow"
L6382,"Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, elbow disarticulation or above elbow"
L6384,"Immediate post surgical or early fitting, application of initial rigid dressing including fitting alignment and suspension of components, and one cast change, shoulder disarticulation or interscapular thoracic"
L6386,"Immediate post surgical or early fitting, each additional cast change and realignment"
L6388,"Immediate post surgical or early fitting, application of rigid dressing only"
L6400,"Below elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping"
L6450,"Elbow disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping"
L6500,"Above elbow, molded socket, endoskeletal system, including soft prosthetic tissue shaping"
L6550,"Shoulder disarticulation, molded socket, endoskeletal system, including soft prosthetic tissue shaping"
L6570,"Interscapular thoracic, molded socket, endoskeletal system, including soft prosthetic tissue shaping"
L6580,"Preparatory, wrist disarticulation or below elbow, single wall plastic socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, molded to patient model"
L6582,"Preparatory, wrist disarticulation or below elbow, single wall socket, friction wrist, flexible elbow hinges, figure of eight harness, humeral cuff, bowden cable control, usmc or equal pylon, no cover, direct formed"
L6584,"Preparatory, elbow disarticulation or above elbow, single wall plastic socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, molded to patient model"
L6586,"Preparatory, elbow disarticulation or above elbow, single wall socket, friction wrist, locking elbow, figure of eight harness, fair lead cable control, usmc or equal pylon, no cover, direct formed"
L6588,"Preparatory, shoulder disarticulation or interscapular thoracic, single wall plastic socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, molded to patient model"
L6590,"Preparatory, shoulder disarticulation or interscapular thoracic, single wall socket, shoulder joint, locking elbow, friction wrist, chest strap, fair lead cable control, usmc or equal pylon, no cover, direct formed"
L6600,"Upper extremity additions, polycentric hinge, pair"
L6605,"Upper extremity additions, single pivot hinge, pair"
L6610,"Upper extremity additions, flexible metal hinge, pair"
L6611,"Addition to upper extremity prosthesis, external powered, additional switch, any type"
L6615,"Upper extremity addition, disconnect locking wrist unit"
L6616,"Upper extremity addition, additional disconnect insert for locking wrist unit, each"
L6620,"Upper extremity addition, flexion/extension wrist unit, with or without friction"
L6621,"Upper extremity prosthesis addition, flexion/extension wrist with or without friction, for use with external powered terminal device"
L6623,"Upper extremity addition, spring assisted rotational wrist unit with latch release"
L6624,"Upper extremity addition, flexion/extension and rotation wrist unit"
L6625,"Upper extremity addition, rotation wrist unit with cable lock"
L6628,"Upper extremity addition, quick disconnect hook adapter, otto bock or equal"
L6629,"Upper extremity addition, quick disconnect lamination collar with coupling piece, otto bock or equal"
L6630,"Upper extremity addition, stainless steel, any wrist"
L6632,"Upper extremity addition, latex suspension sleeve, each"
L6635,"Upper extremity addition, lift assist for elbow"
L6637,"Upper extremity addition, nudge control elbow lock"
L6638,"Upper extremity addition to prosthesis, electric locking feature, only for use with manually powered elbow"
L6640,"Upper extremity additions, shoulder abduction joint, pair"
L6641,"Upper extremity addition, excursion amplifier, pulley type"
L6642,"Upper extremity addition, excursion amplifier, lever type"
L6645,"Upper extremity addition, shoulder flexion-abduction joint, each"
L6646,"Upper extremity addition, shoulder joint, multipositional locking, flexion, adjustable abduction friction control, for use with body powered or external powered system"
L6647,"Upper extremity addition, shoulder lock mechanism, body powered actuator"
L6648,"Upper extremity addition, shoulder lock mechanism, external powered actuator"
L6650,"Upper extremity addition, shoulder universal joint, each"
L6655,"Upper extremity addition, standard control cable, extra"
L6660,"Upper extremity addition, heavy duty control cable"
L6665,"Upper extremity addition, teflon, or equal, cable lining"
L6670,"Upper extremity addition, hook to hand, cable adapter"
L6672,"Upper extremity addition, harness, chest or shoulder, saddle type"
L6675,"Upper extremity addition, harness, (e.g., figure of eight type), single cable design"
L6676,"Upper extremity addition, harness, (e.g., figure of eight type), dual cable design"
L6677,"Upper extremity addition, harness, triple control, simultaneous operation of terminal device and elbow"
L6680,"Upper extremity addition, test socket, wrist disarticulation or below elbow"
L6682,"Upper extremity addition, test socket, elbow disarticulation or above elbow"
L6684,"Upper extremity addition, test socket, shoulder disarticulation or interscapular thoracic"
L6686,"Upper extremity addition, suction socket"
L6687,"Upper extremity addition, frame type socket, below elbow or wrist disarticulation"
L6688,"Upper extremity addition, frame type socket, above elbow or elbow disarticulation"
L6689,"Upper extremity addition, frame type socket, shoulder disarticulation"
L6690,"Upper extremity addition, frame type socket, interscapular-thoracic"
L6691,"Upper extremity addition, removable insert, each"
L6692,"Upper extremity addition, silicone gel insert or equal, with or without locking mechanism, each"
L6693,"Upper extremity addition, locking elbow, forearm counterbalance"
L6694,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, for use with locking mechanism"
L6695,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated from existing mold or prefabricated, socket insert, silicone gel, elastomeric or equal, not for use with locking mechanism"
L6696,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)"
L6697,"Addition to upper extremity prosthesis, below elbow/above elbow, custom fabricated socket insert for other than congenital or atypical traumatic amputee, silicone gel, elastomeric or equal, for use with or without locking mechanism, initial only (for other than initial, use code l6694 or l6695)"
L6698,"Addition to upper extremity prosthesis, lock mechanism, excludes socket insert"
L6700,"Upper extremity addition, external powered feature, myoelectronic control module, additional emg inputs, pattern-recognition decoding intent movement"
L6703,"Terminal device, passive hand/mitt, any material, any size"
L6704,"Terminal device, sport/recreational/work attachment, any material, any size"
L6706,"Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined"
L6707,"Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined"
L6708,"Terminal device, hand, mechanical, voluntary opening, any material, any size"
L6709,"Terminal device, hand, mechanical, voluntary closing, any material, any size"
L6711,"Terminal device, hook, mechanical, voluntary opening, any material, any size, lined or unlined, pediatric"
L6712,"Terminal device, hook, mechanical, voluntary closing, any material, any size, lined or unlined, pediatric"
L6713,"Terminal device, hand, mechanical, voluntary opening, any material, any size, pediatric"
L6714,"Terminal device, hand, mechanical, voluntary closing, any material, any size, pediatric"
L6715,"Terminal device, multiple articulating digit, includes motor(s), initial issue or replacement"
L6721,"Terminal device, hook or hand, heavy duty, mechanical, voluntary opening, any material, any size, lined or unlined"
L6722,"Terminal device, hook or hand, heavy duty, mechanical, voluntary closing, any material, any size, lined or unlined"
L6805,"Addition to terminal device, modifier wrist unit"
L6810,"Addition to terminal device, precision pinch device"
L6880,"Electric hand, switch or myoelectric controlled, independently articulating digits, any grasp pattern or combination of grasp patterns, includes motor(s)"
L6881,"Automatic grasp feature, addition to upper limb electric prosthetic terminal device"
L6882,"Microprocessor control feature, addition to upper limb prosthetic terminal device"
L6883,"Replacement socket, below elbow/wrist disarticulation, molded to patient model, for use with or without external power"
L6884,"Replacement socket, above elbow/elbow disarticulation, molded to patient model, for use with or without external power"
L6885,"Replacement socket, shoulder disarticulation/interscapular thoracic, molded to patient model, for use with or without external power"
L6890,"Addition to upper extremity prosthesis, glove for terminal device, any material, prefabricated, includes fitting and adjustment"
L6895,"Addition to upper extremity prosthesis, glove for terminal device, any material, custom fabricated"
L6900,"Hand restoration (casts, shading and measurements included), partial hand, with glove, thumb or one finger remaining"
L6905,"Hand restoration (casts, shading and measurements included), partial hand, with glove, multiple fingers remaining"
L6910,"Hand restoration (casts, shading and measurements included), partial hand, with glove, no fingers remaining"
L6915,"Hand restoration (shading, and measurements included), replacement glove for above"
L6920,"Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal, switch, cables, two batteries and one charger, switch control of terminal device"
L6925,"Wrist disarticulation, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device"
L6930,"Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device"
L6935,"Below elbow, external power, self-suspended inner socket, removable forearm shell, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device"
L6940,"Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device"
L6945,"Elbow disarticulation, external power, molded inner socket, removable humeral shell, outside locking hinges, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device"
L6950,"Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device"
L6955,"Above elbow, external power, molded inner socket, removable humeral shell, internal locking elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device"
L6960,"Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device"
L6965,"Shoulder disarticulation, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device"
L6970,"Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal switch, cables, two batteries and one charger, switch control of terminal device"
L6975,"Interscapular-thoracic, external power, molded inner socket, removable shoulder shell, shoulder bulkhead, humeral section, mechanical elbow, forearm, otto bock or equal electrodes, cables, two batteries and one charger, myoelectronic control of terminal device"
L7007,"Electric hand, switch or myoelectric controlled, adult"
L7008,"Electric hand, switch or myoelectric, controlled, pediatric"
L7009,"Electric hook, switch or myoelectric controlled, adult"
L7040,"Prehensile actuator, switch controlled"
L7045,"Electric hook, switch or myoelectric controlled, pediatric"
L7170,"Electronic elbow, hosmer or equal, switch controlled"
L7180,"Electronic elbow, microprocessor sequential control of elbow and terminal device"
L7181,"Electronic elbow, microprocessor simultaneous control of elbow and terminal device"
L7185,"Electronic elbow, adolescent, variety village or equal, switch controlled"
L7186,"Electronic elbow, child, variety village or equal, switch controlled"
L7190,"Electronic elbow, adolescent, variety village or equal, myoelectronically controlled"
L7191,"Electronic elbow, child, variety village or equal, myoelectronically controlled"
L7259,"Electronic wrist rotator, any type"
L7260,"Electronic wrist rotator, otto bock or equalTerminated December 31, 2014."
L7261,"Electronic wrist rotator, for utah armTerminated December 31, 2014."
L7360,"Six volt battery, each"
L7362,"Battery charger, six volt, each"
L7364,"Twelve volt battery, each"
L7366,"Battery charger, twelve volt, each"
L7367,"Lithium ion battery, rechargeable, replacement"
L7368,"Lithium ion battery charger, replacement only"
L7400,"Addition to upper extremity prosthesis, below elbow/wrist disarticulation, ultralight material (titanium, carbon fiber or equal)"
L7401,"Addition to upper extremity prosthesis, above elbow disarticulation, ultralight material (titanium, carbon fiber or equal)"
L7402,"Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, ultralight material (titanium, carbon fiber or equal)"
L7403,"Addition to upper extremity prosthesis, below elbow/wrist disarticulation, acrylic material"
L7404,"Addition to upper extremity prosthesis, above elbow disarticulation, acrylic material"
L7405,"Addition to upper extremity prosthesis, shoulder disarticulation/interscapular thoracic, acrylic material"
L7406,"Addition to upper extremity prosthesis, user adjustable, mechanical, residual limb volume management system (with or without lamination kit)"
L7499,"Upper extremity prosthesis, not otherwise specified"
L7510,"Repair of prosthetic device, repair or replace minor parts"
L7520,"Repair prosthetic device, labor component, per 15 minutes"
L7600,"Prosthetic donning sleeve, any material, each"
L7700,"Gasket or seal, for use with prosthetic socket insert, any type, each"
L7900,Male vacuum erection system
L7902,"Tension ring, for vacuum erection device, any type, replacement only, each"
L8000,"Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type"
L8001,"Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, unilateral, any size, any type"
L8002,"Breast prosthesis, mastectomy bra, with integrated breast prosthesis form, bilateral, any size, any type"
L8010,"Breast prosthesis, mastectomy sleeveTerminated March 31, 2025."
L8015,"External breast prosthesis garment, with mastectomy form, post mastectomy"
L8020,"Breast prosthesis, mastectomy form"
L8030,"Breast prosthesis, silicone or equal, without integral adhesive"
L8031,"Breast prosthesis, silicone or equal, with integral adhesive"
L8032,"Nipple prosthesis, prefabricated, reusable, any type, each"
L8033,"Nipple prosthesis, custom fabricated, reusable, any material, any type, each"
L8035,"Custom breast prosthesis, post mastectomy, molded to patient model"
L8039,"Breast prosthesis, not otherwise specified"
L8040,"Nasal prosthesis, provided by a non-physician"
L8041,"Midfacial prosthesis, provided by a non-physician"
L8042,"Orbital prosthesis, provided by a non-physician"
L8043,"Upper facial prosthesis, provided by a non-physician"
L8044,"Hemi-facial prosthesis, provided by a non-physician"
L8045,"Auricular prosthesis, provided by a non-physician"
L8046,"Partial facial prosthesis, provided by a non-physician"
L8047,"Nasal septal prosthesis, provided by a non-physician"
L8048,"Unspecified maxillofacial prosthesis, by report, provided by a non-physician"
L8049,"Repair or modification of maxillofacial prosthesis, labor component, 15 minute increments, provided by a non-physician"
L8300,"Truss, single with standard pad"
L8310,"Truss, double with standard pads"
L8320,"Truss, addition to standard pad, water pad"
L8330,"Truss, addition to standard pad, scrotal pad"
L8400,"Prosthetic sheath, below knee, each"
L8410,"Prosthetic sheath, above knee, each"
L8415,"Prosthetic sheath, upper limb, each"
L8417,"Prosthetic sheath/sock, including a gel cushion layer, below knee or above knee, each"
L8420,"Prosthetic sock, multiple ply, below knee, each"
L8430,"Prosthetic sock, multiple ply, above knee, each"
L8435,"Prosthetic sock, multiple ply, upper limb, each"
L8440,"Prosthetic shrinker, below knee, each"
L8460,"Prosthetic shrinker, above knee, each"
L8465,"Prosthetic shrinker, upper limb, each"
L8470,"Prosthetic sock, single ply, fitting, below knee, each"
L8480,"Prosthetic sock, single ply, fitting, above knee, each"
L8485,"Prosthetic sock, single ply, fitting, upper limb, each"
L8499,Unlisted procedure for miscellaneous prosthetic services
L8500,"Artificial larynx, any type"
L8501,Tracheostomy speaking valve
L8505,"Artificial larynx replacement battery / accessory, any type"
L8507,"Tracheo-esophageal voice prosthesis, patient inserted, any type, each"
L8509,"Tracheo-esophageal voice prosthesis, inserted by a licensed health care provider, any type"
L8510,Voice amplifier
L8511,"Insert for indwelling tracheoesophageal prosthesis, with or without valve, replacement only, each"
L8512,"Gelatin capsules or equivalent, for use with tracheoesophageal voice prosthesis, replacement only, per 10"
L8513,"Cleaning device used with tracheoesophageal voice prosthesis, pipet, brush, or equal, replacement only, each"
L8514,"Tracheoesophageal puncture dilator, replacement only, each"
L8515,"Gelatin capsule, application device for use with tracheoesophageal voice prosthesis, each"
L8600,"Implantable breast prosthesis, silicone or equal"
L8603,"Injectable bulking agent, collagen implant, urinary tract, 2.5 ml syringe, includes shipping and necessary supplies"
L8604,"Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, urinary tract, 1 ml, includes shipping and necessary supplies"
L8605,"Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies"
L8606,"Injectable bulking agent, synthetic implant, urinary tract, 1 ml syringe, includes shipping and necessary supplies"
L8607,"Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies"
L8608,"Miscellaneous external component, supply or accessory for use with the argus ii retinal prosthesis system"
L8609,Artificial cornea
L8610,Ocular implant
L8612,Aqueous shunt
L8613,Ossicula implant
L8614,"Cochlear device, includes all internal and external components"
L8615,"Headset/headpiece for use with cochlear implant device, replacement"
L8616,"Microphone for use with cochlear implant device, replacement"
L8617,"Transmitting coil for use with cochlear implant device, replacement"
L8618,"Transmitter cable for use with cochlear implant device or auditory osseointegrated device, replacement"
L8619,"Cochlear implant, external speech processor and controller, integrated system, replacement"
L8621,"Zinc air battery for use with cochlear implant device and auditory osseointegrated sound processors, replacement, each"
L8622,"Alkaline battery for use with cochlear implant device, any size, replacement, each"
L8623,"Lithium ion battery for use with cochlear implant device speech processor, other than ear level, replacement, each"
L8624,"Lithium ion battery for use with cochlear implant or auditory osseointegrated device speech processor, ear level, replacement, each"
L8625,"External recharging system for battery for use with cochlear implant or auditory osseointegrated device, replacement only, each"
L8627,"Cochlear implant, external speech processor, component, replacement"
L8628,"Cochlear implant, external controller component, replacement"
L8629,"Transmitting coil and cable, integrated, for use with cochlear implant device, replacement"
L8630,Metacarpophalangeal joint implant
L8631,"Metacarpal phalangeal joint replacement, two or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon), for surgical implantation (all sizes, includes entire system)"
L8641,Metatarsal joint implant
L8642,Hallux implant
L8658,"Interphalangeal joint spacer, silicone or equal, each"
L8659,"Interphalangeal finger joint replacement, 2 or more pieces, metal (e.g., stainless steel or cobalt chrome), ceramic-like material (e.g., pyrocarbon) for surgical implantation, any size"
L8670,"Vascular graft material, synthetic, implant"
L8678,"Electrical stimulator supplies (external) for use with implantable neurostimulator, per month"
L8679,"Implantable neurostimulator, pulse generator, any type"
L8680,"Implantable neurostimulator electrode, each"
L8681,"Patient programmer (external) for use with implantable programmable neurostimulator pulse generator, replacement only"
L8682,Implantable neurostimulator radiofrequency receiver
L8683,Radiofrequency transmitter (external) for use with implantable neurostimulator radiofrequency receiver
L8684,"Radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management, replacement"
L8685,"Implantable neurostimulator pulse generator, single array, rechargeable, includes extension"
L8686,"Implantable neurostimulator pulse generator, single array, non-rechargeable, includes extension"
L8687,"Implantable neurostimulator pulse generator, dual array, rechargeable, includes extension"
L8688,"Implantable neurostimulator pulse generator, dual array, non-rechargeable, includes extension"
L8689,"External recharging system for battery (internal) for use with implantable neurostimulator, replacement only"
L8690,"Auditory osseointegrated device, includes all internal and external components"
L8691,"Auditory osseointegrated device, external sound processor, excludes transducer/actuator, replacement only, each"
L8692,"Auditory osseointegrated device, external sound processor, used without osseointegration, body worn, includes headband or other means of external attachment"
L8693,"Auditory osseointegrated device abutment, any length, replacement only"
L8694,"Auditory osseointegrated device, transducer/actuator, replacement only, each"
L8695,"External recharging system for battery (external) for use with implantable neurostimulator, replacement only"
L8696,"Antenna (external) for use with implantable diaphragmatic/phrenic nerve stimulation device, replacement, each"
L8698,"Miscellaneous component, supply or accessory for use with total artificial heart system"
L8699,"Prosthetic implant, not otherwise specified"
L8701,"Powered upper extremity range of motion assist device, elbow, wrist, hand with single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated"
L8702,"Powered upper extremity range of motion assist device, elbow, wrist, hand, finger, single or double upright(s), includes microprocessor, sensors, all components and accessories, custom fabricated"
L8720,"External lower extremity sensory prosthetic device, cutaneous stimulation of mechanoreceptors proximal to the ankle, per leg"
L8721,"Receptor sole for use with l8720, replacement, each"
L9900,"Orthotic and prosthetic supply, accessory, and/or service component of another hcpcs ""l"" code"
M0001,Advancing cancer care mips value pathways
M0002,Optimal care for kidney health mips value pathways
M0003,"Optimal care for patients with episodic neurological conditions mips value pathwaysTerminated December 31, 2024."
M0004,Quality care for patients with neurological conditions mips value pathway
M0005,Value in primary care mips value pathway
M0010,Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
M0064,"Brief office visit for the sole purpose of monitoring or changing drug prescriptions used in the treatment of mental psychoneurotic and personality disordersTerminated December 31, 2014."
M0075,Cellular therapy
M0076,Prolotherapy
M0100,Intragastric hypothermia using gastric freezing
M0201,"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home"
M0220,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoringTerminated December 12, 2024."
M0221,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergencyTerminated December 12, 2024."
M0222,"Intravenous injection, bebtelovimab, includes injection and post administration monitoringTerminated December 12, 2024."
M0223,"Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergencyTerminated December 12, 2024."
M0224,"Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring"
M0235,"Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, first dose"
M0236,"Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose"
M0237,"Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose"
M0238,"Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose"
M0239,"Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoringTerminated April 16, 2021."
M0240,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat dosesTerminated December 12, 2024."
M0241,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat dosesTerminated December 12, 2024."
M0243,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoringTerminated December 12, 2024."
M0244,"Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergencyTerminated December 12, 2024."
M0245,"Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoringTerminated December 13, 2023."
M0246,"Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider based to the hospital during the covid 19 public health emergencyTerminated December 13, 2023."
M0247,"Intravenous infusion, sotrovimab, includes infusion and post administration monitoringTerminated December 12, 2024."
M0248,"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergencyTerminated December 12, 2024."
M0249,"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, first dose"
M0250,"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose"
M0300,Iv chelation therapy (chemical endarterectomy)
M0301,Fabric wrapping of abdominal aneurysm
M1000,"Pain screened as moderate to severeTerminated December 31, 2019."
M1001,"Plan of care to address moderate to severe pain documented on or before the date of the second visit with a clinicianTerminated December 31, 2019."
M1002,"Plan of care for moderate to severe pain not documented on or before the date of the second visit with a clinician, reason not givenTerminated December 31, 2019."
M1003,Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
M1004,"Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)"
M1005,"Tb screening not performed or results not interpreted, reason not given"
M1006,"Disease activity not assessed, reason not given"
M1007,>=50% of total number of a patient's outpatient ra encounters assessed
M1008,<50% of total number of a patient's outpatient ra encounters assessed
M1009,Discharge/discontinuation of the episode of care documented in the medical record
M1010,Discharge/discontinuation of the episode of care documented in the medical record
M1011,Discharge/discontinuation of the episode of care documented in the medical record
M1012,Discharge/discontinuation of the episode of care documented in the medical record
M1013,Discharge/discontinuation of the episode of care documented in the medical record
M1014,Discharge/discontinuation of the episode of care documented in the medical record
M1015,"Discharge/discontinuation of the episode of care documented in the medical recordTerminated December 31, 2020."
M1016,Female patients unable to bear children
M1017,"Patient admitted to palliative care servicesTerminated December 31, 2022."
M1018,"Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients"
M1019,Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5
M1020,Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5
M1021,Patient had only urgent care visits during the performance period
M1022,"Patients who were in hospice at any time during the performance periodTerminated December 31, 2021."
M1023,"Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than fiveTerminated December 31, 2020."
M1024,"Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to fiveTerminated December 31, 2020."
M1025,"Patients who were in hospice at any time during the performance periodTerminated December 31, 2021."
M1026,"Patients who were in hospice at any time during the performance periodTerminated December 31, 2021."
M1027,Imaging of the head (ct or mri) was obtained
M1028,Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
M1029,"Imaging of the head (ct or mri) was not obtained, reason not given"
M1030,"Patients with clinical indications for imaging of the headTerminated December 31, 2019."
M1031,"Patients with no clinical indications for imaging of the headTerminated December 31, 2021."
M1032,Adults currently taking pharmacotherapy for oud
M1033,"Pharmacotherapy for oud initiated after june 30th of performance periodTerminated December 31, 2020."
M1034,Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
M1035,Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
M1036,Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
M1037,Patients with a diagnosis of lumbar spine region cancer at the time of the procedure
M1038,Patients with a diagnosis of lumbar spine region fracture at the time of the procedure
M1039,Patients with a diagnosis of lumbar spine region infection at the time of the procedure
M1040,Patients with a diagnosis of lumbar idiopathic or congenital scoliosis
M1041,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis"
M1042,"Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperativelyTerminated December 31, 2019."
M1043,Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively
M1044,"Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperativelyTerminated December 31, 2019."
M1045,"Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71"
M1046,"Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively"
M1047,"Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperativelyTerminated December 31, 2019."
M1048,"Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperativelyTerminated December 31, 2019."
M1049,Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively
M1050,"Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperativelyTerminated December 31, 2019."
M1051,"Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis"
M1052,Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively
M1053,"Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperativelyTerminated December 31, 2019."
M1054,Patient had only urgent care visits during the performance period
M1055,Aspirin or another antiplatelet therapy used
M1056,"Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease"
M1057,"Aspirin or another antiplatelet therapy not used, reason not given"
M1058,Patient was a permanent nursing home resident at any time during the performance period
M1059,Patient was in hospice or receiving palliative care at any time during the performance period
M1060,Patient died prior to the end of the performance period
M1061,"Patient pregnancyTerminated December 31, 2020."
M1062,"Patient immunocompromisedTerminated December 31, 2020."
M1063,"Patients receiving high doses of immunosuppressive therapyTerminated December 31, 2020."
M1064,"Shingrix vaccine documented as administered or previously receivedTerminated December 31, 2020."
M1065,"Shingrix vaccine was not administered for reasons documented by clinician (e.g. patient administered vaccine other than shingrix, patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)Terminated December 31, 2020."
M1066,"Shingrix vaccine not documented as administered, reason not givenTerminated December 31, 2020."
M1067,Hospice services for patient provided any time during the measurement period
M1068,Adults who are not ambulatory
M1069,Patient screened for future fall risk
M1070,"Patient not screened for future fall risk, reason not given"
M1071,"Patient had any additional spine procedures performed on the same date as the lumbar discectomy/laminotomyTerminated December 31, 2022."
M1106,The start of an episode of care documented in the medical record
M1107,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care"
M1108,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record"
M1109,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery"
M1110,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)"
M1111,The start of an episode of care documented in the medical record
M1112,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care"
M1113,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record"
M1114,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery"
M1115,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)"
M1116,The start of an episode of care documented in the medical record
M1117,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care"
M1118,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record"
M1119,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery"
M1120,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)"
M1121,The start of an episode of care documented in the medical record
M1122,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care"
M1123,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record"
M1124,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery"
M1125,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)"
M1126,The start of an episode of care documented in the medical record
M1127,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care"
M1128,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record"
M1129,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery"
M1130,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)"
M1131,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care"
M1132,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record"
M1133,"Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery"
M1134,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)"
M1135,The start of an episode of care documented in the medical record
M1136,"The start of an episode of care documented in the medical recordTerminated December 31, 2020."
M1137,"Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of careTerminated December 31, 2020."
M1138,"Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation only)Terminated December 31, 2020."
M1139,"Ongoing care not indicated, patient self-discharged early and seen only 1-2 visits (e.g., financial or insurance reasons, transportation problems, or reason unknown)Terminated December 31, 2020."
M1140,"Ongoing care not indicated, patient discharged after only 1-2 visits due to specific medical events, documented in the medical record that make the treatment episode impossible such as the patient becomes hospitalized or scheduled for surgery for surgery or hospitalizedTerminated December 31, 2020."
M1141,"Functional status was not measured by the oxford knee score (oks) or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) at one year (9 to 15 months) postoperatively"
M1142,Emergent cases
M1143,"Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment"
M1144,"Ongoing care not indicated, patient seen only 1-2 visits (e.g., home program only, referred to another provider or facility, consultation onlyTerminated December 31, 2020."
M1145,"Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier)Terminated February 27, 2022."
M1146,"Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record"
M1147,"Ongoing care not medically possible because the patient was  discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery"
M1148,"Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)"
M1149,"Patient unable to complete the neck fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility, and an adequate proxy is not available"
M1150,Current or prior left ventricular ejection fraction (lvef) less than or equal to 40% or documentation of moderately or severely depressed left ventricular systolic function
M1151,Patients with a history of heart transplant or with a left ventricular assist device (lvad)
M1152,Patients with a history of heart transplant or with a left ventricular assist device (lvad)
M1153,Patient with diagnosis of osteoporosis on date of encounter
M1154,"Hospice services provided to patient any time during the measurement periodTerminated December 31, 2024."
M1155,"Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement periodTerminated December 31, 2024."
M1156,"Patient received active chemotherapy any time during the measurement periodTerminated December 31, 2023."
M1157,"Patient received bone marrow transplant any time during the measurement periodTerminated December 31, 2023."
M1158,"Patient had history of immunocompromising conditions prior to or during the measurement periodTerminated December 31, 2023."
M1159,Hospice services provided to patient any time during the measurement period
M1160,Patient had anaphylaxis due to the meningococcal vaccine any time on or before the patient's 13th birthday
M1161,"Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday"
M1162,"Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday"
M1163,Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday
M1164,Patients with dementia any time during the patient's history through the end of the measurement period
M1165,Patients who use hospice services any time during the measurement period
M1166,Pathology report for tissue specimens produced from wide local excisions or re-excisions
M1167,In hospice or using hospice services during the measurement period
M1168,Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
M1169,"Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)"
M1170,Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
M1171,Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
M1172,"Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)"
M1173,Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
M1174,Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
M1175,"Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)"
M1176,Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
M1177,Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
M1178,"Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)"
M1179,"Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period"
M1180,Patients on immune checkpoint inhibitor therapy
M1181,Grade 2 or above diarrhea and/or grade 2 or above colitis
M1182,"Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)"
M1183,Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered
M1184,"Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)"
M1185,"Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given"
M1186,Patients who have an order for or are receiving hospice or palliative care
M1187,Patients with a diagnosis of end stage renal disease (esrd)
M1188,Patients with a diagnosis of chronic kidney disease (ckd) stage 5
M1189,Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed
M1190,Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)
M1191,Hospice services provided to patient any time during the measurement period
M1192,Patients with an existing diagnosis of squamous cell carcinoma of the esophagus
M1193,"Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both"
M1194,"Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)"
M1195,"Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given"
M1196,"Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4"
M1197,Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score
M1198,Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter
M1199,Patients receiving rrt
M1200,Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period
M1201,"Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)"
M1202,"Documentation of patient reason(s) for not prescribing ace inhibitor or arb therapy during the measurement period, (e.g., patient declined, other patient reasons)"
M1203,"Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given"
M1204,"Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4"
M1205,Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score
M1206,Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter
M1207,"Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety"
M1208,"Patient is not screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety"
M1209,"At least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses"
M1210,"At least two orders for high-risk medications from the same drug class, (table 4), not ordered"
M1211,Most recent glycemic status assessment (hba1c or gmi) level > 9.0%
M1212,"Glycemic status assessment (hba1c or gmi) level is missing, or was not performed during the measurement period"
M1213,No history of spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) and present spirometry is >= 70%
M1214,Spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and reviewed
M1215,"Documentation of medical reason(s) for not documenting and reviewing spirometry results (e.g., patients with dementia or tracheostomy)"
M1216,No spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and/or no spirometry performed with results documented during the encounter
M1217,"Documentation of system reason(s) for not documenting and reviewing spirometry results (e.g., spirometry equipment not available at the time of the encounter)"
M1218,"Patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)"
M1219,"Anaphylaxis due to the vaccine on or before the date of the encounterTerminated December 31, 2024."
M1220,Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy
M1221,Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy
M1222,"Glaucoma plan of care not documented, reason not otherwise specified"
M1223,Glaucoma plan of care documented
M1224,Intraocular pressure (iop) reduced by a value less than 20% from the pre-intervention level
M1225,Intraocular pressure (iop) reduced by a value of greater than or equal to 20% from the pre-intervention level
M1226,"Iop measurement not documented, reason not otherwise specified"
M1227,Evidence-based therapy was prescribed
M1228,"Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test"
M1229,"Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection"
M1230,"Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given"
M1231,Patient receives hcv antibody test with nonreactive result
M1232,Patient receives hcv antibody test with reactive result
M1233,"Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given"
M1234,"Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia"
M1235,Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period
M1236,Baseline mrs > 2
M1237,"Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)"
M1238,"Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)"
M1239,Patient did not respond to the question of patient felt heard and understood by this provider and team
M1240,Patient did not respond to the question of patient felt this provider and team put my best interests first when making recommendations about my care
M1241,"Patient did not respond to the question of patient felt this provider and team saw me as a person, not just someone with a medical problem"
M1242,Patient did not respond to the question of patient felt this provider and team understood what is important to me in my life
M1243,"Patient provided a response other than ""completely true"" for the question of patient felt heard and understood by this provider and team"
M1244,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team put my best interests first when making recommendations about my care"
M1245,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem"
M1246,"Patient provided a response other than ""completely true"" for the question of patient felt this provider and team understood what is important to me in my life"
M1247,"Patient responded ""completely true"" for the question of patient felt this provider and team put my best interests first when making recommendations about my care"
M1248,"Patient responded ""completely true"" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem"
M1249,"Patient responded ""completely true"" for the question of patient felt this provider and team understood what is important to me in my life"
M1250,"Patient responded as ""completely true"" for the question of patient felt heard and understood by this provider and team"
M1251,Patients for whom a proxy completed the entire hu survey on their behalf for any reason (no patient involvement)
M1252,Patients who did not complete at least one of the four patient experience hu survey items and return the hu survey within 60 days of the ambulatory palliative care visit
M1253,Patients who respond on the patient experience hu survey that they did not receive care by the listed ambulatory palliative care provider in the last 60 days (disavowal)
M1254,Patients who were deceased when the hu survey reached them
M1255,"Patients who have another reason for visiting the clinic [not prenatal or postpartum care] and have a positive pregnancy test but have not established the clinic as an ob provider (e.g., plan to terminate the pregnancy or seek prenatal services elsewhere)"
M1256,Prior history of known cvd
M1257,"Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was not documented), reason not otherwise specified"
M1258,"Cvd risk assessment performed, have a documented calculated risk score"
M1259,Patient status documented within the first year of initiating dialysis
M1260,Patient status not documented within the first year of initiating dialysis
M1261,Patients that were on the kidney or kidney-pancreas waitlist prior to initiation of dialysis
M1262,Patients who had a transplant prior to initiation of dialysis
M1263,Patients in hospice on their initiation of dialysis date or during the month of evaluation
M1264,"Patients age 75 or older on their initiation of dialysis dateTerminated December 31, 2024."
M1265,Cms medical evidence form 2728 for dialysis patients: initial form completed
M1266,Patients admitted to a skilled nursing facility (snf)
M1267,Patients not observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1268,Patients observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1269,Receiving esrd mcp dialysis services by the provider on the last day of the reporting month
M1270,Patients not on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1271,Patients with dementia at any time prior to or during the month
M1272,Patients observed on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1273,Patients who were admitted to a skilled nursing facility (snf) within one year of dialysis initiation according to the cms-2728 form
M1274,Patients who were admitted to a skilled nursing facility (snf) during the month of evaluation were excluded from that month
M1275,Patients determined to be in hospice were excluded from month of evaluation and the remainder of reporting period
M1276,"Bmi documented outside normal parameters, no follow-up plan documented, no reason given"
M1277,Colorectal cancer screening results documented and reviewed
M1278,"Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented"
M1279,"Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given"
M1280,Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy
M1281,"Blood pressure reading not documented, reason not given"
M1282,Patient screened for tobacco use and identified as a tobacco non-user
M1283,Patient screened for tobacco use and identified as a tobacco user
M1284,"Patients age 66 or older in institutional special needs plans (snp) or residing in long term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period"
M1285,"Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified"
M1286,"Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason"
M1287,Bmi is documented below normal parameters and a follow-up plan is documented
M1288,Documented reason for not screening or recommending a follow-up for high blood pressure
M1289,Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
M1290,Patient not eligible due to active diagnosis of hypertension
M1291,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
M1292,Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
M1293,Bmi is documented above normal parameters and a follow-up plan is documented
M1294,"Normal blood pressure reading documented, follow-up not required"
M1295,Patients with a diagnosis or past history of total colectomy or colorectal cancer
M1296,Bmi is documented within normal parameters and no follow-up plan is required
M1297,Bmi not documented due to medical reason or patient refusal of height or weight measurement
M1298,Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter
M1299,Influenza immunization administered or previously received
M1300,"Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)"
M1301,Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
M1302,"Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed"
M1303,Hospice services provided to patient any time during the measurement period
M1304,Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
M1305,Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
M1306,Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period
M1307,Documentation stating the patient has received or is currently receiving palliative or hospice care
M1308,"Influenza immunization was not administered, reason not given"
M1309,Palliative care services provided to patient any time during the measurement period
M1310,"Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user"
M1311,Anaphylaxis due to the vaccine on or before the date of the encounter
M1312,Patient not screened for tobacco use
M1313,Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period
M1314,Bmi not documented and no reason is given
M1315,Colorectal cancer screening results were not documented and reviewed; reason not otherwise specified
M1316,Current tobacco non-user
M1317,Patients who are counseled on connection with a csp and explicitly opt out
M1318,Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp
M1319,Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening
M1320,Patients who screened positive for at least 1 of the 5 hrsns
M1321,Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg
M1322,Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye
M1323,Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented
M1324,"Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)"
M1325,"Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)"
M1326,Patients with a diagnosis of hypotony
M1327,Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks
M1328,Patients with a diagnosis of acute vitreous hemorrhage
M1329,Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter
M1330,"Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)"
M1331,Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam
M1332,Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks
M1333,Acute vitreous hemorrhage
M1334,Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter
M1335,"Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)"
M1336,Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks
M1337,Acute pvd
M1338,Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
M1339,Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period
M1340,Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period
M1341,Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period
M1342,Patients who died during the performance period
M1343,Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses
M1344,Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score
M1345,Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam score
M1346,Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period
M1347,Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing)
M1348,Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent)
M1349,Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period
M1350,"Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter"
M1351,"Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation"
M1352,Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment
M1353,"Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter"
M1354,"Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation"
M1355,Suicide risk based on their clinician's evaluation or a clinician-rated tool
M1356,Patients who died during the measurement period
M1357,Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment
M1358,Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment
M1359,Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained
M1360,Suicidal ideation and/or behavior symptoms based on the c-ssrs
M1361,Suicide risk based on their clinician's evaluation or a clinician-rated tool
M1362,Patients who died during the measurement period
M1363,Patients who did not have a follow-up assessment within 120 days of the index assessment
M1364,Calculated 10-year ascvd risk score of >= 20 percent during the performance period
M1365,Patient encounter during the performance period with hospice and palliative care specialty code 17
M1366,Focusing on women's health mips value pathway
M1367,"Quality care for the treatment of ear, nose, and throat disorders mips value pathway"
M1368,Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway
M1369,Quality care in mental health and substance use disorders mips value pathway
M1370,Rehabilitative support for musculoskeletal care mips value pathway
M1371,Most recent glycemic status assessment (hba1c or gmi) level < 7.0%
M1372,Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%
M1373,Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%
M1374,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
M1375,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
M1376,An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
M1377,Recommended follow-up interval for repeat colonoscopy of 10 years documented  in colonoscopy report and communicated with patient
M1378,"Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)"
M1379,"A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specified"
M1380,"Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under ""denominator note"" or the long-acting injectable antipsychotic medications listed under ""denominator note"""
M1381,"Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure"
M1382,Patient encounter during the performance period with place of service code 11
M1383,Acute pvd
M1384,Patients who died during the performance period
M1385,"Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up"
M1386,"Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period"
M1387,Patients who died during the performance period
M1388,Patients with documentation of an exam performed for recurrence of melanoma
M1390,Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period
M1391,All patients who were diagnosed with recurrent melanoma during the current performance period
M1392,"Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)"
M1393,Patients who were not diagnosed with recurrent melanoma during the current performance period
M1394,Stages i-iii breast cancer
M1395,Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group
M1396,Patients on a therapeutic clinical trial
M1397,Patients with recurrence/disease progression
M1398,Patients with baseline and follow-up promis surveys documented in the medical record
M1399,Patients who leave the practice during the follow-up period
M1400,Patients who died during the follow-up period
M1401,Stages i-iii breast cancer
M1402,Patients receiving an initial chemotherapy regimen with a defined duration with the eligible clinician or group
M1403,Patients with baseline and follow-up promis surveys documented in the medical record
M1404,Patients on a therapeutic clinical trial
M1405,Patients with recurrence/disease progression
M1406,Patients who leave the practice during the follow-up period
M1407,Patients who died during the follow-up period
M1408,"Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancer"
M1409,Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis
M1410,Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis
M1411,Currently on first-line immune checkpoint inhibitors without chemotherapy
M1412,"Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement"
M1413,Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy
M1414,"Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)"
M1415,Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy
M1416,Patient received hospice services any time during the performance period
M1417,Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
M1418,Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician
M1419,Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
M1420,Complete ophthalmologic care mips value pathway
M1421,Dermatological care mips value pathway
M1422,Gastroenterology care mips value pathway
M1423,Optimal care for patients with urologic conditions mips value pathway
M1424,Pulmonology care mips value pathway
M1425,Surgical care mips value pathway
P2028,"Cephalin floculation, blood"
P2029,"Congo red, blood"
P2031,Hair analysis (excluding arsenic)
P2033,"Thymol turbidity, blood"
P2038,"Mucoprotein, blood (seromucoid) (medical necessity procedure)"
P3000,"Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision"
P3001,"Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician"
P7001,"Culture, bacterial, urine; quantitative, sensitivity study"
P9010,"Blood (whole), for transfusion, per unit"
P9011,"Blood, split unit"
P9012,"Cryoprecipitate, each unit"
P9016,"Red blood cells, leukocytes reduced, each unit"
P9017,"Fresh frozen plasma (single donor), frozen within 8 hours of collection, each unit"
P9019,"Platelets, each unit"
P9020,"Platelet rich plasma, each unit"
P9021,"Red blood cells, each unit"
P9022,"Red blood cells, washed, each unit"
P9023,"Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit"
P9025,"Plasma, cryoprecipitate reduced, pathogen reduced, each unit"
P9026,"Cryoprecipitated fibrinogen complex, pathogen reduced, each unit"
P9027,"Red blood cells, leukocytes reduced, oxygen/ carbon dioxide reduced, each unit"
P9031,"Platelets, leukocytes reduced, each unit"
P9032,"Platelets, irradiated, each unit"
P9033,"Platelets, leukocytes reduced, irradiated, each unit"
P9034,"Platelets, pheresis, each unit"
P9035,"Platelets, pheresis, leukocytes reduced, each unit"
P9036,"Platelets, pheresis, irradiated, each unit"
P9037,"Platelets, pheresis, leukocytes reduced, irradiated, each unit"
P9038,"Red blood cells, irradiated, each unit"
P9039,"Red blood cells, deglycerolized, each unit"
P9040,"Red blood cells, leukocytes reduced, irradiated, each unit"
P9041,"Infusion, albumin (human), 5%, 50 ml"
P9043,"Infusion, plasma protein fraction (human), 5%, 50 ml"
P9044,"Plasma, cryoprecipitate reduced, each unit"
P9045,"Infusion, albumin (human), 5%, 250 ml"
P9046,"Infusion, albumin (human), 25%, 20 ml"
P9047,"Infusion, albumin (human), 25%, 50 ml"
P9048,"Infusion, plasma protein fraction (human), 5%, 250 ml"
P9050,"Granulocytes, pheresis, each unit"
P9051,"Whole blood or red blood cells, leukocytes reduced, cmv-negative, each unit"
P9052,"Platelets, hla-matched leukocytes reduced, apheresis/pheresis, each unit"
P9053,"Platelets, pheresis, leukocytes reduced, cmv-negative, irradiated, each unit"
P9054,"Whole blood or red blood cells, leukocytes reduced, frozen, deglycerol, washed, each unit"
P9055,"Platelets, leukocytes reduced, cmv-negative, apheresis/pheresis, each unit"
P9056,"Whole blood, leukocytes reduced, irradiated, each unit"
P9057,"Red blood cells, frozen/deglycerolized/washed, leukocytes reduced, irradiated, each unit"
P9058,"Red blood cells, leukocytes reduced, cmv-negative, irradiated, each unit"
P9059,"Fresh frozen plasma between 8-24 hours of collection, each unit"
P9060,"Fresh frozen plasma, donor retested, each unit"
P9070,"Plasma, pooled multiple donor, pathogen reduced, frozen, each unit"
P9071,"Plasma (single donor), pathogen reduced, frozen, each unit"
P9072,"Platelets, pheresis, pathogen reduced or rapid bacterial tested, each unitTerminated December 31, 2017."
P9073,"Platelets, pheresis, pathogen-reduced, each unit"
P9099,Blood component or product not otherwise classified
P9100,Pathogen(s) test for platelets
P9603,Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled
P9604,Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge
P9612,"Catheterization for collection of specimen, single patient, all places of service"
P9615,Catheterization for collection of specimen(s) (multiple patients)
Q0035,Cardiokymography
Q0081,"Infusion therapy, using other than chemotherapeutic drugs, per visit"
Q0083,"Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit"
Q0084,"Chemotherapy administration by infusion technique only, per visit"
Q0085,"Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit"
Q0091,"Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory"
Q0092,Set-up portable x-ray equipment
Q0111,"Wet mounts, including preparations of vaginal, cervical or skin specimens"
Q0112,All potassium hydroxide (koh) preparations
Q0113,Pinworm examinations
Q0114,Fern test
Q0115,"Post-coital direct, qualitative examinations of vaginal or cervical mucous"
Q0138,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)"
Q0139,"Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis)"
Q0144,"Azithromycin dihydrate, oral, capsules/powder, 1 gram"
Q0155,"Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0161,"Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0162,"Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0163,"Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen"
Q0164,"Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0166,"Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen"
Q0167,"Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0169,"Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0173,"Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0174,"Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0175,"Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0177,"Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0180,"Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen"
Q0181,"Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen"
Q0220,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune  systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mgTerminated December 12, 2024."
Q0221,"Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 600 mgTerminated December 12, 2024."
Q0222,"Injection, bebtelovimab, 175 mgTerminated December 12, 2024."
Q0224,"Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg"
Q0235,"Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg"
Q0237,"Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg"
Q0239,"Injection, bamlanivimab-xxxx, 700 mgTerminated April 16, 2021."
Q0240,"Injection, casirivimab and imdevimab, 600 mgTerminated December 12, 2024."
Q0243,"Injection, casirivimab and imdevimab, 2400 mgTerminated December 12, 2024."
Q0244,"Injection, casirivimab and imdevimab, 1200 mgTerminated December 12, 2024."
Q0245,"Injection, bamlanivimab and etesevimab, 2100 mgTerminated December 13, 2023."
Q0247,"Injection, sotrovimab, 500 mgTerminated December 12, 2024."
Q0249,"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg"
Q0477,"Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0478,"Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type"
Q0479,"Power module for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0480,"Driver for use with pneumatic ventricular assist device, replacement only"
Q0481,"Microprocessor control unit for use with electric ventricular assist device, replacement only"
Q0482,"Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only"
Q0483,"Monitor/display module for use with electric ventricular assist device, replacement only"
Q0484,"Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0485,"Monitor control cable for use with electric ventricular assist device, replacement only"
Q0486,"Monitor control cable for use with electric/pneumatic ventricular assist device, replacement only"
Q0487,"Leads (pneumatic/electrical) for use with any type electric/pneumatic ventricular assist device, replacement only"
Q0488,"Power pack base for use with electric ventricular assist device, replacement only"
Q0489,"Power pack base for use with electric/pneumatic ventricular assist device, replacement only"
Q0490,"Emergency power source for use with electric ventricular assist device, replacement only"
Q0491,"Emergency power source for use with electric/pneumatic ventricular assist device, replacement only"
Q0492,"Emergency power supply cable for use with electric ventricular assist device, replacement only"
Q0493,"Emergency power supply cable for use with electric/pneumatic ventricular assist device, replacement only"
Q0494,"Emergency hand pump for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0495,"Battery/power pack charger for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0496,"Battery, other than lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0497,"Battery clips for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0498,"Holster for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0499,"Belt/vest/bag for use to carry external peripheral components of any type ventricular assist device, replacement only"
Q0500,"Filters for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0501,"Shower cover for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0502,"Mobility cart for pneumatic ventricular assist device, replacement only"
Q0503,"Battery for pneumatic ventricular assist device, replacement only, each"
Q0504,"Power adapter for pneumatic ventricular assist device, replacement only, vehicle type"
Q0506,"Battery, lithium-ion, for use with electric or electric/pneumatic ventricular assist device, replacement only"
Q0507,Miscellaneous supply or accessory for use with an external ventricular assist device
Q0508,Miscellaneous supply or accessory for use with an implanted ventricular assist device
Q0509,Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a
Q0510,"Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant"
Q0511,"Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period"
Q0512,"Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period"
Q0513,Pharmacy dispensing fee for inhalation drug(s); per 30 days
Q0514,Pharmacy dispensing fee for inhalation drug(s); per 90 days
Q0515,"Injection, sermorelin acetate, 1 microgram"
Q0516,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 30-daysTerminated December 31, 2024."
Q0517,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 60-daysTerminated December 31, 2024."
Q0518,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription oral drug, per 90-daysTerminated December 31, 2024."
Q0519,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 30-daysTerminated December 31, 2024."
Q0520,"Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription injectable drug, per 60-daysTerminated December 31, 2024."
Q0521,Pharmacy supplying fee for hiv pre-exposure prophylaxis fda approved prescription
Q1004,New technology intraocular lens category 4 as defined in federal register notice
Q1005,New technology intraocular lens category 5 as defined in federal register notice
Q2004,"Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml"
Q2009,"Injection, fosphenytoin, 50 mg phenytoin equivalent"
Q2017,"Injection, teniposide, 50 mg"
Q2026,"Injection, radiesse, 0.1 ml"
Q2028,"Injection, sculptra, 0.5 mg"
Q2034,"Influenza virus vaccine, split virus, for intramuscular use (agriflu)"
Q2035,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"
Q2036,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"
Q2037,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"
Q2038,"Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"
Q2039,"Influenza virus vaccine, not otherwise specified"
Q2040,"Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusionTerminated December 31, 2018."
Q2041,"Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose"
Q2042,"Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose"
Q2043,"Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion"
Q2049,"Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg"
Q2050,"Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg"
Q2052,"Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)"
Q2053,"Brexucabtagene autoleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose"
Q2054,"Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose"
Q2055,"Idecabtagene vicleucel, up to 510 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose"
Q2056,"Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose"
Q2057,"Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose"
Q2058,"Obecabtagene autoleucel, 10 up to 400 million cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion"
Q3001,"Radioelements for brachytherapy, any type, each"
Q3014,Telehealth originating site facility fee
Q3027,"Injection, interferon beta-1a, 1 mcg for intramuscular use"
Q3028,"Injection, interferon beta-1a, 1 mcg for subcutaneous use"
Q3031,Collagen skin test
Q4001,"Casting supplies, body cast adult, with or without head, plaster"
Q4002,"Cast supplies, body cast adult, with or without head, fiberglass"
Q4003,"Cast supplies, shoulder cast, adult (11 years +), plaster"
Q4004,"Cast supplies, shoulder cast, adult (11 years +), fiberglass"
Q4005,"Cast supplies, long arm cast, adult (11 years +), plaster"
Q4006,"Cast supplies, long arm cast, adult (11 years +), fiberglass"
Q4007,"Cast supplies, long arm cast, pediatric (0-10 years), plaster"
Q4008,"Cast supplies, long arm cast, pediatric (0-10 years), fiberglass"
Q4009,"Cast supplies, short arm cast, adult (11 years +), plaster"
Q4010,"Cast supplies, short arm cast, adult (11 years +), fiberglass"
Q4011,"Cast supplies, short arm cast, pediatric (0-10 years), plaster"
Q4012,"Cast supplies, short arm cast, pediatric (0-10 years), fiberglass"
Q4013,"Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster"
Q4014,"Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass"
Q4015,"Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster"
Q4016,"Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass"
Q4017,"Cast supplies, long arm splint, adult (11 years +), plaster"
Q4018,"Cast supplies, long arm splint, adult (11 years +), fiberglass"
Q4019,"Cast supplies, long arm splint, pediatric (0-10 years), plaster"
Q4020,"Cast supplies, long arm splint, pediatric (0-10 years), fiberglass"
Q4021,"Cast supplies, short arm splint, adult (11 years +), plaster"
Q4022,"Cast supplies, short arm splint, adult (11 years +), fiberglass"
Q4023,"Cast supplies, short arm splint, pediatric (0-10 years), plaster"
Q4024,"Cast supplies, short arm splint, pediatric (0-10 years), fiberglass"
Q4025,"Cast supplies, hip spica (one or both legs), adult (11 years +), plaster"
Q4026,"Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass"
Q4027,"Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster"
Q4028,"Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass"
Q4029,"Cast supplies, long leg cast, adult (11 years +), plaster"
Q4030,"Cast supplies, long leg cast, adult (11 years +), fiberglass"
Q4031,"Cast supplies, long leg cast, pediatric (0-10 years), plaster"
Q4032,"Cast supplies, long leg cast, pediatric (0-10 years), fiberglass"
Q4033,"Cast supplies, long leg cylinder cast, adult (11 years +), plaster"
Q4034,"Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass"
Q4035,"Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster"
Q4036,"Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass"
Q4037,"Cast supplies, short leg cast, adult (11 years +), plaster"
Q4038,"Cast supplies, short leg cast, adult (11 years +), fiberglass"
Q4039,"Cast supplies, short leg cast, pediatric (0-10 years), plaster"
Q4040,"Cast supplies, short leg cast, pediatric (0-10 years), fiberglass"
Q4041,"Cast supplies, long leg splint, adult (11 years +), plaster"
Q4042,"Cast supplies, long leg splint, adult (11 years +), fiberglass"
Q4043,"Cast supplies, long leg splint, pediatric (0-10 years), plaster"
Q4044,"Cast supplies, long leg splint, pediatric (0-10 years), fiberglass"
Q4045,"Cast supplies, short leg splint, adult (11 years +), plaster"
Q4046,"Cast supplies, short leg splint, adult (11 years +), fiberglass"
Q4047,"Cast supplies, short leg splint, pediatric (0-10 years), plaster"
Q4048,"Cast supplies, short leg splint, pediatric (0-10 years), fiberglass"
Q4049,"Finger splint, static"
Q4050,"Cast supplies, for unlisted types and materials of casts"
Q4051,"Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)"
Q4074,"Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms"
Q4081,"Injection, epoetin alfa, 100 units (for esrd on dialysis)"
Q4082,"Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap)"
Q4100,"Skin substitute, not otherwise specified"
Q4101,"Apligraf, per square centimeter"
Q4102,"Oasis wound matrix, per square centimeter"
Q4103,"Oasis burn matrix, per square centimeter"
Q4104,"Integra bilayer matrix wound dressing (bmwd), per square centimeter"
Q4105,"Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter"
Q4106,"Dermagraft, per square centimeter"
Q4107,"Graftjacket, per square centimeter"
Q4108,"Integra matrix, per square centimeter"
Q4110,"Primatrix, per square centimeter"
Q4111,"Gammagraft, per square centimeter"
Q4112,"Cymetra, injectable, 1 cc"
Q4113,"Graftjacket xpress, injectable, 1 cc"
Q4114,"Integra flowable wound matrix, injectable, 1 cc"
Q4115,"Alloskin, per square centimeter"
Q4116,"Alloderm, per square centimeter"
Q4117,"Hyalomatrix, per square centimeter"
Q4118,"Matristem micromatrix, 1 mg"
Q4119,"Matristem wound matrix, per square centimeterTerminated December 31, 2016."
Q4120,"Matristem burn matrix, per square centimeterTerminated December 31, 2016."
Q4121,"Theraskin, per square centimeter"
Q4122,"Dermacell, dermacell awm or dermacell awm porous, per square centimeter"
Q4123,"Alloskin rt, per square centimeter"
Q4124,"Oasis ultra tri-layer wound matrix, per square centimeter"
Q4125,"Arthroflex, per square centimeter"
Q4126,"Memoderm, dermaspan, tranzgraft or integuply, per square centimeter"
Q4127,"Talymed, per square centimeter"
Q4128,"Flex hd, or allopatch hd, per square centimeter"
Q4129,"Unite biomatrix, per square centimeterTerminated December 31, 2016."
Q4130,"Strattice tm, per square centimeter"
Q4131,"Epifix or epicord, per square centimeterTerminated December 31, 2018."
Q4132,"Grafix core and grafixpl core, per square centimeter"
Q4133,"Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter"
Q4134,"Hmatrix, per square centimeter"
Q4135,"Mediskin, per square centimeter"
Q4136,"Ez-derm, per square centimeter"
Q4137,"Amnioexcel, amnioexcel plus or biodexcel, per square centimeter"
Q4138,"Biodfence dryflex, per square centimeter"
Q4139,"Amniomatrix or biodmatrix, injectable, 1 cc"
Q4140,"Biodfence, per square centimeter"
Q4141,"Alloskin ac, per square centimeter"
Q4142,"Xcm biologic tissue matrix, per square centimeter"
Q4143,"Repriza, per square centimeter"
Q4145,"Epifix, injectable, 1 mg"
Q4146,"Tensix, per square centimeter"
Q4147,"Architect, architect px, or architect fx, extracellular matrix, per square centimeter"
Q4148,"Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter"
Q4149,"Excellagen, 0.1 cc"
Q4150,"Allowrap ds or dry, per square centimeter"
Q4151,"Amnioband or guardian, per square centimeter"
Q4152,"Dermapure, per square centimeter"
Q4153,"Dermavest and plurivest, per square centimeter"
Q4154,"Biovance, per square centimeter"
Q4155,"Neoxflo or clarixflo, 1 mg"
Q4156,"Neox 100 or clarix 100, per square centimeter"
Q4157,"Revitalon, per square centimeter"
Q4158,"Kerecis omega3, per square centimeter"
Q4159,"Affinity, per square centimeter"
Q4160,"Nushield, per square centimeter"
Q4161,"Bio-connekt wound matrix, per square centimeter"
Q4162,"Woundex flow, bioskin flow, 0.5 cc"
Q4163,"Woundex, bioskin, per square centimeter"
Q4164,"Helicoll, per square centimeter"
Q4165,"Keramatrix or kerasorb, per square centimeter"
Q4166,"Cytal, per square centimeter"
Q4167,"Truskin, per square centimeter"
Q4168,"Amnioband, 1 mg"
Q4169,"Artacent wound, per square centimeter"
Q4170,"Cygnus, per square centimeter"
Q4171,"Interfyl, 1 mg"
Q4172,"Puraply or puraply am, per square centimeterTerminated December 31, 2018."
Q4173,"Palingen or palingen xplus, per square centimeter"
Q4174,"Palingen or promatrx, 0.36 mg per 0.25 cc"
Q4175,"Miroderm, per square centimeter"
Q4176,"Neopatch or therion, per square centimeter"
Q4177,"Floweramnioflo, 0.1 cc"
Q4178,"Floweramniopatch, per square centimeter"
Q4179,"Flowerderm, per square centimeter"
Q4180,"Revita, per square centimeter"
Q4181,"Amnio wound, per square centimeter"
Q4182,"Transcyte, per square centimeter"
Q4183,"Surgigraft, per square centimeter"
Q4184,"Cellesta or cellesta duo, per square centimeter"
Q4185,Cellesta flowable amnion (25 mg per cc); per 0.5 cc
Q4186,"Epifix, per square centimeter"
Q4187,"Epicord, per square centimeter"
Q4188,"Amnioarmor, per square centimeter"
Q4189,"Artacent ac, 1 mg"
Q4190,"Artacent ac, per square centimeter"
Q4191,"Restorigin, per square centimeter"
Q4192,"Restorigin, 1 cc"
Q4193,"Coll-e-derm, per square centimeter"
Q4194,"Novachor, per square centimeter"
Q4195,"Puraply, per square centimeter"
Q4196,"Puraply am, per square centimeter"
Q4197,"Puraply xt, per square centimeter"
Q4198,"Genesis amniotic membrane, per square centimeter"
Q4199,"Cygnus matrix, per square centimeter"
Q4200,"Skin te, per square centimeter"
Q4201,"Matrion, per square centimeter"
Q4202,"Keroxx (2.5g/cc), 1cc"
Q4203,"Derma-gide, per square centimeter"
Q4204,"Xwrap, per square centimeter"
Q4205,"Membrane graft or membrane wrap, per square centimeter"
Q4206,"Fluid flow or fluid gf, 1 cc"
Q4208,"Novafix, per square cenitmeter"
Q4209,"Surgraft, per square centimeter"
Q4210,"Axolotl graft or axolotl dualgraft, per square centimeterTerminated June 30, 2024."
Q4211,"Amnion bio or axobiomembrane, per square centimeter"
Q4212,"Allogen, per cc"
Q4213,"Ascent, 0.5 mg"
Q4214,"Cellesta cord, per square centimeter"
Q4215,"Axolotl ambient or axolotl cryo, 0.1 mg"
Q4216,"Artacent cord, per square centimeter"
Q4217,"Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter"
Q4218,"Surgicord, per square centimeter"
Q4219,"Surgigraft-dual, per square centimeter"
Q4220,"Bellacell hd or surederm, per square centimeter"
Q4221,"Amniowrap2, per square centimeter"
Q4222,"Progenamatrix, per square centimeter"
Q4224,"Human health factor 10 amniotic patch (hhf10-p), per square centimeter"
Q4225,"Amniobind or dermabind tl, per square centimeter"
Q4226,"Myown skin, includes harvesting and preparation procedures, per square centimeter"
Q4227,"Amniocore, per square centimeter"
Q4228,"Bionextpatch, per square centimeterTerminated September 30, 2021."
Q4229,"Cogenex amniotic membrane, per square centimeter"
Q4230,"Cogenex flowable amnion, per 0.5 cc"
Q4231,"Corplex p, per ccTerminated March 31, 2025."
Q4232,"Corplex, per square centimeter"
Q4233,"Surfactor or nudyn, per 0.5 cc"
Q4234,"Xcellerate, per square centimeter"
Q4235,"Amniorepair or altiply, per square centimeter"
Q4236,"Carepatch, per square centimeter"
Q4237,"Cryo-cord, per square centimeter"
Q4238,"Derm-maxx, per square centimeter"
Q4239,"Amnio-maxx or amnio-maxx lite, per square centimeter"
Q4240,"Corecyte, for topical use only, per 0.5 cc"
Q4241,"Polycyte, for topical use only, per 0.5 cc"
Q4242,"Amniocyte plus, per 0.5 cc"
Q4244,"Procenta, per 200 mgTerminated March 31, 2024."
Q4245,"Amniotext, per cc"
Q4246,"Coretext or protext, per cc"
Q4247,"Amniotext patch, per square centimeter"
Q4248,"Dermacyte amniotic membrane allograft, per square centimeter"
Q4249,"Amniply, for topical use only, per square centimeter"
Q4250,"Amnioamp-mp, per square centimeter"
Q4251,"Vim, per square centimeter"
Q4252,"Vendaje, per square centimeter"
Q4253,"Zenith amniotic membrane, per square centimeter"
Q4254,"Novafix dl, per square centimeter"
Q4255,"Reguard, for topical use only, per square centimeter"
Q4256,"Mlg-complete, per square centimeter"
Q4257,"Relese, per square centimeter"
Q4258,"Enverse, per square centimeter"
Q4259,"Celera dual layer or celera dual membrane, per square centimeter"
Q4260,"Signature apatch, per square centimeter"
Q4261,"Tag, per square centimeter"
Q4262,"Dual layer impax membrane, per square centimeter"
Q4263,"Surgraft tl, per square centimeter"
Q4264,"Cocoon membrane, per square centimeter"
Q4265,"Neostim tl, per square centimeter"
Q4266,"Neostim membrane, per square centimeter"
Q4267,"Neostim dl, per square centimeter"
Q4268,"Surgraft ft, per square centimeter"
Q4269,"Surgraft xt, per square centimeter"
Q4270,"Complete sl, per square centimeter"
Q4271,"Complete ft, per square centimeter"
Q4272,"Esano a, per square centimeter"
Q4273,"Esano aaa, per square centimeter"
Q4274,"Esano ac, per square centimeter"
Q4275,"Esano aca, per square centimeter"
Q4276,"Orion, per square centimeter"
Q4277,"Woundplus membrane or e-graft, per square centimeterTerminated June 30, 2024."
Q4278,"Epieffect, per square centimeter"
Q4279,"Vendaje ac, per square centimeter"
Q4280,"Xcell amnio matrix, per square centimeter"
Q4281,"Barrera sl or barrera dl, per square centimeter"
Q4282,"Cygnus dual, per square centimeter"
Q4283,"Biovance tri-layer or biovance 3l, per square centimeter"
Q4284,"Dermabind sl, per square centimeter"
Q4285,"Nudyn dl or nudyn dl mesh, per square centimeter"
Q4286,"Nudyn sl or nudyn slw, per square centimeter"
Q4287,"Dermabind dl, per square centimeter"
Q4288,"Dermabind ch, per square centimeter"
Q4289,"Revoshield + amniotic barrier, per square centimeter"
Q4290,"Membrane wrap-hydro, per square centimeter"
Q4291,"Lamellas xt, per square centimeter"
Q4292,"Lamellas, per square centimeter"
Q4293,"Acesso dl, per square centimeter"
Q4294,"Amnio quad-core, per square centimeter"
Q4295,"Amnio tri-core amniotic, per square centimeter"
Q4296,"Rebound matrix, per square centimeter"
Q4297,"Emerge matrix, per square centimeter"
Q4298,"Amnicore pro, per square centimeter"
Q4299,"Amnicore pro+, per square centimeter"
Q4300,"Acesso tl, per square centimeter"
Q4301,"Activate matrix, per square centimeter"
Q4302,"Complete aca, per square centimeter"
Q4303,"Complete aa, per square centimeter"
Q4304,"Grafix plus, per square centimeter"
Q4305,"American amnion ac tri-layer, per square centimeter"
Q4306,"American amnion ac, per square centimeter"
Q4307,"American amnion, per square centimeter"
Q4308,"Sanopellis, per square centimeter"
Q4309,"Via matrix, per square centimeter"
Q4310,"Procenta, per 100 mg"
Q4311,"Acesso, per square centimeter"
Q4312,"Acesso ac, per square centimeter"
Q4313,"Dermabind fm, per square centimeter"
Q4314,"Reeva ft, per square cenitmeter"
Q4315,"Regenelink amniotic membrane allograft, per square centimeter"
Q4316,"Amchoplast, per square centimeter"
Q4317,"Vitograft, per square centimeter"
Q4318,"E-graft, per square centimeter"
Q4319,"Sanograft, per square centimeter"
Q4320,"Pellograft, per square centimeter"
Q4321,"Renograft, per square centimeter"
Q4322,"Caregraft, per square centimeter"
Q4323,"Alloply, per square centimeter"
Q4324,"Amniotx, per square centimeter"
Q4325,"Acapatch, per square centimeter"
Q4326,"Woundplus, per square centimeter"
Q4327,"Duoamnion, per square centimeter"
Q4328,"Most, per square centimeter"
Q4329,"Singlay, per square centimeter"
Q4330,"Total, per square centimeter"
Q4331,"Axolotl graft, per square centimeter"
Q4332,"Axolotl dualgraft, per square centimeter"
Q4333,"Ardeograft, per square centimeter"
Q4334,"Amnioplast 1, per square centimeter"
Q4335,"Amnioplast 2, per square centimeter"
Q4336,"Artacent c, per square centimeter"
Q4337,"Artacent trident, per square centimeter"
Q4338,"Artacent velos, per square centimeter"
Q4339,"Artacent vericlen, per square centimeter"
Q4340,"Simpligraft, per square centimeter"
Q4341,"Simplimax, per square centimeter"
Q4342,"Theramend, per square centimeter"
Q4343,"Dermacyte ac matrix amniotic membrane allograft, per square centimeter"
Q4344,"Tri-membrane wrap, per square centimeter"
Q4345,"Matrix hd allograft dermis, per square centimeter"
Q4346,"Shelter dm matrix, per square centimeter"
Q4347,"Rampart dl matrix, per square centimeter"
Q4348,"Sentry sl matrix, per square centimeter"
Q4349,"Mantle dl matrix, per square centimeter"
Q4350,"Palisade dm matrix, per square centimeter"
Q4351,"Enclose tl matrix, per square centimeter"
Q4352,"Overlay sl matrix, per square centimeter"
Q4353,"Xceed tl matrix, per square centimeter"
Q4354,"Palingen dual-layer membrane, per square centimeter"
Q4355,"Abiomend xplus membrane and abiomend xplus hydromembrane, per square centimeter"
Q4356,"Abiomend membrane and abiomend hydromembrane, per square centimeter"
Q4357,"Xwrap plus, per square  centimeter"
Q4358,"Xwrap dual, per square  centimeter"
Q4359,"Choriply, per square centimeter"
Q4360,"Amchoplast fd, per square centimeter"
Q4361,"Epixpress, per square centimeter"
Q4362,"Cygnus disk, per square centimeter"
Q4363,"Amnio burgeon membrane and hydromembrane, per square centimeter"
Q4364,"Amnio burgeon xplus membrane and xplus hydromembrane, per square centimeter"
Q4365,"Amnio burgeon dual-layer membrane, per square centimeter"
Q4366,"Dual layer amnio burgeon x-membrane, per square centimeter"
Q4367,"Amniocore sl, per square centimeter"
Q4368,"Amchothick, per square centimeter"
Q4369,"Amnioplast 3, per square centimeter"
Q4370,"Aeroguard, per square centimeter"
Q4371,"Neoguard, per square centimeter"
Q4372,"Amchoplast excel, per square centimeter"
Q4373,"Membrane wrap lite, per square centimeter"
Q4375,"Duograft ac, per square centimeter"
Q4376,"Duograft aa, per square centimeter"
Q4377,"Trigraft ft, per square centimeter"
Q4378,"Renew ft matrix, per square centimeter"
Q4379,"Amniodefend ft matrix, per square centimeter"
Q4380,"Advograft one, per square centimeter"
Q4382,"Advograft dual, per square centimeter"
Q4383,"Axolotl graft ultra, per square centimeter"
Q4384,"Axolotl dualgraft ultra, per square centimeter"
Q4385,"Apollo ft, per square centimeter"
Q4386,"Acesso trifaca, per square centimeter"
Q4387,"Neothelium ft, per square centimeter"
Q4388,"Neothelium 4l, per square centimeter"
Q4389,"Neothelium 4l+, per square centimeter"
Q4390,"Ascendion, per square centimeter"
Q4391,"Amnioplast double, per square centimeter"
Q4392,"Grafix duo, per square centimeter"
Q4393,"Surgraft ac, per square centimeter"
Q4394,"Surgraft aca, per square centimeter"
Q4395,"Acelagraft, per square centimeter"
Q4396,"Natalin, per square centimeter"
Q4397,"Summit aaa, per square centimeter"
Q5001,Hospice or home health care provided in patient's home/residence
Q5002,Hospice or home health care provided in assisted living facility
Q5003,Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf)
Q5004,Hospice care provided in skilled nursing facility (snf)
Q5005,Hospice care provided in inpatient hospital
Q5006,Hospice care provided in inpatient hospice facility
Q5007,Hospice care provided in long term care facility
Q5008,Hospice care provided in inpatient psychiatric facility
Q5009,Hospice or home health care provided in place not otherwise specified (nos)
Q5010,Hospice home care provided in a hospice facility
Q5098,"Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mg"
Q5099,"Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mg"
Q5100,"Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mg"
Q5101,"Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram"
Q5102,"Injection, infliximab, biosimilar, 10 mgTerminated March 31, 2018."
Q5103,"Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg"
Q5104,"Injection, infliximab-abda, biosimilar, (renflexis), 10 mg"
Q5105,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units"
Q5106,"Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units"
Q5107,"Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg"
Q5108,"Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg"
Q5109,"Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg"
Q5110,"Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram"
Q5111,"Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg"
Q5112,"Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg"
Q5113,"Injection, trastuzumab-pkrb, biosimilar, (herzuma), 10 mg"
Q5114,"Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg"
Q5115,"Injection, rituximab-abbs, biosimilar, (truxima), 10 mg"
Q5116,"Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg"
Q5117,"Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg"
Q5118,"Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg"
Q5119,"Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg"
Q5120,"Injection, pegfilgrastim-bmez (ziextenzo), biosimilar, 0.5 mg"
Q5121,"Injection, infliximab-axxq, biosimilar, (avsola), 10 mg"
Q5122,"Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg"
Q5123,"Injection, rituximab-arrx, biosimilar, (riabni), 10 mg"
Q5124,"Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg"
Q5125,"Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram"
Q5126,"Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg"
Q5127,"Injection, pegfilgrastim-fpgk (stimufend), biosimilar, 0.5 mg"
Q5128,"Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg"
Q5129,"Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg"
Q5130,"Injection, pegfilgrastim-pbbk (fylnetra), biosimilar, 0.5 mg"
Q5131,"Injection, adalimumab-aacf (idacio), biosimilar, 20 mgTerminated December 31, 2024."
Q5132,"Injection, adalimumab-afzb (abrilada), biosimilar, 10 mgTerminated December 31, 2024."
Q5133,"Injection, tocilizumab-bavi (tofidence), biosimilar, 1 mg"
Q5134,"Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg"
Q5135,"Injection, tocilizumab-aazg (tyenne), biosimilar, 1 mg"
Q5136,"Injection, denosumab-bbdz (jubbonti/wyost), biosimilar, 1 mg"
Q5137,"Injection, ustekinumab-auub (wezlana), biosimilar, subcutaneous, 1 mg"
Q5138,"Injection, ustekinumab-auub (wezlana), biosimilar, intravenous, 1 mg"
Q5139,"Injection, eculizumab-aeeb (bkemv), biosimilar, 10 mgTerminated March 31, 2025."
Q5140,"Injection, adalimumab-fkjp, biosimilar, 1 mg"
Q5141,"Injection, adalimumab-aaty, biosimilar, 1 mg"
Q5142,"Injection, adalimumab-ryvk biosimilar, 1 mg"
Q5143,"Injection, adalimumab-adbm, biosimilar, 1 mg"
Q5144,"Injection, adalimumab-aacf (idacio), biosimilar, 1 mg"
Q5145,"Injection, adalimumab-afzb (abrilada), biosimilar, 1 mg"
Q5146,"Injection, trastuzumab-strf (hercessi), biosimilar, 10 mg"
Q5147,"Injection, aflibercept-ayyh (pavblu), biosimilar, 1 mg"
Q5148,"Injection, filgrastim-txid (nypozi), biosimilar, 1 microgram"
Q5149,"Injection, aflibercept-abzv (enzeevu), biosimilar, 1 mg"
Q5150,"Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg"
Q5151,"Injection, eculizumab-aagh (epysqli), biosimilar, 2 mg"
Q5152,"Injection, eculizumab-aeeb (bkemv), biosimilar, 2 mg"
Q5153,"Injection, aflibercept-yszy (opuviz), biosimilar, 1 mg"
Q5154,"Injection, omalizumab-igec (omlyclo), biosimilar, 5 mg"
Q5155,"Injection, aflibercept-jbvf (yesafili), biosimilar, 1 mg"
Q5156,"Injection, tocilizumab-anoh (avtozma), biosimilar, 1 mg"
Q5157,"Injection, denosumab-bmwo (stoboclo/osenvelt), biosimilar, 1 mg"
Q5158,"Injection, denosumab-bnht (bomyntra/conexxence), biosimilar, 1 mg"
Q5159,"Injection, denosumab-dssb (ospomyv/xbryk), biosimilar, 1 mg"
Q9001,Assessment by chaplain services
Q9002,"Counseling, individual, by chaplain services"
Q9003,"Counseling, group, by chaplain services"
Q9004,Department of veterans affairs whole health partner services
Q9950,"Injection, sulfur hexafluoride lipid microspheres, per ml"
Q9951,"Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml"
Q9953,"Injection, iron-based magnetic resonance contrast agent, per ml"
Q9954,"Oral magnetic resonance contrast agent, per 100 ml"
Q9955,"Injection, perflexane lipid microspheres, per ml"
Q9956,"Injection, octafluoropropane microspheres, per ml"
Q9957,"Injection, perflutren lipid microspheres, per ml"
Q9958,"High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml"
Q9959,"High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml"
Q9960,"High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml"
Q9961,"High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml"
Q9962,"High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml"
Q9963,"High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml"
Q9964,"High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml"
Q9965,"Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml"
Q9966,"Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml"
Q9967,"Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml"
Q9968,"Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg"
Q9969,"Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose"
Q9970,"Injection, ferric carboxymaltose, 1mgTerminated December 31, 2014."
Q9972,"Injection, epoetin beta, 1 microgram, (for esrd on dialysis)Terminated December 31, 2014."
Q9973,"Injection, epoetin beta, 1 microgram, (non-esrd use)Terminated December 31, 2014."
Q9974,"Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mgTerminated December 31, 2014."
Q9975,"Injection, factor viii fc fusion protein (recombinant), per iuTerminated December 31, 2015."
Q9976,"Injection, ferric pyrophosphate citrate solution, 0.1 mg of ironTerminated December 31, 2015."
Q9977,"Compounded drug, not otherwise classifiedTerminated December 31, 2015."
Q9978,"Netupitant 300 mg and palonosetron 0.5 mgTerminated December 31, 2015."
Q9979,"Injection, alemtuzumab, 1 mgTerminated December 31, 2015."
Q9980,"Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mgTerminated December 31, 2016."
Q9981,"Rolapitant, oral, 1 mgTerminated December 31, 2016."
Q9982,"Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries"
Q9983,"Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries"
Q9984,"Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mgTerminated December 31, 2017."
Q9985,"Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mgTerminated December 31, 2017."
Q9986,"Injection, hydroxyprogesterone caproate, (makena), 10 mgTerminated December 31, 2017."
Q9987,"Pathogen(s) test for plateletsTerminated December 31, 2017."
Q9988,"Platelets, pheresis, pathogen-reduced, each unitTerminated December 31, 2017."
Q9989,"Ustekinumab, for intravenous injection, 1 mgTerminated December 31, 2017."
Q9991,"Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg"
Q9992,"Injection, buprenorphine extended-release (sublocade), greater than 100 mg"
Q9993,"Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mgTerminated December 31, 2018."
Q9994,"In-line cartridge containing digestive enzyme(s) for enteral feeding, eachTerminated December 31, 2018."
Q9995,"Injection, emicizumab-kxwh, 0.5 mgTerminated December 31, 2018."
Q9996,"Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg"
Q9997,"Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg"
Q9998,"Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg"
Q9999,"Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg"
R0070,"Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen"
R0075,"Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, more than one patient seen"
R0076,"Transportation of portable ekg to facility or location, per patient"
S0012,"Butorphanol tartrate, nasal spray, 25 mg"
S0013,"Esketamine, nasal spray, 1 mg"
S0014,"Tacrine hydrochloride, 10 mg"
S0017,"Injection, aminocaproic acid, 5 gramsTerminated March 31, 2025."
S0020,"Injection, bupivicaine hydrochloride, 30 mlTerminated June 30, 2023."
S0021,"Injection, cefoperazone sodium, 1 gram"
S0023,"Injection, cimetidine hydrochloride, 300 mg"
S0028,"Injection, famotidine, 20 mgTerminated March 31, 2025."
S0030,"Injection, metronidazole, 500 mgTerminated June 30, 2023."
S0032,"Injection, nafcillin sodium, 2 gramsTerminated March 31, 2025."
S0034,"Injection, ofloxacin, 400 mg"
S0039,"Injection, sulfamethoxazole and trimethoprim, 10 mlTerminated March 31, 2025."
S0040,"Injection, ticarcillin disodium and clavulanate potassium, 3.1 grams"
S0073,"Injection, aztreonam, 500 mgTerminated June 30, 2023."
S0074,"Injection, cefotetan disodium, 500 mgTerminated September 30, 2025."
S0077,"Injection, clindamycin phosphate, 300 mgTerminated June 30, 2023."
S0078,"Injection, fosphenytoin sodium, 750 mg"
S0080,"Injection, pentamidine isethionate, 300 mg"
S0081,"Injection, piperacillin sodium, 500 mg"
S0088,"Imatinib, 100 mg"
S0090,"Sildenafil citrate, 25 mg"
S0091,"Granisetron hydrochloride, 1 mg (for circumstances falling under the medicare statute, use q0166)"
S0092,"Injection, hydromorphone hydrochloride, 250 mg (loading dose for infusion pump)"
S0093,"Injection, morphine sulfate, 500 mg (loading dose for infusion pump)"
S0104,"Zidovudine, oral, 100 mg"
S0106,"Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets"
S0108,"Mercaptopurine, oral, 50 mg"
S0109,"Methadone, oral, 5 mg"
S0117,"Tretinoin, topical, 5 grams"
S0119,"Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)"
S0122,"Injection, menotropins, 75 iu"
S0126,"Injection, follitropin alfa, 75 iu"
S0128,"Injection, follitropin beta, 75 iu"
S0132,"Injection, ganirelix acetate, 250 mcg"
S0136,"Clozapine, 25 mg"
S0137,"Didanosine (ddi), 25 mg"
S0138,"Finasteride, 5 mg"
S0139,"Minoxidil, 10 mg"
S0140,"Saquinavir, 200 mg"
S0142,"Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg"
S0144,"Injection, propofol, 10 mgTerminated December 31, 2014."
S0145,"Injection, pegylated interferon alfa-2a, 180 mcg per ml"
S0148,"Injection, pegylated interferon alfa-2b, 10 mcg"
S0155,"Sterile dilutant for epoprostenol, 50 ml"
S0156,"Exemestane, 25 mg"
S0157,"Becaplermin gel 0.01%, 0.5 gm"
S0160,"Dextroamphetamine sulfate, 5 mg"
S0164,"Injection, pantoprazole sodium, 40 mgTerminated June 30, 2024."
S0166,"Injection, olanzapine, 2.5 mgTerminated September 30, 2023."
S0169,"Calcitrol, 0.25 microgram"
S0170,"Anastrozole, oral, 1 mg"
S0171,"Injection, bumetanide, 0.5 mgTerminated December 31, 2023."
S0172,"Chlorambucil, oral, 2 mg"
S0174,"Dolasetron mesylate, oral 50 mg (for circumstances falling under the medicare statute, use q0180)"
S0175,"Flutamide, oral, 125 mg"
S0176,"Hydroxyurea, oral, 500 mg"
S0177,"Levamisole hydrochloride, oral, 50 mg"
S0178,"Lomustine, oral, 10 mg"
S0179,"Megestrol acetate, oral, 20 mg"
S0182,"Procarbazine hydrochloride, oral, 50 mg"
S0183,"Prochlorperazine maleate, oral, 5 mg (for circumstances falling under the medicare statute, use q0164)"
S0187,"Tamoxifen citrate, oral, 10 mg"
S0189,"Testosterone pellet, 75 mg"
S0190,"Mifepristone, oral, 200 mg"
S0191,"Misoprostol, oral, 200 mcg"
S0194,"Dialysis/stress vitamin supplement, oral, 100 capsules"
S0195,"Pneumococcal conjugate vaccine, polyvalent, intramuscular, for children from five years to nine years of age who have not previously received the vaccineTerminated December 31, 2015."
S0197,"Prenatal vitamins, 30-day supply"
S0199,"Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs"
S0201,"Partial hospitalization services, less than 24 hours, per diem"
S0207,"Paramedic intercept, non-hospital-based als service (non-voluntary), non-transport"
S0208,"Paramedic intercept, hospital-based als service (non-voluntary), non-transport"
S0209,"Wheelchair van, mileage, per mile"
S0215,"Non-emergency transportation; mileage, per mile"
S0220,Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 30 minutes
S0221,Medical conference by a physician with interdisciplinary team of health professionals or representatives of community agencies to coordinate activities of patient care (patient is present); approximately 60 minutes
S0250,Comprehensive geriatric assessment and treatment planning performed by assessment team
S0255,"Hospice referral visit (advising patient and family of care options) performed by nurse, social worker, or other designated staff"
S0257,"Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service)"
S0260,History and physical (outpatient or office) related to surgical procedure (list separately in addition to code for appropriate evaluation and management service)
S0265,"Genetic counseling, under physician supervision, each 15 minutes"
S0270,"Physician management of patient home care, standard monthly case rate (per 30 days)"
S0271,"Physician management of patient home care, hospice monthly case rate (per 30 days)"
S0272,"Physician management of patient home care, episodic care monthly case rate (per 30 days)"
S0273,"Physician visit at member's home, outside of a capitation arrangement"
S0274,"Nurse practitioner visit at member's home, outside of a capitation arrangement"
S0280,"Medical home program, comprehensive care coordination and planning, initial plan"
S0281,"Medical home program, comprehensive care coordination and planning, maintenance of plan"
S0285,Colonoscopy consultation performed prior to a screening colonoscopy procedure
S0302,Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service)
S0310,Hospitalist services (list separately in addition to code for appropriate evaluation and management service)
S0311,"Comprehensive management and care coordination for advanced illness, per calendar month"
S0315,Disease management program; initial assessment and initiation of the program
S0316,"Disease management program, follow-up/reassessment"
S0317,Disease management program; per diem
S0320,Telephone calls by a registered nurse to a disease management program member for monitoring purposes; per month
S0340,"Lifestyle modification program for management of coronary artery disease, including all supportive services; first quarter / stage"
S0341,"Lifestyle modification program for management of coronary artery disease, including all supportive services; second or third quarter / stage"
S0342,"Lifestyle modification program for management of coronary artery disease, including all supportive services; fourth quarter / stage"
S0353,"Treatment planning and care coordination management for cancer, initial treatment"
S0354,"Treatment planning and care coordination management for cancer, established patient with a change of regimen"
S0390,"Routine foot care; removal and/or trimming of corns, calluses and/or nails and preventive maintenance in specific medical conditions (e.g., diabetes), per visit"
S0395,Impression casting of a foot performed by a practitioner other than the manufacturer of the orthotic
S0400,Global fee for extracorporeal shock wave lithotripsy treatment of kidney stone(s)
S0500,"Disposable contact lens, per lens"
S0504,"Single vision prescription lens (safety, athletic, or sunglass), per lens"
S0506,"Bifocal vision prescription lens (safety, athletic, or sunglass), per lens"
S0508,"Trifocal vision prescription lens (safety, athletic, or sunglass), per lens"
S0510,"Non-prescription lens (safety, athletic, or sunglass), per lens"
S0512,"Daily wear specialty contact lens, per lens"
S0514,"Color contact lens, per lens"
S0515,"Scleral lens, liquid bandage device, per lens"
S0516,Safety eyeglass frames
S0518,Sunglasses frames
S0580,Polycarbonate lens (list this code in addition to the basic code for the lens)
S0581,Nonstandard lens (list this code in addition to the basic code for the lens)
S0590,"Integral lens service, miscellaneous services reported separately"
S0592,Comprehensive contact lens evaluation
S0595,Dispensing new spectacle lenses for patient supplied frame
S0596,Phakic intraocular lens for correction of refractive error
S0601,Screening proctoscopy
S0610,"Annual gynecological examination, new patient"
S0612,"Annual gynecological examination, established patient"
S0613,Annual gynecological examination; clinical breast examination without pelvic evaluation
S0618,Audiometry for hearing aid evaluation to determine the level and degree of hearing loss
S0620,Routine ophthalmological examination including refraction; new patient
S0621,Routine ophthalmological examination including refraction; established patient
S0622,"Physical exam for college, new or established patient (list separately in addition to appropriate evaluation and management code)"
S0630,Removal of sutures; by a physician other than the physician who originally closed the wound
S0800,Laser in situ keratomileusis (lasik)
S0810,Photorefractive keratectomy (prk)
S0812,Phototherapeutic keratectomy (ptk)
S1001,"Deluxe item, patient aware (list in addition to code for basic item)"
S1002,Customized item (list in addition to code for basic item)
S1015,Iv tubing extension set
S1016,"Non-pvc (polyvinyl chloride) intravenous administration set, for use with drugs that are not stable in pvc e.g., paclitaxel"
S1030,"Continuous noninvasive glucose monitoring device, purchase (for physician interpretation of data, use cpt code)"
S1031,"Continuous noninvasive glucose monitoring device, rental, including sensor, sensor replacement, and download to monitor (for physician interpretation of data, use cpt code)"
S1034,"Artificial pancreas device system (e.g., low glucose suspend (lgs) feature) including continuous glucose monitor, blood glucose device, insulin pump and computer algorithm that communicates with all of the devices"
S1035,"Sensor; invasive (e.g., subcutaneous), disposable, for use with artificial pancreas device system"
S1036,"Transmitter; external, for use with artificial pancreas device system"
S1037,"Receiver (monitor); external, for use with artificial pancreas device system"
S1040,"Cranial remolding orthosis, pediatric, rigid, with soft interface material, custom fabricated, includes fitting and adjustment(s)"
S1090,"Mometasone furoate sinus implant, 370 microgramsTerminated September 30, 2019."
S1091,"Stent, non-coronary, temporary, with delivery system (propel)"
S2053,Transplantation of small intestine and liver allografts
S2054,Transplantation of multivisceral organs
S2055,"Harvesting of donor multivisceral organs, with preparation and maintenance of allografts; from cadaver donor"
S2060,Lobar lung transplantation
S2061,"Donor lobectomy (lung) for transplantation, living donor"
S2065,Simultaneous pancreas kidney transplantation
S2066,"Breast reconstruction with gluteal artery perforator (gap) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral"
S2067,"Breast reconstruction of a single breast with ""stacked"" deep inferior epigastric perforator (diep) flap(s) and/or gluteal artery perforator (gap) flap(s), including harvesting of the flap(s), microvascular transfer, closure of donor site(s) and shaping the flap into a breast, unilateral"
S2068,"Breast reconstruction with deep inferior epigastric perforator (diep) flap or superficial inferior epigastric artery (siea) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral"
S2070,"Cystourethroscopy, with ureteroscopy and/or pyeloscopy; with endoscopic laser treatment of ureteral calculi (includes ureteral catheterization)"
S2079,Laparoscopic esophagomyotomy (heller type)
S2080,Laser-assisted uvulopalatoplasty (laup)
S2083,Adjustment of gastric band diameter via subcutaneous port by injection or aspiration of saline
S2095,"Transcatheter occlusion or embolization for tumor destruction, percutaneous, any method, using yttrium-90 microspheres"
S2102,Islet cell tissue transplant from pancreas; allogeneic
S2103,Adrenal tissue transplant to brain
S2107,"Adoptive immunotherapy i.e. development of specific anti-tumor reactivity (e.g., tumor-infiltrating lymphocyte therapy) per course of treatment"
S2112,"Arthroscopy, knee, surgical for harvesting of cartilage (chondrocyte cells)"
S2115,"Osteotomy, periacetabular, with internal fixation"
S2117,"Arthroereisis, subtalar"
S2118,"Metal-on-metal total hip resurfacing, including acetabular and femoral components"
S2120,Low density lipoprotein (ldl) apheresis using heparin-induced extracorporeal ldl precipitation
S2140,"Cord blood harvesting for transplantation, allogeneic"
S2142,"Cord blood-derived stem-cell transplantation, allogeneic"
S2150,"Bone marrow or blood-derived stem cells (peripheral or umbilical), allogeneic or autologous, harvesting, transplantation, and related complications; including: pheresis and cell preparation/storage; marrow ablative therapy; drugs, supplies, hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services; and the number of days of pre-and post-transplant care in the global definition"
S2152,"Solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurement, transplantation, and related complications; including: drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services, and the number of days of pre- and post-transplant care in the global definition"
S2202,Echosclerotherapy
S2205,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), single coronary arterial graft"
S2206,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using arterial graft(s), two coronary arterial grafts"
S2207,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using venous graft only, single coronary venous graft"
S2208,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using single arterial and venous graft(s), single venous graft"
S2209,"Minimally invasive direct coronary artery bypass surgery involving mini-thoracotomy or mini-sternotomy surgery, performed under direct vision; using two arterial grafts and single venous graft"
S2225,"Myringotomy, laser-assisted"
S2230,Implantation of magnetic component of semi-implantable hearing device on ossicles in middle ear
S2235,Implantation of auditory brain stem implant
S2260,"Induced abortion, 17 to 24 weeks"
S2265,"Induced abortion, 25 to 28 weeks"
S2266,"Induced abortion, 29 to 31 weeks"
S2267,"Induced abortion, 32 weeks or greater"
S2300,"Arthroscopy, shoulder, surgical; with thermally-induced capsulorrhaphy"
S2325,Hip core decompression
S2340,Chemodenervation of abductor muscle(s) of vocal cord
S2341,Chemodenervation of adductor muscle(s) of vocal cord
S2342,"Nasal endoscopy for post-operative debridement following functional endoscopic sinus surgery, nasal and/or sinus cavity(s), unilateral or bilateral"
S2348,"Decompression procedure, percutaneous, of nucleus pulposus of intervertebral disc, using radiofrequency energy, single or multiple levels, lumbar"
S2350,"Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, single interspace"
S2351,"Diskectomy, anterior, with decompression of spinal cord and/or nerve root(s), including osteophytectomy; lumbar, each additional interspace (list separately in addition to code for primary procedure)"
S2360,"Percutaneous vertebroplasty, one vertebral body, unilateral or bilateral injection; cervicalTerminated December 31, 2015."
S2361,"Each additional cervical vertebral body (list separately in addition to code for primary procedure)Terminated December 31, 2015."
S2400,"Repair, congenital diaphragmatic hernia in the fetus using temporary tracheal occlusion, procedure performed in utero"
S2401,"Repair, urinary tract obstruction in the fetus, procedure performed in utero"
S2402,"Repair, congenital cystic adenomatoid malformation in the fetus, procedure performed in utero"
S2403,"Repair, extralobar pulmonary sequestration in the fetus, procedure performed in utero"
S2404,"Repair, myelomeningocele in the fetus, procedure performed in utero"
S2405,"Repair of sacrococcygeal teratoma in the fetus, procedure performed in utero"
S2409,"Repair, congenital malformation of fetus, procedure performed in utero, not otherwise classified"
S2411,Fetoscopic laser therapy for treatment of twin-to-twin transfusion syndrome
S2900,Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)
S3000,"Diabetic indicator; retinal eye exam, dilated, bilateral"
S3005,"Performance measurement, evaluation of patient self assessment, depression"
S3600,Stat laboratory request (situations other than s3601)
S3601,Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility
S3620,"Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis;  hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)"
S3630,"Eosinophil count, blood, direct"
S3645,Hiv-1 antibody testing of oral mucosal transudate
S3650,"Saliva test, hormone level; during menopause"
S3652,"Saliva test, hormone level; to assess preterm labor risk"
S3655,Antisperm antibodies test (immunobead)
S3708,Gastrointestinal fat absorption study
S3721,"Prostate cancer antigen 3 (pca3) testingTerminated December 31, 2015."
S3722,"Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil"
S3800,Genetic testing for amyotrophic lateral sclerosis (als)
S3840,Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
S3841,Genetic testing for retinoblastoma
S3842,Genetic testing for von hippel-lindau disease
S3844,"Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness"
S3845,Genetic testing for alpha-thalassemia
S3846,Genetic testing for hemoglobin e beta-thalassemia
S3849,Genetic testing for niemann-pick disease
S3850,Genetic testing for sickle cell anemia
S3852,Dna analysis for apoe epsilon 4 allele for susceptibility to alzheimer's disease
S3853,Genetic testing for myotonic muscular dystrophy
S3854,Gene expression profiling panel for use in the management of breast cancer treatment
S3855,"Genetic testing for detection of mutations in the presenilin - 1 geneTerminated December 31, 2014."
S3861,"Genetic testing, sodium channel, voltage-gated, type v, alpha subunit (scn5a) and variants for suspected brugada syndrome"
S3865,Comprehensive gene sequence analysis for hypertrophic cardiomyopathy
S3866,Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (hcm) in an individual with a known hcm mutation in the family
S3870,"Comparative genomic hybridization (cgh) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability"
S3890,"Dna analysis, fecal, for colorectal cancer screeningTerminated December 31, 2015."
S3900,Surface electromyography (emg)
S3902,Ballistocardiogram
S3904,Masters two step
S4005,Interim labor facility global (labor occurring but not resulting in delivery)
S4011,"In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development"
S4013,"Complete cycle, gamete intrafallopian transfer (gift), case rate"
S4014,"Complete cycle, zygote intrafallopian transfer (zift), case rate"
S4015,"Complete in vitro fertilization cycle, not otherwise specified, case rate"
S4016,"Frozen in vitro fertilization cycle, case rate"
S4017,"Incomplete cycle, treatment cancelled prior to stimulation, case rate"
S4018,"Frozen embryo transfer procedure cancelled before transfer, case rate"
S4020,"In vitro fertilization procedure cancelled before aspiration, case rate"
S4021,"In vitro fertilization procedure cancelled after aspiration, case rate"
S4022,"Assisted oocyte fertilization, case rate"
S4023,"Donor egg cycle, incomplete, case rate"
S4024,"Air polymer-type a intrauterine foam, per study dose"
S4025,"Donor services for in vitro fertilization (sperm or embryo), case rate"
S4026,Procurement of donor sperm from sperm bank
S4027,Storage of previously frozen embryos
S4028,Microsurgical epididymal sperm aspiration (mesa)
S4030,Sperm procurement and cryopreservation services; initial visit
S4031,Sperm procurement and cryopreservation services; subsequent visit
S4035,"Stimulated intrauterine insemination (iui), case rate"
S4037,"Cryopreserved embryo transfer, case rate"
S4040,"Monitoring and storage of cryopreserved embryos, per 30 days"
S4042,"Management of ovulation induction (interpretation of diagnostic tests and studies, non-face-to-face medical management of the patient), per cycle"
S4981,Insertion of levonorgestrel-releasing intrauterine system
S4988,"Penile contracture device, manual, greater than 3 lbs traction forceTerminated March 31, 2025."
S4989,"Contraceptive intrauterine device (e.g., progestacert iud), including implants and supplies"
S4990,"Nicotine patches, legend"
S4991,"Nicotine patches, non-legend"
S4993,Contraceptive pills for birth control
S4995,Smoking cessation gum
S5000,"Prescription drug, generic"
S5001,"Prescription drug, brand name"
S5010,"5% dextrose and 0.45% normal saline, 1000 ml"
S5011,"5% dextrose in lactated ringer's, 1000 mlTerminated December 31, 2015."
S5012,"5% dextrose with potassium chloride, 1000 ml"
S5013,"5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1000 ml"
S5014,"5% dextrose/0.45% normal saline with potassium chloride and magnesium sulfate, 1500 ml"
S5035,"Home infusion therapy, routine service of infusion device (e.g., pump maintenance)"
S5036,"Home infusion therapy, repair of infusion device (e.g., pump repair)"
S5100,"Day care services, adult; per 15 minutes"
S5101,"Day care services, adult; per half day"
S5102,"Day care services, adult; per diem"
S5105,"Day care services, center-based; services not included in program fee, per diem"
S5108,"Home care training to home care client, per 15 minutes"
S5109,"Home care training to home care client, per session"
S5110,"Home care training, family; per 15 minutes"
S5111,"Home care training, family; per session"
S5115,"Home care training, non-family; per 15 minutes"
S5116,"Home care training, non-family; per session"
S5120,Chore services; per 15 minutes
S5121,Chore services; per diem
S5125,Attendant care services; per 15 minutes
S5126,Attendant care services; per diem
S5130,"Homemaker service, nos; per 15 minutes"
S5131,"Homemaker service, nos; per diem"
S5135,"Companion care, adult (e.g., iadl/adl); per 15 minutes"
S5136,"Companion care, adult (e.g., iadl/adl); per diem"
S5140,"Foster care, adult; per diem"
S5141,"Foster care, adult; per month"
S5145,"Foster care, therapeutic, child; per diem"
S5146,"Foster care, therapeutic, child; per month"
S5150,"Unskilled respite care, not hospice; per 15 minutes"
S5151,"Unskilled respite care, not hospice; per diem"
S5160,Emergency response system; installation and testing
S5161,"Emergency response system; service fee, per month (excludes installation and testing)"
S5162,Emergency response system; purchase only
S5165,Home modifications; per service
S5170,"Home delivered meals, including preparation; per meal"
S5175,"Laundry service, external, professional; per order"
S5180,"Home health respiratory therapy, initial evaluation"
S5181,"Home health respiratory therapy, nos, per diem"
S5185,"Medication reminder service, non-face-to-face; per month"
S5190,"Wellness assessment, performed by non-physician"
S5199,"Personal care item, nos, each"
S5497,"Home infusion therapy, catheter care / maintenance, not otherwise classified; includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S5498,"Home infusion therapy, catheter care / maintenance, simple (single lumen), includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem"
S5501,"Home infusion therapy, catheter care / maintenance, complex (more than one lumen), includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S5502,"Home infusion therapy, catheter care / maintenance, implanted access device, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (use this code for interim maintenance of vascular access not currently in use)"
S5517,"Home infusion therapy, all supplies necessary for restoration of catheter patency or declotting"
S5518,"Home infusion therapy, all supplies necessary for catheter repair"
S5520,"Home infusion therapy, all supplies (including catheter) necessary for a peripherally inserted central venous catheter (picc) line insertion"
S5521,"Home infusion therapy, all supplies (including catheter) necessary for a midline catheter insertion"
S5522,"Home infusion therapy, insertion of peripherally inserted central venous catheter (picc), nursing services only (no supplies or catheter included)"
S5523,"Home infusion therapy, insertion of midline venous catheter, nursing services only (no supplies or catheter included)"
S5550,"Insulin, rapid onset, 5 units"
S5551,"Insulin, most rapid onset (lispro or aspart); 5 units"
S5552,"Insulin, intermediate acting (nph or lente); 5 units"
S5553,"Insulin, long acting; 5 units"
S5560,"Insulin delivery device, reusable pen; 1.5 ml size"
S5561,"Insulin delivery device, reusable pen; 3 ml size"
S5565,Insulin cartridge for use in insulin delivery device other than pump; 150 units
S5566,Insulin cartridge for use in insulin delivery device other than pump; 300 units
S5570,"Insulin delivery device, disposable pen (including insulin); 1.5 ml size"
S5571,"Insulin delivery device, disposable pen (including insulin); 3 ml size"
S8030,Scleral application of tantalum ring(s) for localization of lesions for proton beam therapy
S8032,"Low-dose computed tomography for lung cancer screeningTerminated September 30, 2016."
S8035,Magnetic source imaging
S8037,Magnetic resonance cholangiopancreatography (mrcp)
S8040,Topographic brain mapping
S8042,"Magnetic resonance imaging (mri), low-field"
S8055,"Ultrasound guidance for multifetal pregnancy reduction(s), technical component (only to be used when the physician doing the reduction procedure does not perform the ultrasound, guidance is included in the cpt code for multifetal pregnancy reduction - 59866)"
S8080,"Scintimammography (radioimmunoscintigraphy of the breast), unilateral, including supply of radiopharmaceutical"
S8085,Fluorine-18 fluorodeoxyglucose (f-18 fdg) imaging using dual-head coincidence detection system (non-dedicated pet scan)
S8092,"Electron beam computed tomography (also known as ultrafast ct, cine ct)"
S8096,Portable peak flow meter
S8097,"Asthma kit (including but not limited to portable peak expiratory flow meter, instructional video, brochure, and/or spacer)"
S8100,Holding chamber or spacer for use with an inhaler or nebulizer; without mask
S8101,Holding chamber or spacer for use with an inhaler or nebulizer; with mask
S8110,Peak expiratory flow rate (physician services)
S8120,"Oxygen contents, gaseous, 1 unit equals 1 cubic foot"
S8121,"Oxygen contents, liquid, 1 unit equals 1 pound"
S8130,"Interferential current stimulator, 2 channel"
S8131,"Interferential current stimulator, 4 channel"
S8185,Flutter device
S8186,Swivel adapter
S8189,"Tracheostomy supply, not otherwise classified"
S8210,Mucus trap
S8262,"Mandibular orthopedic repositioning device, eachTerminated June 30, 2015."
S8265,Haberman feeder for cleft lip/palate
S8270,"Enuresis alarm, using auditory buzzer and/or vibration device"
S8301,"Infection control supplies, not otherwise specified"
S8415,Supplies for home delivery of infant
S8420,"Gradient pressure aid (sleeve and glove combination), custom made"
S8421,"Gradient pressure aid (sleeve and glove combination), ready made"
S8422,"Gradient pressure aid (sleeve), custom made, medium weight"
S8423,"Gradient pressure aid (sleeve), custom made, heavy weight"
S8424,"Gradient pressure aid (sleeve), ready made"
S8425,"Gradient pressure aid (glove), custom made, medium weight"
S8426,"Gradient pressure aid (glove), custom made, heavy weight"
S8427,"Gradient pressure aid (glove), ready made"
S8428,"Gradient pressure aid (gauntlet), ready made"
S8429,Gradient pressure exterior wrap
S8430,"Padding for compression bandage, roll"
S8431,"Compression bandage, roll"
S8450,"Splint, prefabricated, digit (specify digit by use of modifier)"
S8451,"Splint, prefabricated, wrist or ankle"
S8452,"Splint, prefabricated, elbow"
S8460,"Camisole, post-mastectomy"
S8490,"Insulin syringes (100 syringes, any size)"
S8930,Electrical stimulation of auricular acupuncture points; each 15 minutes of personal one-on-one contact with the patient
S8940,"Equestrian/hippotherapy, per session"
S8948,Application of a modality (requiring constant provider attendance) to one or more areas; low-level laser; each 15 minutes
S8950,"Complex lymphedema therapy, each 15 minutes"
S8990,Physical or manipulative therapy performed for maintenance rather than restoration
S8999,Resuscitation bag (for use by patient on artificial respiration during power failure or other catastrophic event)
S9001,Home uterine monitor with or without associated nursing services
S9002,"Intra-vaginal motion sensor system, provides biofeedback for pelvic floor muscle rehabilitation device"
S9007,Ultrafiltration monitor
S9015,"Automated eeg monitoringTerminated December 31, 2015."
S9024,Paranasal sinus ultrasound
S9025,Omnicardiogram/cardiointegram
S9034,"Extracorporeal shockwave lithotripsy for gall stones (if performed with ercp, use 43265)"
S9055,Procuren or other growth factor preparation to promote wound healing
S9056,Coma stimulation per diem
S9061,"Home administration of aerosolized drug therapy (e.g., pentamidine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9083,Global fee urgent care centers
S9088,Services provided in an urgent care center (list in addition to code for service)
S9090,"Vertebral axial decompression, per session"
S9097,Home visit for wound care
S9098,"Home visit, phototherapy services (e.g., bili-lite), including equipment rental, nursing services, blood draw, supplies, and other services, per diem"
S9110,"Telemonitoring of patient in their home, including all necessary equipment; computer system, connections, and software; maintenance; patient education and support; per month"
S9117,"Back school, per visit"
S9122,"Home health aide or certified nurse assistant, providing care in the home; per hour"
S9123,"Nursing care, in the home; by registered nurse, per hour (use for general nursing care only, not to be used when cpt codes 99500-99602 can be used)"
S9124,"Nursing care, in the home; by licensed practical nurse, per hour"
S9125,"Respite care, in the home, per diem"
S9126,"Hospice care, in the home, per diem"
S9127,"Social work visit, in the home, per diem"
S9128,"Speech therapy, in the home, per diem"
S9129,"Occupational therapy, in the home, per diem"
S9131,"Physical therapy; in the home, per diem"
S9140,"Diabetic management program, follow-up visit to non-md provider"
S9141,"Diabetic management program, follow-up visit to md provider"
S9145,"Insulin pump initiation, instruction in initial use of pump (pump not included)"
S9150,Evaluation by ocularist
S9152,"Speech therapy, re-evaluation"
S9208,"Home management of preterm labor, including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)"
S9209,"Home management of preterm premature rupture of membranes (pprom), including administrative services, professional pharmacy services, care coordination, and all necessary supplies or equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)"
S9211,"Home management of gestational hypertension, includes administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)"
S9212,"Home management of postpartum hypertension, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with any home infusion per diem code)"
S9213,"Home management of preeclampsia, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately); per diem (do not use this code with any home infusion per diem code)"
S9214,"Home management of gestational diabetes, includes administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately); per diem (do not use this code with any home infusion per diem code)"
S9325,"Home infusion therapy, pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment, (drugs and nursing visits coded separately), per diem (do not use this code with s9326, s9327 or s9328)"
S9326,"Home infusion therapy, continuous (twenty-four hours or more) pain management infusion; administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9327,"Home infusion therapy, intermittent (less than twenty-four hours) pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9328,"Home infusion therapy, implanted pump pain management infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9329,"Home infusion therapy, chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with s9330 or s9331)"
S9330,"Home infusion therapy, continuous (twenty-four hours or more) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9331,"Home infusion therapy, intermittent (less than twenty-four hours) chemotherapy infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9335,"Home therapy, hemodialysis; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing services coded separately), per diem"
S9336,"Home infusion therapy, continuous anticoagulant infusion therapy (e.g., heparin), administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9338,"Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9339,"Home therapy; peritoneal dialysis, administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9340,"Home therapy; enteral nutrition; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem"
S9341,"Home therapy; enteral nutrition via gravity; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem"
S9342,"Home therapy; enteral nutrition via pump; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem"
S9343,"Home therapy; enteral nutrition via bolus; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (enteral formula and nursing visits coded separately), per diem"
S9345,"Home infusion therapy, anti-hemophilic agent infusion therapy (e.g., factor viii); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9346,"Home infusion therapy, alpha-1-proteinase inhibitor (e.g., prolastin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9347,"Home infusion therapy, uninterrupted, long-term, controlled rate intravenous or subcutaneous infusion therapy (e.g., epoprostenol); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9348,"Home infusion therapy, sympathomimetic/inotropic agent infusion therapy (e.g., dobutamine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9349,"Home infusion therapy, tocolytic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9351,"Home infusion therapy, continuous or intermittent anti-emetic infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and visits coded separately), per diem"
S9353,"Home infusion therapy, continuous insulin infusion therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9355,"Home infusion therapy, chelation therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9357,"Home infusion therapy, enzyme replacement intravenous therapy; (e.g., imiglucerase); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9359,"Home infusion therapy, anti-tumor necrosis factor intravenous therapy; (e.g., infliximab); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9361,"Home infusion therapy, diuretic intravenous therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9363,"Home infusion therapy, anti-spasmotic therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9364,"Home infusion therapy, total parenteral nutrition (tpn); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem (do not use with home infusion codes s9365-s9368 using daily volume scales)"
S9365,"Home infusion therapy, total parenteral nutrition (tpn); one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem"
S9366,"Home infusion therapy, total parenteral nutrition (tpn); more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem"
S9367,"Home infusion therapy, total parenteral nutrition (tpn); more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem"
S9368,"Home infusion therapy, total parenteral nutrition (tpn); more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment including standard tpn formula (lipids, specialty amino acid formulas, drugs other than in standard formula and nursing visits coded separately), per diem"
S9370,"Home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9372,"Home therapy; intermittent anticoagulant injection therapy (e.g., heparin); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code for flushing of infusion devices with heparin to maintain patency)"
S9373,"Home infusion therapy, hydration therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use with hydration therapy codes s9374-s9377 using daily volume scales)"
S9374,"Home infusion therapy, hydration therapy; one liter per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9375,"Home infusion therapy, hydration therapy; more than one liter but no more than two liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9376,"Home infusion therapy, hydration therapy; more than two liters but no more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9377,"Home infusion therapy, hydration therapy; more than three liters per day, administrative services, professional pharmacy services, care coordination, and all necessary supplies (drugs and nursing visits coded separately), per diem"
S9379,"Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9381,"Delivery or service to high risk areas requiring escort or extra protection, per visit"
S9401,"Anticoagulation clinic, inclusive of all services except laboratory tests, per session"
S9430,Pharmacy compounding and dispensing services
S9432,Medical foods for non-inborn errors of metabolism
S9433,"Medical food nutritionally complete, administered orally, providing 100% of nutritional intake"
S9434,Modified solid food supplements for inborn errors of metabolism
S9435,Medical foods for inborn errors of metabolism
S9436,"Childbirth preparation/lamaze classes, non-physician provider, per session"
S9437,"Childbirth refresher classes, non-physician provider, per session"
S9438,"Cesarean birth classes, non-physician provider, per session"
S9439,"Vbac (vaginal birth after cesarean) classes, non-physician provider, per session"
S9441,"Asthma education, non-physician provider, per session"
S9442,"Birthing classes, non-physician provider, per session"
S9443,"Lactation classes, non-physician provider, per session"
S9444,"Parenting classes, non-physician provider, per session"
S9445,"Patient education, not otherwise classified, non-physician provider, individual, per session"
S9446,"Patient education, not otherwise classified, non-physician provider, group, per session"
S9447,"Infant safety (including cpr) classes, non-physician provider, per session"
S9449,"Weight management classes, non-physician provider, per session"
S9451,"Exercise classes, non-physician provider, per session"
S9452,"Nutrition classes, non-physician provider, per session"
S9453,"Smoking cessation classes, non-physician provider, per session"
S9454,"Stress management classes, non-physician provider, per session"
S9455,"Diabetic management program, group session"
S9460,"Diabetic management program, nurse visit"
S9465,"Diabetic management program, dietitian visit"
S9470,"Nutritional counseling, dietitian visit"
S9472,"Cardiac rehabilitation program, non-physician provider, per diem"
S9473,"Pulmonary rehabilitation program, non-physician provider, per diem"
S9474,"Enterostomal therapy by a registered nurse certified in enterostomal therapy, per diem"
S9475,"Ambulatory setting substance abuse treatment or detoxification services, per diem"
S9476,"Vestibular rehabilitation program, non-physician provider, per diem"
S9480,"Intensive outpatient psychiatric services, per diem"
S9482,"Family stabilization services, per 15 minutes"
S9484,"Crisis intervention mental health services, per hour"
S9485,"Crisis intervention mental health services, per diem"
S9490,"Home infusion therapy, corticosteroid infusion; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9494,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem (do not use this code with home infusion codes for hourly dosing schedules s9497-s9504)"
S9497,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 3 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9500,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9501,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 12 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9502,"Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 8 hours, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9503,"Home infusion therapy, antibiotic, antiviral, or antifungal; once every 6 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9504,"Home infusion therapy, antibiotic, antiviral, or antifungal; once every 4 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9529,"Routine venipuncture for collection of specimen(s), single home bound, nursing home, or skilled nursing facility patient"
S9537,"Home therapy; hematopoietic hormone injection therapy (e.g., erythropoietin, g-csf, gm-csf); administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9538,"Home transfusion of blood product(s); administrative services, professional pharmacy services, care coordination and all necessary supplies and equipment (blood products, drugs, and nursing visits coded separately), per diem"
S9542,"Home injectable therapy, not otherwise classified, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9558,"Home injectable therapy; growth hormone, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9559,"Home injectable therapy, interferon, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9560,"Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9562,"Home injectable therapy, palivizumab or other monoclonal antibody for rsv, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9563,"Home injectable therapy, immunotherapy, including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9590,"Home therapy, irrigation therapy (e.g., sterile irrigation of an organ or anatomical cavity); including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem"
S9810,"Home therapy; professional pharmacy services for provision of infusion, specialty drug administration, and/or disease state management, not otherwise classified, per hour (do not use this code with any per diem code)"
S9900,"Services by a journal-listed christian science practitioner for the purpose of healing, per diem"
S9901,"Services by a journal-listed christian science nurse, per hour"
S9960,"Ambulance service, conventional air service, nonemergency transport, one way (fixed wing)"
S9961,"Ambulance service, conventional air service, nonemergency transport, one way (rotary wing)"
S9970,"Health club membership, annual"
S9975,"Transplant related lodging, meals and transportation, per diem"
S9976,"Lodging, per diem, not otherwise classified"
S9977,"Meals, per diem, not otherwise specified"
S9981,"Medical records copying fee, administrative"
S9982,"Medical records copying fee, per page"
S9986,Not medically necessary service (patient is aware that service not medically necessary)
S9988,Services provided as part of a phase i clinical trial
S9989,Services provided outside of the united states of america (list in addition to code(s) for service(s))
S9990,Services provided as part of a phase ii clinical trial
S9991,Services provided as part of a phase iii clinical trial
S9992,"Transportation costs to and from trial location and local transportation costs (e.g., fares for taxicab or bus) for clinical trial participant and one caregiver/companion"
S9994,"Lodging costs (e.g., hotel charges) for clinical trial participant and one caregiver/companion"
S9996,Meals for clinical trial participant and one caregiver/companion
S9999,Sales tax
T1000,"Private duty / independent nursing service(s) - licensed, up to 15 minutes"
T1001,Nursing assessment / evaluation
T1002,"Rn services, up to 15 minutes"
T1003,"Lpn/lvn services, up to 15 minutes"
T1004,"Services of a qualified nursing aide, up to 15 minutes"
T1005,"Respite care services, up to 15 minutes"
T1006,"Alcohol and/or substance abuse services, family/couple counseling"
T1007,"Alcohol and/or substance abuse services, treatment plan development and/or modification"
T1009,Child sitting services for children of the individual receiving alcohol and/or substance abuse services
T1010,Meals for individuals receiving alcohol and/or substance abuse services (when meals not included in the program)
T1012,"Alcohol and/or substance abuse services, skills development"
T1013,"Sign language or oral interpretive services, per 15 minutes"
T1014,"Telehealth transmission, per minute, professional services bill separately"
T1015,"Clinic visit/encounter, all-inclusive"
T1016,"Case management, each 15 minutes"
T1017,"Targeted case management, each 15 minutes"
T1018,"School-based individualized education program (iep) services, bundled"
T1019,"Personal care services, per 15 minutes, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)"
T1020,"Personal care services, per diem, not for an inpatient or resident of a hospital, nursing facility, icf/mr or imd, part of the individualized plan of treatment (code may not be used to identify services provided by home health aide or certified nurse assistant)"
T1021,"Home health aide or certified nurse assistant, per visit"
T1022,"Contracted home health agency services, all services provided under contract, per day"
T1023,"Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter"
T1024,"Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter"
T1025,"Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per diem"
T1026,"Intensive, extended multidisciplinary services provided in a clinic setting to children with complex medical, physical, mental and psychosocial impairments, per hour"
T1027,"Family training and counseling for child development, per 15 minutes"
T1028,"Assessment of home, physical and family environment, to determine suitability to meet patient's medical needs"
T1029,"Comprehensive environmental lead investigation, not including laboratory analysis, per dwelling"
T1030,"Nursing care, in the home, by registered nurse, per diem"
T1031,"Nursing care, in the home, by licensed practical nurse, per diem"
T1032,"Services performed by a doula birth worker, per 15 minutes"
T1033,"Services performed by a doula birth worker, per diem"
T1040,"Medicaid certified community behavioral health clinic services, per diem"
T1041,"Medicaid certified community behavioral health clinic services, per month"
T1502,"Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit"
T1503,"Administration of medication, other than oral and/or injectable, by a health care agency/professional, per visit"
T1505,"Electronic medication compliance management device, includes all components and accessories, not otherwise classified"
T1999,"Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in ""remarks"""
T2001,Non-emergency transportation; patient attendant/escort
T2002,Non-emergency transportation; per diem
T2003,Non-emergency transportation; encounter/trip
T2004,"Non-emergency transport; commercial carrier, multi-pass"
T2005,Non-emergency transportation; stretcher van
T2007,"Transportation waiting time, air ambulance and non-emergency vehicle, one-half (1/2) hour increments"
T2010,"Preadmission screening and resident review (pasrr) level i identification screening, per screen"
T2011,"Preadmission screening and resident review (pasrr) level ii evaluation, per evaluation"
T2012,"Habilitation, educational; waiver, per diem"
T2013,"Habilitation, educational, waiver; per hour"
T2014,"Habilitation, prevocational, waiver; per diem"
T2015,"Habilitation, prevocational, waiver; per hour"
T2016,"Habilitation, residential, waiver; per diem"
T2017,"Habilitation, residential, waiver; 15 minutes"
T2018,"Habilitation, supported employment, waiver; per diem"
T2019,"Habilitation, supported employment, waiver; per 15 minutes"
T2020,"Day habilitation, waiver; per diem"
T2021,"Day habilitation, waiver; per 15 minutes"
T2022,"Case management, per month"
T2023,Targeted case management; per month
T2024,"Service assessment/plan of care development, waiver"
T2025,Waiver services; not otherwise specified (nos)
T2026,"Specialized childcare, waiver; per diem"
T2027,"Specialized childcare, waiver; per 15 minutes"
T2028,"Specialized supply, not otherwise specified, waiver"
T2029,"Specialized medical equipment, not otherwise specified, waiver"
T2030,"Assisted living, waiver; per month"
T2031,"Assisted living; waiver, per diem"
T2032,"Residential care, not otherwise specified (nos), waiver; per month"
T2033,"Residential care, not otherwise specified (nos), waiver; per diem"
T2034,"Crisis intervention, waiver; per diem"
T2035,"Utility services to support medical equipment and assistive technology/devices, waiver"
T2036,"Therapeutic camping, overnight, waiver; each session"
T2037,"Therapeutic camping, day, waiver; each session"
T2038,"Community transition, waiver; per service"
T2039,"Vehicle modifications, waiver; per service"
T2040,"Financial management, self-directed, waiver; per 15 minutes"
T2041,"Supports brokerage, self-directed, waiver; per 15 minutes"
T2042,Hospice routine home care; per diem
T2043,Hospice continuous home care; per hour
T2044,Hospice inpatient respite care; per diem
T2045,Hospice general inpatient care; per diem
T2046,"Hospice long term care, room and board only; per diem"
T2047,"Habilitation, prevocational, waiver; per 15 minutes"
T2048,"Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem"
T2049,"Non-emergency transportation; stretcher van, mileage; per mile"
T2050,"Financial management, self-directed, waiver; per diem"
T2051,"Supports brokerage, self-directed, waiver; per diem"
T2101,"Human breast milk processing, storage and distribution only"
T4521,"Adult sized disposable incontinence product, brief/diaper, small, each"
T4522,"Adult sized disposable incontinence product, brief/diaper, medium, each"
T4523,"Adult sized disposable incontinence product, brief/diaper, large, each"
T4524,"Adult sized disposable incontinence product, brief/diaper, extra large, each"
T4525,"Adult sized disposable incontinence product, protective underwear/pull-on, small size, each"
T4526,"Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each"
T4527,"Adult sized disposable incontinence product, protective underwear/pull-on, large size, each"
T4528,"Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each"
T4529,"Pediatric sized disposable incontinence product, brief/diaper, small/medium size, each"
T4530,"Pediatric sized disposable incontinence product, brief/diaper, large size, each"
T4531,"Pediatric sized disposable incontinence product, protective underwear/pull-on, small/medium size, each"
T4532,"Pediatric sized disposable incontinence product, protective underwear/pull-on, large size, each"
T4533,"Youth sized disposable incontinence product, brief/diaper, each"
T4534,"Youth sized disposable incontinence product, protective underwear/pull-on, each"
T4535,"Disposable liner/shield/guard/pad/undergarment, for incontinence, each"
T4536,"Incontinence product, protective underwear/pull-on, reusable, any size, each"
T4537,"Incontinence product, protective underpad, reusable, bed size, each"
T4538,"Diaper service, reusable diaper, each diaper"
T4539,"Incontinence product, diaper/brief, reusable, any size, each"
T4540,"Incontinence product, protective underpad, reusable, chair size, each"
T4541,"Incontinence product, disposable underpad, large, each"
T4542,"Incontinence product, disposable underpad, small size, each"
T4543,"Adult sized disposable incontinence product, protective brief/diaper, above extra large, each"
T4544,"Adult sized disposable incontinence product, protective underwear/pull-on, above extra large, each"
T4545,"Incontinence product, disposable, penile wrap, each"
T5001,Positioning seat for persons with special orthopedic needs
T5999,"Supply, not otherwise specified"
U0001,Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel
U0002,"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc"
U0003,"Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by  cms-2020-01-rTerminated May 11, 2023."
U0004,"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-rTerminated May 11, 2023."
U0005,"Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2Terminated May 11, 2023."
V2020,"Frames, purchases"
V2025,Deluxe frame
V2100,"Sphere, single vision, plano to plus or minus 4.00, per lens"
V2101,"Sphere, single vision, plus or minus 4.12 to plus or minus 7.00d, per lens"
V2102,"Sphere, single vision, plus or minus 7.12 to plus or minus 20.00d, per lens"
V2103,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens"
V2104,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens"
V2105,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens"
V2106,"Spherocylinder, single vision, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens"
V2107,"Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00 sphere, .12 to 2.00d cylinder, per lens"
V2108,"Spherocylinder, single vision, plus or minus 4.25d to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens"
V2109,"Spherocylinder, single vision, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens"
V2110,"Spherocylinder, single vision, plus or minus 4.25 to 7.00d sphere, over 6.00d cylinder, per lens"
V2111,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens"
V2112,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25d to 4.00d cylinder, per lens"
V2113,"Spherocylinder, single vision, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens"
V2114,"Spherocylinder, single vision, sphere over plus or minus 12.00d, per lens"
V2115,"Lenticular, (myodisc), per lens, single vision"
V2118,"Aniseikonic lens, single vision"
V2121,"Lenticular lens, per lens, single"
V2199,"Not otherwise classified, single vision lens"
V2200,"Sphere, bifocal, plano to plus or minus 4.00d, per lens"
V2201,"Sphere, bifocal, plus or minus 4.12 to plus or minus 7.00d, per lens"
V2202,"Sphere, bifocal, plus or minus 7.12 to plus or minus 20.00d, per lens"
V2203,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens"
V2204,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens"
V2205,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00d cylinder, per lens"
V2206,"Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens"
V2207,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere,.12 to 2.00d cylinder, per lens"
V2208,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens"
V2209,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens"
V2210,"Spherocylinder, bifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens"
V2211,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens"
V2212,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens"
V2213,"Spherocylinder, bifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens"
V2214,"Spherocylinder, bifocal, sphere over plus or minus 12.00d, per lens"
V2215,"Lenticular (myodisc), per lens, bifocal"
V2218,"Aniseikonic, per lens, bifocal"
V2219,Bifocal seg width over 28 mm
V2220,Bifocal add over 3.25d
V2221,"Lenticular lens, per lens, bifocal"
V2299,Specialty bifocal (by report)
V2300,"Sphere, trifocal, plano to plus or minus 4.00d, per lens"
V2301,"Sphere, trifocal, plus or minus 4.12 to plus or minus 7.00d, per lens"
V2302,"Sphere, trifocal, plus or minus 7.12 to plus or minus 20.00, per lens"
V2303,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens"
V2304,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 2.25-4.00d cylinder, per lens"
V2305,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, 4.25 to 6.00 cylinder, per lens"
V2306,"Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, over 6.00d cylinder, per lens"
V2307,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, .12 to 2.00d cylinder, per lens"
V2308,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 2.12 to 4.00d cylinder, per lens"
V2309,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, 4.25 to 6.00d cylinder, per lens"
V2310,"Spherocylinder, trifocal, plus or minus 4.25 to plus or minus 7.00d sphere, over 6.00d cylinder, per lens"
V2311,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, .25 to 2.25d cylinder, per lens"
V2312,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 2.25 to 4.00d cylinder, per lens"
V2313,"Spherocylinder, trifocal, plus or minus 7.25 to plus or minus 12.00d sphere, 4.25 to 6.00d cylinder, per lens"
V2314,"Spherocylinder, trifocal, sphere over plus or minus 12.00d, per lens"
V2315,"Lenticular, (myodisc), per lens, trifocal"
V2318,"Aniseikonic lens, trifocal"
V2319,Trifocal seg width over 28 mm
V2320,Trifocal add over 3.25d
V2321,"Lenticular lens, per lens, trifocal"
V2399,Specialty trifocal (by report)
V2410,"Variable asphericity lens, single vision, full field, glass or plastic, per lens"
V2430,"Variable asphericity lens, bifocal, full field, glass or plastic, per lens"
V2499,"Variable sphericity lens, other type"
V2500,"Contact lens, pmma, spherical, per lens"
V2501,"Contact lens, pmma, toric or prism ballast, per lens"
V2502,"Contact lens, pmma, bifocal, per lens"
V2503,"Contact lens, pmma, color vision deficiency, per lens"
V2510,"Contact lens, gas permeable, spherical, per lens"
V2511,"Contact lens, gas permeable, toric, prism ballast, per lens"
V2512,"Contact lens, gas permeable, bifocal, per lens"
V2513,"Contact lens, gas permeable, extended wear, per lens"
V2520,"Contact lens, hydrophilic, spherical, per lens"
V2521,"Contact lens, hydrophilic, toric, or prism ballast, per lens"
V2522,"Contact lens, hydrophilic, bifocal, per lens"
V2523,"Contact lens, hydrophilic, extended wear, per lens"
V2524,"Contact lens, hydrophilic, spherical, photochromic additive, per lens"
V2525,"Contact lens, hydrophilic, dual focus, per lens"
V2526,"Contact lens, hydrophilic, with blue-violet filter, per lens"
V2530,"Contact lens, scleral, gas impermeable, per lens (for contact lens modification, see 92325)"
V2531,"Contact lens, scleral, gas permeable, per lens (for contact lens modification, see 92325)"
V2599,"Contact lens, other type"
V2600,Hand held low vision aids and other nonspectacle mounted aids
V2610,Single lens spectacle mounted low vision aids
V2615,"Telescopic and other compound lens system, including distance vision telescopic, near vision telescopes and compound microscopic lens system"
V2623,"Prosthetic eye, plastic, custom"
V2624,Polishing/resurfacing of ocular prosthesis
V2625,Enlargement of ocular prosthesis
V2626,Reduction of ocular prosthesis
V2627,Scleral cover shell
V2628,Fabrication and fitting of ocular conformer
V2629,"Prosthetic eye, other type"
V2630,Anterior chamber intraocular lens
V2631,Iris supported intraocular lens
V2632,Posterior chamber intraocular lens
V2700,"Balance lens, per lens"
V2702,Deluxe lens feature
V2710,"Slab off prism, glass or plastic, per lens"
V2715,"Prism, per lens"
V2718,"Press-on lens, fresnell prism, per lens"
V2730,"Special base curve, glass or plastic, per lens"
V2744,"Tint, photochromatic, per lens"
V2745,"Addition to lens; tint, any color, solid, gradient or equal, excludes photochromatic, any lens material, per lens"
V2750,"Anti-reflective coating, per lens"
V2755,"U-v lens, per lens"
V2756,Eye glass case
V2760,"Scratch resistant coating, per lens"
V2761,"Mirror coating, any type, solid, gradient or equal, any lens material, per lens"
V2762,"Polarization, any lens material, per lens"
V2770,"Occluder lens, per lens"
V2780,"Oversize lens, per lens"
V2781,"Progressive lens, per lens"
V2782,"Lens, index 1.54 to 1.65 plastic or 1.60 to 1.79 glass, excludes polycarbonate, per lens"
V2783,"Lens, index greater than or equal to 1.66 plastic or greater than or equal to 1.80 glass, excludes polycarbonate, per lens"
V2784,"Lens, polycarbonate or equal, any index, per lens"
V2785,"Processing, preserving and transporting corneal tissue"
V2786,"Specialty occupational multifocal lens, per lens"
V2787,Astigmatism correcting function of intraocular lens
V2788,Presbyopia correcting function of intraocular lens
V2790,"Amniotic membrane for surgical reconstruction, per procedure"
V2797,"Vision supply, accessory and/or service component of another hcpcs vision code"
V2799,"Vision item or service, miscellaneous"
V5008,Hearing screening
V5010,Assessment for hearing aid
V5011,Fitting/orientation/checking of hearing aid
V5014,Repair/modification of a hearing aid
V5020,Conformity evaluation
V5030,"Hearing aid, monaural, body worn, air conduction"
V5040,"Hearing aid, monaural, body worn, bone conduction"
V5050,"Hearing aid, monaural, in the ear"
V5060,"Hearing aid, monaural, behind the ear"
V5070,"Glasses, air conduction"
V5080,"Glasses, bone conduction"
V5090,"Dispensing fee, unspecified hearing aid"
V5095,Semi-implantable middle ear hearing prosthesis
V5100,"Hearing aid, bilateral, body worn"
V5110,"Dispensing fee, bilateral"
V5120,"Binaural, body"
V5130,"Binaural, in the ear"
V5140,"Binaural, behind the ear"
V5150,"Binaural, glasses"
V5160,"Dispensing fee, binaural"
V5170,"Hearing aid, cros, in the earTerminated December 31, 2018."
V5171,"Hearing aid, contralateral routing device, monaural, in the ear (ite)"
V5172,"Hearing aid, contralateral routing device, monaural, in the canal (itc)"
V5180,"Hearing aid, cros, behind the earTerminated December 31, 2018."
V5181,"Hearing aid, contralateral routing device, monaural, behind the ear (bte)"
V5190,"Hearing aid, contralateral routing, monaural, glasses"
V5200,"Dispensing fee, contralateral, monaural"
V5210,"Hearing aid, bicros, in the earTerminated December 31, 2018."
V5211,"Hearing aid, contralateral routing system, binaural, ite/ite"
V5212,"Hearing aid, contralateral routing system, binaural, ite/itc"
V5213,"Hearing aid, contralateral routing system, binaural, ite/bte"
V5214,"Hearing aid, contralateral routing system, binaural, itc/itc"
V5215,"Hearing aid, contralateral routing system, binaural, itc/bte"
V5220,"Hearing aid, bicros, behind the earTerminated December 31, 2018."
V5221,"Hearing aid, contralateral routing system, binaural, bte/bte"
V5230,"Hearing aid, contralateral routing system, binaural, glasses"
V5240,"Dispensing fee, contralateral routing system, binaural"
V5241,"Dispensing fee, monaural hearing aid, any type"
V5242,"Hearing aid, analog, monaural, cic (completely in the ear canal)"
V5243,"Hearing aid, analog, monaural, itc (in the canal)"
V5244,"Hearing aid, digitally programmable analog, monaural, cic"
V5245,"Hearing aid, digitally programmable, analog, monaural, itc"
V5246,"Hearing aid, digitally programmable analog, monaural, ite (in the ear)"
V5247,"Hearing aid, digitally programmable analog, monaural, bte (behind the ear)"
V5248,"Hearing aid, analog, binaural, cic"
V5249,"Hearing aid, analog, binaural, itc"
V5250,"Hearing aid, digitally programmable analog, binaural, cic"
V5251,"Hearing aid, digitally programmable analog, binaural, itc"
V5252,"Hearing aid, digitally programmable, binaural, ite"
V5253,"Hearing aid, digitally programmable, binaural, bte"
V5254,"Hearing aid, digital, monaural, cic"
V5255,"Hearing aid, digital, monaural, itc"
V5256,"Hearing aid, digital, monaural, ite"
V5257,"Hearing aid, digital, monaural, bte"
V5258,"Hearing aid, digital, binaural, cic"
V5259,"Hearing aid, digital, binaural, itc"
V5260,"Hearing aid, digital, binaural, ite"
V5261,"Hearing aid, digital, binaural, bte"
V5262,"Hearing aid, disposable, any type, monaural"
V5263,"Hearing aid, disposable, any type, binaural"
V5264,"Ear mold/insert, not disposable, any type"
V5265,"Ear mold/insert, disposable, any type"
V5266,Battery for use in hearing device
V5267,"Hearing aid or assistive listening device/supplies/accessories, not otherwise specified"
V5268,"Assistive listening device, telephone amplifier, any type"
V5269,"Assistive listening device, alerting, any type"
V5270,"Assistive listening device, television amplifier, any type"
V5271,"Assistive listening device, television caption decoder"
V5272,"Assistive listening device, tdd"
V5273,"Assistive listening device, for use with cochlear implant"
V5274,"Assistive listening device, not otherwise specified"
V5275,"Ear impression, each"
V5281,"Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type"
V5282,"Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type"
V5283,"Assistive listening device, personal fm/dm neck, loop induction receiver"
V5284,"Assistive listening device, personal fm/dm, ear level receiver"
V5285,"Assistive listening device, personal fm/dm, direct audio input receiver"
V5286,"Assistive listening device, personal blue tooth fm/dm receiver"
V5287,"Assistive listening device, personal fm/dm receiver, not otherwise specified"
V5288,"Assistive listening device, personal fm/dm transmitter assistive listening device"
V5289,"Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type"
V5290,"Assistive listening device, transmitter microphone, any type"
V5298,"Hearing aid, not otherwise classified"
V5299,"Hearing service, miscellaneous"
V5336,Repair/modification of augmentative communicative system or device (excludes adaptive hearing aid)
V5362,Speech screening
V5363,Language screening
V5364,Dysphagia screening
